data_2cqp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cqp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.865 0.277 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.4 m -92.07 117.39 29.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . 0.446 ' CD1' ' HB1' ' A' ' 973' ' ' ALA . 50.8 mm -96.45 127.31 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 974' ' ' PHE . 96.5 mt -105.54 148.09 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.406 ' N ' HG21 ' A' ' 928' ' ' ILE . 17.2 mtpp -113.15 124.39 52.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.43 130.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.08 170.46 16.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.79 50.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.493 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 3.3 mtm -117.04 132.56 23.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 167.81 23.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.73 2.287 . . . . 0.0 112.379 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.38 -29.88 70.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.5 p -59.28 -26.8 65.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.163 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 78.8 t -50.78 141.07 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 21.3 m -143.66 168.21 20.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.96 -42.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.96 -45.53 92.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.15 -43.24 99.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.0 -49.51 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.4 mt -56.21 -41.44 75.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.83 -31.46 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.456 ' CD2' ' CD1' ' A' ' 992' ' ' ILE . 11.9 t80 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -91.9 17.3 9.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -52.21 151.89 3.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 89.69 -39.01 3.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -95.08 144.15 25.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.04 100.72 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.02 125.6 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . 0.472 ' CG2' ' HD2' ' A' ' 953' ' ' PRO . 53.1 mt -55.81 138.38 70.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.582 0.706 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 952' ' ' ILE . 54.0 Cg_endo -69.69 138.82 38.95 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.29 -9.03 22.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 60.5 p -63.61 -56.8 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 81.1 t -41.32 100.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -113.8 110.23 19.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.98 132.51 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.07 138.12 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -126.32 156.75 39.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 965' ' ' MET . 2.9 m-80 -67.95 -178.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.01 -34.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -72.41 -36.36 68.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 128.61 -14.05 6.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.43 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.447 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 29.7 mmt -66.5 157.04 84.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 129.55 17.79 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.4 p -92.51 5.8 49.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.4 23.96 77.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -123.9 145.89 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.35 152.78 34.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 10.1 mtm -127.03 143.69 51.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 2.7 m -137.6 163.61 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 927' ' ' ILE . . . -127.91 155.85 43.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 928' ' ' ILE . 42.1 m-85 -138.05 138.38 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.73 -31.28 64.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.9 t -117.57 130.05 56.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -63.21 -40.75 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . 0.451 ' OD1' ' CD ' ' A' ' 979' ' ' GLU . 0.5 OUTLIER -57.92 -40.04 79.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . 0.451 ' CD ' ' OD1' ' A' ' 978' ' ' ASP . 0.2 OUTLIER -67.29 -45.73 75.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.56 -48.8 79.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' THR . . . . . 0.403 HG23 ' CD1' ' A' ' 985' ' ' ILE . 4.0 m -63.35 -43.99 96.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.84 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.58 99.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 988' ' ' ASN . 92.9 t -61.84 -48.82 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . 0.403 ' CD1' HG23 ' A' ' 981' ' ' THR . 21.5 mt -65.0 -41.69 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.96 -24.18 59.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 66.1 mt -116.79 20.65 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.1 t-20 -80.64 120.54 24.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.8 t70 73.33 39.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -83.49 128.66 63.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 0.0 110.852 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 87.72 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.456 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 10.7 mt -85.98 123.28 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.71 -94.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 40.9 t -129.48 -3.15 4.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 0.0 110.797 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -133.49 156.61 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -87.29 143.31 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.493 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.4 m -101.12 151.04 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -115.22 125.2 53.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 48.7 mt -111.05 129.51 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.4 t -132.18 138.82 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.22 142.17 45.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.871 0.28 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.42 125.29 37.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.67 125.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.565 HD11 ' CE1' ' A' ' 974' ' ' PHE . 86.9 mt -109.61 143.04 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.437 ' N ' HG21 ' A' ' 928' ' ' ILE . 3.5 mppt? -112.19 127.87 56.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 999' ' ' LEU . 40.6 t -108.21 128.62 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.457 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -133.67 169.77 16.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.75 47.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.459 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 10.7 mtm -114.9 134.27 22.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.521 0.676 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 174.22 9.75 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.89 -26.02 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.5 p -62.52 -31.43 72.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 88.6 t -45.64 151.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 19.1 m -158.19 172.53 18.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.9 mt -57.95 -41.86 81.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.156 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.17 -44.34 95.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.33 -43.45 90.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.08 -48.24 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -57.76 -42.03 83.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.35 -31.54 67.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 4.0 t80 -65.73 -35.87 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -91.51 11.91 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -49.33 149.27 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.0 -39.83 2.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.492 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -94.56 150.76 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.88 83.12 8.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.19 130.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.15 129.4 79.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.644 0.735 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 133.68 26.09 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.297 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 84.35 -4.4 83.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 956' ' ' VAL . 10.1 p -75.25 -56.22 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 955' ' ' SER . 94.3 t -37.25 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -119.03 114.4 22.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.28 129.88 34.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -93.41 127.49 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -116.86 160.19 21.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 965' ' ' MET . 3.4 m-80 -79.38 -178.79 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -58.49 -36.23 73.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -74.63 -27.68 60.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 119.51 -18.66 10.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.46 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 6.8 mmt -58.86 158.17 17.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 127.47 14.62 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 0.0 112.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 71.2 p -87.12 8.77 22.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 61.92 30.07 74.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.457 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 25.4 mt-10 -134.2 146.1 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.04 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 34.5 mtp -122.04 147.44 46.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 3.6 m -140.84 165.32 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -130.98 148.48 52.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.565 ' CE1' HD11 ' A' ' 928' ' ' ILE . 30.1 m-85 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.86 -33.35 45.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.5 m -108.49 128.53 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -61.83 -49.96 74.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.04 -35.71 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -45.12 78.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.29 -47.85 77.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' THR . . . . . 0.45 HG22 ' CD1' ' A' ' 985' ' ' ILE . 4.6 m -62.71 -42.48 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.1 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.75 -43.98 94.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.106 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 988' ' ' ASN . 68.9 t -66.75 -47.93 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . 0.45 ' CD1' HG22 ' A' ' 981' ' ' THR . 58.2 mt -61.9 -45.55 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 15.2 mt -120.67 30.5 6.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -88.05 136.66 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.6 p30 49.68 43.3 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -86.05 134.04 39.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 92.27 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.436 HD12 ' CG1' ' A' ' 997' ' ' VAL . 12.5 mt -89.98 126.73 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.83 -90.57 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.6 m -133.54 -0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -134.05 162.04 33.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -90.9 144.03 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.459 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.8 m -105.0 151.1 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . 0.427 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 0.1 OUTLIER -115.47 127.31 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 79.3 mt -110.98 133.9 53.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.427 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 60.0 t -126.39 141.75 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -81.18 137.06 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.869 0.279 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.8 m -92.02 133.94 35.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 32.7 mm -101.91 128.52 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.441 ' HB ' ' CG2' ' A' ' 972' ' ' VAL . 63.2 mt -105.07 144.54 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -111.46 128.36 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.59 127.98 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.465 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -138.14 164.77 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.38 45.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.5 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 14.3 mtm -115.18 133.02 22.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 170.98 15.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.351 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -67.0 -35.73 80.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 68.6 p -53.24 -30.03 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 938' ' ' SER . 80.3 t -49.82 143.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 938' ' ' SER . . . . . 0.418 ' N ' HG13 ' A' ' 937' ' ' VAL . 17.8 m -147.9 170.61 17.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.05 -42.12 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.24 -45.99 89.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.02 -44.5 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.17 -49.68 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -56.03 -41.99 75.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.83 -30.16 65.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 1.3 t80 -66.22 -34.92 79.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -90.91 8.49 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -41.7 148.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.61 -42.95 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.546 ' CE2' HD13 ' A' ' 987' ' ' LEU . 45.8 m-85 -91.65 146.07 24.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -82.61 85.98 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.25 125.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.3 mt -50.86 130.25 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.714 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 125.24 11.91 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.95 65.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 5.2 p -84.52 -45.5 12.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.87 100.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.3 t -114.36 108.05 16.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 37.7 mt -80.34 142.08 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 129.24 54.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.05 175.75 5.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.41 ' CG ' HG21 ' A' ' 967' ' ' THR . 65.7 m-80 -91.13 -175.01 4.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.06 -6.64 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -100.4 -36.78 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.37 -3.31 5.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 31.2 mtp -86.03 151.56 54.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.44 13.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.7 2.267 . . . . 0.0 112.345 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' THR . . . . . 0.41 HG21 ' CG ' ' A' ' 961' ' ' ASN . 9.3 p -86.02 12.89 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 63.59 30.49 77.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.465 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 27.5 mt-10 -126.2 146.01 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.11 33.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtt -131.41 141.28 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.441 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 28.5 m -136.9 165.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.68 50.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.64 137.37 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -69.86 -34.7 73.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 4.1 m -107.85 125.84 51.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -61.5 -48.19 82.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.04 -36.97 71.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.74 84.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.16 80.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -43.59 97.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.71 99.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.28 -40.27 95.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 988' ' ' ASN . 71.9 t -66.48 -48.61 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.05 -43.78 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.77 -21.44 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 4.1 mt -120.41 24.27 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -85.65 135.39 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 55.65 41.71 30.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -84.63 131.62 49.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.8 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 994' ' ' SER . 13.9 mt -82.15 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 48.81 -92.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 994' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 992' ' ' ILE . 58.4 m -132.48 -1.25 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.04 160.76 36.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.2 143.83 26.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.5 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.1 m -104.85 151.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -114.39 126.27 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.457 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 82.8 mt -111.31 127.85 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' 1001 ' ' LEU . 43.4 t -124.94 139.72 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1001 ' ' LEU . . . . . 0.408 ' N ' HG13 ' A' 1000 ' ' VAL . 12.9 mt -76.04 128.37 34.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.45 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.824 0.26 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 27.0 m -92.32 130.72 37.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.0 mm -103.84 125.46 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 974' ' ' PHE . 75.6 mt -105.56 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.99 125.38 54.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.67 124.54 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.26 171.46 12.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.09 49.35 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.465 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 16.9 mtm -115.79 127.03 27.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 166.4 27.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.72 -40.5 88.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 70.8 p -48.11 -27.7 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.71 135.53 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 34.3 m -143.86 171.64 13.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 56.0 mt -57.22 -42.07 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.1 -45.99 89.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.48 -43.96 88.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 33.0 mt -61.1 -49.75 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.64 -41.78 77.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.35 -31.42 67.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 8.2 t80 -66.01 -34.4 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.23 12.93 22.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.58 150.41 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.61 -32.94 5.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.446 ' CD2' ' HB1' ' A' ' 983' ' ' ALA . 95.8 m-85 -102.22 137.61 40.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.56 89.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 88.2 t -85.43 123.09 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . 0.415 HD12 ' C ' ' A' ' 973' ' ' ALA . 96.7 mt -51.66 129.48 35.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 125.56 12.29 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 0.0 112.317 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.75 -9.82 75.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 28.5 p -66.92 -49.13 66.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.843 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -43.87 107.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 t -118.95 118.28 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 65.2 mt -91.09 127.12 36.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -98.03 130.37 44.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -112.14 -175.31 2.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 965' ' ' MET . 2.7 p30 -107.39 -177.01 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.12 -34.57 73.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.75 -35.76 75.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 120.64 -2.6 12.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.464 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 3.0 mmt -83.7 155.76 65.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 127.48 14.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.264 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.9 p -86.46 27.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 48.32 38.7 20.03 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.5 145.32 40.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.71 151.12 31.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 49.5 mtp -122.57 142.71 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 13.3 m -135.26 164.08 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . 0.415 ' C ' HD12 ' A' ' 952' ' ' ILE . . . -128.49 146.74 50.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 928' ' ' ILE . 36.0 m-85 -129.87 139.51 51.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.17 -35.88 66.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.3 m -105.4 127.57 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -64.22 -47.79 78.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.11 -34.77 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.69 -47.61 68.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.59 73.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 985' ' ' ILE . 7.4 m -64.41 -43.75 93.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.27 89.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 949' ' ' TYR . . . -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 988' ' ' ASN . 90.4 t -66.05 -49.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' A' ' 981' ' ' THR . 33.2 mt -59.02 -46.0 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.64 -27.95 61.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.7 mt -112.46 28.06 9.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.13 128.8 36.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.6 t0 59.84 42.67 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -86.51 133.38 40.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.827 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 85.7 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.37 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.43 HD13 ' CE2' ' A' ' 945' ' ' PHE . 7.4 mt -85.7 134.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.47 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 10.0 p -131.97 -2.41 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -134.02 161.49 34.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -88.65 142.88 27.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 3.0 m -104.43 151.04 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -115.73 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 80.1 mt -112.24 131.5 55.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.0 t -123.98 148.87 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.3 mt -91.1 129.58 37.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.894 0.289 . . . . 0.0 112.316 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 57.2 m -95.03 121.44 36.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 6.7 mm -92.25 128.33 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 984' ' ' VAL . 77.6 mt -105.03 148.35 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -115.46 121.58 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.66 129.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.47 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.4 tm0? -134.38 170.24 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 50.12 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.495 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 8.6 mtm -116.79 128.28 26.13 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.614 0.721 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 174.42 9.52 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.41 -37.89 86.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -50.96 -30.57 15.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 92.0 t -52.24 125.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.9 m -131.28 171.54 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.79 -42.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.113 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.1 -45.77 90.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.38 -43.34 97.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.98 -49.98 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.76 -41.5 86.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.98 -31.46 66.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 945' ' ' PHE . 5.4 t80 -66.08 -35.19 79.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.12 11.31 23.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -48.36 149.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 93.25 -39.93 2.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 89.6 m-85 -95.33 141.17 29.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -71.77 100.2 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.4 t -95.9 124.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 87.3 mt -52.75 131.11 47.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.639 0.733 . . . . 0.0 111.115 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.11 18.78 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.374 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.49 -7.21 77.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.6 p -68.01 -55.44 12.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.1 t -35.63 112.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 27.5 m -124.07 119.2 28.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 40.8 mt -87.21 132.31 33.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -93.32 137.69 32.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 66.2 m-85 -125.87 -178.62 4.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 964' ' ' GLY . 0.3 OUTLIER -121.47 177.78 5.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -40.68 -53.15 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -64.57 -27.7 69.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 111.03 -21.75 22.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 37.7 mmt -54.53 152.98 11.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.54 0.686 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 134.65 28.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 35.5 p -97.42 25.98 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 52.79 38.06 53.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.47 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 9.5 mt-10 -138.31 145.69 41.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.55 151.25 32.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 31.8 mtp -125.11 142.73 51.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 29.2 m -138.68 165.33 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -127.97 150.77 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 925' ' ' PRO . 36.4 m-85 -131.8 142.96 49.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.45 -34.03 60.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 26.6 t -109.62 124.93 51.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.2 ttp-105 -61.74 -44.01 97.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.24 -37.33 74.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.83 -42.46 81.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.86 76.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.3 m -64.75 -43.92 91.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.91 95.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.11 -43.64 86.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 988' ' ' ASN . 91.3 t -60.29 -48.12 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.25 -44.84 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 47.2 mt -119.91 20.07 12.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.2 t-20 -79.82 127.19 31.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 64.62 41.83 5.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -84.36 131.79 49.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 83.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 10.9 mt -82.39 127.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.9 -93.86 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 23.1 p -131.78 -0.26 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.886 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -133.67 163.45 29.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -91.79 143.36 26.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.2 m -106.04 151.1 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -113.48 126.07 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.93 128.0 55.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' 1001 ' ' LEU . 59.5 t -132.9 142.13 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1001 ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' 1000 ' ' VAL . 13.7 mt -72.93 140.84 47.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.875 0.281 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.4 m -92.13 125.28 36.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.5 mm -99.39 126.58 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' A' ' 974' ' ' PHE . 95.7 mt -105.59 145.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -111.44 133.94 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.15 127.97 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.24 170.17 16.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.88 51.74 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.476 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 21.6 mtm -118.64 129.84 25.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.46 ' HD2' ' CG2' ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.79 171.43 14.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.703 2.269 . . . . 0.0 112.333 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -63.68 -37.47 87.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 67.0 p -52.07 -34.1 42.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . 0.46 ' CG2' ' HD2' ' A' ' 934' ' ' PRO . 76.2 t -48.54 122.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 4.6 m -130.62 176.15 8.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.9 -41.96 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.147 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.02 -45.9 90.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.56 -45.0 96.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.14 -50.0 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.11 -42.03 84.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.562 ' CD2' HD13 ' A' ' 992' ' ' ILE . 8.5 t80 -66.69 -31.14 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -97.0 12.17 33.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -50.51 152.88 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.04 -37.57 3.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.555 ' CE2' HD11 ' A' ' 987' ' ' LEU . 57.0 m-85 -96.37 127.83 42.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -60.78 97.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.68 122.36 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 89.7 mt -48.23 130.06 12.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 123.52 10.17 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.5 -2.62 74.16 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.0 p -72.33 -53.33 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 955' ' ' SER . 99.3 t -37.04 105.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.26 114.6 22.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.72 137.47 34.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.957 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -95.48 139.28 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.897 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -132.54 161.5 33.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -95.96 -175.7 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -50.48 -51.52 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . 0.407 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 37.3 mmtt -56.48 -44.11 80.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 126.88 -4.56 7.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 43.8 mtm -73.38 153.62 90.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 128.34 15.93 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.732 2.288 . . . . 0.0 112.369 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 65.0 p -90.32 37.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.14 40.53 1.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -140.97 146.97 38.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 3.2 mtt -122.62 143.69 49.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.63 160.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -122.32 153.8 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.058 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.442 ' CD1' HD11 ' A' ' 928' ' ' ILE . 32.0 m-85 -134.5 141.14 46.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.821 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.13 -37.41 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 19.0 m -108.06 126.12 52.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -61.01 -45.75 93.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -57.39 -38.88 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.94 -44.12 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.28 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 10.0 m -64.27 -43.37 95.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.43 89.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.91 -39.17 93.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 988' ' ' ASN . 75.4 t -64.63 -49.08 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.45 -46.54 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -23.73 59.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 949' ' ' TYR . 14.8 mt -115.47 25.94 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.1 t-20 -91.45 128.57 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.93 40.63 15.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -86.2 133.33 40.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.845 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 85.51 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.562 HD13 ' CD2' ' A' ' 945' ' ' PHE . 8.8 mt -84.44 125.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.85 -92.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 5.1 m -129.28 -5.76 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -133.08 156.25 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -86.42 143.33 27.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.476 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.8 m -101.1 151.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . 0.404 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 1.7 tmmm? -116.26 128.29 55.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.01 138.43 47.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.404 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 47.3 t -133.84 137.14 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.131 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.6 mt -73.81 136.36 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.459 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.841 0.267 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 12.0 m -92.77 119.67 32.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 973' ' ' ALA . 38.7 mm -97.89 125.15 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.156 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.565 HD12 ' CE1' ' A' ' 974' ' ' PHE . 98.3 mt -104.98 143.49 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -111.85 130.58 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.5 t -112.02 131.34 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.462 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.68 167.23 21.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.08 53.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.496 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 6.1 mtm -121.32 128.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 156.49 63.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.324 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -54.29 -33.53 58.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.2 p -53.24 -34.69 58.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 88.4 t -46.81 137.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 5.7 m -140.5 175.69 9.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.83 -41.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.19 -45.82 89.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.08 -38.18 87.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.21 -49.1 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.24 -41.68 84.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.72 -30.75 65.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 987' ' ' LEU . 7.0 t80 -64.92 -39.06 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -87.22 13.17 10.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.66 148.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.89 2.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 983' ' ' ALA . 90.7 m-85 -92.01 134.87 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -72.14 84.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.4 t -74.66 123.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.43 129.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.645 2.23 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.19 6.1 84.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 957' ' ' CYS . 81.5 p -87.07 -55.54 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 955' ' ' SER . 48.2 t -35.99 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 955' ' ' SER . 3.0 t -112.62 126.07 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 138.04 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -94.51 123.92 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 92.3 m-85 -111.6 175.08 5.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.96 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.39 -18.47 28.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -35.97 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 120.08 -15.13 10.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 77.9 mmm -69.2 155.73 92.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 137.73 36.26 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -100.38 0.27 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 81.73 31.52 32.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.462 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 12.4 mt-10 -128.98 146.88 50.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.91 142.2 23.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 28.4 mtp -120.97 142.89 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 4.1 m -137.45 166.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 927' ' ' ILE . . . -129.55 150.1 51.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.565 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -129.95 157.21 42.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -82.31 -42.95 18.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 20.4 m -117.44 139.07 51.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.1 mtp85 -61.29 -36.6 80.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -58.08 -43.44 87.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -45.14 78.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.72 79.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -62.36 -43.98 97.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.78 89.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 949' ' ' TYR . . . -60.59 -40.93 93.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 988' ' ' ASN . 86.5 t -64.76 -50.23 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.25 -45.03 99.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -22.29 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.462 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 8.9 mt -119.86 29.18 7.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.959 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.0 OUTLIER -89.96 128.61 36.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.71 43.09 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -85.78 131.63 46.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.99 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.745 2.296 . . . . 0.0 112.315 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 16.1 mt -81.26 126.91 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.58 -92.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 17.2 t -132.82 -1.13 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -132.76 163.48 28.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -92.53 141.0 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.496 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.4 m -102.6 151.08 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.57 128.17 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 78.7 mt -111.16 131.08 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.921 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 57.6 t -124.79 143.03 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.36 134.82 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.842 0.267 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 50.7 m -101.13 132.99 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 30.3 mm -100.6 128.0 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 974' ' ' PHE . 75.7 mt -108.55 145.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 928' ' ' ILE . 4.1 mtpm? -114.76 131.48 56.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.29 126.92 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 167.21 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.07 50.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.465 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 23.8 mtm -119.3 130.59 24.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 158.49 56.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -56.63 -33.46 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 47.8 p -53.11 -32.39 47.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 938' ' ' SER . 94.2 t -49.71 140.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 938' ' ' SER . . . . . 0.406 ' N ' HG13 ' A' ' 937' ' ' VAL . 72.7 m -145.93 172.96 12.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.81 -42.01 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.12 -46.05 89.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -65.61 -45.27 83.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . 0.452 ' CD1' HD23 ' A' ' 958' ' ' LEU . 38.5 mt -61.01 -48.48 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.4 mt -58.45 -42.02 86.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.55 -31.2 66.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.493 ' C ' ' CD1' ' A' ' 945' ' ' PHE . 2.9 t80 -65.02 -41.24 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -81.41 7.7 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -41.28 149.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.32 -40.62 2.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 92.2 m-85 -97.25 130.91 44.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.58 92.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.5 t -78.04 125.68 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 75.9 mt -54.18 133.83 60.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.614 0.721 . . . . 0.0 111.156 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 147.17 62.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.356 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.33 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 -56.21 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.87 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.0 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.99 129.17 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.452 HD23 ' CD1' ' A' ' 942' ' ' ILE . 45.1 mt -94.84 139.21 31.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -93.5 131.58 38.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -115.09 160.22 19.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.556 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.0 OUTLIER -99.68 -176.41 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.33 -47.43 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -24.77 66.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . 0.556 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 117.08 -28.67 7.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.462 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 7.5 ptp -57.82 153.64 31.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.44 17.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.704 2.269 . . . . 0.0 112.358 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 38.8 p -83.97 26.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 56.35 33.04 61.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -129.11 147.96 51.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.69 147.08 26.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.5 mtt -123.0 141.82 51.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 18.9 m -139.3 164.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.49 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 928' ' ' ILE . 23.1 m-85 -128.2 148.09 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.16 -35.99 61.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 9.4 t -115.82 134.61 54.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 52.6 ttp85 -61.26 -39.91 92.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -41.68 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -62.67 -45.17 94.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.03 -49.36 77.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.9 m -62.75 -44.0 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.92 92.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -62.59 -38.06 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 988' ' ' ASN . 84.9 t -66.04 -49.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 32.9 mt -60.95 -47.61 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.93 -21.55 61.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 999' ' ' LEU . 8.2 mt -119.37 27.23 8.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.92 129.65 36.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 60.48 41.46 15.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -84.13 130.89 52.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.617 0.722 . . . . 0.0 110.826 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 84.46 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.475 HD11 ' CE2' ' A' ' 945' ' ' PHE . 9.0 mt -84.39 130.66 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.52 -94.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 12.8 t -129.35 -0.87 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -133.96 163.67 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -93.07 143.28 26.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 3.8 m -101.89 149.89 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.26 127.1 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 78.9 mt -111.73 131.08 55.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.858 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' 1001 ' ' LEU . 47.2 t -120.67 140.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1001 ' ' LEU . . . . . 0.456 ' N ' HG13 ' A' 1000 ' ' VAL . 13.4 mt -81.22 122.89 27.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . 0.439 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.822 0.259 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.4 m -94.28 117.13 29.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . 0.45 ' CD1' ' HB1' ' A' ' 973' ' ' ALA . 27.4 mm -91.35 125.27 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.562 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.8 mt -105.18 147.95 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 928' ' ' ILE . 37.1 mtmt -111.29 131.39 55.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.54 125.03 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 171.27 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.7 47.76 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.466 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 18.3 mtm -111.47 125.75 29.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 159.38 53.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.664 2.243 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -56.9 -32.94 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.4 p -55.04 -30.94 60.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 938' ' ' SER . 75.3 t -48.31 145.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 938' ' ' SER . . . . . 0.442 ' N ' HG12 ' A' ' 937' ' ' VAL . 33.4 m -153.64 173.19 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.92 -42.16 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -46.06 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -65.61 -46.13 80.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.02 -46.27 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.6 mt -57.97 -41.92 83.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.91 -34.21 68.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 3.9 t80 -61.81 -37.15 83.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.17 23.58 6.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -60.61 161.23 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 80.69 -41.89 2.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 79.6 m-85 -85.25 135.52 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.89 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -65.59 83.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.64 119.85 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.64 132.14 13.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.613 0.721 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 111.62 2.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 0.0 112.357 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.81 31.72 9.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.466 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 956' ' ' VAL . 81.0 p -103.58 -53.86 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 955' ' ' SER . 86.7 t -34.62 114.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 8.5 t -119.93 112.7 19.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 44.5 mt -81.85 131.59 35.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -95.48 138.69 32.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . 0.419 ' C ' HG22 ' A' ' 967' ' ' THR . 90.6 m-85 -128.7 171.87 11.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.7 OUTLIER -100.19 -179.07 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -50.81 -47.1 60.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.53 96.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . 0.415 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.91 -27.34 3.19 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.476 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 158.43 1.89 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 137.55 35.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.331 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' THR . . . . . 0.419 HG22 ' C ' ' A' ' 960' ' ' TYR . 82.5 p -100.76 37.47 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 967' ' ' THR . . . 37.07 39.14 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -141.79 145.59 34.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.94 148.56 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.0 mtt -119.0 143.18 47.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.436 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 23.8 m -135.39 160.53 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 927' ' ' ILE . . . -123.39 147.15 47.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -129.14 137.71 51.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.66 -34.02 64.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.8 m -108.81 130.99 55.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -61.77 -48.91 78.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -56.91 -39.17 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.32 -44.44 94.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.02 73.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' THR . . . . . 0.455 HG22 ' CD1' ' A' ' 985' ' ' ILE . 24.3 m -64.51 -43.41 94.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.14 93.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.68 -41.91 98.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 988' ' ' ASN . 84.1 t -66.28 -49.76 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . 0.455 ' CD1' HG22 ' A' ' 981' ' ' THR . 41.7 mt -58.66 -46.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.66 -30.31 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 12.5 mt -109.5 28.87 8.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -89.48 133.57 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 22.9 t70 54.37 43.44 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -87.85 130.16 47.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 94.61 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.517 HD11 ' CD2' ' A' ' 945' ' ' PHE . 15.7 mt -92.59 124.47 45.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.08 -90.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 9.5 t -131.34 -3.38 3.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.809 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -134.11 154.3 51.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -88.82 140.54 29.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 4.9 m -100.1 150.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.0 129.42 56.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 81.7 mt -110.93 128.66 55.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' 1001 ' ' LEU . 89.3 t -123.39 137.93 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1001 ' ' LEU . . . . . 0.434 ' N ' HG12 ' A' 1000 ' ' VAL . 11.9 mt -71.55 134.27 46.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.29 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 29.9 m -91.93 125.78 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.52 127.86 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.432 HD13 ' CE1' ' A' ' 974' ' ' PHE . 65.7 mt -107.33 146.46 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -113.5 130.09 56.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.64 127.23 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.438 ' HG3' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -131.71 172.48 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 49.23 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.523 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 16.7 mtm -114.44 129.2 25.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 167.52 24.25 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.69 -25.0 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 64.8 p -63.88 -21.78 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.48 139.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.0 m -144.41 177.81 8.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.03 -42.17 92.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -63.29 -46.05 88.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.47 -45.29 93.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 24.1 mt -60.98 -49.64 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.03 -42.0 89.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -72.07 -31.18 65.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 38.6 t80 -65.25 -38.43 90.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -87.91 10.96 17.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -47.03 145.58 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 99.07 -32.51 7.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 87.5 m-85 -103.57 143.78 32.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.12 87.03 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.46 127.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.48 132.71 70.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 0.0 111.163 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 132.74 23.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.3 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.12 85.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 956' ' ' VAL . 24.6 p -82.16 -60.39 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.824 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 955' ' ' SER . 98.0 t -34.79 112.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 13.5 m -124.43 125.49 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.9 146.57 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -100.26 135.76 41.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -128.74 160.67 31.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 965' ' ' MET . 49.4 p-10 -98.81 -177.05 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.93 -41.39 61.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -67.1 -33.67 75.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 113.16 -1.32 25.43 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.458 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 8.7 ptp -80.1 151.96 73.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 133.34 25.37 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -95.45 22.23 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.88 38.87 93.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 931' ' ' GLN . 8.1 mt-10 -138.7 145.46 40.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -147.88 145.66 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 40.8 mtp -119.45 138.7 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.1 163.29 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -125.06 155.14 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.432 ' CE1' HD13 ' A' ' 928' ' ' ILE . 24.1 m-85 -133.18 144.71 50.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.43 -34.92 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.4 t -115.85 131.62 56.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -63.23 -38.13 89.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.9 -41.43 96.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.51 -46.79 78.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.22 70.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.6 m -64.87 -43.65 92.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.96 94.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.72 -40.01 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 988' ' ' ASN . 81.4 t -66.03 -48.57 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.04 -44.55 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.5 -26.42 59.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 15.1 mt -115.34 27.39 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.86 127.9 35.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.5 t70 61.0 41.74 13.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . 0.403 ' HD3' ' CE1' ' A' ' 945' ' ' PHE . 15.3 mtp85 -87.17 134.63 36.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.72 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 85.64 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.321 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 7.5 mt -83.69 128.85 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.03 -92.97 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.5 t -131.6 -2.74 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -133.73 158.52 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -85.91 143.88 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.523 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 0.2 OUTLIER -104.98 151.03 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.22 125.12 53.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 71.2 mt -111.04 132.32 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 23.3 t -128.14 143.34 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.5 mt -78.67 134.38 37.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.913 0.297 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 5.1 m -98.31 119.52 37.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 973' ' ' ALA . 49.9 mm -91.36 129.19 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.531 HD13 ' CE1' ' A' ' 974' ' ' PHE . 95.8 mt -104.99 148.97 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 9.6 t -109.44 128.11 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.468 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.54 170.19 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.01 47.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.469 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 6.9 mtm -114.12 130.7 23.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.697 . . . . 0.0 110.895 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 170.19 17.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -68.91 -28.8 66.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.7 p -59.46 -30.12 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.16 155.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 10.0 m -162.32 170.96 18.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.89 -45.54 92.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.13 -39.32 92.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.77 -49.48 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.01 -41.56 83.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 987' ' ' LEU . 25.8 t80 -65.05 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.02 14.61 13.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -49.54 148.35 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.52 -39.52 2.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 67.1 m-85 -94.37 150.54 20.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.961 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.17 90.04 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.94 126.61 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 78.2 mt -56.28 129.73 74.55 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 125.05 11.68 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 0.0 112.343 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.25 -6.99 78.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 4.0 p -70.39 -51.5 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 110.796 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 69.1 t -41.23 109.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.18 118.95 31.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.94 146.74 26.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -97.36 138.14 35.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.93 163.91 29.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -108.39 172.38 6.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 963' ' ' LYS . 0.5 OUTLIER -47.86 -34.41 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 962' ' ' GLU . 37.3 mttp -69.12 -31.7 70.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 103.62 16.64 19.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 4.9 mmt -101.43 154.69 37.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.585 0.707 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.1 41.91 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 25.1 p -106.83 27.78 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 51.39 37.24 39.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.468 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 11.9 mt-10 -137.48 144.97 42.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.97 152.53 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtm -126.18 142.41 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.8 163.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' A' ' 927' ' ' ILE . . . -128.34 153.88 46.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.531 ' CE1' HD13 ' A' ' 928' ' ' ILE . 33.5 m-85 -134.29 143.17 47.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.75 -34.61 75.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -120.73 129.07 53.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 978' ' ' ASP . 1.4 ptp180 -61.87 -29.75 70.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 977' ' ' ARG . 7.3 m-20 -66.23 -41.5 89.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.99 -44.45 76.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -57.16 -47.85 80.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.2 m -64.42 -43.58 93.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.46 95.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.12 -38.91 86.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 988' ' ' ASN . 79.8 t -64.75 -49.32 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.78 -43.45 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.67 -23.29 58.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.0 mt -116.42 21.46 13.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.8 t-20 -80.25 144.26 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.2 p30 49.98 39.53 19.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -84.16 127.58 66.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 86.93 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 10.5 mt -85.14 125.1 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.5 -93.98 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 49.6 p -130.04 -2.3 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -133.05 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -93.39 142.9 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.8 m -102.37 151.07 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -115.21 125.21 53.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 70.0 mt -111.29 128.21 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 58.0 t -133.72 141.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.7 134.45 49.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.846 0.269 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.3 m -92.0 121.93 34.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 973' ' ' ALA . 42.9 mm -95.49 129.01 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 984' ' ' VAL . 53.5 mt -104.98 148.8 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -113.43 129.48 56.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.74 133.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.125 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 173.49 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.99 51.43 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.502 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 6.1 mtm -118.8 128.38 26.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 161.14 47.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -57.87 -31.79 67.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 82.2 p -55.8 -33.9 64.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 93.4 t -47.32 135.7 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.1 m -138.48 171.76 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.6 mt -58.77 -42.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -63.1 -46.05 89.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -62.39 -41.86 98.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 25.2 mt -62.47 -48.79 86.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.14 -41.94 84.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -71.93 -30.38 65.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 7.9 t80 -64.79 -39.65 93.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -87.62 13.29 10.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -48.05 147.78 1.99 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 97.58 -43.92 1.91 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 91.1 m-85 -91.39 159.29 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -91.54 90.74 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.49 131.35 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.0 129.59 86.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 129.14 17.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.714 2.276 . . . . 0.0 112.295 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.03 -9.61 77.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 24.4 p -70.36 -49.73 46.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 110.825 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -40.41 104.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.8 117.47 27.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.82 136.2 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 121.47 40.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.1 175.74 5.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -95.46 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.41 -39.28 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . 0.438 ' CE ' ' HA ' ' A' ' 963' ' ' LYS . 0.3 OUTLIER -77.4 -36.64 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.63 -1.84 4.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.448 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.19 146.3 70.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 136.75 33.73 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.0 p -101.65 -0.08 35.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.2 38.22 59.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.44 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -132.4 146.33 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -146.89 149.95 34.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 22.2 mtp -123.07 143.6 49.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.46 160.78 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 927' ' ' ILE . . . -124.17 148.93 46.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -131.29 141.5 49.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.94 -32.43 57.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 15.7 t -114.92 130.54 56.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -63.27 -41.54 99.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.26 -38.81 81.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.96 -43.53 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -59.42 -50.01 75.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.143 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.54 97.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.15 -42.75 96.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 988' ' ' ASN . 95.8 t -66.14 -48.91 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.18 -44.97 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -29.24 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 3.8 mt -113.55 30.73 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.8 131.98 34.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 55.77 43.53 27.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -86.69 134.1 38.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.611 0.72 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.93 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.26 . . . . 0.0 112.363 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.457 HD13 ' CE2' ' A' ' 945' ' ' PHE . 8.4 mt -82.74 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.19 -92.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.1 p -132.45 -1.8 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -133.63 161.9 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -90.47 139.54 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.502 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.2 m -100.73 151.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.109 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -114.46 126.26 54.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 69.5 mt -111.17 131.83 54.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 97.4 t -130.94 137.44 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.35 132.4 43.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.479 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.834 0.264 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 93.3 m -92.39 118.92 31.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 6.5 mm -90.97 130.03 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 974' ' ' PHE . 93.6 mt -104.99 148.34 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -112.66 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.77 124.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.476 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.0 OUTLIER -128.06 166.58 18.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . 0.476 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.1 OUTLIER 67.15 52.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.406 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 3.0 mtm -115.85 125.24 28.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.539 0.685 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 168.46 21.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.307 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -61.94 -39.64 92.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -49.09 -30.32 6.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 74.5 t -52.19 145.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 15.1 m -151.68 179.26 8.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.34 -41.98 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.173 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.04 -45.98 89.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.04 -42.17 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.25 -47.63 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.02 -41.77 88.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.7 -30.9 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.93 -39.15 93.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -88.95 12.92 14.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -48.77 147.64 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.3 -33.3 5.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 65.0 m-85 -102.56 143.37 32.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -74.97 94.04 2.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.66 122.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 52.9 mt -51.47 130.19 34.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.591 0.71 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 126.78 13.73 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.268 . . . . 0.0 112.327 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.05 -6.03 81.66 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 52.1 p -72.87 -51.62 17.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.835 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 78.1 t -38.39 110.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 19.8 m -125.34 125.76 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 46.9 mt -97.14 140.08 32.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.0 45.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -119.87 169.08 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.8 OUTLIER -96.35 -177.38 3.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.91 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.93 -49.94 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . 0.418 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 27.0 mtmt -58.48 -43.97 89.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.86 -21.93 3.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.542 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 5.7 mtp -59.9 157.96 27.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 145.57 57.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 20.8 p -105.23 34.99 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.6 44.37 3.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -147.86 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.24 152.84 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.096 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 15.7 mtm -126.28 142.37 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.44 163.91 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.117 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.32 148.2 47.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.506 ' CD1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -127.83 137.52 52.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.42 -38.52 71.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -108.72 128.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -60.96 -40.99 95.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -67.44 -44.61 78.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.95 73.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 9.8 m -65.06 -44.02 90.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.56 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -68.07 -41.3 82.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 988' ' ' ASN . 92.8 t -62.43 -48.98 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.6 -46.46 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.88 -21.21 60.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 20.0 mt -116.19 21.48 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.7 t-20 -83.27 135.71 34.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 54.89 43.82 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -86.69 130.2 49.82 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.834 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 81.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.93 131.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.7 -92.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.1 t -131.07 -3.67 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -84.97 143.9 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.8 m -105.32 151.07 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -113.16 128.58 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.91 130.54 55.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1000 ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' 1001 ' ' LEU . 25.1 t -128.58 140.98 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1001 ' ' LEU . . . . . 0.418 ' N ' HG13 ' A' 1000 ' ' VAL . 12.9 mt -81.94 121.29 26.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 179.883 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.819 0.258 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.12 127.53 37.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.1 125.97 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.563 HD13 ' CE1' ' A' ' 974' ' ' PHE . 98.4 mt -105.29 147.0 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -112.02 127.69 55.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 14.9 t -111.85 123.5 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.431 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.3 tm0? -127.61 173.34 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.48 53.87 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 10.2 mtm -119.47 125.75 27.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 166.03 28.94 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.357 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.85 -35.14 77.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.4 p -53.75 -23.35 11.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.04 139.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 23.0 m -140.04 173.36 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.12 -41.96 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -63.13 -45.45 91.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.68 -42.04 98.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.9 mt -62.27 -49.33 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.13 -40.85 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.01 -31.32 66.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 987' ' ' LEU . 3.5 t80 -65.51 -36.97 85.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.71 12.47 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -46.9 155.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.47 3.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 69.9 m-85 -92.57 147.14 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -79.91 100.53 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.6 t -93.93 130.88 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 46.7 mt -59.33 132.34 87.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 128.03 15.42 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.664 2.243 . . . . 0.0 112.322 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.54 76.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 12.7 p -66.18 -56.09 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 93.8 t -40.45 109.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -122.28 116.27 23.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 45.3 mt -82.71 132.24 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.66 136.96 33.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.48 180.0 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -114.77 -177.85 3.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.32 -32.17 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -77.19 -33.58 56.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.85 12.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.7 mtt -79.16 156.97 76.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 134.09 27.09 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 27.3 p -95.25 35.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 46.35 30.22 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.519 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.431 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.6 mt-10 -128.85 145.19 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.909 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.97 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 60.9 mtp -121.62 141.0 51.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.89 164.35 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.83 50.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.563 ' CE1' HD13 ' A' ' 928' ' ' ILE . 26.8 m-85 -127.48 137.29 52.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.94 -35.7 74.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 976' ' ' SER . . . . . 0.457 ' CB ' ' CD ' ' A' ' 979' ' ' GLU . 4.1 m -109.62 130.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.848 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.69 -48.46 77.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.04 -36.99 71.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . 0.457 ' CD ' ' CB ' ' A' ' 976' ' ' SER . 1.0 OUTLIER -64.24 -50.11 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.0 70.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 4.8 m -63.91 -42.41 97.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.66 94.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.45 -38.48 84.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 988' ' ' ASN . 69.6 t -68.32 -48.92 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -44.89 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -30.45 63.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 4.8 mt -109.72 23.79 13.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -83.2 136.0 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.22 42.73 32.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -85.19 133.67 42.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 0.0 110.826 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 87.29 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 945' ' ' PHE . 7.7 mt -87.78 130.93 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.23 -92.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.3 p -131.14 -3.66 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -134.11 158.6 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -88.05 138.36 31.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.4 m -95.8 150.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -112.7 125.63 54.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 80.0 mt -111.21 130.02 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 62.6 t -126.63 147.49 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.06 137.03 36.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.493 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.26 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 10.8 m -92.06 128.67 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.1 mm -100.81 128.23 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.542 HD11 ' CD1' ' A' ' 974' ' ' PHE . 95.4 mt -105.36 145.1 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -111.02 127.49 55.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 8.5 t -107.72 127.7 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.442 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.0 OUTLIER -132.44 169.34 16.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.1 54.69 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.458 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 7.2 mtm -118.94 124.89 28.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.32 21.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.662 2.241 . . . . 0.0 112.326 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.1 -27.16 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 63.2 p -59.58 -27.95 66.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.62 144.52 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.8 m -146.72 171.64 14.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.04 -42.01 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.01 -45.84 90.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.52 -42.63 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.97 -49.55 84.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.95 -41.84 88.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.41 -40.56 96.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -87.46 13.77 9.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -52.1 146.54 8.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.92 -35.06 4.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -99.58 139.42 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -70.88 90.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.5 t -86.24 124.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 97.3 mt -52.02 129.66 39.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 111.155 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.4 23.29 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.93 -2.46 87.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 956' ' ' VAL . 5.0 p -72.5 -53.37 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 955' ' ' SER . 61.1 t -36.37 108.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.49 108.18 12.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.1 mt -76.98 141.0 40.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -94.59 137.79 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 72.8 m-85 -130.5 158.61 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.453 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -97.31 178.48 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -44.07 -49.56 8.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . 0.453 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtmp? -61.86 -42.72 99.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 124.87 -11.14 7.85 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.9 mmt -65.74 157.48 79.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.78 43.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.4 p -107.77 33.79 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.05 44.96 6.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.442 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.2 mt-10 -147.81 145.32 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.62 35.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 27.1 mtt -126.56 142.71 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.62 164.49 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.31 150.05 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.542 ' CD1' HD11 ' A' ' 928' ' ' ILE . 25.1 m-85 -130.36 137.67 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.65 -37.78 67.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 24.5 t -106.1 131.76 52.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.859 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -63.42 -46.91 84.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.74 -34.66 69.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -47.33 69.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.96 -49.01 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 3.7 m -64.92 -43.9 91.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.91 99.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.61 97.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 988' ' ' ASN . 96.2 t -65.68 -49.85 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 34.5 mt -65.0 -44.8 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.98 -27.69 67.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.06 30.2 6.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -82.56 127.98 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 61.4 41.9 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -84.08 133.87 44.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.39 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.646 2.231 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 7.1 mt -85.95 129.04 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.02 -93.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 22.8 t -131.23 -3.34 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -133.47 160.83 36.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -88.31 142.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.458 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 1.7 m -102.81 150.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 126.63 55.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.02 133.12 53.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.9 t -126.61 149.48 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.95 121.6 30.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.497 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.825 0.261 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 7.0 m -96.79 118.98 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.5 mm -95.98 123.83 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.568 HD13 ' CE1' ' A' ' 974' ' ' PHE . 97.7 mt -106.48 145.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.437 ' N ' HG22 ' A' ' 928' ' ' ILE . 4.0 mtmp? -111.95 134.25 53.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.47 125.95 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.92 169.0 14.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.81 53.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.433 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 14.3 mtm -117.92 121.72 31.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.615 0.722 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 162.97 40.04 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -55.35 -41.38 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.2 p -45.47 -36.33 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.13 142.44 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 27.9 m -148.5 179.23 7.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.02 -42.04 94.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -62.97 -45.89 90.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -65.21 -42.71 93.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.8 mt -61.29 -48.61 88.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.1 -41.97 89.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.94 -30.78 65.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 945' ' ' PHE . 1.6 t80 -64.92 -38.67 91.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.29 13.16 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -49.38 154.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 88.26 -36.66 3.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 77.6 m-85 -95.84 136.33 36.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.986 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 950' ' ' GLN . 2.6 mp0 -73.74 82.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 952' ' ' ILE . 97.5 t -75.54 135.52 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . 0.422 ' N ' HG12 ' A' ' 951' ' ' VAL . 35.7 mt -62.25 130.95 93.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 0.0 111.145 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 132.27 23.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 0.0 112.409 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 90.19 -4.11 82.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 957' ' ' CYS . 1.5 m -80.6 -56.47 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 955' ' ' SER . 65.2 t -36.32 95.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 955' ' ' SER . 20.9 m -112.41 136.74 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 71.2 mt -99.9 137.23 38.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -96.54 133.34 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.49 175.57 5.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 965' ' ' MET . 4.6 p30 -107.63 -177.58 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.36 -29.19 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -79.21 -35.57 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 124.45 -17.76 7.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.442 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 15.0 mtp -68.36 157.9 86.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.04 15.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 19.3 p -89.05 35.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.47 45.54 6.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -142.17 148.53 38.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.86 152.82 35.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 63.1 mtp -130.54 141.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.79 162.55 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.63 44.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 928' ' ' ILE . 28.7 m-85 -129.96 141.31 50.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.32 -34.84 68.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.34 135.0 54.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.814 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -62.25 -41.37 98.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.28 -42.97 82.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -47.87 79.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.75 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 981' ' ' THR . . . . . 0.462 HG22 ' CD1' ' A' ' 985' ' ' ILE . 3.8 m -64.61 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.6 87.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -66.92 -45.49 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 988' ' ' ASN . 79.2 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' A' ' 981' ' ' THR . 37.4 mt -64.27 -46.15 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.99 -22.73 58.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.501 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 16.6 mt -116.75 23.66 11.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.8 OUTLIER -80.74 136.16 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.4 t0 50.63 45.42 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -83.23 129.7 59.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.701 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 84.96 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 10.4 mt -85.8 133.28 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.29 -91.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 3.3 m -134.64 0.54 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -134.14 155.41 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -86.65 136.72 32.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.433 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 1.9 m -97.12 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.59 128.39 56.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 71.4 mt -110.98 138.72 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.4 t -134.56 144.18 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.3 mt -82.72 141.51 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 179.873 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.891 0.288 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.9 m -96.04 120.97 37.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 33.3 mm -100.38 122.28 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 974' ' ' PHE . 85.4 mt -105.0 141.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -110.42 128.66 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.59 130.18 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.02 171.65 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.79 52.67 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.465 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 25.9 mtm -115.11 135.89 22.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 937' ' ' VAL . 53.7 Cg_endo -69.75 171.9 13.61 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.84 -20.43 59.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 77.5 p -72.15 -15.63 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 938' ' ' SER . 74.2 t -59.21 147.93 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 938' ' ' SER . . . . . 0.451 ' N ' HG11 ' A' ' 937' ' ' VAL . 8.6 m -154.15 171.37 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.39 -42.03 79.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.12 -45.17 93.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.27 -41.68 93.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.4 mt -64.1 -49.53 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.83 -41.97 83.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.0 -31.2 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -65.86 -36.21 82.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -88.43 10.12 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -44.24 153.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 90.48 -42.3 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 84.1 m-85 -92.85 149.4 21.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.95 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.75 91.38 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.36 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.97 136.35 83.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 147.97 64.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.64 2.226 . . . . 0.0 112.352 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 63.55 13.24 50.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 63.1 m -94.2 -51.33 4.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.938 0.399 . . . . 0.0 110.822 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 93.9 t -46.94 103.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.086 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 12.1 m -117.42 134.21 55.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.85 138.77 34.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -92.42 135.85 33.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -124.71 166.86 15.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 965' ' ' MET . 1.0 OUTLIER -100.25 -176.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.01 -8.86 25.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -98.2 -28.28 13.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 112.95 -3.8 25.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 20.8 mtm -84.77 150.12 55.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.583 0.706 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 128.27 15.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 36.3 p -89.38 24.25 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.09 38.44 89.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.519 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -137.51 145.47 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.13 151.45 33.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 20.8 mtt -122.02 143.15 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.85 160.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.94 151.71 43.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 928' ' ' ILE . 31.8 m-85 -133.8 138.86 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -73.22 -34.67 66.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 5.5 t -111.17 129.89 55.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -63.42 -44.37 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -57.11 -37.16 71.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -48.57 66.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.9 69.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 981' ' ' THR . . . . . 0.423 HG21 ' CD1' ' A' ' 985' ' ' ILE . 4.7 m -62.53 -43.57 98.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.31 93.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.48 -45.96 92.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 988' ' ' ASN . 53.3 t -61.71 -50.11 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . 0.423 ' CD1' HG21 ' A' ' 981' ' ' THR . 30.7 mt -61.42 -48.82 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.22 -21.9 62.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 999' ' ' LEU . 16.4 mt -119.14 26.52 9.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.5 t-20 -89.03 120.72 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.9 t0 73.13 38.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.4 129.69 56.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 87.51 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 14.3 mt -83.93 129.33 37.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.64 -92.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.0 p -132.76 -0.65 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -131.2 163.91 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.25 143.85 26.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.7 m -107.53 151.08 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -117.67 127.73 54.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 37.6 mt -111.64 130.44 55.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 46.4 t -131.97 136.52 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.16 155.95 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.803 0.251 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.1 m -92.53 117.87 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.197 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 47.8 mm -95.47 125.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 974' ' ' PHE . 80.8 mt -106.13 148.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . 0.434 ' N ' HG23 ' A' ' 928' ' ' ILE . 18.0 mtmm -112.65 130.55 56.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.04 123.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.1 tm0? -125.02 167.25 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . 0.425 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.3 OUTLIER 65.89 53.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.461 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 12.2 mtm -115.78 123.98 30.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 168.32 21.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -63.93 -39.41 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.8 p -48.17 -34.32 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 81.3 t -45.66 154.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.5 m -160.58 172.71 16.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.44 -41.94 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.01 -45.74 90.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.34 -41.55 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.29 -48.25 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.8 -42.06 92.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.97 -31.56 66.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.5 ' CD2' ' CD1' ' A' ' 992' ' ' ILE . 9.5 t80 -64.94 -37.34 87.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -92.14 14.82 14.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.46 157.6 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.932 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 85.46 -41.7 3.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 72.1 m-85 -87.84 141.51 28.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -73.01 87.04 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.5 t -82.73 125.46 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 97.5 mt -51.55 134.99 34.32 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.573 0.702 . . . . 0.0 111.142 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.64 2.226 . . . . 0.0 112.362 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 86.42 24.86 38.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 82.3 p -93.66 -50.86 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.84 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 97.2 t -39.34 113.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 3.2 t -122.9 109.7 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 25.6 mt -81.74 136.78 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -103.13 138.88 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.84 174.44 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . 0.465 ' ND2' ' HD3' ' A' ' 963' ' ' LYS . 7.9 p30 -98.56 176.97 5.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.26 -33.92 65.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . 0.465 ' HD3' ' ND2' ' A' ' 961' ' ' ASN . 0.0 OUTLIER -68.21 -45.94 71.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.838 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 138.61 -27.78 2.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 965' ' ' MET . . . . . 0.401 ' O ' ' OD1' ' A' ' 961' ' ' ASN . 85.0 mtp -63.76 153.47 83.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.556 0.693 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 144.1 52.83 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.658 2.239 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.3 p -99.37 37.7 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 39.43 42.19 1.8 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.54 145.84 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.56 153.02 35.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 9.8 mtp -122.22 143.66 49.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.61 165.7 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -127.46 147.18 50.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.096 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 928' ' ' ILE . 20.8 m-85 -127.36 144.29 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -78.06 -34.43 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 50.7 m -111.57 130.76 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.57 -40.09 78.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -62.87 -45.74 91.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -55.72 -49.31 73.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 4.6 m -64.26 -43.9 93.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.35 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.36 -42.87 95.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 988' ' ' ASN . 91.4 t -62.7 -50.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 27.9 mt -63.62 -42.18 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.26 -28.04 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 77.2 mt -115.68 25.86 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.25 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 t0 58.69 43.15 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.92 130.37 57.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 82.47 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.743 2.295 . . . . 0.0 112.309 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.02 123.36 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.88 -95.83 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 11.7 t -126.06 -6.53 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -129.48 159.65 35.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -93.15 136.42 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 5.6 m -96.15 150.14 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -113.79 129.72 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 68.1 mt -110.87 128.74 55.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 76.0 t -126.43 141.97 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.64 130.98 41.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 179.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.876 0.282 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.9 m -92.61 126.19 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 43.2 mm -97.6 129.94 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.123 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.465 ' HB ' ' CG2' ' A' ' 972' ' ' VAL . 51.3 mt -104.88 147.72 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.139 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.16 127.99 56.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.39 129.72 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . 0.417 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.8 tm0? -136.17 168.22 19.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.53 46.89 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.47 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 10.7 mtm -113.86 124.99 30.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 110.88 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.315 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.98 -35.8 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 65.5 p -52.41 -25.49 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 74.7 t -57.5 141.69 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 67.0 m -143.76 174.21 11.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.5 mt -58.64 -42.12 84.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.17 -45.13 93.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -62.05 -44.1 97.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.24 -49.85 81.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.46 -41.62 80.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -71.91 -31.85 66.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.51 ' CD2' ' CD1' ' A' ' 992' ' ' ILE . 6.3 t80 -64.73 -35.78 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.09 17.38 14.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -50.59 142.99 9.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 100.28 -40.64 2.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 86.4 m-85 -89.57 148.52 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -81.62 79.57 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.92 124.23 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -53.54 129.39 53.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 111.171 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 131.54 21.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.39 84.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 955' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 956' ' ' VAL . 9.7 p -72.5 -54.8 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.0 t -35.59 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.13 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.5 m -116.73 110.94 19.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.53 134.19 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -92.69 130.53 38.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -120.1 159.35 24.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -102.88 176.2 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.02 -28.85 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -71.59 -33.0 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 110.5 -1.55 29.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.534 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.32 161.6 24.77 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.58 0.705 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 134.4 27.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 67.1 p -93.5 16.0 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 76.27 21.72 74.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . 0.417 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 24.4 mt-10 -121.9 145.03 48.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.16 150.39 31.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 14.9 mtm -129.82 140.44 51.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.465 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 34.7 m -137.54 165.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.48 149.57 44.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.463 ' CE1' HD11 ' A' ' 928' ' ' ILE . 13.5 m-85 -128.92 141.62 51.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.41 -37.5 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -105.12 132.29 51.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -63.27 -51.03 67.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.03 -33.35 67.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -44.69 77.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.13 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.7 m -62.6 -43.98 97.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.3 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.511 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -63.19 -39.53 94.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 988' ' ' ASN . 74.1 t -69.84 -50.21 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.96 -45.15 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 1.9 mt -122.31 33.08 5.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -85.54 131.34 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 54.89 43.57 29.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -84.45 133.53 44.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.607 0.717 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 90.51 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . 0.51 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 10.2 mt -90.46 126.26 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.47 -92.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 4.6 m -131.31 -3.09 3.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -133.89 161.29 35.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -90.03 142.29 27.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.47 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.2 m -99.97 149.75 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.23 125.7 54.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 77.1 mt -111.21 127.92 55.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 90.9 t -122.64 137.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 11.5 mt -77.45 127.94 33.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.913 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.862 0.276 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 28.5 m -97.98 127.71 44.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.84 126.69 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 974' ' ' PHE . 72.4 mt -105.37 147.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 128.46 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.8 122.92 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 170.03 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 932' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 996' ' ' LYS . 0.2 OUTLIER 65.48 47.67 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 933' ' ' MET . . . . . 0.488 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 19.2 mtm -114.87 129.25 25.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 168.53 21.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.724 2.283 . . . . 0.0 112.345 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -63.43 -35.92 82.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 75.0 p -52.44 -36.61 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 78.8 t -41.57 140.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.3 m -148.59 172.96 13.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.92 -42.13 77.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -45.94 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -63.34 -43.35 97.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.2 mt -63.3 -49.31 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.51 -41.95 91.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -71.21 -31.96 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 945' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 39.7 t80 -65.37 -37.1 85.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -88.84 11.49 17.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -48.04 145.68 2.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 96.06 -43.45 2.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 949' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 78.6 m-85 -90.99 132.51 35.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.359 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.07 93.29 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.73 124.88 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 952' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 953' ' ' PRO . 65.0 mt -51.53 134.34 34.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.632 0.73 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 953' ' ' PRO . . . . . 0.408 ' N ' HG23 ' A' ' 952' ' ' ILE . 53.3 Cg_endo -69.85 126.47 13.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.241 . . . . 0.0 112.33 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.17 12.69 78.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 68.2 p -83.78 -49.16 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 67.4 t -42.12 107.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 9.9 t -115.52 110.46 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 29.3 mt -88.16 131.92 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -101.47 132.47 47.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -123.67 157.58 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -67.03 -175.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.63 -9.71 57.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -32.58 12.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 127.9 -18.31 5.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 57.2 mtt -67.69 154.95 92.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.76 13.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 44.8 p -86.42 13.42 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 64.21 30.58 78.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.2 145.35 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.17 149.81 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 5.9 mtt -124.24 144.95 49.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 972' ' ' VAL . . . . . 0.432 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 16.6 m -139.31 165.62 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.57 155.55 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 974' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 928' ' ' ILE . 22.4 m-85 -136.1 140.79 44.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -72.3 -38.51 68.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 10.5 t -110.45 129.71 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -61.4 -41.87 97.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.85 -38.88 79.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.5 -44.14 83.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.29 77.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 8.3 m -63.45 -43.7 96.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.44 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 983' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.43 -39.57 89.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 988' ' ' ASN . 72.2 t -67.39 -48.82 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 82.7 mt -64.13 -45.64 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.25 -22.15 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 987' ' ' LEU . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.5 mt -117.15 18.92 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 988' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 984' ' ' VAL . 3.6 t-20 -80.5 134.57 35.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.6 40.61 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.69 130.69 52.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 82.91 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 10.1 mt -81.76 135.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 52.6 -91.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 2.7 m -133.77 -0.35 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -133.96 161.48 34.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 996' ' ' LYS . . . . . 0.448 ' O ' ' ND2' ' A' ' 932' ' ' ASN . 61.2 mttt -90.03 140.88 29.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 997' ' ' VAL . . . . . 0.488 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 1.2 m -102.95 151.08 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 125.23 52.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 41.9 mt -111.24 128.81 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.2 142.99 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 11.2 mt -80.28 132.7 35.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.545 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 47.1 t -72.9 103.77 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 39.2 t -68.0 102.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -98.33 129.52 9.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 83.1 p -81.9 135.75 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.861 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 87.8 p -133.34 173.59 11.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -131.7 -67.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -155.25 123.76 5.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 10.4 t -147.38 116.21 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 24.8 p -131.06 145.14 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -71.31 164.97 53.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 152.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.665 2.244 . . . . 0.0 112.343 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 109.02 -156.43 15.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 176.59 6.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.256 . . . . 0.0 112.331 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.4 m -92.07 117.39 29.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . 0.446 ' CD1' ' HB1' ' A' ' 973' ' ' ALA . 50.8 mm -96.45 127.31 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 974' ' ' PHE . 96.5 mt -105.54 148.09 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.406 ' N ' HG21 ' A' ' 928' ' ' ILE . 17.2 mtpp -113.15 124.39 52.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.43 130.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.08 170.46 16.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.79 50.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.493 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 3.3 mtm -117.04 132.56 23.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 167.81 23.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.73 2.287 . . . . 0.0 112.379 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.38 -29.88 70.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.5 p -59.28 -26.8 65.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.163 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 78.8 t -50.78 141.07 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 21.3 m -143.66 168.21 20.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.96 -42.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.96 -45.53 92.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.15 -43.24 99.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.2 mt -61.0 -49.51 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.4 mt -56.21 -41.44 75.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.83 -31.46 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.456 ' CD2' ' CD1' ' A' ' 992' ' ' ILE . 11.9 t80 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -91.9 17.3 9.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -52.21 151.89 3.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 89.69 -39.01 3.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -95.08 144.15 25.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.04 100.72 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.02 125.6 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . 0.472 ' CG2' ' HD2' ' A' ' 953' ' ' PRO . 53.1 mt -55.81 138.38 70.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.582 0.706 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 952' ' ' ILE . 54.0 Cg_endo -69.69 138.82 38.95 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.29 -9.03 22.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 60.5 p -63.61 -56.8 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 81.1 t -41.32 100.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -113.8 110.23 19.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.98 132.51 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.07 138.12 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -126.32 156.75 39.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 965' ' ' MET . 2.9 m-80 -67.95 -178.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.01 -34.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -72.41 -36.36 68.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 128.61 -14.05 6.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.43 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.447 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 29.7 mmt -66.5 157.04 84.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 129.55 17.79 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.4 p -92.51 5.8 49.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.4 23.96 77.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -123.9 145.89 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.35 152.78 34.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 10.1 mtm -127.03 143.69 51.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 2.7 m -137.6 163.61 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 927' ' ' ILE . . . -127.91 155.85 43.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 928' ' ' ILE . 42.1 m-85 -138.05 138.38 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.73 -31.28 64.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.9 t -117.57 130.05 56.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -63.21 -40.75 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . 0.451 ' OD1' ' CD ' ' A' ' 979' ' ' GLU . 0.5 OUTLIER -57.92 -40.04 79.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . 0.451 ' CD ' ' OD1' ' A' ' 978' ' ' ASP . 0.2 OUTLIER -67.29 -45.73 75.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.56 -48.8 79.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' THR . . . . . 0.403 HG23 ' CD1' ' A' ' 985' ' ' ILE . 4.0 m -63.35 -43.99 96.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.84 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.58 99.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 988' ' ' ASN . 92.9 t -61.84 -48.82 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . 0.403 ' CD1' HG23 ' A' ' 981' ' ' THR . 21.5 mt -65.0 -41.69 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.96 -24.18 59.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 66.1 mt -116.79 20.65 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.1 t-20 -80.64 120.54 24.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.8 t70 73.33 39.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -83.49 128.66 63.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 0.0 110.852 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 87.72 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.456 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 10.7 mt -85.98 123.28 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.71 -94.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 40.9 t -129.48 -3.15 4.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 0.0 110.797 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -133.49 156.61 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -87.29 143.31 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.493 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.4 m -101.12 151.04 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -115.22 125.2 53.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 48.7 mt -111.05 129.51 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.4 t -132.18 138.82 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.22 142.17 45.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -68.96 -74.94 0.57 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 41.9 p -63.66 152.56 38.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' 1006 ' ' SER . . . 114.57 -178.66 18.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.52 9.43 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.655 -1.81 . . . . 0.0 112.34 0.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1006 ' ' SER . . . . . 0.401 ' N ' ' HA2' ' A' 1004 ' ' GLY . 10.7 t -76.74 125.33 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 3.2 m -98.69 123.23 42.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.84 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 98.2 p -125.31 108.07 11.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.364 . . . . 0.0 110.883 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 37.7 p -55.16 127.38 28.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.05 43.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 38.4 t -134.11 86.26 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 25.2 t -54.01 159.52 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -77.03 -149.08 3.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -131.88 42.59 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 11.7 t -166.02 128.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 3.8 m -71.85 102.02 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 53.31 176.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.411 ' HD3' ' N ' ' A' ' 922' ' ' LYS . 2.1 mppt? -129.52 148.15 68.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 109.22 2.26 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.25 10.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.487 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 177.35 5.69 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.695 2.263 . . . . 0.0 112.3 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.42 125.29 37.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.67 125.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.565 HD11 ' CE1' ' A' ' 974' ' ' PHE . 86.9 mt -109.61 143.04 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.437 ' N ' HG21 ' A' ' 928' ' ' ILE . 3.5 mppt? -112.19 127.87 56.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 999' ' ' LEU . 40.6 t -108.21 128.62 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.457 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -133.67 169.77 16.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.75 47.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.459 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 10.7 mtm -114.9 134.27 22.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.521 0.676 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 174.22 9.75 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.89 -26.02 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.5 p -62.52 -31.43 72.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 88.6 t -45.64 151.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 19.1 m -158.19 172.53 18.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.9 mt -57.95 -41.86 81.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.156 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.17 -44.34 95.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.33 -43.45 90.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.08 -48.24 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -57.76 -42.03 83.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.35 -31.54 67.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 4.0 t80 -65.73 -35.87 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -91.51 11.91 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -49.33 149.27 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.0 -39.83 2.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.492 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -94.56 150.76 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.88 83.12 8.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.19 130.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.15 129.4 79.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.644 0.735 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 133.68 26.09 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.297 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 84.35 -4.4 83.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 956' ' ' VAL . 10.1 p -75.25 -56.22 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 955' ' ' SER . 94.3 t -37.25 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -119.03 114.4 22.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.28 129.88 34.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -93.41 127.49 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -116.86 160.19 21.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 965' ' ' MET . 3.4 m-80 -79.38 -178.79 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -58.49 -36.23 73.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -74.63 -27.68 60.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 119.51 -18.66 10.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.46 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 6.8 mmt -58.86 158.17 17.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 127.47 14.62 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 0.0 112.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 71.2 p -87.12 8.77 22.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 61.92 30.07 74.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.457 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 25.4 mt-10 -134.2 146.1 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.04 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 34.5 mtp -122.04 147.44 46.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 3.6 m -140.84 165.32 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -130.98 148.48 52.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.565 ' CE1' HD11 ' A' ' 928' ' ' ILE . 30.1 m-85 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.86 -33.35 45.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.5 m -108.49 128.53 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -61.83 -49.96 74.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.04 -35.71 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -45.12 78.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.29 -47.85 77.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' THR . . . . . 0.45 HG22 ' CD1' ' A' ' 985' ' ' ILE . 4.6 m -62.71 -42.48 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.1 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.75 -43.98 94.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.106 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 988' ' ' ASN . 68.9 t -66.75 -47.93 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . 0.45 ' CD1' HG22 ' A' ' 981' ' ' THR . 58.2 mt -61.9 -45.55 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 15.2 mt -120.67 30.5 6.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -88.05 136.66 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.6 p30 49.68 43.3 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -86.05 134.04 39.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 92.27 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.436 HD12 ' CG1' ' A' ' 997' ' ' VAL . 12.5 mt -89.98 126.73 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.83 -90.57 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.6 m -133.54 -0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -134.05 162.04 33.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -90.9 144.03 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.459 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.8 m -105.0 151.1 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . 0.427 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 0.1 OUTLIER -115.47 127.31 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 79.3 mt -110.98 133.9 53.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.427 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 60.0 t -126.39 141.75 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -81.18 137.06 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1002 ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' 1003 ' ' SER . . . -48.42 165.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1003 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1002 ' ' GLY . 83.7 p -34.65 149.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -146.61 -162.88 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -48.45 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 -1.814 . . . . 0.0 112.318 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 3.6 m -140.73 154.54 46.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 78.3 p -67.56 139.23 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.821 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.461 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 25.9 m -115.97 125.71 52.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.6 m -89.36 164.48 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 164.68 98.19 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.3 p -94.42 158.61 15.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 26.1 p -163.42 122.02 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 89.94 -61.72 3.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -89.69 40.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.4 m -65.04 -55.92 16.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 20.3 t -56.34 124.51 18.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -84.64 176.11 50.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -136.0 142.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 115.4 4.07 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 158.17 -155.01 26.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.553 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 171.33 14.69 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.8 m -92.02 133.94 35.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 32.7 mm -101.91 128.52 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.441 ' HB ' ' CG2' ' A' ' 972' ' ' VAL . 63.2 mt -105.07 144.54 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -111.46 128.36 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.59 127.98 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.465 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -138.14 164.77 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.38 45.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.5 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 14.3 mtm -115.18 133.02 22.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 170.98 15.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.351 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -67.0 -35.73 80.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 68.6 p -53.24 -30.03 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 938' ' ' SER . 80.3 t -49.82 143.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 938' ' ' SER . . . . . 0.418 ' N ' HG13 ' A' ' 937' ' ' VAL . 17.8 m -147.9 170.61 17.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.05 -42.12 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.24 -45.99 89.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.02 -44.5 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.17 -49.68 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -56.03 -41.99 75.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.83 -30.16 65.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 1.3 t80 -66.22 -34.92 79.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -90.91 8.49 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -41.7 148.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.61 -42.95 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.546 ' CE2' HD13 ' A' ' 987' ' ' LEU . 45.8 m-85 -91.65 146.07 24.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -82.61 85.98 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.25 125.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.3 mt -50.86 130.25 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.714 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 125.24 11.91 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.95 65.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 5.2 p -84.52 -45.5 12.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.87 100.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.3 t -114.36 108.05 16.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 37.7 mt -80.34 142.08 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 129.24 54.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.05 175.75 5.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.41 ' CG ' HG21 ' A' ' 967' ' ' THR . 65.7 m-80 -91.13 -175.01 4.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.06 -6.64 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -100.4 -36.78 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.37 -3.31 5.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 31.2 mtp -86.03 151.56 54.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.44 13.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.7 2.267 . . . . 0.0 112.345 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' THR . . . . . 0.41 HG21 ' CG ' ' A' ' 961' ' ' ASN . 9.3 p -86.02 12.89 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 63.59 30.49 77.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.465 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 27.5 mt-10 -126.2 146.01 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.11 33.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtt -131.41 141.28 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.441 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 28.5 m -136.9 165.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.68 50.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.64 137.37 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -69.86 -34.7 73.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 4.1 m -107.85 125.84 51.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -61.5 -48.19 82.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.04 -36.97 71.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.74 84.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.16 80.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 4.3 m -60.66 -43.59 97.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.71 99.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.28 -40.27 95.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 988' ' ' ASN . 71.9 t -66.48 -48.61 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.05 -43.78 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.77 -21.44 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 4.1 mt -120.41 24.27 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -85.65 135.39 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 55.65 41.71 30.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -84.63 131.62 49.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.8 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 994' ' ' SER . 13.9 mt -82.15 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 48.81 -92.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 992' ' ' ILE . 58.4 m -132.48 -1.25 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.04 160.76 36.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.2 143.83 26.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.5 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.1 m -104.85 151.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -114.39 126.27 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.457 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 82.8 mt -111.31 127.85 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' 1001 ' ' LEU . 43.4 t -124.94 139.72 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1001 ' ' LEU . . . . . 0.408 ' N ' HG13 ' A' 1000 ' ' VAL . 12.9 mt -76.04 128.37 34.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -40.58 -60.98 1.95 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.45 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 77.7 p -162.64 134.14 5.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 0.0 110.885 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.417 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 166.88 172.38 34.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' 1004 ' ' GLY . 54.1 Cg_endo -69.81 -23.93 8.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.337 0.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 86.1 p -135.82 140.95 44.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 30.6 t -143.57 117.03 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 44.0 m -126.28 -45.79 1.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 22.5 t 60.72 42.04 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 71.2 -134.35 22.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 38.2 m -40.77 160.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 2.1 m -86.37 130.7 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 153.62 160.06 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -98.89 174.31 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.762 0.315 . . . . 0.0 111.096 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 33.0 p -124.89 -49.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 6.8 t 60.35 47.45 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 45.0 -127.3 7.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . 0.4 ' NZ ' ' HA3' ' A' 1002 ' ' GLY . 0.0 OUTLIER -157.76 152.49 20.93 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.61 0.719 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 171.86 13.63 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 87.61 -157.83 29.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 27.0 m -92.32 130.72 37.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.0 mm -103.84 125.46 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 974' ' ' PHE . 75.6 mt -105.56 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.99 125.38 54.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.67 124.54 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.26 171.46 12.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.09 49.35 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.465 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 16.9 mtm -115.79 127.03 27.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 166.4 27.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.72 -40.5 88.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 70.8 p -48.11 -27.7 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.71 135.53 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 34.3 m -143.86 171.64 13.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 56.0 mt -57.22 -42.07 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.1 -45.99 89.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.48 -43.96 88.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 33.0 mt -61.1 -49.75 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.64 -41.78 77.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.35 -31.42 67.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 8.2 t80 -66.01 -34.4 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.23 12.93 22.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.58 150.41 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.61 -32.94 5.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.446 ' CD2' ' HB1' ' A' ' 983' ' ' ALA . 95.8 m-85 -102.22 137.61 40.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.56 89.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 88.2 t -85.43 123.09 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . 0.415 HD12 ' C ' ' A' ' 973' ' ' ALA . 96.7 mt -51.66 129.48 35.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 125.56 12.29 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 0.0 112.317 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.75 -9.82 75.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 28.5 p -66.92 -49.13 66.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.843 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -43.87 107.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 t -118.95 118.28 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 65.2 mt -91.09 127.12 36.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -98.03 130.37 44.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -112.14 -175.31 2.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 965' ' ' MET . 2.7 p30 -107.39 -177.01 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.12 -34.57 73.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.75 -35.76 75.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 120.64 -2.6 12.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.464 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 3.0 mmt -83.7 155.76 65.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 127.48 14.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.264 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.9 p -86.46 27.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 48.32 38.7 20.03 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.5 145.32 40.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.71 151.12 31.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 49.5 mtp -122.57 142.71 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 13.3 m -135.26 164.08 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . 0.415 ' C ' HD12 ' A' ' 952' ' ' ILE . . . -128.49 146.74 50.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 928' ' ' ILE . 36.0 m-85 -129.87 139.51 51.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.17 -35.88 66.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.3 m -105.4 127.57 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -64.22 -47.79 78.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.11 -34.77 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.69 -47.61 68.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.59 73.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 985' ' ' ILE . 7.4 m -64.41 -43.75 93.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.27 89.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 949' ' ' TYR . . . -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 988' ' ' ASN . 90.4 t -66.05 -49.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . 0.406 ' CD1' HG21 ' A' ' 981' ' ' THR . 33.2 mt -59.02 -46.0 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.64 -27.95 61.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.7 mt -112.46 28.06 9.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.13 128.8 36.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.6 t0 59.84 42.67 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 5.3 mtp85 -86.51 133.38 40.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.827 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 85.7 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.37 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.43 HD13 ' CE2' ' A' ' 945' ' ' PHE . 7.4 mt -85.7 134.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.47 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 10.0 p -131.97 -2.41 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -134.02 161.49 34.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -88.65 142.88 27.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 3.0 m -104.43 151.04 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -115.73 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 80.1 mt -112.24 131.5 55.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.0 t -123.98 148.87 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.3 mt -91.1 129.58 37.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1002 ' ' GLY . . . . . 0.4 ' HA3' ' NZ ' ' A' ' 922' ' ' LYS . . . -61.92 -47.21 91.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 31.7 t -115.59 126.84 54.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.918 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 127.22 -163.23 21.12 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.64 0.18 OUTLIER 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.335 0.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1006 ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' 1007 ' ' SER . 36.8 m -92.45 89.9 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.824 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' 1006 ' ' SER . 75.7 p 34.52 44.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 5.0 t -140.6 131.29 25.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.902 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 17.9 m -112.06 139.01 47.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -110.35 94.89 0.82 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 1.5 p -98.02 41.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.837 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.3 t -168.28 115.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -114.81 113.71 3.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -97.51 -38.8 9.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.335 . . . . 0.0 111.151 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 15.5 m -165.34 107.78 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.4 p -60.74 125.27 23.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 60.68 135.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.18 140.85 31.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.534 0.683 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 88.4 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.44 26.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 54.0 Cg_endo -69.73 171.55 14.22 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 57.2 m -95.03 121.44 36.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 6.7 mm -92.25 128.33 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 984' ' ' VAL . 77.6 mt -105.03 148.35 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -115.46 121.58 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.66 129.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.47 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.4 tm0? -134.38 170.24 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 50.12 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.495 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 8.6 mtm -116.79 128.28 26.13 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.614 0.721 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 174.42 9.52 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.41 -37.89 86.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -50.96 -30.57 15.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 92.0 t -52.24 125.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.9 m -131.28 171.54 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.79 -42.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.113 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.1 -45.77 90.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.38 -43.34 97.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.98 -49.98 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.76 -41.5 86.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.98 -31.46 66.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 945' ' ' PHE . 5.4 t80 -66.08 -35.19 79.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.12 11.31 23.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -48.36 149.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 93.25 -39.93 2.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 89.6 m-85 -95.33 141.17 29.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -71.77 100.2 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.4 t -95.9 124.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 87.3 mt -52.75 131.11 47.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.639 0.733 . . . . 0.0 111.115 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.11 18.78 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.374 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.49 -7.21 77.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.6 p -68.01 -55.44 12.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.1 t -35.63 112.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 27.5 m -124.07 119.2 28.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 40.8 mt -87.21 132.31 33.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -93.32 137.69 32.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 66.2 m-85 -125.87 -178.62 4.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 964' ' ' GLY . 0.3 OUTLIER -121.47 177.78 5.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -40.68 -53.15 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -64.57 -27.7 69.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 111.03 -21.75 22.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 37.7 mmt -54.53 152.98 11.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.54 0.686 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 134.65 28.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 35.5 p -97.42 25.98 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 52.79 38.06 53.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.47 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 9.5 mt-10 -138.31 145.69 41.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.55 151.25 32.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 31.8 mtp -125.11 142.73 51.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 29.2 m -138.68 165.33 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -127.97 150.77 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 925' ' ' PRO . 36.4 m-85 -131.8 142.96 49.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.45 -34.03 60.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 26.6 t -109.62 124.93 51.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.2 ttp-105 -61.74 -44.01 97.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.24 -37.33 74.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.83 -42.46 81.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.86 76.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.3 m -64.75 -43.92 91.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.91 95.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.509 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.11 -43.64 86.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 988' ' ' ASN . 91.3 t -60.29 -48.12 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.25 -44.84 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 47.2 mt -119.91 20.07 12.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.2 t-20 -79.82 127.19 31.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 64.62 41.83 5.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -84.36 131.79 49.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 83.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 10.9 mt -82.39 127.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.9 -93.86 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 23.1 p -131.78 -0.26 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.886 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -133.67 163.45 29.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -91.79 143.36 26.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.2 m -106.04 151.1 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -113.48 126.07 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.93 128.0 55.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' 1001 ' ' LEU . 59.5 t -132.9 142.13 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1001 ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' 1000 ' ' VAL . 13.7 mt -72.93 140.84 47.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -84.99 47.29 3.83 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 37.4 m -67.62 -55.08 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -58.52 -176.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 163.43 81.85 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 -1.808 . . . . 0.0 112.366 0.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 70.3 m -143.46 116.53 8.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 3.6 t -84.12 125.07 31.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.457 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 28.8 p -69.69 137.08 51.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.838 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.5 m -111.78 163.25 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 149.43 -72.1 0.3 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.529 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 80.7 p -52.23 -20.31 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.846 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 11.6 m -105.89 -63.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 114.61 -157.44 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -122.22 138.07 54.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 47.0 t -76.12 120.81 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.853 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.6 m -145.02 129.84 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 157.6 -169.97 34.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -64.68 153.36 87.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.583 0.706 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.12 2.49 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.69 2.26 . . . . 0.0 112.317 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -121.43 -153.11 8.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.518 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 170.3 16.94 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.233 . . . . 0.0 112.349 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.4 m -92.13 125.28 36.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.5 mm -99.39 126.58 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' A' ' 974' ' ' PHE . 95.7 mt -105.59 145.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -111.44 133.94 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.15 127.97 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.24 170.17 16.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.88 51.74 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.476 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 21.6 mtm -118.64 129.84 25.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.46 ' HD2' ' CG2' ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.79 171.43 14.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.703 2.269 . . . . 0.0 112.333 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -63.68 -37.47 87.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 67.0 p -52.07 -34.1 42.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . 0.46 ' CG2' ' HD2' ' A' ' 934' ' ' PRO . 76.2 t -48.54 122.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 4.6 m -130.62 176.15 8.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.9 -41.96 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.147 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.02 -45.9 90.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.56 -45.0 96.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.14 -50.0 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.11 -42.03 84.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.562 ' CD2' HD13 ' A' ' 992' ' ' ILE . 8.5 t80 -66.69 -31.14 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -97.0 12.17 33.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -50.51 152.88 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.04 -37.57 3.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.555 ' CE2' HD11 ' A' ' 987' ' ' LEU . 57.0 m-85 -96.37 127.83 42.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -60.78 97.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.68 122.36 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 89.7 mt -48.23 130.06 12.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 123.52 10.17 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.5 -2.62 74.16 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.0 p -72.33 -53.33 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 955' ' ' SER . 99.3 t -37.04 105.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.26 114.6 22.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.72 137.47 34.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.957 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -95.48 139.28 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.897 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -132.54 161.5 33.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -95.96 -175.7 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -50.48 -51.52 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . 0.407 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 37.3 mmtt -56.48 -44.11 80.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 126.88 -4.56 7.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 43.8 mtm -73.38 153.62 90.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 128.34 15.93 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.732 2.288 . . . . 0.0 112.369 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 65.0 p -90.32 37.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.14 40.53 1.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -140.97 146.97 38.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 3.2 mtt -122.62 143.69 49.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.63 160.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -122.32 153.8 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.058 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.442 ' CD1' HD11 ' A' ' 928' ' ' ILE . 32.0 m-85 -134.5 141.14 46.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.821 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.13 -37.41 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 19.0 m -108.06 126.12 52.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -61.01 -45.75 93.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -57.39 -38.88 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.94 -44.12 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.28 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 10.0 m -64.27 -43.37 95.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.43 89.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.91 -39.17 93.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 988' ' ' ASN . 75.4 t -64.63 -49.08 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.45 -46.54 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -23.73 59.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 949' ' ' TYR . 14.8 mt -115.47 25.94 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.1 t-20 -91.45 128.57 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.93 40.63 15.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 8.2 mtp85 -86.2 133.33 40.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.845 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 85.51 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.562 HD13 ' CD2' ' A' ' 945' ' ' PHE . 8.8 mt -84.44 125.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.85 -92.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 5.1 m -129.28 -5.76 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -133.08 156.25 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -86.42 143.33 27.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.476 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.8 m -101.1 151.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . 0.404 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 1.7 tmmm? -116.26 128.29 55.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.01 138.43 47.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.404 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 47.3 t -133.84 137.14 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.131 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.6 mt -73.81 136.36 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -81.39 61.36 4.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 12.0 t -155.15 137.09 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.929 0.395 . . . . 0.0 110.89 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.411 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 151.07 172.04 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.411 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.5 Cg_endo -69.79 123.93 7.22 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.738 -1.776 . . . . 0.0 112.292 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 5.3 t -59.31 98.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 58.1 m -115.63 115.73 26.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 913' ' ' SER . 4.5 m 38.95 42.17 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 110.845 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 912' ' ' SER . 33.6 t -35.96 128.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -86.31 167.95 39.92 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.6 t -88.5 131.23 34.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 26.7 p -159.75 174.28 14.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -150.72 104.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -84.58 79.92 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 54.0 m -120.76 129.56 53.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 7.4 t 71.61 42.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.863 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -68.59 -151.36 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -110.48 142.71 26.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 179.16 3.88 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 128.19 167.18 12.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.455 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 171.63 14.04 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.683 2.255 . . . . 0.0 112.391 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 12.0 m -92.77 119.67 32.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 973' ' ' ALA . 38.7 mm -97.89 125.15 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.156 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.565 HD12 ' CE1' ' A' ' 974' ' ' PHE . 98.3 mt -104.98 143.49 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -111.85 130.58 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.5 t -112.02 131.34 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.462 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.68 167.23 21.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.08 53.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.496 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 6.1 mtm -121.32 128.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 156.49 63.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.324 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -54.29 -33.53 58.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.2 p -53.24 -34.69 58.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 88.4 t -46.81 137.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 5.7 m -140.5 175.69 9.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.83 -41.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.19 -45.82 89.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.08 -38.18 87.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.21 -49.1 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.24 -41.68 84.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.72 -30.75 65.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 987' ' ' LEU . 7.0 t80 -64.92 -39.06 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -87.22 13.17 10.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.66 148.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.89 2.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 983' ' ' ALA . 90.7 m-85 -92.01 134.87 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -72.14 84.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.4 t -74.66 123.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.43 129.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.645 2.23 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.19 6.1 84.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 957' ' ' CYS . 81.5 p -87.07 -55.54 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 955' ' ' SER . 48.2 t -35.99 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 955' ' ' SER . 3.0 t -112.62 126.07 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 138.04 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -94.51 123.92 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 92.3 m-85 -111.6 175.08 5.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.96 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.39 -18.47 28.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -35.97 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 120.08 -15.13 10.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 77.9 mmm -69.2 155.73 92.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 137.73 36.26 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -100.38 0.27 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 81.73 31.52 32.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.462 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 12.4 mt-10 -128.98 146.88 50.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.91 142.2 23.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 28.4 mtp -120.97 142.89 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 4.1 m -137.45 166.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 927' ' ' ILE . . . -129.55 150.1 51.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.565 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -129.95 157.21 42.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -82.31 -42.95 18.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 20.4 m -117.44 139.07 51.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.1 mtp85 -61.29 -36.6 80.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -58.08 -43.44 87.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -45.14 78.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.72 79.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -62.36 -43.98 97.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.78 89.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 949' ' ' TYR . . . -60.59 -40.93 93.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 988' ' ' ASN . 86.5 t -64.76 -50.23 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.25 -45.03 99.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -22.29 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.462 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 8.9 mt -119.86 29.18 7.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.959 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.0 OUTLIER -89.96 128.61 36.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.71 43.09 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -85.78 131.63 46.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 110.885 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.99 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.745 2.296 . . . . 0.0 112.315 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 16.1 mt -81.26 126.91 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.58 -92.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 17.2 t -132.82 -1.13 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -132.76 163.48 28.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -92.53 141.0 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.496 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.4 m -102.6 151.08 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.57 128.17 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 78.7 mt -111.16 131.08 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.921 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 57.6 t -124.79 143.03 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 19.4 mt -82.36 134.82 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -60.82 -124.27 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 7.9 t -48.78 177.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.945 0.402 . . . . 0.0 110.883 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 76.79 79.94 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 161.07 87.16 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.349 0.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 80.1 p -86.73 -175.26 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 9.0 t -139.14 179.7 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 65.7 m -127.85 138.74 52.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 33.6 m -63.41 115.58 4.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 174.02 69.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 66.8 m -48.73 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 4.6 t -71.48 136.67 47.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 153.68 66.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -43.91 130.97 5.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 4.4 m -82.36 45.67 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.805 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 4.8 m -57.35 160.75 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -159.24 156.8 27.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 143.71 63.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 114.25 3.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.347 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 154.21 -151.28 22.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.5 Cg_endo -69.83 169.03 19.96 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 50.7 m -101.13 132.99 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 30.3 mm -100.6 128.0 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.545 HD11 ' CE1' ' A' ' 974' ' ' PHE . 75.7 mt -108.55 145.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.449 ' N ' HG22 ' A' ' 928' ' ' ILE . 4.1 mtpm? -114.76 131.48 56.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.29 126.92 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.116 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 167.21 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.07 50.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.465 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 23.8 mtm -119.3 130.59 24.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 158.49 56.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -56.63 -33.46 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 47.8 p -53.11 -32.39 47.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 938' ' ' SER . 94.2 t -49.71 140.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 938' ' ' SER . . . . . 0.406 ' N ' HG13 ' A' ' 937' ' ' VAL . 72.7 m -145.93 172.96 12.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.81 -42.01 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.12 -46.05 89.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -65.61 -45.27 83.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . 0.452 ' CD1' HD23 ' A' ' 958' ' ' LEU . 38.5 mt -61.01 -48.48 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.4 mt -58.45 -42.02 86.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.55 -31.2 66.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 945' ' ' PHE . 2.9 t80 -65.02 -41.24 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -81.41 7.7 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -41.28 149.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.32 -40.62 2.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 92.2 m-85 -97.25 130.91 44.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.58 92.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.5 t -78.04 125.68 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 75.9 mt -54.18 133.83 60.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.614 0.721 . . . . 0.0 111.156 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 147.17 62.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.356 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.33 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 2.2 m -93.37 -56.21 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.87 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.0 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.99 129.17 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.452 HD23 ' CD1' ' A' ' 942' ' ' ILE . 45.1 mt -94.84 139.21 31.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -93.5 131.58 38.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -115.09 160.22 19.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.556 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.0 OUTLIER -99.68 -176.41 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.33 -47.43 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -24.77 66.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . 0.556 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 117.08 -28.67 7.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.462 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 7.5 ptp -57.82 153.64 31.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.44 17.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.704 2.269 . . . . 0.0 112.358 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 38.8 p -83.97 26.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 56.35 33.04 61.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -129.11 147.96 51.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.69 147.08 26.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.5 mtt -123.0 141.82 51.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 18.9 m -139.3 164.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.49 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 928' ' ' ILE . 23.1 m-85 -128.2 148.09 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.16 -35.99 61.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 9.4 t -115.82 134.61 54.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . 0.404 ' NH2' ' HB3' ' A' 1005 ' ' PRO . 52.6 ttp85 -61.26 -39.91 92.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -41.68 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -62.67 -45.17 94.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.03 -49.36 77.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.9 m -62.75 -44.0 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.92 92.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -62.59 -38.06 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 988' ' ' ASN . 84.9 t -66.04 -49.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 32.9 mt -60.95 -47.61 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.93 -21.55 61.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 999' ' ' LEU . 8.2 mt -119.37 27.23 8.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.92 129.65 36.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 60.48 41.46 15.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -84.13 130.89 52.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.617 0.722 . . . . 0.0 110.826 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 84.46 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.475 HD11 ' CE2' ' A' ' 945' ' ' PHE . 9.0 mt -84.39 130.66 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.52 -94.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 12.8 t -129.35 -0.87 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -133.96 163.67 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -93.07 143.28 26.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 3.8 m -101.89 149.89 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.26 127.1 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 78.9 mt -111.73 131.08 55.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.858 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' 1001 ' ' LEU . 47.2 t -120.67 140.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1001 ' ' LEU . . . . . 0.456 ' N ' HG13 ' A' 1000 ' ' VAL . 13.4 mt -81.22 122.89 27.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -46.79 -81.96 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 67.7 m -149.13 163.41 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.94 0.4 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 150.89 178.01 25.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.459 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.404 ' HB3' ' NH2' ' A' ' 977' ' ' ARG . 53.8 Cg_endo -69.76 158.17 91.29 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.362 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 30.2 t -72.24 110.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 19.3 m -83.87 -59.0 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.837 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 4.0 m -116.13 99.06 6.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.911 0.386 . . . . 0.0 110.888 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.5 t -58.05 149.99 22.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 75.52 157.93 6.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 52.1 m -120.18 -56.89 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 87.2 p -46.42 111.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -179.91 159.89 24.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -113.42 137.8 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 7.8 t -82.47 99.81 9.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.3 t -94.06 93.93 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -66.52 123.37 22.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -161.79 139.81 6.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.554 0.692 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 174.11 9.98 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 146.15 178.95 21.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . 0.439 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.6 Cg_endo -69.76 169.58 18.57 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.354 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.4 m -94.28 117.13 29.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . 0.45 ' CD1' ' HB1' ' A' ' 973' ' ' ALA . 27.4 mm -91.35 125.27 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.562 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.8 mt -105.18 147.95 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.454 ' N ' HG22 ' A' ' 928' ' ' ILE . 37.1 mtmt -111.29 131.39 55.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.54 125.03 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 171.27 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.7 47.76 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.466 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 18.3 mtm -111.47 125.75 29.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 159.38 53.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.664 2.243 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -56.9 -32.94 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.4 p -55.04 -30.94 60.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 938' ' ' SER . 75.3 t -48.31 145.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 938' ' ' SER . . . . . 0.442 ' N ' HG12 ' A' ' 937' ' ' VAL . 33.4 m -153.64 173.19 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.92 -42.16 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -46.06 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -65.61 -46.13 80.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.02 -46.27 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.6 mt -57.97 -41.92 83.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.91 -34.21 68.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 3.9 t80 -61.81 -37.15 83.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.17 23.58 6.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -60.61 161.23 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 80.69 -41.89 2.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 79.6 m-85 -85.25 135.52 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.89 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -65.59 83.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.64 119.85 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.64 132.14 13.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.613 0.721 . . . . 0.0 111.15 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 111.62 2.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 0.0 112.357 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.81 31.72 9.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.466 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 956' ' ' VAL . 81.0 p -103.58 -53.86 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 955' ' ' SER . 86.7 t -34.62 114.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 8.5 t -119.93 112.7 19.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 44.5 mt -81.85 131.59 35.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -95.48 138.69 32.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . 0.419 ' C ' HG22 ' A' ' 967' ' ' THR . 90.6 m-85 -128.7 171.87 11.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.7 OUTLIER -100.19 -179.07 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -50.81 -47.1 60.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -43.53 96.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . 0.415 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.91 -27.34 3.19 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.476 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 158.43 1.89 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 137.55 35.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.331 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' THR . . . . . 0.419 HG22 ' C ' ' A' ' 960' ' ' TYR . 82.5 p -100.76 37.47 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 967' ' ' THR . . . 37.07 39.14 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -141.79 145.59 34.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.94 148.56 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.0 mtt -119.0 143.18 47.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.436 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 23.8 m -135.39 160.53 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 927' ' ' ILE . . . -123.39 147.15 47.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -129.14 137.71 51.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.66 -34.02 64.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.8 m -108.81 130.99 55.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -61.77 -48.91 78.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -56.91 -39.17 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -63.32 -44.44 94.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.02 73.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' THR . . . . . 0.455 HG22 ' CD1' ' A' ' 985' ' ' ILE . 24.3 m -64.51 -43.41 94.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.14 93.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.68 -41.91 98.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 988' ' ' ASN . 84.1 t -66.28 -49.76 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . 0.455 ' CD1' HG22 ' A' ' 981' ' ' THR . 41.7 mt -58.66 -46.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.66 -30.31 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 12.5 mt -109.5 28.87 8.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -89.48 133.57 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 22.9 t70 54.37 43.44 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -87.85 130.16 47.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 94.61 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.517 HD11 ' CD2' ' A' ' 945' ' ' PHE . 15.7 mt -92.59 124.47 45.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.08 -90.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 9.5 t -131.34 -3.38 3.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.809 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -134.11 154.3 51.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -88.82 140.54 29.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 4.9 m -100.1 150.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.0 129.42 56.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 81.7 mt -110.93 128.66 55.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' 1001 ' ' LEU . 89.3 t -123.39 137.93 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1001 ' ' LEU . . . . . 0.434 ' N ' HG12 ' A' 1000 ' ' VAL . 11.9 mt -71.55 134.27 46.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -57.94 -166.77 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 21.8 t -108.97 127.59 54.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.832 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 70.35 -162.74 53.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 135.47 33.85 Favored 'Cis proline' 0 C--O 1.231 0.141 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.364 0.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 72.9 p -45.47 130.01 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 13.6 t -64.06 136.13 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.454 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 21.4 m -147.83 157.11 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 110.859 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 41.3 p -54.55 -46.81 73.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 153.44 -162.66 30.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 92.0 p -155.11 169.51 23.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.9 t -105.77 142.42 35.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 61.0 -162.79 22.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -94.72 102.74 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 13.6 p -48.05 151.17 1.01 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.1 m -140.75 131.48 25.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -139.37 -161.59 8.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -147.22 146.94 27.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.6 0.714 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -176.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.659 2.239 . . . . 0.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 106.65 -145.64 15.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 175.73 7.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 29.9 m -91.93 125.78 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.52 127.86 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.432 HD13 ' CE1' ' A' ' 974' ' ' PHE . 65.7 mt -107.33 146.46 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -113.5 130.09 56.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.64 127.23 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.438 ' HG3' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -131.71 172.48 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 49.23 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.523 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 16.7 mtm -114.44 129.2 25.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 167.52 24.25 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.69 -25.0 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 64.8 p -63.88 -21.78 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.48 139.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.0 m -144.41 177.81 8.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.03 -42.17 92.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -63.29 -46.05 88.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.47 -45.29 93.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 24.1 mt -60.98 -49.64 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.03 -42.0 89.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -72.07 -31.18 65.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 38.6 t80 -65.25 -38.43 90.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -87.91 10.96 17.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -47.03 145.58 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 99.07 -32.51 7.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 87.5 m-85 -103.57 143.78 32.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.12 87.03 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.46 127.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.7 mt -55.48 132.71 70.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 0.0 111.163 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 132.74 23.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.3 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.12 85.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 956' ' ' VAL . 24.6 p -82.16 -60.39 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.824 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 955' ' ' SER . 98.0 t -34.79 112.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 13.5 m -124.43 125.49 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.9 146.57 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -100.26 135.76 41.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -128.74 160.67 31.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 965' ' ' MET . 49.4 p-10 -98.81 -177.05 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.93 -41.39 61.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -67.1 -33.67 75.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 113.16 -1.32 25.43 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.458 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 8.7 ptp -80.1 151.96 73.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 133.34 25.37 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -95.45 22.23 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.88 38.87 93.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.438 ' CG ' ' HG3' ' A' ' 931' ' ' GLN . 8.1 mt-10 -138.7 145.46 40.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -147.88 145.66 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 40.8 mtp -119.45 138.7 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.1 163.29 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -125.06 155.14 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.432 ' CE1' HD13 ' A' ' 928' ' ' ILE . 24.1 m-85 -133.18 144.71 50.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.43 -34.92 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.4 t -115.85 131.62 56.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -63.23 -38.13 89.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.9 -41.43 96.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.51 -46.79 78.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.78 -48.22 70.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.6 m -64.87 -43.65 92.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.96 94.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.72 -40.01 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 988' ' ' ASN . 81.4 t -66.03 -48.57 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.04 -44.55 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.5 -26.42 59.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 15.1 mt -115.34 27.39 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.86 127.9 35.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.5 t70 61.0 41.74 13.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . 0.403 ' HD3' ' CE1' ' A' ' 945' ' ' PHE . 15.3 mtp85 -87.17 134.63 36.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.72 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 85.64 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.321 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 7.5 mt -83.69 128.85 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.03 -92.97 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.5 t -131.6 -2.74 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -133.73 158.52 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -85.91 143.88 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.523 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 0.2 OUTLIER -104.98 151.03 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.22 125.12 53.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 71.2 mt -111.04 132.32 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 23.3 t -128.14 143.34 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.5 mt -78.67 134.38 37.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -52.97 126.19 32.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 20.8 t -87.33 97.0 10.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 160.62 176.07 32.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 169.52 63.21 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.349 0.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 15.8 t -105.57 96.75 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 5.4 t -101.76 94.34 5.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.565 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 67.5 m -95.39 103.85 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 97.2 p -98.67 110.42 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 70.85 -131.15 20.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 39.4 p -169.74 175.95 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 48.4 t -49.6 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -44.55 123.47 5.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -132.03 129.34 39.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 10.0 t -130.76 141.97 50.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.7 p -97.2 65.53 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -178.62 137.27 3.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -57.32 144.26 71.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.586 0.708 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 167.14 25.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.366 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -117.35 -170.27 15.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.18 25.24 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 0.0 112.314 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 5.1 m -98.31 119.52 37.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 973' ' ' ALA . 49.9 mm -91.36 129.19 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.531 HD13 ' CE1' ' A' ' 974' ' ' PHE . 95.8 mt -104.99 148.97 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 9.6 t -109.44 128.11 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.468 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.54 170.19 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.01 47.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.469 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 6.9 mtm -114.12 130.7 23.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.697 . . . . 0.0 110.895 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 170.19 17.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -68.91 -28.8 66.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.7 p -59.46 -30.12 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.16 155.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 10.0 m -162.32 170.96 18.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.89 -45.54 92.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.13 -39.32 92.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.77 -49.48 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.01 -41.56 83.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 987' ' ' LEU . 25.8 t80 -65.05 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.02 14.61 13.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -49.54 148.35 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.52 -39.52 2.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 67.1 m-85 -94.37 150.54 20.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.961 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.17 90.04 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.94 126.61 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 78.2 mt -56.28 129.73 74.55 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 125.05 11.68 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 0.0 112.343 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.25 -6.99 78.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 4.0 p -70.39 -51.5 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 110.796 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 69.1 t -41.23 109.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.18 118.95 31.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.94 146.74 26.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -97.36 138.14 35.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.93 163.91 29.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -108.39 172.38 6.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 963' ' ' LYS . 0.5 OUTLIER -47.86 -34.41 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 962' ' ' GLU . 37.3 mttp -69.12 -31.7 70.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 103.62 16.64 19.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 4.9 mmt -101.43 154.69 37.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.585 0.707 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.1 41.91 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 25.1 p -106.83 27.78 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 51.39 37.24 39.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.468 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 11.9 mt-10 -137.48 144.97 42.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.97 152.53 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtm -126.18 142.41 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.8 163.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' A' ' 927' ' ' ILE . . . -128.34 153.88 46.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.531 ' CE1' HD13 ' A' ' 928' ' ' ILE . 33.5 m-85 -134.29 143.17 47.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.75 -34.61 75.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -120.73 129.07 53.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 978' ' ' ASP . 1.4 ptp180 -61.87 -29.75 70.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 977' ' ' ARG . 7.3 m-20 -66.23 -41.5 89.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.99 -44.45 76.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -57.16 -47.85 80.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.2 m -64.42 -43.58 93.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.46 95.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.12 -38.91 86.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 988' ' ' ASN . 79.8 t -64.75 -49.32 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.78 -43.45 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.67 -23.29 58.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.0 mt -116.42 21.46 13.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.8 t-20 -80.25 144.26 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.2 p30 49.98 39.53 19.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -84.16 127.58 66.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 86.93 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 10.5 mt -85.14 125.1 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.5 -93.98 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 49.6 p -130.04 -2.3 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -133.05 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -93.39 142.9 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.8 m -102.37 151.07 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -115.21 125.21 53.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 70.0 mt -111.29 128.21 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 58.0 t -133.72 141.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.7 134.45 49.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -47.33 119.5 4.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 1.4 t -86.5 32.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.879 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.403 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 103.18 173.81 26.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' 1006 ' ' SER . 53.6 Cg_endo -69.72 123.5 6.84 Favored 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 -1.798 . . . . 0.0 112.312 0.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1006 ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' 1005 ' ' PRO . 45.3 t -34.61 -58.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' 1008 ' ' GLY . 60.3 p -76.94 152.83 35.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' 1007 ' ' SER . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 95.9 p -116.14 137.94 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 10.2 t -105.99 117.71 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -100.67 159.64 19.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 89.9 p -92.95 108.9 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 58.8 m -90.8 96.43 10.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -176.74 58.48 0.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -120.86 84.62 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.336 . . . . 0.0 111.13 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 53.0 m -117.05 175.45 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 30.2 t -57.63 137.63 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.16 13.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -106.62 156.16 37.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 127.71 15.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 160.47 -155.66 26.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 170.68 16.03 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.3 m -92.0 121.93 34.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 973' ' ' ALA . 42.9 mm -95.49 129.01 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 984' ' ' VAL . 53.5 mt -104.98 148.8 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -113.43 129.48 56.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.74 133.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.125 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 173.49 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.99 51.43 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.502 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 6.1 mtm -118.8 128.38 26.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 161.14 47.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -57.87 -31.79 67.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 82.2 p -55.8 -33.9 64.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 93.4 t -47.32 135.7 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.1 m -138.48 171.76 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.6 mt -58.77 -42.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -63.1 -46.05 89.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -62.39 -41.86 98.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 25.2 mt -62.47 -48.79 86.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.14 -41.94 84.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -71.93 -30.38 65.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 7.9 t80 -64.79 -39.65 93.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -87.62 13.29 10.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -48.05 147.78 1.99 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 97.58 -43.92 1.91 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 91.1 m-85 -91.39 159.29 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -91.54 90.74 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.49 131.35 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.0 129.59 86.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 129.14 17.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.714 2.276 . . . . 0.0 112.295 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.03 -9.61 77.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 24.4 p -70.36 -49.73 46.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 110.825 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -40.41 104.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.8 117.47 27.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.82 136.2 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 121.47 40.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.1 175.74 5.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -95.46 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.41 -39.28 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . 0.438 ' CE ' ' HA ' ' A' ' 963' ' ' LYS . 0.3 OUTLIER -77.4 -36.64 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.63 -1.84 4.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.448 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.19 146.3 70.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 136.75 33.73 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.0 p -101.65 -0.08 35.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.2 38.22 59.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.44 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -132.4 146.33 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -146.89 149.95 34.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 22.2 mtp -123.07 143.6 49.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.46 160.78 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 927' ' ' ILE . . . -124.17 148.93 46.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -131.29 141.5 49.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.94 -32.43 57.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 15.7 t -114.92 130.54 56.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -63.27 -41.54 99.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.26 -38.81 81.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.96 -43.53 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -59.42 -50.01 75.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.143 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.7 m -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.54 97.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.15 -42.75 96.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 988' ' ' ASN . 95.8 t -66.14 -48.91 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.18 -44.97 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -29.24 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 3.8 mt -113.55 30.73 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.8 131.98 34.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 55.77 43.53 27.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -86.69 134.1 38.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.611 0.72 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.93 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.26 . . . . 0.0 112.363 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.457 HD13 ' CE2' ' A' ' 945' ' ' PHE . 8.4 mt -82.74 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.19 -92.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.1 p -132.45 -1.8 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -133.63 161.9 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -90.47 139.54 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.502 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 2.2 m -100.73 151.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.109 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -114.46 126.26 54.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 69.5 mt -111.17 131.83 54.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 97.4 t -130.94 137.44 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.35 132.4 43.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -45.93 -74.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.479 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 4.4 m -105.81 117.85 35.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.471 ' HA3' ' C ' ' A' 1005 ' ' PRO . . . -118.0 -76.46 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.443 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.471 ' C ' ' HA3' ' A' 1004 ' ' GLY . 53.4 Cg_endo -69.84 140.09 58.7 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 0.0 112.346 0.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 45.5 t -84.19 140.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 52.7 p -159.53 170.78 20.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 41.1 t -77.89 -50.64 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.1 t -75.01 143.32 43.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 134.93 65.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 58.3 m -47.32 116.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 18.4 m -61.32 162.19 8.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 101.37 77.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -93.08 79.82 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 0.0 111.072 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.9 t -92.98 140.47 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 16.1 t -108.87 -64.81 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 112.12 -48.75 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -65.41 143.81 98.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.539 0.685 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -172.22 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.333 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 115.78 -156.68 15.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.523 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 170.82 15.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 0.0 112.337 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 93.3 m -92.39 118.92 31.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 6.5 mm -90.97 130.03 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.506 HD12 ' CD1' ' A' ' 974' ' ' PHE . 93.6 mt -104.99 148.34 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -112.66 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.77 124.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.476 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.0 OUTLIER -128.06 166.58 18.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . 0.476 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.1 OUTLIER 67.15 52.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.406 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 3.0 mtm -115.85 125.24 28.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.539 0.685 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 168.46 21.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.307 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -61.94 -39.64 92.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -49.09 -30.32 6.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 74.5 t -52.19 145.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 15.1 m -151.68 179.26 8.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.34 -41.98 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.173 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.04 -45.98 89.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.04 -42.17 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.25 -47.63 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.02 -41.77 88.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.7 -30.9 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -64.93 -39.15 93.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -88.95 12.92 14.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -48.77 147.64 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.3 -33.3 5.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 65.0 m-85 -102.56 143.37 32.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -74.97 94.04 2.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.66 122.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 52.9 mt -51.47 130.19 34.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.591 0.71 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 126.78 13.73 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.268 . . . . 0.0 112.327 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.05 -6.03 81.66 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 52.1 p -72.87 -51.62 17.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.835 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 78.1 t -38.39 110.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 19.8 m -125.34 125.76 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 46.9 mt -97.14 140.08 32.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.0 45.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -119.87 169.08 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.8 OUTLIER -96.35 -177.38 3.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.91 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.93 -49.94 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . 0.418 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 27.0 mtmt -58.48 -43.97 89.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.86 -21.93 3.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.542 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 5.7 mtp -59.9 157.96 27.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 145.57 57.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 20.8 p -105.23 34.99 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.6 44.37 3.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -147.86 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.24 152.84 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.096 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 15.7 mtm -126.28 142.37 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.44 163.91 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.117 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.32 148.2 47.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.506 ' CD1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -127.83 137.52 52.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.42 -38.52 71.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -108.72 128.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -60.96 -40.99 95.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -67.44 -44.61 78.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.95 73.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 9.8 m -65.06 -44.02 90.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.56 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -68.07 -41.3 82.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 988' ' ' ASN . 92.8 t -62.43 -48.98 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.6 -46.46 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.88 -21.21 60.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 20.0 mt -116.19 21.48 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.7 t-20 -83.27 135.71 34.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 54.89 43.82 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -86.69 130.2 49.82 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.834 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 81.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 8.8 mt -79.93 131.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.7 -92.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.1 t -131.07 -3.67 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -84.97 143.9 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.8 m -105.32 151.07 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -113.16 128.58 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 78.7 mt -110.91 130.54 55.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1000 ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' 1001 ' ' LEU . 25.1 t -128.58 140.98 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1001 ' ' LEU . . . . . 0.418 ' N ' HG13 ' A' 1000 ' ' VAL . 12.9 mt -81.94 121.29 26.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -45.05 -48.11 9.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 47.7 t -134.88 114.93 13.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.848 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 127.68 -162.79 21.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -41.93 0.83 Allowed 'Cis proline' 0 C--N 1.341 0.149 0 C-N-CA 122.716 -1.785 . . . . 0.0 112.323 0.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1006 ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' 1007 ' ' SER . 3.6 m 62.89 25.35 15.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' 1006 ' ' SER . 91.9 p -37.06 113.98 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.846 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 912' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 911' ' ' GLY . 60.1 p -34.86 138.06 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.83 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.0 m -52.11 160.46 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -78.53 116.96 4.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 87.9 p -72.0 108.09 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 72.0 p -86.32 34.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -162.48 -134.61 1.67 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -165.28 169.92 15.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.2 m -116.81 149.9 39.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 68.2 m -69.23 131.89 45.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.851 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -101.41 172.7 23.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -138.71 146.4 50.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -167.43 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 91.79 -156.99 24.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 169.85 17.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.658 2.239 . . . . 0.0 112.336 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.12 127.53 37.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.1 125.97 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.563 HD13 ' CE1' ' A' ' 974' ' ' PHE . 98.4 mt -105.29 147.0 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -112.02 127.69 55.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 14.9 t -111.85 123.5 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.431 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.3 tm0? -127.61 173.34 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.48 53.87 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 10.2 mtm -119.47 125.75 27.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 166.03 28.94 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.357 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.85 -35.14 77.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.4 p -53.75 -23.35 11.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.04 139.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 23.0 m -140.04 173.36 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.12 -41.96 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -63.13 -45.45 91.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.68 -42.04 98.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.9 mt -62.27 -49.33 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.13 -40.85 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.01 -31.32 66.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 987' ' ' LEU . 3.5 t80 -65.51 -36.97 85.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.71 12.47 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -46.9 155.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.47 3.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 69.9 m-85 -92.57 147.14 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -79.91 100.53 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.6 t -93.93 130.88 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 46.7 mt -59.33 132.34 87.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.137 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 128.03 15.42 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.664 2.243 . . . . 0.0 112.322 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.54 76.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 12.7 p -66.18 -56.09 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 93.8 t -40.45 109.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -122.28 116.27 23.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 45.3 mt -82.71 132.24 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.66 136.96 33.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.48 180.0 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -114.77 -177.85 3.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.32 -32.17 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -77.19 -33.58 56.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.85 12.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.7 mtt -79.16 156.97 76.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 134.09 27.09 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 27.3 p -95.25 35.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 46.35 30.22 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.519 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.431 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.6 mt-10 -128.85 145.19 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.909 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.97 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 60.9 mtp -121.62 141.0 51.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.89 164.35 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.83 50.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.563 ' CE1' HD13 ' A' ' 928' ' ' ILE . 26.8 m-85 -127.48 137.29 52.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.94 -35.7 74.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 976' ' ' SER . . . . . 0.457 ' CB ' ' CD ' ' A' ' 979' ' ' GLU . 4.1 m -109.62 130.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.848 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.69 -48.46 77.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.04 -36.99 71.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . 0.457 ' CD ' ' CB ' ' A' ' 976' ' ' SER . 1.0 OUTLIER -64.24 -50.11 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.7 -46.0 70.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 4.8 m -63.91 -42.41 97.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.66 94.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.45 -38.48 84.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 988' ' ' ASN . 69.6 t -68.32 -48.92 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -44.89 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -30.45 63.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 4.8 mt -109.72 23.79 13.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -83.2 136.0 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.22 42.73 32.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -85.19 133.67 42.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 0.0 110.826 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 87.29 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 945' ' ' PHE . 7.7 mt -87.78 130.93 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.23 -92.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.3 p -131.14 -3.66 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -134.11 158.6 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -88.05 138.36 31.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.4 m -95.8 150.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -112.7 125.63 54.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 80.0 mt -111.21 130.02 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 62.6 t -126.63 147.49 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.06 137.03 36.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -53.28 117.53 7.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 31.0 t -58.14 108.03 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.47 ' HA3' ' C ' ' A' 1005 ' ' PRO . . . -99.64 -74.62 1.13 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.478 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.47 ' C ' ' HA3' ' A' 1004 ' ' GLY . 54.0 Cg_endo -69.72 -28.13 6.42 Favored 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.385 -0.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 86.1 p -173.09 174.17 3.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 6.0 t -59.31 96.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 68.6 m -59.25 -53.28 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 110.845 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 19.7 m -78.3 130.39 36.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -136.92 173.96 21.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 29.4 t -107.3 102.61 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.84 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 8.3 t -63.32 99.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -54.68 162.87 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -96.47 113.74 25.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 11.2 t -95.12 -54.97 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 66.1 m -69.09 103.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -95.88 -103.28 1.99 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -118.72 154.85 52.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.607 0.718 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 81.51 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -153.04 -148.87 5.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 168.44 21.64 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.24 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 10.8 m -92.06 128.67 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.1 mm -100.81 128.23 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.542 HD11 ' CD1' ' A' ' 974' ' ' PHE . 95.4 mt -105.36 145.1 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -111.02 127.49 55.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 8.5 t -107.72 127.7 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.442 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.0 OUTLIER -132.44 169.34 16.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.1 54.69 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.458 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 7.2 mtm -118.94 124.89 28.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.32 21.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.662 2.241 . . . . 0.0 112.326 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.1 -27.16 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 63.2 p -59.58 -27.95 66.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.62 144.52 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.8 m -146.72 171.64 14.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.04 -42.01 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.01 -45.84 90.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.52 -42.63 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.97 -49.55 84.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.95 -41.84 88.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.41 -40.56 96.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -87.46 13.77 9.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -52.1 146.54 8.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.92 -35.06 4.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -99.58 139.42 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -70.88 90.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.5 t -86.24 124.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 97.3 mt -52.02 129.66 39.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 111.155 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.4 23.29 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.93 -2.46 87.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 956' ' ' VAL . 5.0 p -72.5 -53.37 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 955' ' ' SER . 61.1 t -36.37 108.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.49 108.18 12.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.1 mt -76.98 141.0 40.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -94.59 137.79 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 72.8 m-85 -130.5 158.61 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.453 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -97.31 178.48 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -44.07 -49.56 8.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . 0.453 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtmp? -61.86 -42.72 99.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 124.87 -11.14 7.85 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.9 mmt -65.74 157.48 79.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.78 43.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.4 p -107.77 33.79 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.05 44.96 6.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.442 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.2 mt-10 -147.81 145.32 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.62 35.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 27.1 mtt -126.56 142.71 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.62 164.49 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.31 150.05 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.542 ' CD1' HD11 ' A' ' 928' ' ' ILE . 25.1 m-85 -130.36 137.67 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.65 -37.78 67.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 24.5 t -106.1 131.76 52.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.859 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -63.42 -46.91 84.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.74 -34.66 69.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -47.33 69.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.96 -49.01 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 3.7 m -64.92 -43.9 91.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.91 99.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.61 97.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 988' ' ' ASN . 96.2 t -65.68 -49.85 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 34.5 mt -65.0 -44.8 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.98 -27.69 67.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.06 30.2 6.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -82.56 127.98 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 61.4 41.9 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -84.08 133.87 44.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.39 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.646 2.231 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 7.1 mt -85.95 129.04 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.02 -93.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 22.8 t -131.23 -3.34 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -133.47 160.83 36.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -88.31 142.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.458 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 1.7 m -102.81 150.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 126.63 55.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.02 133.12 53.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.9 t -126.61 149.48 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.95 121.6 30.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -66.91 -63.65 3.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 97.2 p -51.8 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 175.52 -165.01 35.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 157.48 92.03 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.668 -1.805 . . . . 0.0 112.365 0.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 91.24 8.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.8 t -102.44 88.76 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 51.9 p -154.58 121.28 5.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 93.8 p -52.35 161.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -78.74 -143.04 2.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 48.9 m 62.73 42.22 8.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 73.7 p -138.72 156.89 47.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.34 20.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -110.0 113.83 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 15.0 m -95.43 149.96 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 15.8 m -77.27 88.9 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -54.1 155.54 7.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.442 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -136.23 153.22 76.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.17 7.13 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.341 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 133.79 -155.97 22.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -176.86 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.223 . . . . 0.0 112.351 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 7.0 m -96.79 118.98 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.5 mm -95.98 123.83 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.568 HD13 ' CE1' ' A' ' 974' ' ' PHE . 97.7 mt -106.48 145.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.437 ' N ' HG22 ' A' ' 928' ' ' ILE . 4.0 mtmp? -111.95 134.25 53.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.47 125.95 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.92 169.0 14.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.81 53.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.433 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 14.3 mtm -117.92 121.72 31.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.615 0.722 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 162.97 40.04 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -55.35 -41.38 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.2 p -45.47 -36.33 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 92.5 t -49.13 142.44 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 27.9 m -148.5 179.23 7.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.02 -42.04 94.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -62.97 -45.89 90.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -65.21 -42.71 93.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.8 mt -61.29 -48.61 88.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.1 -41.97 89.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.94 -30.78 65.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 945' ' ' PHE . 1.6 t80 -64.92 -38.67 91.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.29 13.16 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -49.38 154.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 88.26 -36.66 3.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 77.6 m-85 -95.84 136.33 36.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.986 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 950' ' ' GLN . 2.6 mp0 -73.74 82.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 952' ' ' ILE . 97.5 t -75.54 135.52 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . 0.422 ' N ' HG12 ' A' ' 951' ' ' VAL . 35.7 mt -62.25 130.95 93.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 0.0 111.145 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 132.27 23.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 0.0 112.409 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 90.19 -4.11 82.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 957' ' ' CYS . 1.5 m -80.6 -56.47 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 955' ' ' SER . 65.2 t -36.32 95.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 955' ' ' SER . 20.9 m -112.41 136.74 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 71.2 mt -99.9 137.23 38.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -96.54 133.34 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.49 175.57 5.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 965' ' ' MET . 4.6 p30 -107.63 -177.58 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.36 -29.19 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -79.21 -35.57 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 124.45 -17.76 7.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.442 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 15.0 mtp -68.36 157.9 86.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.04 15.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 19.3 p -89.05 35.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.47 45.54 6.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -142.17 148.53 38.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.86 152.82 35.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 63.1 mtp -130.54 141.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.79 162.55 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.63 44.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 928' ' ' ILE . 28.7 m-85 -129.96 141.31 50.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.32 -34.84 68.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.34 135.0 54.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.814 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -62.25 -41.37 98.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.28 -42.97 82.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -47.87 79.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.75 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 981' ' ' THR . . . . . 0.462 HG22 ' CD1' ' A' ' 985' ' ' ILE . 3.8 m -64.61 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.6 87.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -66.92 -45.49 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 988' ' ' ASN . 79.2 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' A' ' 981' ' ' THR . 37.4 mt -64.27 -46.15 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.99 -22.73 58.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.501 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 16.6 mt -116.75 23.66 11.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.8 OUTLIER -80.74 136.16 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.4 t0 50.63 45.42 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -83.23 129.7 59.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.701 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 84.96 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 10.4 mt -85.8 133.28 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.29 -91.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 3.3 m -134.64 0.54 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -134.14 155.41 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -86.65 136.72 32.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.433 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 1.9 m -97.12 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.59 128.39 56.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 71.4 mt -110.98 138.72 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.4 t -134.56 144.18 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.3 mt -82.72 141.51 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -47.67 167.88 0.1 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 90.0 p -114.73 10.64 16.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.929 0.395 . . . . 0.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . -115.38 172.44 14.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.416 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.8 Cg_endo -69.79 173.32 45.19 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.315 0.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 4.0 m -93.66 -56.9 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 65.6 p -101.84 130.36 48.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 84.0 p -108.74 118.21 36.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 30.5 t -44.77 -49.79 10.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.818 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 51.43 62.29 5.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 10.3 t -117.83 157.34 26.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.919 0.39 . . . . 0.0 110.817 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.5 p -161.98 129.1 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -130.47 125.72 4.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -81.75 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 1.1 t -101.74 136.57 41.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.4 t -50.22 144.4 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -129.17 173.9 19.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.27 143.78 36.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.859 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 128.67 16.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.662 2.242 . . . . 0.0 112.379 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -139.24 -166.63 10.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.424 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.27 8.29 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.9 m -96.04 120.97 37.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 33.3 mm -100.38 122.28 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 974' ' ' PHE . 85.4 mt -105.0 141.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -110.42 128.66 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.59 130.18 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.02 171.65 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.79 52.67 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.465 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 25.9 mtm -115.11 135.89 22.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 937' ' ' VAL . 53.7 Cg_endo -69.75 171.9 13.61 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.84 -20.43 59.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 77.5 p -72.15 -15.63 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 938' ' ' SER . 74.2 t -59.21 147.93 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 938' ' ' SER . . . . . 0.451 ' N ' HG11 ' A' ' 937' ' ' VAL . 8.6 m -154.15 171.37 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.39 -42.03 79.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.12 -45.17 93.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.27 -41.68 93.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.4 mt -64.1 -49.53 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.83 -41.97 83.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.0 -31.2 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -65.86 -36.21 82.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -88.43 10.12 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -44.24 153.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 90.48 -42.3 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.5 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 84.1 m-85 -92.85 149.4 21.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.95 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.75 91.38 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.36 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.97 136.35 83.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 147.97 64.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.64 2.226 . . . . 0.0 112.352 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 63.55 13.24 50.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 63.1 m -94.2 -51.33 4.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.938 0.399 . . . . 0.0 110.822 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 93.9 t -46.94 103.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.086 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 12.1 m -117.42 134.21 55.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.85 138.77 34.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -92.42 135.85 33.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -124.71 166.86 15.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 965' ' ' MET . 1.0 OUTLIER -100.25 -176.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.01 -8.86 25.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -98.2 -28.28 13.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 112.95 -3.8 25.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 20.8 mtm -84.77 150.12 55.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.583 0.706 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 128.27 15.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 36.3 p -89.38 24.25 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.09 38.44 89.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.519 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -137.51 145.47 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.13 151.45 33.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 20.8 mtt -122.02 143.15 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.85 160.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.94 151.71 43.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 928' ' ' ILE . 31.8 m-85 -133.8 138.86 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -73.22 -34.67 66.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 5.5 t -111.17 129.89 55.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -63.42 -44.37 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -57.11 -37.16 71.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -48.57 66.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.9 69.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 981' ' ' THR . . . . . 0.423 HG21 ' CD1' ' A' ' 985' ' ' ILE . 4.7 m -62.53 -43.57 98.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.31 93.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.48 -45.96 92.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 988' ' ' ASN . 53.3 t -61.71 -50.11 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . 0.423 ' CD1' HG21 ' A' ' 981' ' ' THR . 30.7 mt -61.42 -48.82 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.22 -21.9 62.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 999' ' ' LEU . 16.4 mt -119.14 26.52 9.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.5 t-20 -89.03 120.72 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.9 t0 73.13 38.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -84.4 129.69 56.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 87.51 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 14.3 mt -83.93 129.33 37.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.64 -92.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.0 p -132.76 -0.65 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -131.2 163.91 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.25 143.85 26.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.7 m -107.53 151.08 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -117.67 127.73 54.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 987' ' ' LEU . 37.6 mt -111.64 130.44 55.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 46.4 t -131.97 136.52 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.16 155.95 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1002 ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' 1003 ' ' SER . . . -80.3 39.0 2.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1003 ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' 1002 ' ' GLY . 23.0 t 34.25 54.78 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.848 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 65.78 -162.76 41.47 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.61 92.5 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 -1.799 . . . . 0.0 112.342 0.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 27.5 m -82.04 168.85 17.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' 1008 ' ' GLY . 2.7 t -118.69 -59.57 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.849 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1008 ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' 1007 ' ' SER . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 51.1 m -110.27 -69.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.353 . . . . 0.0 110.862 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.3 t 73.84 48.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -148.3 84.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.0 m -150.04 151.85 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 81.8 p -171.34 132.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -98.35 139.91 14.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -149.92 113.5 5.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 55.6 p -113.66 100.08 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.6 m -56.33 166.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -60.03 -94.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -75.78 144.07 75.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 87.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.337 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -74.28 -161.08 7.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 169.65 18.46 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.1 m -92.53 117.87 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.197 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 47.8 mm -95.47 125.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 974' ' ' PHE . 80.8 mt -106.13 148.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . 0.434 ' N ' HG23 ' A' ' 928' ' ' ILE . 18.0 mtmm -112.65 130.55 56.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.04 123.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.1 tm0? -125.02 167.25 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . 0.425 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.3 OUTLIER 65.89 53.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.461 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 12.2 mtm -115.78 123.98 30.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 168.32 21.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -63.93 -39.41 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.8 p -48.17 -34.32 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 81.3 t -45.66 154.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.5 m -160.58 172.71 16.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.44 -41.94 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.01 -45.74 90.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.34 -41.55 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.29 -48.25 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.8 -42.06 92.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.97 -31.56 66.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.5 ' CD2' ' CD1' ' A' ' 992' ' ' ILE . 9.5 t80 -64.94 -37.34 87.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -92.14 14.82 14.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.46 157.6 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.932 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 85.46 -41.7 3.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 72.1 m-85 -87.84 141.51 28.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -73.01 87.04 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.5 t -82.73 125.46 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 97.5 mt -51.55 134.99 34.32 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.573 0.702 . . . . 0.0 111.142 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.64 2.226 . . . . 0.0 112.362 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 86.42 24.86 38.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 82.3 p -93.66 -50.86 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.84 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 97.2 t -39.34 113.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 3.2 t -122.9 109.7 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 25.6 mt -81.74 136.78 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -103.13 138.88 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.84 174.44 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . 0.465 ' ND2' ' HD3' ' A' ' 963' ' ' LYS . 7.9 p30 -98.56 176.97 5.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.26 -33.92 65.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . 0.465 ' HD3' ' ND2' ' A' ' 961' ' ' ASN . 0.0 OUTLIER -68.21 -45.94 71.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.838 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 138.61 -27.78 2.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' MET . . . . . 0.401 ' O ' ' OD1' ' A' ' 961' ' ' ASN . 85.0 mtp -63.76 153.47 83.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.556 0.693 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 144.1 52.83 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.658 2.239 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.3 p -99.37 37.7 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 39.43 42.19 1.8 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.54 145.84 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.56 153.02 35.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 9.8 mtp -122.22 143.66 49.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.61 165.7 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -127.46 147.18 50.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.096 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 928' ' ' ILE . 20.8 m-85 -127.36 144.29 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -78.06 -34.43 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 50.7 m -111.57 130.76 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.57 -40.09 78.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -62.87 -45.74 91.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -55.72 -49.31 73.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.119 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 4.6 m -64.26 -43.9 93.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.35 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.36 -42.87 95.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 988' ' ' ASN . 91.4 t -62.7 -50.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 27.9 mt -63.62 -42.18 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.26 -28.04 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 77.2 mt -115.68 25.86 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.25 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 t0 58.69 43.15 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.92 130.37 57.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 82.47 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.743 2.295 . . . . 0.0 112.309 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.02 123.36 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.88 -95.83 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 11.7 t -126.06 -6.53 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -129.48 159.65 35.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -93.15 136.42 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 5.6 m -96.15 150.14 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -113.79 129.72 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 68.1 mt -110.87 128.74 55.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 76.0 t -126.43 141.97 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.64 130.98 41.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -51.54 -71.78 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 67.0 p -68.96 150.01 48.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 112.19 -163.28 12.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.365 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 93.8 p -145.95 124.56 12.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 22.9 m -44.69 134.81 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.445 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 3.3 m -115.57 -55.02 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.846 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.0 t -93.51 133.84 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 101.87 72.69 0.97 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 12.7 t -73.95 140.16 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.849 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 117.04 9.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -145.02 121.8 1.61 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . 58.4 41.78 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 94.5 p -49.25 139.9 10.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -166.24 174.21 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -128.72 132.3 7.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -145.53 137.86 13.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -179.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 93.47 -157.73 23.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.447 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.31 11.17 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.653 2.235 . . . . 0.0 112.304 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.9 m -92.61 126.19 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 43.2 mm -97.6 129.94 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.123 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.465 ' HB ' ' CG2' ' A' ' 972' ' ' VAL . 51.3 mt -104.88 147.72 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.139 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.16 127.99 56.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.39 129.72 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . 0.417 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.8 tm0? -136.17 168.22 19.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.53 46.89 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.47 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 10.7 mtm -113.86 124.99 30.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 110.88 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.315 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.98 -35.8 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 65.5 p -52.41 -25.49 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 74.7 t -57.5 141.69 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 67.0 m -143.76 174.21 11.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.5 mt -58.64 -42.12 84.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.17 -45.13 93.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -62.05 -44.1 97.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.24 -49.85 81.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.46 -41.62 80.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -71.91 -31.85 66.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.51 ' CD2' ' CD1' ' A' ' 992' ' ' ILE . 6.3 t80 -64.73 -35.78 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.09 17.38 14.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -50.59 142.99 9.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 100.28 -40.64 2.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 86.4 m-85 -89.57 148.52 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -81.62 79.57 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.92 124.23 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -53.54 129.39 53.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 111.171 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 131.54 21.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.39 84.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 955' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 956' ' ' VAL . 9.7 p -72.5 -54.8 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.0 t -35.59 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.13 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.5 m -116.73 110.94 19.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.53 134.19 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -92.69 130.53 38.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -120.1 159.35 24.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -102.88 176.2 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.02 -28.85 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -71.59 -33.0 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 110.5 -1.55 29.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.534 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.32 161.6 24.77 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.58 0.705 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 134.4 27.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 67.1 p -93.5 16.0 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 76.27 21.72 74.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . 0.417 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 24.4 mt-10 -121.9 145.03 48.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.16 150.39 31.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 14.9 mtm -129.82 140.44 51.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.465 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 34.7 m -137.54 165.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.48 149.57 44.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.463 ' CE1' HD11 ' A' ' 928' ' ' ILE . 13.5 m-85 -128.92 141.62 51.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.41 -37.5 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -105.12 132.29 51.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -63.27 -51.03 67.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.03 -33.35 67.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -44.69 77.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.13 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.7 m -62.6 -43.98 97.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.3 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.511 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -63.19 -39.53 94.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 988' ' ' ASN . 74.1 t -69.84 -50.21 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.96 -45.15 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 1.9 mt -122.31 33.08 5.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -85.54 131.34 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 54.89 43.57 29.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -84.45 133.53 44.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.607 0.717 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 90.51 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . 0.51 ' CD1' ' CD2' ' A' ' 945' ' ' PHE . 10.2 mt -90.46 126.26 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.47 -92.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 4.6 m -131.31 -3.09 3.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -133.89 161.29 35.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -90.03 142.29 27.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.47 ' CG1' ' HG2' ' A' ' 933' ' ' MET . 2.2 m -99.97 149.75 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.23 125.7 54.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 77.1 mt -111.21 127.92 55.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 90.9 t -122.64 137.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 11.5 mt -77.45 127.94 33.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -55.5 -77.89 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 10.1 t -116.38 143.97 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 110.894 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 106.33 -164.9 13.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.7 12.24 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.703 -1.79 . . . . 0.0 112.38 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 30.2 p -72.75 119.06 16.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 11.2 t -134.69 88.7 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 1.9 t -68.34 94.33 0.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.861 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.7 t -101.13 89.17 3.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -122.0 119.15 3.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 80.6 p -78.9 130.16 35.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 110.845 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 3.6 t 69.36 41.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.896 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.79 6.76 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -130.59 -46.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 0.0 111.105 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 83.8 p -127.37 123.1 35.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 94.1 p -122.14 -8.6 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -109.59 123.29 6.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.454 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -139.29 140.06 24.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.705 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 109.2 2.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.66 2.24 . . . . 0.0 112.338 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 143.9 -139.74 8.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 169.88 17.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 28.5 m -97.98 127.71 44.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.84 126.69 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 974' ' ' PHE . 72.4 mt -105.37 147.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 128.46 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.8 122.92 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 170.03 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 932' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 996' ' ' LYS . 0.2 OUTLIER 65.48 47.67 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 933' ' ' MET . . . . . 0.488 ' CG ' ' CG1' ' A' ' 997' ' ' VAL . 19.2 mtm -114.87 129.25 25.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 168.53 21.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.724 2.283 . . . . 0.0 112.345 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -63.43 -35.92 82.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 75.0 p -52.44 -36.61 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 937' ' ' VAL . . . . . . . . . . . . . 78.8 t -41.57 140.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.3 m -148.59 172.96 13.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.92 -42.13 77.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -45.94 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -63.34 -43.35 97.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.2 mt -63.3 -49.31 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.51 -41.95 91.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -71.21 -31.96 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 945' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 39.7 t80 -65.37 -37.1 85.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -88.84 11.49 17.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -48.04 145.68 2.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 96.06 -43.45 2.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 949' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 78.6 m-85 -90.99 132.51 35.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.359 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.07 93.29 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.73 124.88 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 952' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 953' ' ' PRO . 65.0 mt -51.53 134.34 34.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.632 0.73 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 953' ' ' PRO . . . . . 0.408 ' N ' HG23 ' A' ' 952' ' ' ILE . 53.3 Cg_endo -69.85 126.47 13.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.241 . . . . 0.0 112.33 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.17 12.69 78.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 68.2 p -83.78 -49.16 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 67.4 t -42.12 107.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 9.9 t -115.52 110.46 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 29.3 mt -88.16 131.92 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -101.47 132.47 47.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -123.67 157.58 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -67.03 -175.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.63 -9.71 57.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -32.58 12.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 127.9 -18.31 5.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 57.2 mtt -67.69 154.95 92.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.76 13.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 44.8 p -86.42 13.42 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 64.21 30.58 78.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.2 145.35 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.17 149.81 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 5.9 mtt -124.24 144.95 49.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 972' ' ' VAL . . . . . 0.432 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 16.6 m -139.31 165.62 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.57 155.55 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 974' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 928' ' ' ILE . 22.4 m-85 -136.1 140.79 44.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -72.3 -38.51 68.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 10.5 t -110.45 129.71 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -61.4 -41.87 97.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.85 -38.88 79.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.5 -44.14 83.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.29 77.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 8.3 m -63.45 -43.7 96.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.44 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 983' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.43 -39.57 89.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 988' ' ' ASN . 72.2 t -67.39 -48.82 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 82.7 mt -64.13 -45.64 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.25 -22.15 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 987' ' ' LEU . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.5 mt -117.15 18.92 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 988' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 984' ' ' VAL . 3.6 t-20 -80.5 134.57 35.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.6 40.61 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.69 130.69 52.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 82.91 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 992' ' ' ILE . . . . . . . . . . . . . 10.1 mt -81.76 135.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 52.6 -91.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 2.7 m -133.77 -0.35 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -133.96 161.48 34.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 996' ' ' LYS . . . . . 0.448 ' O ' ' ND2' ' A' ' 932' ' ' ASN . 61.2 mttt -90.03 140.88 29.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 997' ' ' VAL . . . . . 0.488 ' CG1' ' CG ' ' A' ' 933' ' ' MET . 1.2 m -102.95 151.08 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 125.23 52.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 999' ' ' LEU . . . . . . . . . . . . . 41.9 mt -111.24 128.81 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.2 142.99 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 11.2 mt -80.28 132.7 35.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -42.75 -54.29 5.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.545 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 60.7 p -174.3 -179.75 1.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1004 ' ' GLY . . . . . 0.413 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 137.04 172.53 12.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1005 ' ' PRO . . . . . 0.413 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.5 Cg_endo -69.77 134.84 31.06 Favored 'Cis proline' 0 C--N 1.342 0.231 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.357 0.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1006 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1007 ' ' SER . 27.5 m -90.06 -58.5 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1007 ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' 1006 ' ' SER . 4.6 t -34.74 123.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.865 0.277 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.4 m -92.07 117.39 29.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 50.8 mm -96.45 127.31 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.688 ' HB ' HG23 ' A' ' 972' ' ' VAL . 96.5 mt -105.54 148.09 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -113.15 124.39 52.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.696 HG22 HD23 ' A' ' 999' ' ' LEU . 45.7 t -106.43 130.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.08 170.46 16.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.79 50.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.746 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.3 mtm -117.04 132.56 23.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.456 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.3 Cg_endo -69.76 167.81 23.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.73 2.287 . . . . 0.0 112.379 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.38 -29.88 70.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.5 p -59.28 -26.8 65.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.163 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 933' ' ' MET . 78.8 t -50.78 141.07 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 21.3 m -143.66 168.21 20.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.96 -42.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.96 -45.53 92.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.15 -43.24 99.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 942' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 958' ' ' LEU . 45.2 mt -61.0 -49.51 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 943' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.4 mt -56.21 -41.44 75.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.83 -31.46 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.806 ' CD2' HD11 ' A' ' 992' ' ' ILE . 11.9 t80 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -91.9 17.3 9.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -52.21 151.89 3.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 89.69 -39.01 3.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -95.08 144.15 25.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.04 100.72 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.02 125.6 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.634 HG23 ' HD2' ' A' ' 953' ' ' PRO . 53.1 mt -55.81 138.38 70.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.582 0.706 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.634 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.0 Cg_endo -69.69 138.82 38.95 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.29 -9.03 22.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 60.5 p -63.61 -56.8 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 81.1 t -41.32 100.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -113.8 110.23 19.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 942' ' ' ILE . 82.7 mt -86.98 132.51 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.07 138.12 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 960' ' ' TYR . . . . . 0.459 ' HA ' HG23 ' A' ' 967' ' ' THR . 76.9 m-85 -126.32 156.75 39.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.924 ' ND2' HG22 ' A' ' 967' ' ' THR . 2.9 m120 -67.95 -178.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.01 -34.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -72.41 -36.36 68.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 128.61 -14.05 6.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.43 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 29.7 mmt -66.5 157.04 84.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 129.55 17.79 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 967' ' ' THR . . . . . 0.924 HG22 ' ND2' ' A' ' 961' ' ' ASN . 17.4 p -92.51 5.8 49.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.4 23.96 77.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -123.9 145.89 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.35 152.78 34.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 10.1 mtm -127.03 143.69 51.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 928' ' ' ILE . 2.7 m -137.6 163.61 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.91 155.85 43.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 928' ' ' ILE . 42.1 m-85 -138.05 138.38 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.73 -31.28 64.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.9 t -117.57 130.05 56.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -63.21 -40.75 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 978' ' ' ASP . . . . . 0.451 ' OD1' ' CD ' ' A' ' 979' ' ' GLU . 0.5 OUTLIER -57.92 -40.04 79.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 979' ' ' GLU . . . . . 0.451 ' CD ' ' OD1' ' A' ' 978' ' ' ASP . 0.2 OUTLIER -67.29 -45.73 75.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.56 -48.8 79.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.637 HG22 HD11 ' A' ' 985' ' ' ILE . 4.0 m -63.35 -43.99 96.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.84 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.58 99.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.9 t -61.84 -48.82 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 981' ' ' THR . 21.5 mt -65.0 -41.69 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.96 -24.18 59.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.457 HD23 ' HE ' ' A' ' 990' ' ' ARG . 66.1 mt -116.79 20.65 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.1 t-20 -80.64 120.54 24.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.8 t70 73.33 39.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 997' ' ' VAL . 19.1 mmt180 -83.49 128.66 63.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 87.72 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.903 HD12 HG11 ' A' ' 997' ' ' VAL . 10.7 mt -85.98 123.28 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.71 -94.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 40.9 t -129.48 -3.15 4.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 0.0 110.797 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -133.49 156.61 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -87.29 143.31 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.903 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -101.12 151.04 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -115.22 125.2 53.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.696 HD23 HG22 ' A' ' 930' ' ' VAL . 48.7 mt -111.05 129.51 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.4 t -132.18 138.82 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.22 142.17 45.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.871 0.28 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.42 125.29 37.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.67 125.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 972' ' ' VAL . 86.9 mt -109.61 143.04 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -112.19 127.87 56.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.756 HG22 HD23 ' A' ' 999' ' ' LEU . 40.6 t -108.21 128.62 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.67 169.77 16.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.75 47.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.69 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -114.9 134.27 22.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.521 0.676 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.9 Cg_endo -69.67 174.22 9.75 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.89 -26.02 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.5 p -62.52 -31.43 72.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 933' ' ' MET . 88.6 t -45.64 151.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 19.1 m -158.19 172.53 18.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.9 mt -57.95 -41.86 81.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.156 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.17 -44.34 95.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.33 -43.45 90.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.08 -48.24 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 943' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 943' ' ' LEU . 13.1 mt -57.76 -42.03 83.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.35 -31.54 67.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 992' ' ' ILE . 4.0 t80 -65.73 -35.87 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -91.51 11.91 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -49.33 149.27 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.0 -39.83 2.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -94.56 150.76 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.88 83.12 8.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.19 130.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 973' ' ' ALA . 83.2 mt -57.15 129.4 79.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.644 0.735 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 133.68 26.09 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.297 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 84.35 -4.4 83.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 956' ' ' VAL . 10.1 p -75.25 -56.22 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 955' ' ' SER . 94.3 t -37.25 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -119.03 114.4 22.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.28 129.88 34.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -93.41 127.49 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -116.86 160.19 21.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 1.019 ' ND2' HG22 ' A' ' 967' ' ' THR . 3.3 m120 -79.38 -178.79 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -58.49 -36.23 73.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -74.63 -27.68 60.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 119.51 -18.66 10.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 6.8 mmt -58.86 158.17 17.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 127.47 14.62 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 0.0 112.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 967' ' ' THR . . . . . 1.019 HG22 ' ND2' ' A' ' 961' ' ' ASN . 71.2 p -87.12 8.77 22.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 61.92 30.07 74.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -134.2 146.1 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.04 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 34.5 mtp -122.04 147.44 46.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.6 m -140.84 165.32 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.475 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -130.98 148.48 52.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.483 ' CE1' HD12 ' A' ' 928' ' ' ILE . 30.1 m-85 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.86 -33.35 45.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.5 m -108.49 128.53 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -61.83 -49.96 74.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.04 -35.71 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -45.12 78.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.29 -47.85 77.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.57 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -62.71 -42.48 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.1 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.75 -43.98 94.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.106 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 999' ' ' LEU . 68.9 t -66.75 -47.93 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 981' ' ' THR . 58.2 mt -61.9 -45.55 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.2 mt -120.67 30.5 6.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -88.05 136.66 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 989' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.6 p30 49.68 43.3 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.534 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.2 mtt-85 -86.05 134.04 39.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 92.27 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 1.008 HD12 HG11 ' A' ' 997' ' ' VAL . 12.5 mt -89.98 126.73 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.83 -90.57 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.6 m -133.54 -0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -134.05 162.04 33.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -90.9 144.03 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 1.008 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.0 151.1 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 998' ' ' LYS . . . . . 0.419 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 0.1 OUTLIER -115.47 127.31 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.756 HD23 HG22 ' A' ' 930' ' ' VAL . 79.3 mt -110.98 133.9 53.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1000 ' ' VAL . . . . . 0.419 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 60.0 t -126.39 141.75 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 981' ' ' THR . 13.0 mt -81.18 137.06 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.869 0.279 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.8 m -92.02 133.94 35.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 32.7 mm -101.91 128.52 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.458 HD12 ' CE1' ' A' ' 974' ' ' PHE . 63.2 mt -105.07 144.54 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -111.46 128.36 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.59 127.98 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.77 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.38 45.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.701 ' HG3' HG12 ' A' ' 997' ' ' VAL . 14.3 mtm -115.18 133.02 22.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.74 170.98 15.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -67.0 -35.73 80.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 68.6 p -53.24 -30.03 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 80.3 t -49.82 143.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.8 m -147.9 170.61 17.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.05 -42.12 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.24 -45.99 89.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.02 -44.5 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.17 -49.68 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -56.03 -41.99 75.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.83 -30.16 65.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.772 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.3 t80 -66.22 -34.92 79.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -90.91 8.49 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -41.7 148.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.61 -42.95 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 987' ' ' LEU . 45.8 m-85 -91.65 146.07 24.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -82.61 85.98 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.25 125.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.3 mt -50.86 130.25 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.714 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 125.24 11.91 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.95 65.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 5.2 p -84.52 -45.5 12.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.87 100.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.3 t -114.36 108.05 16.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 37.7 mt -80.34 142.08 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 129.24 54.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 960' ' ' TYR . . . . . 0.434 ' C ' HG23 ' A' ' 967' ' ' THR . 88.7 m-85 -115.05 175.75 5.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.764 ' OD1' HG22 ' A' ' 967' ' ' THR . 65.7 m-80 -91.13 -175.01 4.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.06 -6.64 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -100.4 -36.78 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.37 -3.31 5.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 31.2 mtp -86.03 151.56 54.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.44 13.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.7 2.267 . . . . 0.0 112.345 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 967' ' ' THR . . . . . 0.764 HG22 ' OD1' ' A' ' 961' ' ' ASN . 9.3 p -86.02 12.89 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 63.59 30.49 77.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -126.2 146.01 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.11 33.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtt -131.41 141.28 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 28.5 m -136.9 165.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.68 50.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.458 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.0 m-85 -128.64 137.37 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -69.86 -34.7 73.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 4.1 m -107.85 125.84 51.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -61.5 -48.19 82.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.04 -36.97 71.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.74 84.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -57.81 -48.16 80.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.691 HG23 HD11 ' A' 1001 ' ' LEU . 4.3 m -60.66 -43.59 97.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.71 99.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.555 ' O ' HD12 ' A' ' 987' ' ' LEU . . . -64.28 -40.27 95.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 999' ' ' LEU . 71.9 t -66.48 -48.61 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.05 -43.78 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.77 -21.44 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 949' ' ' TYR . 4.1 mt -120.41 24.27 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -85.65 135.39 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 55.65 41.71 30.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.567 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.2 mtp180 -84.63 131.62 49.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.8 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.924 HD12 HG11 ' A' ' 997' ' ' VAL . 13.9 mt -82.15 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 48.81 -92.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 994' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 992' ' ' ILE . 58.4 m -132.48 -1.25 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.04 160.76 36.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.2 143.83 26.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.924 HG11 HD12 ' A' ' 992' ' ' ILE . 2.1 m -104.85 151.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -114.39 126.27 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.655 ' CB ' HG13 ' A' ' 984' ' ' VAL . 82.8 mt -111.31 127.85 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 43.4 t -124.94 139.72 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.691 HD11 HG23 ' A' ' 981' ' ' THR . 12.9 mt -76.04 128.37 34.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.45 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.824 0.26 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 27.0 m -92.32 130.72 37.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.0 mm -103.84 125.46 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.509 HD12 ' CE1' ' A' ' 974' ' ' PHE . 75.6 mt -105.56 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.99 125.38 54.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.67 124.54 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.26 171.46 12.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.09 49.35 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 16.9 mtm -115.79 127.03 27.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 166.4 27.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.72 -40.5 88.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 70.8 p -48.11 -27.7 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 933' ' ' MET . 91.4 t -55.71 135.53 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 34.3 m -143.86 171.64 13.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 56.0 mt -57.22 -42.07 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.1 -45.99 89.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.48 -43.96 88.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 33.0 mt -61.1 -49.75 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.64 -41.78 77.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.35 -31.42 67.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.2 t80 -66.01 -34.4 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.23 12.93 22.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.58 150.41 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.61 -32.94 5.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 95.8 m-85 -102.22 137.61 40.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.56 89.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 88.2 t -85.43 123.09 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.66 129.48 35.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 125.56 12.29 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 0.0 112.317 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.75 -9.82 75.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 28.5 p -66.92 -49.13 66.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.843 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -43.87 107.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 t -118.95 118.28 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 970' ' ' ALA . 65.2 mt -91.09 127.12 36.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -98.03 130.37 44.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -112.14 -175.31 2.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 965' ' ' MET . 2.7 p30 -107.39 -177.01 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.12 -34.57 73.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.75 -35.76 75.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 120.64 -2.6 12.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.464 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 3.0 mmt -83.7 155.76 65.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 127.48 14.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.264 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.9 p -86.46 27.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 48.32 38.7 20.03 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.5 145.32 40.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.71 151.12 31.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 49.5 mtp -122.57 142.71 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 13.3 m -135.26 164.08 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.49 146.74 50.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.509 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.0 m-85 -129.87 139.51 51.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.17 -35.88 66.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.3 m -105.4 127.57 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -64.22 -47.79 78.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.11 -34.77 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.69 -47.61 68.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -54.63 -46.59 73.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.622 HG22 HD11 ' A' ' 985' ' ' ILE . 7.4 m -64.41 -43.75 93.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.27 89.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 980' ' ' ALA . 90.4 t -66.05 -49.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.622 HD11 HG22 ' A' ' 981' ' ' THR . 33.2 mt -59.02 -46.0 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.64 -27.95 61.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.7 mt -112.46 28.06 9.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.13 128.8 36.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.6 t0 59.84 42.67 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.3 mtp85 -86.51 133.38 40.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.827 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 85.7 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.37 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.763 HD12 HG11 ' A' ' 997' ' ' VAL . 7.4 mt -85.7 134.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.47 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 10.0 p -131.97 -2.41 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -134.02 161.49 34.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -88.65 142.88 27.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.763 HG11 HD12 ' A' ' 992' ' ' ILE . 3.0 m -104.43 151.04 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -115.73 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.657 ' HB2' HG13 ' A' ' 984' ' ' VAL . 80.1 mt -112.24 131.5 55.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.0 t -123.98 148.87 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 981' ' ' THR . 16.3 mt -91.1 129.58 37.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.894 0.289 . . . . 0.0 112.316 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 57.2 m -95.03 121.44 36.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.7 mm -92.25 128.33 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 77.6 mt -105.03 148.35 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -115.46 121.58 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 999' ' ' LEU . 18.1 t -105.66 129.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 931' ' ' GLN . . . . . 0.482 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.4 tm0? -134.38 170.24 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 50.12 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.676 ' HG3' HG12 ' A' ' 997' ' ' VAL . 8.6 mtm -116.79 128.28 26.13 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.614 0.721 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 174.42 9.52 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.41 -37.89 86.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -50.96 -30.57 15.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.669 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.0 t -52.24 125.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.9 m -131.28 171.54 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.79 -42.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.113 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.1 -45.77 90.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.38 -43.34 97.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.98 -49.98 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.76 -41.5 86.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.98 -31.46 66.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.674 ' CD2' HD11 ' A' ' 992' ' ' ILE . 5.4 t80 -66.08 -35.19 79.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.12 11.31 23.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -48.36 149.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 93.25 -39.93 2.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 983' ' ' ALA . 89.6 m-85 -95.33 141.17 29.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -71.77 100.2 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.4 t -95.9 124.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.478 HD12 ' CB ' ' A' ' 973' ' ' ALA . 87.3 mt -52.75 131.11 47.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.639 0.733 . . . . 0.0 111.115 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.11 18.78 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.374 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.49 -7.21 77.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.6 p -68.01 -55.44 12.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.1 t -35.63 112.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 27.5 m -124.07 119.2 28.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 40.8 mt -87.21 132.31 33.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -93.32 137.69 32.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 960' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 66.2 m-85 -125.87 -178.62 4.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 964' ' ' GLY . 0.3 OUTLIER -121.47 177.78 5.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -40.68 -53.15 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -64.57 -27.7 69.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 964' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 111.03 -21.75 22.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 37.7 mmt -54.53 152.98 11.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.54 0.686 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 134.65 28.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 35.5 p -97.42 25.98 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 52.79 38.06 53.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 969' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 9.5 mt-10 -138.31 145.69 41.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.55 151.25 32.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 31.8 mtp -125.11 142.73 51.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 29.2 m -138.68 165.33 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -127.97 150.77 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.4 m-85 -131.8 142.96 49.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.45 -34.03 60.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 26.6 t -109.62 124.93 51.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.2 ttp-105 -61.74 -44.01 97.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.24 -37.33 74.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.83 -42.46 81.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.63 -49.86 76.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.3 m -64.75 -43.92 91.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.91 95.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 949' ' ' TYR . . . -66.11 -43.64 86.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 980' ' ' ALA . 91.3 t -60.29 -48.12 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.25 -44.84 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 999' ' ' LEU . 47.2 mt -119.91 20.07 12.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.2 t-20 -79.82 127.19 31.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 64.62 41.83 5.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.574 ' O ' HG22 ' A' ' 997' ' ' VAL . 9.1 mmm180 -84.36 131.79 49.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 83.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 997' ' ' VAL . 10.9 mt -82.39 127.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.9 -93.86 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 23.1 p -131.78 -0.26 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.886 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -133.67 163.45 29.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -91.79 143.36 26.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.823 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -106.04 151.1 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -113.48 126.07 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.746 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.7 mt -110.93 128.0 55.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 59.5 t -132.9 142.13 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.93 140.84 47.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.875 0.281 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.4 m -92.13 125.28 36.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.5 mm -99.39 126.58 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.581 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.7 mt -105.59 145.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -111.44 133.94 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 999' ' ' LEU . 21.7 t -116.15 127.97 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.24 170.17 16.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.88 51.74 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.779 ' SD ' HG11 ' A' ' 937' ' ' VAL . 21.6 mtm -118.64 129.84 25.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.473 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.79 171.43 14.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.703 2.269 . . . . 0.0 112.333 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -63.68 -37.47 87.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 67.0 p -52.07 -34.1 42.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.779 HG11 ' SD ' ' A' ' 933' ' ' MET . 76.2 t -48.54 122.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 4.6 m -130.62 176.15 8.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.9 -41.96 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.147 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.02 -45.9 90.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.56 -45.0 96.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.14 -50.0 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.11 -42.03 84.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.889 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.5 t80 -66.69 -31.14 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 946' ' ' PHE . . . . . 0.434 ' HB3' HG21 ' A' ' 951' ' ' VAL . 42.1 m-85 -97.0 12.17 33.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -50.51 152.88 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.04 -37.57 3.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 987' ' ' LEU . 57.0 m-85 -96.37 127.83 42.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -60.78 97.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 951' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 946' ' ' PHE . 87.4 t -94.68 122.36 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 973' ' ' ALA . 89.7 mt -48.23 130.06 12.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 123.52 10.17 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.5 -2.62 74.16 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.0 p -72.33 -53.33 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 955' ' ' SER . 99.3 t -37.04 105.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.26 114.6 22.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.72 137.47 34.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.957 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -95.48 139.28 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.897 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -132.54 161.5 33.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -95.96 -175.7 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -50.48 -51.52 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 963' ' ' LYS . . . . . 0.41 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 37.3 mmtt -56.48 -44.11 80.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 126.88 -4.56 7.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 43.8 mtm -73.38 153.62 90.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 128.34 15.93 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.732 2.288 . . . . 0.0 112.369 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 65.0 p -90.32 37.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.14 40.53 1.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -140.97 146.97 38.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 3.2 mtt -122.62 143.69 49.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.63 160.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -122.32 153.8 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.058 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 928' ' ' ILE . 32.0 m-85 -134.5 141.14 46.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.821 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.13 -37.41 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 19.0 m -108.06 126.12 52.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -61.01 -45.75 93.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -57.39 -38.88 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.94 -44.12 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.35 -48.28 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.421 HG23 HD11 ' A' 1001 ' ' LEU . 10.0 m -64.27 -43.37 95.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.43 89.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.91 -39.17 93.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 980' ' ' ALA . 75.4 t -64.63 -49.08 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.45 -46.54 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -23.73 59.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.8 mt -115.47 25.94 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.1 t-20 -91.45 128.57 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.93 40.63 15.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 8.2 mtp85 -86.2 133.33 40.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.845 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 85.51 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.889 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.8 mt -84.44 125.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.85 -92.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 5.1 m -129.28 -5.76 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -133.08 156.25 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -86.42 143.33 27.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.876 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -101.1 151.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -116.26 128.29 55.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.611 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.3 mt -111.01 138.43 47.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.3 t -133.84 137.14 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 981' ' ' THR . 13.6 mt -73.81 136.36 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.459 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.841 0.267 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 12.0 m -92.77 119.67 32.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.7 mm -97.89 125.15 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.609 ' HB ' HG23 ' A' ' 972' ' ' VAL . 98.3 mt -104.98 143.49 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -111.85 130.58 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 999' ' ' LEU . 6.5 t -112.02 131.34 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.68 167.23 21.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.08 53.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -121.32 128.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 156.49 63.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.324 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -54.29 -33.53 58.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.2 p -53.24 -34.69 58.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.421 HG11 ' SD ' ' A' ' 933' ' ' MET . 88.4 t -46.81 137.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 5.7 m -140.5 175.69 9.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.83 -41.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.19 -45.82 89.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.08 -38.18 87.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.21 -49.1 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.24 -41.68 84.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.72 -30.75 65.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.0 t80 -64.92 -39.06 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -87.22 13.17 10.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.66 148.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.89 2.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -92.01 134.87 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -72.14 84.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.4 t -74.66 123.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.43 129.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.645 2.23 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.19 6.1 84.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 957' ' ' CYS . 81.5 p -87.07 -55.54 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 955' ' ' SER . 48.2 t -35.99 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 957' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 955' ' ' SER . 3.0 t -112.62 126.07 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 138.04 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -94.51 123.92 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 92.3 m-85 -111.6 175.08 5.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.96 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.39 -18.47 28.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -35.97 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 120.08 -15.13 10.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 77.9 mmm -69.2 155.73 92.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 137.73 36.26 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -100.38 0.27 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 81.73 31.52 32.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -128.98 146.88 50.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.422 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.91 142.2 23.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 28.4 mtp -120.97 142.89 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 928' ' ' ILE . 4.1 m -137.45 166.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.55 150.1 51.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -129.95 157.21 42.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -82.31 -42.95 18.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 20.4 m -117.44 139.07 51.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.1 mtp85 -61.29 -36.6 80.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -58.08 -43.44 87.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -45.14 78.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -61.49 -48.72 79.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.613 HG23 HD11 ' A' 1001 ' ' LEU . 6.8 m -62.36 -43.98 97.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.78 89.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -60.59 -40.93 93.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 980' ' ' ALA . 86.5 t -64.76 -50.23 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.25 -45.03 99.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -22.29 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.9 mt -119.86 29.18 7.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.959 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.0 OUTLIER -89.96 128.61 36.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.71 43.09 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.7 mmp_? -85.78 131.63 46.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 110.885 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.99 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.745 2.296 . . . . 0.0 112.315 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.902 HD12 HG11 ' A' ' 997' ' ' VAL . 16.1 mt -81.26 126.91 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.58 -92.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 17.2 t -132.82 -1.13 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -132.76 163.48 28.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -92.53 141.0 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.902 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -102.6 151.08 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.57 128.17 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -111.16 131.08 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.921 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 57.6 t -124.79 143.03 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 981' ' ' THR . 19.4 mt -82.36 134.82 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.842 0.267 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 50.7 m -101.13 132.99 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 30.3 mm -100.6 128.0 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 984' ' ' VAL . 75.7 mt -108.55 145.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -114.76 131.48 56.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 999' ' ' LEU . 61.9 t -113.29 126.92 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.116 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 167.21 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.07 50.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.618 ' CG ' HG12 ' A' ' 997' ' ' VAL . 23.8 mtm -119.3 130.59 24.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 158.49 56.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -56.63 -33.46 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 47.8 p -53.11 -32.39 47.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.554 HG11 ' SD ' ' A' ' 933' ' ' MET . 94.2 t -49.71 140.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 72.7 m -145.93 172.96 12.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.81 -42.01 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.12 -46.05 89.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -65.61 -45.27 83.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 942' ' ' ILE . . . . . 0.482 ' CD1' HD21 ' A' ' 958' ' ' LEU . 38.5 mt -61.01 -48.48 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.4 mt -58.45 -42.02 86.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.55 -31.2 66.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.804 ' CD2' HD11 ' A' ' 992' ' ' ILE . 2.9 t80 -65.02 -41.24 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -81.41 7.7 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -41.28 149.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.32 -40.62 2.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 92.2 m-85 -97.25 130.91 44.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.58 92.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.5 t -78.04 125.68 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 953' ' ' PRO . 75.9 mt -54.18 133.83 60.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.614 0.721 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.1 Cg_endo -69.75 147.17 62.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.356 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.33 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.438 ' OG ' HG22 ' A' ' 952' ' ' ILE . 2.2 m -93.37 -56.21 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.87 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.0 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.99 129.17 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 942' ' ' ILE . 45.1 mt -94.84 139.21 31.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -93.5 131.58 38.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -115.09 160.22 19.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.522 HD22 ' HB2' ' A' ' 963' ' ' LYS . 1.1 p-10 -99.68 -176.41 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.33 -47.43 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 963' ' ' LYS . . . . . 0.522 ' HB2' HD22 ' A' ' 961' ' ' ASN . 0.8 OUTLIER -66.33 -24.77 66.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 117.08 -28.67 7.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.5 ptp -57.82 153.64 31.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.44 17.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.704 2.269 . . . . 0.0 112.358 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 38.8 p -83.97 26.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 56.35 33.04 61.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -129.11 147.96 51.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.69 147.08 26.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.5 mtt -123.0 141.82 51.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 18.9 m -139.3 164.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.49 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 925' ' ' PRO . 23.1 m-85 -128.2 148.09 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.16 -35.99 61.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 9.4 t -115.82 134.61 54.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 52.6 ttp85 -61.26 -39.91 92.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -41.68 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -62.67 -45.17 94.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.764 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.03 -49.36 77.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.942 HG23 HD11 ' A' 1001 ' ' LEU . 5.9 m -62.75 -44.0 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.92 92.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -62.59 -38.06 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 980' ' ' ALA . 84.9 t -66.04 -49.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 32.9 mt -60.95 -47.61 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.93 -21.55 61.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.2 mt -119.37 27.23 8.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.92 129.65 36.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 60.48 41.46 15.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 997' ' ' VAL . 18.0 mtp180 -84.13 130.89 52.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.617 0.722 . . . . 0.0 110.826 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 84.46 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.943 HD12 HG11 ' A' ' 997' ' ' VAL . 9.0 mt -84.39 130.66 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.52 -94.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 12.8 t -129.35 -0.87 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -133.96 163.67 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -93.07 143.28 26.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.943 HG11 HD12 ' A' ' 992' ' ' ILE . 3.8 m -101.89 149.89 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.26 127.1 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 930' ' ' VAL . 78.9 mt -111.73 131.08 55.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.858 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.2 t -120.67 140.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 981' ' ' THR . 13.4 mt -81.22 122.89 27.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 925' ' ' PRO . . . . . 0.439 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.822 0.259 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.4 m -94.28 117.13 29.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.35 125.27 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.8 mt -105.18 147.95 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -111.29 131.39 55.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.54 125.03 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 171.27 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.7 47.76 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.513 ' SD ' HG11 ' A' ' 937' ' ' VAL . 18.3 mtm -111.47 125.75 29.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 159.38 53.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.664 2.243 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -56.9 -32.94 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.4 p -55.04 -30.94 60.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.513 HG11 ' SD ' ' A' ' 933' ' ' MET . 75.3 t -48.31 145.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 33.4 m -153.64 173.19 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.92 -42.16 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -46.06 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -65.61 -46.13 80.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.02 -46.27 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.6 mt -57.97 -41.92 83.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.91 -34.21 68.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.9 t80 -61.81 -37.15 83.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.17 23.58 6.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -60.61 161.23 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 80.69 -41.89 2.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 79.6 m-85 -85.25 135.52 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.89 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -65.59 83.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.64 119.85 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 953' ' ' PRO . 95.3 mt -48.64 132.14 13.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.613 0.721 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.8 Cg_endo -69.76 111.62 2.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 0.0 112.357 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.81 31.72 9.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.466 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 956' ' ' VAL . 81.0 p -103.58 -53.86 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 955' ' ' SER . 86.7 t -34.62 114.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 8.5 t -119.93 112.7 19.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 44.5 mt -81.85 131.59 35.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -95.48 138.69 32.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.7 171.87 11.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 965' ' ' MET . 1.1 p30 -100.19 -179.07 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 962' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 963' ' ' LYS . 17.1 pt-20 -50.81 -47.1 60.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 963' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 962' ' ' GLU . 0.0 OUTLIER -63.51 -43.53 96.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 134.91 -27.34 3.19 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.415 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 0.1 OUTLIER -52.23 158.43 1.89 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 0.0 110.854 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 137.55 35.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.331 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 967' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 968' ' ' GLY . 82.5 p -100.76 37.47 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 968' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 967' ' ' THR . . . 37.07 39.14 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -141.79 145.59 34.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.94 148.56 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.0 mtt -119.0 143.18 47.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 23.8 m -135.39 160.53 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.39 147.15 47.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -129.14 137.71 51.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.66 -34.02 64.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 976' ' ' SER . . . . . 0.404 ' HB2' ' CD ' ' A' ' 979' ' ' GLU . 1.8 m -108.81 130.99 55.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -61.77 -48.91 78.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -56.91 -39.17 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 979' ' ' GLU . . . . . 0.404 ' CD ' ' HB2' ' A' ' 976' ' ' SER . 20.4 mt-10 -63.32 -44.44 94.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.88 -50.02 73.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.635 HG22 HD11 ' A' ' 985' ' ' ILE . 24.3 m -64.51 -43.41 94.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.14 93.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.68 -41.91 98.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 999' ' ' LEU . 84.1 t -66.28 -49.76 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 981' ' ' THR . 41.7 mt -58.66 -46.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.66 -30.31 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 999' ' ' LEU . 12.5 mt -109.5 28.87 8.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -89.48 133.57 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 22.9 t70 54.37 43.44 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -87.85 130.16 47.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 94.61 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 945' ' ' PHE . 15.7 mt -92.59 124.47 45.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.08 -90.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 9.5 t -131.34 -3.38 3.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.809 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -134.11 154.3 51.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -88.82 140.54 29.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 992' ' ' ILE . 4.9 m -100.1 150.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.0 129.42 56.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.711 ' HB2' HG13 ' A' ' 984' ' ' VAL . 81.7 mt -110.93 128.66 55.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 89.3 t -123.39 137.93 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 981' ' ' THR . 11.9 mt -71.55 134.27 46.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.29 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 29.9 m -91.93 125.78 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 41.6 mm -101.52 127.86 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.568 HD12 ' CE1' ' A' ' 974' ' ' PHE . 65.7 mt -107.33 146.46 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 929' ' ' LYS . . . . . 0.401 ' NZ ' ' HA2' ' A' 1002 ' ' GLY . 2.9 mppt? -113.5 130.09 56.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 999' ' ' LEU . 19.8 t -115.64 127.23 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 931' ' ' GLN . . . . . 0.434 ' HG3' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -131.71 172.48 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 49.23 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.706 ' HG3' HG12 ' A' ' 997' ' ' VAL . 16.7 mtm -114.44 129.2 25.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 167.52 24.25 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.69 -25.0 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 64.8 p -63.88 -21.78 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.552 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.3 t -60.48 139.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.0 m -144.41 177.81 8.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.03 -42.17 92.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -63.29 -46.05 88.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.47 -45.29 93.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 24.1 mt -60.98 -49.64 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.03 -42.0 89.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -72.07 -31.18 65.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 38.6 t80 -65.25 -38.43 90.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -87.91 10.96 17.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -47.03 145.58 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 99.07 -32.51 7.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 87.5 m-85 -103.57 143.78 32.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.12 87.03 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.46 127.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 953' ' ' PRO . 63.7 mt -55.48 132.71 70.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.77 132.74 23.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.12 85.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 956' ' ' VAL . 24.6 p -82.16 -60.39 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.824 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 972' ' ' VAL . 98.0 t -34.79 112.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 13.5 m -124.43 125.49 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.9 146.57 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -100.26 135.76 41.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -128.74 160.67 31.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 965' ' ' MET . 49.4 p-10 -98.81 -177.05 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.93 -41.39 61.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -67.1 -33.67 75.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 113.16 -1.32 25.43 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.463 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 8.7 ptp -80.1 151.96 73.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 133.34 25.37 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -95.45 22.23 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.88 38.87 93.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 969' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 931' ' ' GLN . 8.1 mt-10 -138.7 145.46 40.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -147.88 145.66 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 40.8 mtp -119.45 138.7 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 956' ' ' VAL . 28.1 m -135.1 163.29 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -125.06 155.14 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -133.18 144.71 50.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.43 -34.92 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.4 t -115.85 131.62 56.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -63.23 -38.13 89.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.9 -41.43 96.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.51 -46.79 78.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.78 -48.22 70.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.556 HG22 HD11 ' A' ' 985' ' ' ILE . 19.6 m -64.87 -43.65 92.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.96 94.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.72 -40.01 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 980' ' ' ALA . 81.4 t -66.03 -48.57 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.556 HD11 HG22 ' A' ' 981' ' ' THR . 37.0 mt -62.04 -44.55 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.5 -26.42 59.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.678 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.1 mt -115.34 27.39 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.86 127.9 35.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.5 t70 61.0 41.74 13.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 997' ' ' VAL . 15.3 mtp85 -87.17 134.63 36.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.72 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 85.64 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.321 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 7.5 mt -83.69 128.85 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.03 -92.97 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.5 t -131.6 -2.74 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -133.73 158.52 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -85.91 143.88 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 0.2 OUTLIER -104.98 151.03 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 998' ' ' LYS . . . . . 0.41 ' HE2' HG22 ' A' 1000 ' ' VAL . 0.8 OUTLIER -114.22 125.12 53.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.2 mt -111.04 132.32 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1000 ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 998' ' ' LYS . 23.3 t -128.14 143.34 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 981' ' ' THR . 13.5 mt -78.67 134.38 37.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1002 ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 929' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.913 0.297 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 5.1 m -98.31 119.52 37.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.651 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 49.9 mm -91.36 129.19 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.645 HD11 ' HB1' ' A' ' 980' ' ' ALA . 95.8 mt -104.99 148.97 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 9.6 t -109.44 128.11 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.54 170.19 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.01 47.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.631 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.9 mtm -114.12 130.7 23.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.697 . . . . 0.0 110.895 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.452 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.5 Cg_endo -69.77 170.19 17.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -68.91 -28.8 66.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.7 p -59.46 -30.12 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 938' ' ' SER . 94.1 t -47.16 155.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 938' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 937' ' ' VAL . 10.0 m -162.32 170.96 18.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.89 -45.54 92.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.13 -39.32 92.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.77 -49.48 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.01 -41.56 83.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 992' ' ' ILE . 25.8 t80 -65.05 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.02 14.61 13.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -49.54 148.35 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.52 -39.52 2.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 67.1 m-85 -94.37 150.54 20.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.961 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.17 90.04 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.94 126.61 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 78.2 mt -56.28 129.73 74.55 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 125.05 11.68 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 0.0 112.343 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.25 -6.99 78.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 4.0 p -70.39 -51.5 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 110.796 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 69.1 t -41.23 109.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.18 118.95 31.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.94 146.74 26.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -97.36 138.14 35.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.93 163.91 29.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -108.39 172.38 6.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -34.41 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -69.12 -31.7 70.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 103.62 16.64 19.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 4.9 mmt -101.43 154.69 37.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.585 0.707 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.1 41.91 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 25.1 p -106.83 27.78 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 51.39 37.24 39.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.48 144.97 42.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.97 152.53 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtm -126.18 142.41 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.8 163.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -128.34 153.88 46.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.5 m-85 -134.29 143.17 47.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.75 -34.61 75.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -120.73 129.07 53.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 977' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 978' ' ' ASP . 1.4 ptp180 -61.87 -29.75 70.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 978' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 977' ' ' ARG . 7.3 m-20 -66.23 -41.5 89.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.99 -44.45 76.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 928' ' ' ILE . . . -57.16 -47.85 80.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.2 m -64.42 -43.58 93.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.46 95.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.12 -38.91 86.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 999' ' ' LEU . 79.8 t -64.75 -49.32 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.78 -43.45 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.67 -23.29 58.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.534 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.0 mt -116.42 21.46 13.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.8 t-20 -80.25 144.26 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 989' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.2 p30 49.98 39.53 19.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.509 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.6 mmp_? -84.16 127.58 66.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 86.93 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.864 HD12 HG11 ' A' ' 997' ' ' VAL . 10.5 mt -85.14 125.1 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.5 -93.98 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 49.6 p -130.04 -2.3 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -133.05 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -93.39 142.9 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.864 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -102.37 151.07 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -115.21 125.21 53.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.837 ' HB2' HG13 ' A' ' 984' ' ' VAL . 70.0 mt -111.29 128.21 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 58.0 t -133.72 141.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.7 134.45 49.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.846 0.269 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.3 m -92.0 121.93 34.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 42.9 mm -95.49 129.01 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 984' ' ' VAL . 53.5 mt -104.98 148.8 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -113.43 129.48 56.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.569 HG22 HD23 ' A' ' 999' ' ' LEU . 21.8 t -111.74 133.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.125 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 173.49 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.99 51.43 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.685 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -118.8 128.38 26.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 161.14 47.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -57.87 -31.79 67.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 82.2 p -55.8 -33.9 64.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.4 t -47.32 135.7 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.1 m -138.48 171.76 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.6 mt -58.77 -42.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -63.1 -46.05 89.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -62.39 -41.86 98.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 25.2 mt -62.47 -48.79 86.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.14 -41.94 84.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -71.93 -30.38 65.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.9 t80 -64.79 -39.65 93.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -87.62 13.29 10.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -48.05 147.78 1.99 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 97.58 -43.92 1.91 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 91.1 m-85 -91.39 159.29 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -91.54 90.74 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.49 131.35 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.0 129.59 86.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 129.14 17.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.714 2.276 . . . . 0.0 112.295 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.03 -9.61 77.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 24.4 p -70.36 -49.73 46.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 110.825 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -40.41 104.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.8 117.47 27.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.82 136.2 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 121.47 40.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.1 175.74 5.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -95.46 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.41 -39.28 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 963' ' ' LYS . . . . . 0.444 ' CE ' ' HA ' ' A' ' 963' ' ' LYS . 0.3 OUTLIER -77.4 -36.64 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.63 -1.84 4.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.448 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.19 146.3 70.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 136.75 33.73 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.0 p -101.65 -0.08 35.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.2 38.22 59.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.44 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -132.4 146.33 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -146.89 149.95 34.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 22.2 mtp -123.07 143.6 49.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.0 m -141.46 160.78 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.618 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -124.17 148.93 46.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 928' ' ' ILE . 39.2 m-85 -131.29 141.5 49.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.94 -32.43 57.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 15.7 t -114.92 130.54 56.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -63.27 -41.54 99.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.26 -38.81 81.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.96 -43.53 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.42 -50.01 75.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.632 HG22 ' CD1' ' A' ' 985' ' ' ILE . 19.7 m -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.54 97.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.15 -42.75 96.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.723 HG13 ' CB ' ' A' ' 999' ' ' LEU . 95.8 t -66.14 -48.91 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.632 ' CD1' HG22 ' A' ' 981' ' ' THR . 54.6 mt -60.18 -44.97 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -29.24 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 999' ' ' LEU . 3.8 mt -113.55 30.73 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.8 131.98 34.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 55.77 43.53 27.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 997' ' ' VAL . 20.2 mtp85 -86.69 134.1 38.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.611 0.72 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.93 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.26 . . . . 0.0 112.363 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.79 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.74 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.19 -92.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.1 p -132.45 -1.8 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -133.63 161.9 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -90.47 139.54 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -100.73 151.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.109 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -114.46 126.26 54.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.723 ' CB ' HG13 ' A' ' 984' ' ' VAL . 69.5 mt -111.17 131.83 54.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 97.4 t -130.94 137.44 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.35 132.4 43.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.479 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.834 0.264 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 93.3 m -92.39 118.92 31.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.5 mm -90.97 130.03 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.6 mt -104.99 148.34 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -112.66 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.6 HG22 HD23 ' A' ' 999' ' ' LEU . 59.9 t -110.77 124.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.06 166.58 18.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.15 52.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.474 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.0 mtm -115.85 125.24 28.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.539 0.685 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.2 Cg_endo -69.81 168.46 21.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.307 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -61.94 -39.64 92.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -49.09 -30.32 6.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.447 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.5 t -52.19 145.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 15.1 m -151.68 179.26 8.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.34 -41.98 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.173 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.04 -45.98 89.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.04 -42.17 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.25 -47.63 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.02 -41.77 88.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.7 -30.9 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.607 ' CD2' HD11 ' A' ' 992' ' ' ILE . 55.5 t80 -64.93 -39.15 93.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -88.95 12.92 14.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -48.77 147.64 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.3 -33.3 5.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 65.0 m-85 -102.56 143.37 32.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -74.97 94.04 2.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.66 122.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 52.9 mt -51.47 130.19 34.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.591 0.71 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 126.78 13.73 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.268 . . . . 0.0 112.327 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.05 -6.03 81.66 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 52.1 p -72.87 -51.62 17.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.835 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 78.1 t -38.39 110.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 19.8 m -125.34 125.76 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 46.9 mt -97.14 140.08 32.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.0 45.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -119.87 169.08 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 965' ' ' MET . 1.4 p30 -96.35 -177.38 3.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.93 -49.94 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -58.48 -43.97 89.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 134.86 -21.93 3.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.542 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.518 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtp -59.9 157.96 27.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 145.57 57.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 20.8 p -105.23 34.99 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.6 44.37 3.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -147.86 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.45 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.24 152.84 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 15.7 mtm -126.28 142.37 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.1 m -135.44 163.91 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.117 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -124.32 148.2 47.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -127.83 137.52 52.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.42 -38.52 71.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -108.72 128.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -60.96 -40.99 95.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -67.44 -44.61 78.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.64 -49.95 73.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 9.8 m -65.06 -44.02 90.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.56 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -68.07 -41.3 82.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.8 t -62.43 -48.98 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.6 -46.46 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.88 -21.21 60.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 20.0 mt -116.19 21.48 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.7 t-20 -83.27 135.71 34.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 54.89 43.82 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.8 mmp_? -86.69 130.2 49.82 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.834 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 81.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 8.8 mt -79.93 131.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.7 -92.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.1 t -131.07 -3.67 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -84.97 143.9 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.32 151.07 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -113.16 128.58 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.711 ' CB ' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -110.91 130.54 55.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 25.1 t -128.58 140.98 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.94 121.29 26.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 179.883 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.819 0.258 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.12 127.53 37.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.1 125.97 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 974' ' ' PHE . 98.4 mt -105.29 147.0 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -112.02 127.69 55.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.604 HG22 ' CD2' ' A' ' 999' ' ' LEU . 14.9 t -111.85 123.5 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 931' ' ' GLN . . . . . 0.446 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.3 tm0? -127.61 173.34 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.48 53.87 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.589 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.2 mtm -119.47 125.75 27.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.415 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.2 Cg_endo -69.73 166.03 28.94 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.357 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.85 -35.14 77.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.4 p -53.75 -23.35 11.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 933' ' ' MET . 73.3 t -60.04 139.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 23.0 m -140.04 173.36 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.12 -41.96 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -63.13 -45.45 91.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.68 -42.04 98.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.9 mt -62.27 -49.33 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.13 -40.85 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.01 -31.32 66.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.794 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.5 t80 -65.51 -36.97 85.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.71 12.47 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -46.9 155.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.47 3.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 69.9 m-85 -92.57 147.14 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -79.91 100.53 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.6 t -93.93 130.88 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.43 HG23 ' HD2' ' A' ' 953' ' ' PRO . 46.7 mt -59.33 132.34 87.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.9 Cg_endo -69.79 128.03 15.42 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.664 2.243 . . . . 0.0 112.322 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.54 76.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 12.7 p -66.18 -56.09 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 972' ' ' VAL . 93.8 t -40.45 109.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -122.28 116.27 23.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 45.3 mt -82.71 132.24 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.66 136.96 33.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.48 180.0 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -114.77 -177.85 3.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.32 -32.17 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -77.19 -33.58 56.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.85 12.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.7 mtt -79.16 156.97 76.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 134.09 27.09 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 27.3 p -95.25 35.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 46.35 30.22 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.519 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 969' ' ' GLU . . . . . 0.446 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.6 mt-10 -128.85 145.19 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.909 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.97 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 60.9 mtp -121.62 141.0 51.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.504 HG12 HG22 ' A' ' 956' ' ' VAL . 15.5 m -135.89 164.35 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.83 50.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 928' ' ' ILE . 26.8 m-85 -127.48 137.29 52.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.94 -35.7 74.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 976' ' ' SER . . . . . 0.457 ' CB ' ' CD ' ' A' ' 979' ' ' GLU . 4.1 m -109.62 130.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.848 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.69 -48.46 77.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.04 -36.99 71.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 979' ' ' GLU . . . . . 0.457 ' CD ' ' CB ' ' A' ' 976' ' ' SER . 1.0 OUTLIER -64.24 -50.11 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.7 -46.0 70.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.464 HG23 HD11 ' A' 1001 ' ' LEU . 4.8 m -63.91 -42.41 97.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.66 94.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.45 -38.48 84.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 999' ' ' LEU . 69.6 t -68.32 -48.92 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -44.89 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -30.45 63.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.536 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 4.8 mt -109.72 23.79 13.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -83.2 136.0 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.22 42.73 32.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 12.4 mtt-85 -85.19 133.67 42.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 0.0 110.826 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 87.29 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.836 HD12 HG11 ' A' ' 997' ' ' VAL . 7.7 mt -87.78 130.93 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.23 -92.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.3 p -131.14 -3.66 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -134.11 158.6 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -88.05 138.36 31.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -95.8 150.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -112.7 125.63 54.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.706 ' CB ' HG13 ' A' ' 984' ' ' VAL . 80.0 mt -111.21 130.02 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 62.6 t -126.63 147.49 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -80.06 137.03 36.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.493 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.26 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 10.8 m -92.06 128.67 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 973' ' ' ALA . 4.1 mm -100.81 128.23 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.091 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.4 mt -105.36 145.1 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -111.02 127.49 55.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 8.5 t -107.72 127.7 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 931' ' ' GLN . . . . . 0.452 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -132.44 169.34 16.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 63.1 54.69 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.533 ' HG3' HG12 ' A' ' 997' ' ' VAL . 7.2 mtm -118.94 124.89 28.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.8 Cg_endo -69.79 168.32 21.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.662 2.241 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.1 -27.16 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 63.2 p -59.58 -27.95 66.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.41 HG23 ' HG2' ' A' ' 934' ' ' PRO . 60.1 t -57.62 144.52 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.8 m -146.72 171.64 14.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.04 -42.01 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.01 -45.84 90.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.52 -42.63 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.97 -49.55 84.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 943' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.7 mt -58.95 -41.84 88.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.41 -40.56 96.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -87.46 13.77 9.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -52.1 146.54 8.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.92 -35.06 4.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -99.58 139.42 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -70.88 90.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.5 t -86.24 124.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.434 HD12 ' CB ' ' A' ' 973' ' ' ALA . 97.3 mt -52.02 129.66 39.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.4 23.29 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.93 -2.46 87.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 956' ' ' VAL . 5.0 p -72.5 -53.37 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 955' ' ' SER . 61.1 t -36.37 108.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.49 108.18 12.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.1 mt -76.98 141.0 40.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -94.59 137.79 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 72.8 m-85 -130.5 158.61 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -97.31 178.48 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -44.07 -49.56 8.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 963' ' ' LYS . . . . . 0.463 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtmp? -61.86 -42.72 99.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 124.87 -11.14 7.85 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.9 mmt -65.74 157.48 79.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.78 43.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.4 p -107.77 33.79 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.05 44.96 6.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 969' ' ' GLU . . . . . 0.452 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.2 mt-10 -147.81 145.32 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.62 35.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 27.1 mtt -126.56 142.71 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.62 164.49 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -123.31 150.05 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 25.1 m-85 -130.36 137.67 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.65 -37.78 67.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 24.5 t -106.1 131.76 52.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.859 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -63.42 -46.91 84.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.74 -34.66 69.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -47.33 69.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.96 -49.01 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.946 HG23 HD11 ' A' 1001 ' ' LEU . 3.7 m -64.92 -43.9 91.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.91 99.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.61 97.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 999' ' ' LEU . 96.2 t -65.68 -49.85 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 981' ' ' THR . 34.5 mt -65.0 -44.8 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.98 -27.69 67.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.06 30.2 6.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.56 127.98 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 61.4 41.9 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.501 ' O ' HG22 ' A' ' 997' ' ' VAL . 11.6 mmp_? -84.08 133.87 44.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.39 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.646 2.231 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 997' ' ' VAL . 7.1 mt -85.95 129.04 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.02 -93.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 22.8 t -131.23 -3.34 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -133.47 160.83 36.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -88.31 142.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 992' ' ' ILE . 1.7 m -102.81 150.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 126.63 55.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 984' ' ' VAL . 62.8 mt -111.02 133.12 53.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.9 t -126.61 149.48 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -87.95 121.6 30.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.497 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.825 0.261 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 7.0 m -96.79 118.98 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.5 mm -95.98 123.83 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.518 HD12 ' CE1' ' A' ' 974' ' ' PHE . 97.7 mt -106.48 145.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -111.95 134.25 53.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.692 HG22 ' CD2' ' A' ' 999' ' ' LEU . 70.4 t -114.47 125.95 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.92 169.0 14.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.81 53.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.5 ' HE1' ' HB2' ' A' ' 970' ' ' ALA . 14.3 mtm -117.92 121.72 31.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.615 0.722 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 162.97 40.04 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -55.35 -41.38 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.2 p -45.47 -36.33 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.5 t -49.13 142.44 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 27.9 m -148.5 179.23 7.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.02 -42.04 94.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -62.97 -45.89 90.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -65.21 -42.71 93.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 942' ' ' ILE . . . . . 0.441 ' CD1' HD21 ' A' ' 958' ' ' LEU . 26.8 mt -61.29 -48.61 88.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.1 -41.97 89.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.94 -30.78 65.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.6 t80 -64.92 -38.67 91.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.29 13.16 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -49.38 154.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 88.26 -36.66 3.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 77.6 m-85 -95.84 136.33 36.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.986 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 950' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 950' ' ' GLN . 2.6 mp0 -73.74 82.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.54 135.52 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.25 130.95 93.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 132.27 23.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 0.0 112.409 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 90.19 -4.11 82.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 957' ' ' CYS . 1.5 m -80.6 -56.47 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 955' ' ' SER . 65.2 t -36.32 95.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 957' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 955' ' ' SER . 20.9 m -112.41 136.74 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.441 HD21 ' CD1' ' A' ' 942' ' ' ILE . 71.2 mt -99.9 137.23 38.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -96.54 133.34 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.49 175.57 5.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 965' ' ' MET . 4.6 p30 -107.63 -177.58 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 962' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.36 -29.19 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -79.21 -35.57 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 124.45 -17.76 7.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.442 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 15.0 mtp -68.36 157.9 86.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.04 15.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 19.3 p -89.05 35.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.47 45.54 6.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -142.17 148.53 38.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.5 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -149.86 152.82 35.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 63.1 mtp -130.54 141.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.79 162.55 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.63 44.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.7 m-85 -129.96 141.31 50.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.32 -34.84 68.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.34 135.0 54.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.814 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -62.25 -41.37 98.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.28 -42.97 82.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -47.87 79.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 974' ' ' PHE . . . -54.89 -49.75 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.669 HG22 HD11 ' A' ' 985' ' ' ILE . 3.8 m -64.61 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.6 87.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -66.92 -45.49 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.685 HG13 ' CB ' ' A' ' 999' ' ' LEU . 79.2 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 981' ' ' THR . 37.4 mt -64.27 -46.15 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.99 -22.73 58.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 16.6 mt -116.75 23.66 11.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.8 OUTLIER -80.74 136.16 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.4 t0 50.63 45.42 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 997' ' ' VAL . 1.9 mmp_? -83.23 129.7 59.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.701 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 84.96 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 945' ' ' PHE . 10.4 mt -85.8 133.28 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.29 -91.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 3.3 m -134.64 0.54 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -134.14 155.41 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -86.65 136.72 32.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.739 HG11 HD12 ' A' ' 992' ' ' ILE . 1.9 m -97.12 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.59 128.39 56.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.4 mt -110.98 138.72 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.4 t -134.56 144.18 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 981' ' ' THR . 15.3 mt -82.72 141.51 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 179.873 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.891 0.288 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.9 m -96.04 120.97 37.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 33.3 mm -100.38 122.28 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 974' ' ' PHE . 85.4 mt -105.0 141.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -110.42 128.66 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.59 130.18 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.02 171.65 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 62.79 52.67 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 25.9 mtm -115.11 135.89 22.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.7 Cg_endo -69.75 171.9 13.61 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.84 -20.43 59.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 77.5 p -72.15 -15.63 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 934' ' ' PRO . 74.2 t -59.21 147.93 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.6 m -154.15 171.37 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.39 -42.03 79.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.12 -45.17 93.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.27 -41.68 93.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.4 mt -64.1 -49.53 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.83 -41.97 83.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.0 -31.2 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 992' ' ' ILE . 14.7 t80 -65.86 -36.21 82.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -88.43 10.12 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -44.24 153.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 90.48 -42.3 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 84.1 m-85 -92.85 149.4 21.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.95 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.75 91.38 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.36 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.581 HG23 ' HD2' ' A' ' 953' ' ' PRO . 92.7 mt -57.97 136.35 83.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.76 147.97 64.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.64 2.226 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 63.55 13.24 50.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 63.1 m -94.2 -51.33 4.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.938 0.399 . . . . 0.0 110.822 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 972' ' ' VAL . 93.9 t -46.94 103.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 12.1 m -117.42 134.21 55.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.85 138.77 34.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -92.42 135.85 33.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -124.71 166.86 15.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 965' ' ' MET . 1.0 OUTLIER -100.25 -176.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.01 -8.86 25.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -98.2 -28.28 13.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 112.95 -3.8 25.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 20.8 mtm -84.77 150.12 55.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.583 0.706 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 128.27 15.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 36.3 p -89.38 24.25 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.09 38.44 89.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.519 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -137.51 145.47 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.13 151.45 33.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 20.8 mtt -122.02 143.15 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 956' ' ' VAL . 15.4 m -137.85 160.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.94 151.71 43.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 928' ' ' ILE . 31.8 m-85 -133.8 138.86 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -73.22 -34.67 66.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 5.5 t -111.17 129.89 55.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -63.42 -44.37 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -57.11 -37.16 71.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -48.57 66.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.9 69.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.693 HG22 HD11 ' A' ' 985' ' ' ILE . 4.7 m -62.53 -43.57 98.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.31 93.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.48 -45.96 92.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 999' ' ' LEU . 53.3 t -61.71 -50.11 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 981' ' ' THR . 30.7 mt -61.42 -48.82 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.22 -21.9 62.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 999' ' ' LEU . 16.4 mt -119.14 26.52 9.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.5 t-20 -89.03 120.72 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.9 t0 73.13 38.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.4 mmp_? -84.4 129.69 56.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 87.51 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.849 HD12 HG11 ' A' ' 997' ' ' VAL . 14.3 mt -83.93 129.33 37.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.177 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.64 -92.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.0 p -132.76 -0.65 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -131.2 163.91 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.25 143.85 26.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.849 HG11 HD12 ' A' ' 992' ' ' ILE . 2.7 m -107.53 151.08 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 998' ' ' LYS . . . . . 0.512 ' HE3' HG22 ' A' 1000 ' ' VAL . 8.2 tmtm? -117.67 127.73 54.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 987' ' ' LEU . 37.6 mt -111.64 130.44 55.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1000 ' ' VAL . . . . . 0.512 HG22 ' HE3' ' A' ' 998' ' ' LYS . 46.4 t -131.97 136.52 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.16 155.95 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.803 0.251 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.1 m -92.53 117.87 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.197 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 927' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 47.8 mm -95.47 125.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 80.8 mt -106.13 148.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -112.65 130.55 56.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 999' ' ' LEU . 20.6 t -111.04 123.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.02 167.25 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.89 53.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.484 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 12.2 mtm -115.78 123.98 30.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.4 Cg_endo -69.73 168.32 21.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -63.93 -39.41 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.8 p -48.17 -34.32 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 938' ' ' SER . 81.3 t -45.66 154.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 938' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 937' ' ' VAL . 7.5 m -160.58 172.71 16.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.44 -41.94 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.01 -45.74 90.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.34 -41.55 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.29 -48.25 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.8 -42.06 92.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.97 -31.56 66.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 992' ' ' ILE . 9.5 t80 -64.94 -37.34 87.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -92.14 14.82 14.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.46 157.6 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.932 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 85.46 -41.7 3.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 72.1 m-85 -87.84 141.51 28.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -73.01 87.04 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.5 t -82.73 125.46 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.527 HG23 ' HD2' ' A' ' 953' ' ' PRO . 97.5 mt -51.55 134.99 34.32 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.573 0.702 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.527 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.4 Cg_endo -69.77 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.64 2.226 . . . . 0.0 112.362 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 86.42 24.86 38.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 82.3 p -93.66 -50.86 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.84 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 97.2 t -39.34 113.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 3.2 t -122.9 109.7 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 25.6 mt -81.74 136.78 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -103.13 138.88 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.84 174.44 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.481 ' ND2' ' HD3' ' A' ' 963' ' ' LYS . 7.9 p30 -98.56 176.97 5.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 962' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.26 -33.92 65.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 963' ' ' LYS . . . . . 0.481 ' HD3' ' ND2' ' A' ' 961' ' ' ASN . 0.0 OUTLIER -68.21 -45.94 71.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.838 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 138.61 -27.78 2.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 965' ' ' MET . . . . . 0.401 ' O ' ' OD1' ' A' ' 961' ' ' ASN . 85.0 mtp -63.76 153.47 83.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.556 0.693 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 144.1 52.83 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.658 2.239 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.3 p -99.37 37.7 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 39.43 42.19 1.8 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.54 145.84 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.56 153.02 35.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 9.8 mtp -122.22 143.66 49.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.61 165.7 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 973' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.46 147.18 50.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.096 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 20.8 m-85 -127.36 144.29 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -78.06 -34.43 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 50.7 m -111.57 130.76 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.57 -40.09 78.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -62.87 -45.74 91.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -55.72 -49.31 73.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.546 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -64.26 -43.9 93.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.35 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.36 -42.87 95.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 999' ' ' LEU . 91.4 t -62.7 -50.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 981' ' ' THR . 27.9 mt -63.62 -42.18 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.26 -28.04 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 999' ' ' LEU . 77.2 mt -115.68 25.86 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.25 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 t0 58.69 43.15 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.8 mmt180 -82.92 130.37 57.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 82.47 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.743 2.295 . . . . 0.0 112.309 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.828 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.02 123.36 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.88 -95.83 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 11.7 t -126.06 -6.53 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -129.48 159.65 35.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -93.15 136.42 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.787 HG11 HD12 ' A' ' 992' ' ' ILE . 5.6 m -96.15 150.14 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -113.79 129.72 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.658 ' CB ' HG13 ' A' ' 984' ' ' VAL . 68.1 mt -110.87 128.74 55.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 76.0 t -126.43 141.97 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.64 130.98 41.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 179.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.876 0.282 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.9 m -92.61 126.19 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 43.2 mm -97.6 129.94 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.123 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.611 HD12 ' CE1' ' A' ' 974' ' ' PHE . 51.3 mt -104.88 147.72 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.139 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.16 127.99 56.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 930' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 999' ' ' LEU . 16.0 t -116.39 129.72 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 931' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -136.17 168.22 19.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.53 46.89 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.537 ' CG ' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -113.86 124.99 30.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 110.88 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.315 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.98 -35.8 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 65.5 p -52.41 -25.49 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.459 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.7 t -57.5 141.69 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 67.0 m -143.76 174.21 11.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.5 mt -58.64 -42.12 84.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.17 -45.13 93.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -62.05 -44.1 97.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.24 -49.85 81.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.46 -41.62 80.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -71.91 -31.85 66.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.902 ' CD2' HD11 ' A' ' 992' ' ' ILE . 6.3 t80 -64.73 -35.78 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.09 17.38 14.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -50.59 142.99 9.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 100.28 -40.64 2.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 86.4 m-85 -89.57 148.52 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -81.62 79.57 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.92 124.23 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -53.54 129.39 53.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 111.171 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 131.54 21.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.39 84.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 955' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 956' ' ' VAL . 9.7 p -72.5 -54.8 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 956' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 972' ' ' VAL . 88.0 t -35.59 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.13 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.5 m -116.73 110.94 19.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.53 134.19 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -92.69 130.53 38.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -120.1 159.35 24.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -102.88 176.2 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.02 -28.85 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -71.59 -33.0 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 110.5 -1.55 29.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.534 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.32 161.6 24.77 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.58 0.705 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 134.4 27.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 67.1 p -93.5 16.0 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 76.27 21.72 74.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 969' ' ' GLU . . . . . 0.435 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 24.4 mt-10 -121.9 145.03 48.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 970' ' ' ALA . . . . . 0.4 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.16 150.39 31.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 14.9 mtm -129.82 140.44 51.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 34.7 m -137.54 165.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.48 149.57 44.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 928' ' ' ILE . 13.5 m-85 -128.92 141.62 51.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.41 -37.5 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -105.12 132.29 51.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -63.27 -51.03 67.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.03 -33.35 67.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -44.69 77.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.13 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.657 HG23 HD11 ' A' 1001 ' ' LEU . 11.7 m -62.6 -43.98 97.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 982' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 986' ' ' ASP . . . -62.06 -40.3 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -63.19 -39.53 94.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 999' ' ' LEU . 74.1 t -69.84 -50.21 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.96 -45.15 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 986' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 982' ' ' ALA . 5.0 t70 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 999' ' ' LEU . 1.9 mt -122.31 33.08 5.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -85.54 131.34 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 54.89 43.57 29.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 997' ' ' VAL . 24.5 mtp180 -84.45 133.53 44.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.607 0.717 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 90.51 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.911 HD12 HG11 ' A' ' 997' ' ' VAL . 10.2 mt -90.46 126.26 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.47 -92.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 4.6 m -131.31 -3.09 3.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -133.89 161.29 35.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -90.03 142.29 27.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.911 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -99.97 149.75 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.23 125.7 54.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.65 ' HB2' HG13 ' A' ' 984' ' ' VAL . 77.1 mt -111.21 127.92 55.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 90.9 t -122.64 137.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.657 HD11 HG23 ' A' ' 981' ' ' THR . 11.5 mt -77.45 127.94 33.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.913 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.862 0.276 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 28.5 m -97.98 127.71 44.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.84 126.69 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 974' ' ' PHE . 72.4 mt -105.37 147.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 128.46 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.8 122.92 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 170.03 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 932' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 996' ' ' LYS . 0.2 OUTLIER 65.48 47.67 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 933' ' ' MET . . . . . 0.664 ' HG3' HG12 ' A' ' 997' ' ' VAL . 19.2 mtm -114.87 129.25 25.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 934' ' ' PRO . . . . . 0.419 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.75 168.53 21.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.724 2.283 . . . . 0.0 112.345 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -63.43 -35.92 82.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 75.0 p -52.44 -36.61 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 937' ' ' VAL . . . . . 0.506 HG11 ' SD ' ' A' ' 933' ' ' MET . 78.8 t -41.57 140.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.3 m -148.59 172.96 13.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.92 -42.13 77.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -45.94 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -63.34 -43.35 97.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.2 mt -63.3 -49.31 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.51 -41.95 91.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -71.21 -31.96 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 945' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 39.7 t80 -65.37 -37.1 85.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -88.84 11.49 17.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -48.04 145.68 2.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 96.06 -43.45 2.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 949' ' ' TYR . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 78.6 m-85 -90.99 132.51 35.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.359 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.07 93.29 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.73 124.88 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 952' ' ' ILE . . . . . 0.505 HG23 ' HD2' ' A' ' 953' ' ' PRO . 65.0 mt -51.53 134.34 34.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.632 0.73 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 953' ' ' PRO . . . . . 0.505 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.3 Cg_endo -69.85 126.47 13.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.241 . . . . 0.0 112.33 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.17 12.69 78.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 68.2 p -83.78 -49.16 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 67.4 t -42.12 107.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 9.9 t -115.52 110.46 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 29.3 mt -88.16 131.92 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -101.47 132.47 47.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -123.67 157.58 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 961' ' ' ASN . . . . . 0.895 ' ND2' HG22 ' A' ' 967' ' ' THR . 4.0 m120 -67.03 -175.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.63 -9.71 57.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -32.58 12.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 127.9 -18.31 5.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 57.2 mtt -67.69 154.95 92.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.76 13.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 967' ' ' THR . . . . . 0.895 HG22 ' ND2' ' A' ' 961' ' ' ASN . 44.8 p -86.42 13.42 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 64.21 30.58 78.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.2 145.35 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.17 149.81 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 5.9 mtt -124.24 144.95 49.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 972' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 16.6 m -139.31 165.62 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.57 155.55 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 974' ' ' PHE . . . . . 0.553 ' CE1' HD12 ' A' ' 928' ' ' ILE . 22.4 m-85 -136.1 140.79 44.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -72.3 -38.51 68.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 10.5 t -110.45 129.71 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -61.4 -41.87 97.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.85 -38.88 79.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.5 -44.14 83.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.3 -49.29 77.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.927 HG23 HD11 ' A' 1001 ' ' LEU . 8.3 m -63.45 -43.7 96.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.44 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 983' ' ' ALA . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.43 -39.57 89.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.692 HG13 ' CB ' ' A' ' 999' ' ' LEU . 72.2 t -67.39 -48.82 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 985' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 981' ' ' THR . 82.7 mt -64.13 -45.64 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.25 -22.15 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 987' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.5 mt -117.15 18.92 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 988' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 984' ' ' VAL . 3.6 t-20 -80.5 134.57 35.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.6 40.61 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 990' ' ' ARG . . . . . 0.522 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.2 mmp_? -84.69 130.69 52.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 82.91 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 992' ' ' ILE . . . . . 0.755 HD12 HG11 ' A' ' 997' ' ' VAL . 10.1 mt -81.76 135.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 52.6 -91.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 2.7 m -133.77 -0.35 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -133.96 161.48 34.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 996' ' ' LYS . . . . . 0.448 ' O ' ' ND2' ' A' ' 932' ' ' ASN . 61.2 mttt -90.03 140.88 29.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 997' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 992' ' ' ILE . 1.2 m -102.95 151.08 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 125.23 52.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CB ' HG13 ' A' ' 984' ' ' VAL . 41.9 mt -111.24 128.81 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.2 142.99 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1001 ' ' LEU . . . . . 0.927 HD11 HG23 ' A' ' 981' ' ' THR . 11.2 mt -80.28 132.7 35.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.545 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 47.1 t -72.9 103.77 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 39.2 t -68.0 102.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -98.33 129.52 9.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 83.1 p -81.9 135.75 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.861 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 87.8 p -133.34 173.59 11.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -131.7 -67.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -155.25 123.76 5.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 10.4 t -147.38 116.21 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 24.8 p -131.06 145.14 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -71.31 164.97 53.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 152.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.665 2.244 . . . . 0.0 112.343 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 109.02 -156.43 15.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 176.59 6.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.256 . . . . 0.0 112.331 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.4 m -92.07 117.39 29.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 50.8 mm -96.45 127.31 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.688 ' HB ' HG23 ' A' ' 972' ' ' VAL . 96.5 mt -105.54 148.09 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -113.15 124.39 52.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.696 HG22 HD23 ' A' ' 999' ' ' LEU . 45.7 t -106.43 130.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.08 170.46 16.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.79 50.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.746 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.3 mtm -117.04 132.56 23.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.456 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.3 Cg_endo -69.76 167.81 23.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.73 2.287 . . . . 0.0 112.379 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.38 -29.88 70.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.5 p -59.28 -26.8 65.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.163 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 933' ' ' MET . 78.8 t -50.78 141.07 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 21.3 m -143.66 168.21 20.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.96 -42.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.96 -45.53 92.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.15 -43.24 99.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 942' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 958' ' ' LEU . 45.2 mt -61.0 -49.51 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 943' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.4 mt -56.21 -41.44 75.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.83 -31.46 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.806 ' CD2' HD11 ' A' ' 992' ' ' ILE . 11.9 t80 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -91.9 17.3 9.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -52.21 151.89 3.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 89.69 -39.01 3.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -95.08 144.15 25.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.04 100.72 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.02 125.6 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.634 HG23 ' HD2' ' A' ' 953' ' ' PRO . 53.1 mt -55.81 138.38 70.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.582 0.706 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.634 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.0 Cg_endo -69.69 138.82 38.95 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.29 -9.03 22.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 60.5 p -63.61 -56.8 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 81.1 t -41.32 100.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -113.8 110.23 19.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 942' ' ' ILE . 82.7 mt -86.98 132.51 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.07 138.12 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 960' ' ' TYR . . . . . 0.459 ' HA ' HG23 ' A' ' 967' ' ' THR . 76.9 m-85 -126.32 156.75 39.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.924 ' ND2' HG22 ' A' ' 967' ' ' THR . 2.9 m120 -67.95 -178.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.01 -34.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -72.41 -36.36 68.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 128.61 -14.05 6.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.43 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 29.7 mmt -66.5 157.04 84.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 129.55 17.79 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 967' ' ' THR . . . . . 0.924 HG22 ' ND2' ' A' ' 961' ' ' ASN . 17.4 p -92.51 5.8 49.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.4 23.96 77.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -123.9 145.89 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.35 152.78 34.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 10.1 mtm -127.03 143.69 51.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 928' ' ' ILE . 2.7 m -137.6 163.61 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.91 155.85 43.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 928' ' ' ILE . 42.1 m-85 -138.05 138.38 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.73 -31.28 64.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.9 t -117.57 130.05 56.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -63.21 -40.75 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 978' ' ' ASP . . . . . 0.451 ' OD1' ' CD ' ' A' ' 979' ' ' GLU . 0.5 OUTLIER -57.92 -40.04 79.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 979' ' ' GLU . . . . . 0.451 ' CD ' ' OD1' ' A' ' 978' ' ' ASP . 0.2 OUTLIER -67.29 -45.73 75.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.56 -48.8 79.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.637 HG22 HD11 ' A' ' 985' ' ' ILE . 4.0 m -63.35 -43.99 96.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.84 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.58 99.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.9 t -61.84 -48.82 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 981' ' ' THR . 21.5 mt -65.0 -41.69 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.96 -24.18 59.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.457 HD23 ' HE ' ' A' ' 990' ' ' ARG . 66.1 mt -116.79 20.65 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.1 t-20 -80.64 120.54 24.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.8 t70 73.33 39.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 997' ' ' VAL . 19.1 mmt180 -83.49 128.66 63.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 87.72 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.903 HD12 HG11 ' A' ' 997' ' ' VAL . 10.7 mt -85.98 123.28 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.71 -94.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 40.9 t -129.48 -3.15 4.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 0.0 110.797 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -133.49 156.61 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -87.29 143.31 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.903 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -101.12 151.04 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -115.22 125.2 53.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.696 HD23 HG22 ' A' ' 930' ' ' VAL . 48.7 mt -111.05 129.51 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.4 t -132.18 138.82 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.22 142.17 45.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -68.96 -74.94 0.57 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 41.9 p -63.66 152.56 38.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.405 ' HA2' ' N ' ' A' 1006 ' ' SER . . . 114.57 -178.66 18.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.52 9.43 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.655 -1.81 . . . . 0.0 112.34 0.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1006 ' ' SER . . . . . 0.405 ' N ' ' HA2' ' A' 1004 ' ' GLY . 10.7 t -76.74 125.33 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 3.2 m -98.69 123.23 42.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.84 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 98.2 p -125.31 108.07 11.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.364 . . . . 0.0 110.883 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 37.7 p -55.16 127.38 28.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.05 43.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 38.4 t -134.11 86.26 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 25.2 t -54.01 159.52 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -77.03 -149.08 3.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -131.88 42.59 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 11.7 t -166.02 128.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 3.8 m -71.85 102.02 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 53.31 176.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 922' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 922' ' ' LYS . 2.1 mppt? -129.52 148.15 68.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 109.22 2.26 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.25 10.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.487 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 177.35 5.69 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.695 2.263 . . . . 0.0 112.3 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.42 125.29 37.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.67 125.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 972' ' ' VAL . 86.9 mt -109.61 143.04 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -112.19 127.87 56.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.756 HG22 HD23 ' A' ' 999' ' ' LEU . 40.6 t -108.21 128.62 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.67 169.77 16.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.75 47.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.69 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -114.9 134.27 22.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.521 0.676 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.9 Cg_endo -69.67 174.22 9.75 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.89 -26.02 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.5 p -62.52 -31.43 72.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 933' ' ' MET . 88.6 t -45.64 151.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 19.1 m -158.19 172.53 18.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.9 mt -57.95 -41.86 81.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.156 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.17 -44.34 95.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.33 -43.45 90.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.08 -48.24 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 943' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 943' ' ' LEU . 13.1 mt -57.76 -42.03 83.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.35 -31.54 67.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 992' ' ' ILE . 4.0 t80 -65.73 -35.87 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -91.51 11.91 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -49.33 149.27 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.0 -39.83 2.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -94.56 150.76 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.88 83.12 8.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.19 130.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 973' ' ' ALA . 83.2 mt -57.15 129.4 79.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.644 0.735 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 133.68 26.09 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.297 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 84.35 -4.4 83.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 956' ' ' VAL . 10.1 p -75.25 -56.22 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 955' ' ' SER . 94.3 t -37.25 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -119.03 114.4 22.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.28 129.88 34.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -93.41 127.49 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -116.86 160.19 21.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 1.019 ' ND2' HG22 ' A' ' 967' ' ' THR . 3.3 m120 -79.38 -178.79 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -58.49 -36.23 73.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -74.63 -27.68 60.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 119.51 -18.66 10.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 6.8 mmt -58.86 158.17 17.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 127.47 14.62 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 0.0 112.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 967' ' ' THR . . . . . 1.019 HG22 ' ND2' ' A' ' 961' ' ' ASN . 71.2 p -87.12 8.77 22.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 61.92 30.07 74.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -134.2 146.1 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.04 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 34.5 mtp -122.04 147.44 46.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.6 m -140.84 165.32 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.475 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -130.98 148.48 52.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.483 ' CE1' HD12 ' A' ' 928' ' ' ILE . 30.1 m-85 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.86 -33.35 45.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.5 m -108.49 128.53 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -61.83 -49.96 74.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.04 -35.71 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -45.12 78.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.29 -47.85 77.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.57 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -62.71 -42.48 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.1 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.75 -43.98 94.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.106 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 999' ' ' LEU . 68.9 t -66.75 -47.93 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 981' ' ' THR . 58.2 mt -61.9 -45.55 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.2 mt -120.67 30.5 6.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -88.05 136.66 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 989' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.6 p30 49.68 43.3 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.534 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.2 mtt-85 -86.05 134.04 39.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 92.27 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 1.008 HD12 HG11 ' A' ' 997' ' ' VAL . 12.5 mt -89.98 126.73 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.83 -90.57 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.6 m -133.54 -0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -134.05 162.04 33.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -90.9 144.03 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 1.008 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.0 151.1 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 998' ' ' LYS . . . . . 0.419 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 0.1 OUTLIER -115.47 127.31 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.756 HD23 HG22 ' A' ' 930' ' ' VAL . 79.3 mt -110.98 133.9 53.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1000 ' ' VAL . . . . . 0.419 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 60.0 t -126.39 141.75 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 981' ' ' THR . 13.0 mt -81.18 137.06 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1002 ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' 1003 ' ' SER . . . -48.42 165.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1003 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1002 ' ' GLY . 83.7 p -34.65 149.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -146.61 -162.88 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -48.45 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 -1.814 . . . . 0.0 112.318 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 3.6 m -140.73 154.54 46.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 78.3 p -67.56 139.23 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.821 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.461 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 25.9 m -115.97 125.71 52.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.6 m -89.36 164.48 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 164.68 98.19 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.3 p -94.42 158.61 15.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 26.1 p -163.42 122.02 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 89.94 -61.72 3.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -89.69 40.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.4 m -65.04 -55.92 16.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 20.3 t -56.34 124.51 18.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -84.64 176.11 50.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -136.0 142.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 115.4 4.07 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 158.17 -155.01 26.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.553 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 171.33 14.69 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.8 m -92.02 133.94 35.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 32.7 mm -101.91 128.52 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.458 HD12 ' CE1' ' A' ' 974' ' ' PHE . 63.2 mt -105.07 144.54 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -111.46 128.36 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.59 127.98 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.77 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.38 45.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.701 ' HG3' HG12 ' A' ' 997' ' ' VAL . 14.3 mtm -115.18 133.02 22.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.74 170.98 15.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -67.0 -35.73 80.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 68.6 p -53.24 -30.03 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 80.3 t -49.82 143.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.8 m -147.9 170.61 17.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.05 -42.12 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.24 -45.99 89.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.02 -44.5 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.17 -49.68 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -56.03 -41.99 75.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.83 -30.16 65.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.772 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.3 t80 -66.22 -34.92 79.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -90.91 8.49 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -41.7 148.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.61 -42.95 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 987' ' ' LEU . 45.8 m-85 -91.65 146.07 24.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -82.61 85.98 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.25 125.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.3 mt -50.86 130.25 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.714 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 125.24 11.91 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.95 65.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 5.2 p -84.52 -45.5 12.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.87 100.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.3 t -114.36 108.05 16.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 37.7 mt -80.34 142.08 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 129.24 54.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 960' ' ' TYR . . . . . 0.434 ' C ' HG23 ' A' ' 967' ' ' THR . 88.7 m-85 -115.05 175.75 5.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.764 ' OD1' HG22 ' A' ' 967' ' ' THR . 65.7 m-80 -91.13 -175.01 4.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.06 -6.64 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -100.4 -36.78 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.37 -3.31 5.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 31.2 mtp -86.03 151.56 54.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.44 13.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.7 2.267 . . . . 0.0 112.345 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 967' ' ' THR . . . . . 0.764 HG22 ' OD1' ' A' ' 961' ' ' ASN . 9.3 p -86.02 12.89 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 63.59 30.49 77.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -126.2 146.01 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.11 33.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtt -131.41 141.28 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 28.5 m -136.9 165.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.68 50.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.458 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.0 m-85 -128.64 137.37 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -69.86 -34.7 73.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 4.1 m -107.85 125.84 51.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -61.5 -48.19 82.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.04 -36.97 71.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.74 84.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -57.81 -48.16 80.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.691 HG23 HD11 ' A' 1001 ' ' LEU . 4.3 m -60.66 -43.59 97.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.71 99.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.555 ' O ' HD12 ' A' ' 987' ' ' LEU . . . -64.28 -40.27 95.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 999' ' ' LEU . 71.9 t -66.48 -48.61 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.05 -43.78 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.77 -21.44 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 949' ' ' TYR . 4.1 mt -120.41 24.27 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -85.65 135.39 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 55.65 41.71 30.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.567 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.2 mtp180 -84.63 131.62 49.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.8 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.924 HD12 HG11 ' A' ' 997' ' ' VAL . 13.9 mt -82.15 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 48.81 -92.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 994' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 992' ' ' ILE . 58.4 m -132.48 -1.25 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.04 160.76 36.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.2 143.83 26.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.924 HG11 HD12 ' A' ' 992' ' ' ILE . 2.1 m -104.85 151.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -114.39 126.27 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.655 ' CB ' HG13 ' A' ' 984' ' ' VAL . 82.8 mt -111.31 127.85 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 43.4 t -124.94 139.72 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.691 HD11 HG23 ' A' ' 981' ' ' THR . 12.9 mt -76.04 128.37 34.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -40.58 -60.98 1.95 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.45 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 77.7 p -162.64 134.14 5.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 0.0 110.885 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 166.88 172.38 34.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.426 ' C ' ' HA2' ' A' 1004 ' ' GLY . 54.1 Cg_endo -69.81 -23.93 8.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.337 0.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 86.1 p -135.82 140.95 44.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 30.6 t -143.57 117.03 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 44.0 m -126.28 -45.79 1.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 22.5 t 60.72 42.04 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 71.2 -134.35 22.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 38.2 m -40.77 160.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 2.1 m -86.37 130.7 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 153.62 160.06 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -98.89 174.31 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.762 0.315 . . . . 0.0 111.096 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 33.0 p -124.89 -49.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 6.8 t 60.35 47.45 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 45.0 -127.3 7.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' LYS . . . . . 0.404 ' NZ ' ' HA3' ' A' 1002 ' ' GLY . 0.0 OUTLIER -157.76 152.49 20.93 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.61 0.719 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 171.86 13.63 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 87.61 -157.83 29.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 27.0 m -92.32 130.72 37.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.0 mm -103.84 125.46 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.509 HD12 ' CE1' ' A' ' 974' ' ' PHE . 75.6 mt -105.56 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.99 125.38 54.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.67 124.54 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.26 171.46 12.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.09 49.35 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 16.9 mtm -115.79 127.03 27.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 166.4 27.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.72 -40.5 88.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 70.8 p -48.11 -27.7 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 933' ' ' MET . 91.4 t -55.71 135.53 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 34.3 m -143.86 171.64 13.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 56.0 mt -57.22 -42.07 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.1 -45.99 89.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.48 -43.96 88.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 33.0 mt -61.1 -49.75 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.64 -41.78 77.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.35 -31.42 67.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.2 t80 -66.01 -34.4 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.23 12.93 22.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.58 150.41 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.61 -32.94 5.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 95.8 m-85 -102.22 137.61 40.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.56 89.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 88.2 t -85.43 123.09 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.66 129.48 35.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 125.56 12.29 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 0.0 112.317 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.75 -9.82 75.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 28.5 p -66.92 -49.13 66.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.843 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -43.87 107.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 t -118.95 118.28 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 970' ' ' ALA . 65.2 mt -91.09 127.12 36.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -98.03 130.37 44.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -112.14 -175.31 2.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 965' ' ' MET . 2.7 p30 -107.39 -177.01 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.12 -34.57 73.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.75 -35.76 75.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 120.64 -2.6 12.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.464 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 3.0 mmt -83.7 155.76 65.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 127.48 14.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.264 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.9 p -86.46 27.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 48.32 38.7 20.03 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.5 145.32 40.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.71 151.12 31.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 49.5 mtp -122.57 142.71 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 13.3 m -135.26 164.08 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.49 146.74 50.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.509 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.0 m-85 -129.87 139.51 51.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.17 -35.88 66.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.3 m -105.4 127.57 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -64.22 -47.79 78.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.11 -34.77 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.69 -47.61 68.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -54.63 -46.59 73.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.622 HG22 HD11 ' A' ' 985' ' ' ILE . 7.4 m -64.41 -43.75 93.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.27 89.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 980' ' ' ALA . 90.4 t -66.05 -49.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.622 HD11 HG22 ' A' ' 981' ' ' THR . 33.2 mt -59.02 -46.0 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.64 -27.95 61.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.7 mt -112.46 28.06 9.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.13 128.8 36.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.6 t0 59.84 42.67 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.3 mtp85 -86.51 133.38 40.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.827 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 85.7 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.37 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.763 HD12 HG11 ' A' ' 997' ' ' VAL . 7.4 mt -85.7 134.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.47 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 10.0 p -131.97 -2.41 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -134.02 161.49 34.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -88.65 142.88 27.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.763 HG11 HD12 ' A' ' 992' ' ' ILE . 3.0 m -104.43 151.04 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -115.73 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.657 ' HB2' HG13 ' A' ' 984' ' ' VAL . 80.1 mt -112.24 131.5 55.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.0 t -123.98 148.87 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 981' ' ' THR . 16.3 mt -91.1 129.58 37.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1002 ' ' GLY . . . . . 0.404 ' HA3' ' NZ ' ' A' ' 922' ' ' LYS . . . -61.92 -47.21 91.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 31.7 t -115.59 126.84 54.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.918 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 127.22 -163.23 21.12 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.64 0.18 OUTLIER 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.335 0.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1006 ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' 1007 ' ' SER . 36.8 m -92.45 89.9 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.824 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' 1006 ' ' SER . 75.7 p 34.52 44.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 5.0 t -140.6 131.29 25.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.902 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 17.9 m -112.06 139.01 47.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -110.35 94.89 0.82 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 1.5 p -98.02 41.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.837 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.3 t -168.28 115.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -114.81 113.71 3.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -97.51 -38.8 9.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.335 . . . . 0.0 111.151 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 15.5 m -165.34 107.78 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.4 p -60.74 125.27 23.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 60.68 135.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.18 140.85 31.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.534 0.683 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 88.4 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.44 26.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 54.0 Cg_endo -69.73 171.55 14.22 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 57.2 m -95.03 121.44 36.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.7 mm -92.25 128.33 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 77.6 mt -105.03 148.35 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -115.46 121.58 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 999' ' ' LEU . 18.1 t -105.66 129.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 931' ' ' GLN . . . . . 0.482 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.4 tm0? -134.38 170.24 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 50.12 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.676 ' HG3' HG12 ' A' ' 997' ' ' VAL . 8.6 mtm -116.79 128.28 26.13 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.614 0.721 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 174.42 9.52 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.41 -37.89 86.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -50.96 -30.57 15.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.669 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.0 t -52.24 125.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.9 m -131.28 171.54 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.79 -42.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.113 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.1 -45.77 90.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.38 -43.34 97.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.98 -49.98 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.76 -41.5 86.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.98 -31.46 66.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.674 ' CD2' HD11 ' A' ' 992' ' ' ILE . 5.4 t80 -66.08 -35.19 79.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.12 11.31 23.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -48.36 149.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 93.25 -39.93 2.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 983' ' ' ALA . 89.6 m-85 -95.33 141.17 29.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -71.77 100.2 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.4 t -95.9 124.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.478 HD12 ' CB ' ' A' ' 973' ' ' ALA . 87.3 mt -52.75 131.11 47.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.639 0.733 . . . . 0.0 111.115 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.11 18.78 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.374 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.49 -7.21 77.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.6 p -68.01 -55.44 12.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.1 t -35.63 112.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 27.5 m -124.07 119.2 28.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 40.8 mt -87.21 132.31 33.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -93.32 137.69 32.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 960' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 66.2 m-85 -125.87 -178.62 4.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 964' ' ' GLY . 0.3 OUTLIER -121.47 177.78 5.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -40.68 -53.15 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -64.57 -27.7 69.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 964' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 111.03 -21.75 22.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 37.7 mmt -54.53 152.98 11.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.54 0.686 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 134.65 28.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 35.5 p -97.42 25.98 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 52.79 38.06 53.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 9.5 mt-10 -138.31 145.69 41.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.55 151.25 32.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 31.8 mtp -125.11 142.73 51.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 29.2 m -138.68 165.33 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -127.97 150.77 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.4 m-85 -131.8 142.96 49.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.45 -34.03 60.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 26.6 t -109.62 124.93 51.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.2 ttp-105 -61.74 -44.01 97.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.24 -37.33 74.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.83 -42.46 81.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.63 -49.86 76.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.3 m -64.75 -43.92 91.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.91 95.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 949' ' ' TYR . . . -66.11 -43.64 86.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 980' ' ' ALA . 91.3 t -60.29 -48.12 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.25 -44.84 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 999' ' ' LEU . 47.2 mt -119.91 20.07 12.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.2 t-20 -79.82 127.19 31.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 64.62 41.83 5.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.574 ' O ' HG22 ' A' ' 997' ' ' VAL . 9.1 mmm180 -84.36 131.79 49.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 83.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 997' ' ' VAL . 10.9 mt -82.39 127.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.9 -93.86 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 23.1 p -131.78 -0.26 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.886 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -133.67 163.45 29.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -91.79 143.36 26.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.823 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -106.04 151.1 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -113.48 126.07 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.746 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.7 mt -110.93 128.0 55.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 59.5 t -132.9 142.13 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.93 140.84 47.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -84.99 47.29 3.83 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 37.4 m -67.62 -55.08 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -58.52 -176.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 163.43 81.85 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 -1.808 . . . . 0.0 112.366 0.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 70.3 m -143.46 116.53 8.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 3.6 t -84.12 125.07 31.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.457 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 28.8 p -69.69 137.08 51.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.838 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.5 m -111.78 163.25 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 149.43 -72.1 0.3 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.529 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 80.7 p -52.23 -20.31 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.846 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 11.6 m -105.89 -63.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 114.61 -157.44 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -122.22 138.07 54.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 47.0 t -76.12 120.81 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.853 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.6 m -145.02 129.84 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 157.6 -169.97 34.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -64.68 153.36 87.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.583 0.706 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.12 2.49 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.69 2.26 . . . . 0.0 112.317 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -121.43 -153.11 8.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.518 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 170.3 16.94 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.233 . . . . 0.0 112.349 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.4 m -92.13 125.28 36.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.5 mm -99.39 126.58 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.581 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.7 mt -105.59 145.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -111.44 133.94 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 999' ' ' LEU . 21.7 t -116.15 127.97 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.24 170.17 16.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.88 51.74 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.779 ' SD ' HG11 ' A' ' 937' ' ' VAL . 21.6 mtm -118.64 129.84 25.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.473 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.79 171.43 14.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.703 2.269 . . . . 0.0 112.333 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -63.68 -37.47 87.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 67.0 p -52.07 -34.1 42.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.779 HG11 ' SD ' ' A' ' 933' ' ' MET . 76.2 t -48.54 122.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 4.6 m -130.62 176.15 8.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.9 -41.96 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.147 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.02 -45.9 90.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.56 -45.0 96.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.14 -50.0 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.11 -42.03 84.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.889 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.5 t80 -66.69 -31.14 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 946' ' ' PHE . . . . . 0.434 ' HB3' HG21 ' A' ' 951' ' ' VAL . 42.1 m-85 -97.0 12.17 33.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -50.51 152.88 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.04 -37.57 3.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 987' ' ' LEU . 57.0 m-85 -96.37 127.83 42.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -60.78 97.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 951' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 946' ' ' PHE . 87.4 t -94.68 122.36 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 973' ' ' ALA . 89.7 mt -48.23 130.06 12.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 123.52 10.17 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.5 -2.62 74.16 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.0 p -72.33 -53.33 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 955' ' ' SER . 99.3 t -37.04 105.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.26 114.6 22.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.72 137.47 34.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.957 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -95.48 139.28 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.897 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -132.54 161.5 33.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -95.96 -175.7 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -50.48 -51.52 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 963' ' ' LYS . . . . . 0.41 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 37.3 mmtt -56.48 -44.11 80.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 126.88 -4.56 7.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 43.8 mtm -73.38 153.62 90.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 128.34 15.93 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.732 2.288 . . . . 0.0 112.369 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 65.0 p -90.32 37.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.14 40.53 1.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -140.97 146.97 38.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 3.2 mtt -122.62 143.69 49.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.63 160.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -122.32 153.8 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.058 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 928' ' ' ILE . 32.0 m-85 -134.5 141.14 46.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.821 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.13 -37.41 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 19.0 m -108.06 126.12 52.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -61.01 -45.75 93.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -57.39 -38.88 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.94 -44.12 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.35 -48.28 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.421 HG23 HD11 ' A' 1001 ' ' LEU . 10.0 m -64.27 -43.37 95.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.43 89.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.91 -39.17 93.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 980' ' ' ALA . 75.4 t -64.63 -49.08 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.45 -46.54 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -23.73 59.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.8 mt -115.47 25.94 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.1 t-20 -91.45 128.57 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.93 40.63 15.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 8.2 mtp85 -86.2 133.33 40.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.845 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 85.51 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.889 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.8 mt -84.44 125.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.85 -92.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 5.1 m -129.28 -5.76 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -133.08 156.25 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -86.42 143.33 27.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.876 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -101.1 151.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -116.26 128.29 55.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.611 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.3 mt -111.01 138.43 47.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.3 t -133.84 137.14 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 981' ' ' THR . 13.6 mt -73.81 136.36 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -81.39 61.36 4.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 12.0 t -155.15 137.09 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.929 0.395 . . . . 0.0 110.89 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 151.07 172.04 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.421 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.5 Cg_endo -69.79 123.93 7.22 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.738 -1.776 . . . . 0.0 112.292 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 5.3 t -59.31 98.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 58.1 m -115.63 115.73 26.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 912' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 913' ' ' SER . 4.5 m 38.95 42.17 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 110.845 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 912' ' ' SER . 33.6 t -35.96 128.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -86.31 167.95 39.92 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.6 t -88.5 131.23 34.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 26.7 p -159.75 174.28 14.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -150.72 104.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -84.58 79.92 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 54.0 m -120.76 129.56 53.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 7.4 t 71.61 42.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.863 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -68.59 -151.36 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -110.48 142.71 26.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 179.16 3.88 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 128.19 167.18 12.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.455 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 171.63 14.04 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.683 2.255 . . . . 0.0 112.391 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 12.0 m -92.77 119.67 32.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.7 mm -97.89 125.15 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.609 ' HB ' HG23 ' A' ' 972' ' ' VAL . 98.3 mt -104.98 143.49 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -111.85 130.58 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 999' ' ' LEU . 6.5 t -112.02 131.34 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.68 167.23 21.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.08 53.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -121.32 128.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 156.49 63.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.324 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -54.29 -33.53 58.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.2 p -53.24 -34.69 58.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.421 HG11 ' SD ' ' A' ' 933' ' ' MET . 88.4 t -46.81 137.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 5.7 m -140.5 175.69 9.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.83 -41.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.19 -45.82 89.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.08 -38.18 87.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.21 -49.1 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.24 -41.68 84.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.72 -30.75 65.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.0 t80 -64.92 -39.06 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -87.22 13.17 10.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.66 148.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.89 2.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -92.01 134.87 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -72.14 84.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.4 t -74.66 123.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.43 129.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.645 2.23 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.19 6.1 84.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 957' ' ' CYS . 81.5 p -87.07 -55.54 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 955' ' ' SER . 48.2 t -35.99 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 957' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 955' ' ' SER . 3.0 t -112.62 126.07 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 138.04 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -94.51 123.92 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 92.3 m-85 -111.6 175.08 5.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.96 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.39 -18.47 28.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -35.97 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 120.08 -15.13 10.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 77.9 mmm -69.2 155.73 92.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 137.73 36.26 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -100.38 0.27 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 81.73 31.52 32.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -128.98 146.88 50.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.422 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.91 142.2 23.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 28.4 mtp -120.97 142.89 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 928' ' ' ILE . 4.1 m -137.45 166.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.55 150.1 51.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -129.95 157.21 42.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -82.31 -42.95 18.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 20.4 m -117.44 139.07 51.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.1 mtp85 -61.29 -36.6 80.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -58.08 -43.44 87.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -45.14 78.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -61.49 -48.72 79.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.613 HG23 HD11 ' A' 1001 ' ' LEU . 6.8 m -62.36 -43.98 97.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.78 89.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -60.59 -40.93 93.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 980' ' ' ALA . 86.5 t -64.76 -50.23 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.25 -45.03 99.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -22.29 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.9 mt -119.86 29.18 7.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.959 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.0 OUTLIER -89.96 128.61 36.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.71 43.09 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.7 mmp_? -85.78 131.63 46.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 110.885 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.99 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.745 2.296 . . . . 0.0 112.315 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.902 HD12 HG11 ' A' ' 997' ' ' VAL . 16.1 mt -81.26 126.91 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.58 -92.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 17.2 t -132.82 -1.13 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -132.76 163.48 28.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -92.53 141.0 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.902 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -102.6 151.08 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.57 128.17 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -111.16 131.08 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.921 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 57.6 t -124.79 143.03 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 981' ' ' THR . 19.4 mt -82.36 134.82 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -60.82 -124.27 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 7.9 t -48.78 177.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.945 0.402 . . . . 0.0 110.883 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' 1005 ' ' PRO . . . 76.79 79.94 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' 1004 ' ' GLY . 53.3 Cg_endo -69.84 161.07 87.16 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.349 0.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 80.1 p -86.73 -175.26 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 9.0 t -139.14 179.7 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 65.7 m -127.85 138.74 52.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 33.6 m -63.41 115.58 4.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 174.02 69.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 66.8 m -48.73 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 4.6 t -71.48 136.67 47.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 153.68 66.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -43.91 130.97 5.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 4.4 m -82.36 45.67 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.805 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 4.8 m -57.35 160.75 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -159.24 156.8 27.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 143.71 63.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 114.25 3.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.347 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 154.21 -151.28 22.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.5 Cg_endo -69.83 169.03 19.96 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 50.7 m -101.13 132.99 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 30.3 mm -100.6 128.0 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 984' ' ' VAL . 75.7 mt -108.55 145.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -114.76 131.48 56.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 999' ' ' LEU . 61.9 t -113.29 126.92 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.116 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 167.21 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.07 50.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.618 ' CG ' HG12 ' A' ' 997' ' ' VAL . 23.8 mtm -119.3 130.59 24.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 158.49 56.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -56.63 -33.46 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 47.8 p -53.11 -32.39 47.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.554 HG11 ' SD ' ' A' ' 933' ' ' MET . 94.2 t -49.71 140.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 72.7 m -145.93 172.96 12.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.81 -42.01 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.12 -46.05 89.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -65.61 -45.27 83.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 942' ' ' ILE . . . . . 0.482 ' CD1' HD21 ' A' ' 958' ' ' LEU . 38.5 mt -61.01 -48.48 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.4 mt -58.45 -42.02 86.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.55 -31.2 66.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.804 ' CD2' HD11 ' A' ' 992' ' ' ILE . 2.9 t80 -65.02 -41.24 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -81.41 7.7 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -41.28 149.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.32 -40.62 2.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 92.2 m-85 -97.25 130.91 44.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.58 92.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.5 t -78.04 125.68 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 953' ' ' PRO . 75.9 mt -54.18 133.83 60.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.614 0.721 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.1 Cg_endo -69.75 147.17 62.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.356 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.33 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.438 ' OG ' HG22 ' A' ' 952' ' ' ILE . 2.2 m -93.37 -56.21 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.87 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.0 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.99 129.17 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 942' ' ' ILE . 45.1 mt -94.84 139.21 31.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -93.5 131.58 38.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -115.09 160.22 19.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.522 HD22 ' HB2' ' A' ' 963' ' ' LYS . 1.1 p-10 -99.68 -176.41 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.33 -47.43 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 963' ' ' LYS . . . . . 0.522 ' HB2' HD22 ' A' ' 961' ' ' ASN . 0.8 OUTLIER -66.33 -24.77 66.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 117.08 -28.67 7.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.5 ptp -57.82 153.64 31.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.44 17.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.704 2.269 . . . . 0.0 112.358 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 38.8 p -83.97 26.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 56.35 33.04 61.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -129.11 147.96 51.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.69 147.08 26.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.5 mtt -123.0 141.82 51.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 18.9 m -139.3 164.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.49 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 925' ' ' PRO . 23.1 m-85 -128.2 148.09 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.16 -35.99 61.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 9.4 t -115.82 134.61 54.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 977' ' ' ARG . . . . . 0.424 ' NH2' ' HB3' ' A' 1005 ' ' PRO . 52.6 ttp85 -61.26 -39.91 92.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -41.68 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -62.67 -45.17 94.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.764 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.03 -49.36 77.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.942 HG23 HD11 ' A' 1001 ' ' LEU . 5.9 m -62.75 -44.0 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.92 92.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -62.59 -38.06 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 980' ' ' ALA . 84.9 t -66.04 -49.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 32.9 mt -60.95 -47.61 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.93 -21.55 61.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.2 mt -119.37 27.23 8.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.92 129.65 36.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 60.48 41.46 15.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 997' ' ' VAL . 18.0 mtp180 -84.13 130.89 52.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.617 0.722 . . . . 0.0 110.826 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 84.46 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.943 HD12 HG11 ' A' ' 997' ' ' VAL . 9.0 mt -84.39 130.66 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.52 -94.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 12.8 t -129.35 -0.87 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -133.96 163.67 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -93.07 143.28 26.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.943 HG11 HD12 ' A' ' 992' ' ' ILE . 3.8 m -101.89 149.89 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.26 127.1 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 930' ' ' VAL . 78.9 mt -111.73 131.08 55.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.858 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.2 t -120.67 140.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 981' ' ' THR . 13.4 mt -81.22 122.89 27.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -46.79 -81.96 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 67.7 m -149.13 163.41 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.94 0.4 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 150.89 178.01 25.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.459 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.424 ' HB3' ' NH2' ' A' ' 977' ' ' ARG . 53.8 Cg_endo -69.76 158.17 91.29 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.362 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 30.2 t -72.24 110.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 19.3 m -83.87 -59.0 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.837 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 4.0 m -116.13 99.06 6.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.911 0.386 . . . . 0.0 110.888 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.5 t -58.05 149.99 22.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 75.52 157.93 6.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 52.1 m -120.18 -56.89 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 87.2 p -46.42 111.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -179.91 159.89 24.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -113.42 137.8 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 7.8 t -82.47 99.81 9.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.3 t -94.06 93.93 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -66.52 123.37 22.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -161.79 139.81 6.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.554 0.692 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 174.11 9.98 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 146.15 178.95 21.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 925' ' ' PRO . . . . . 0.439 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.6 Cg_endo -69.76 169.58 18.57 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.354 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.4 m -94.28 117.13 29.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.35 125.27 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.8 mt -105.18 147.95 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -111.29 131.39 55.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.54 125.03 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 171.27 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.7 47.76 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.513 ' SD ' HG11 ' A' ' 937' ' ' VAL . 18.3 mtm -111.47 125.75 29.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 159.38 53.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.664 2.243 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -56.9 -32.94 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.4 p -55.04 -30.94 60.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.513 HG11 ' SD ' ' A' ' 933' ' ' MET . 75.3 t -48.31 145.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 33.4 m -153.64 173.19 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.92 -42.16 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -46.06 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -65.61 -46.13 80.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.02 -46.27 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.6 mt -57.97 -41.92 83.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.91 -34.21 68.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.9 t80 -61.81 -37.15 83.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.17 23.58 6.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -60.61 161.23 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 80.69 -41.89 2.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 79.6 m-85 -85.25 135.52 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.89 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -65.59 83.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.64 119.85 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 953' ' ' PRO . 95.3 mt -48.64 132.14 13.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.613 0.721 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.8 Cg_endo -69.76 111.62 2.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 0.0 112.357 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.81 31.72 9.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.466 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 956' ' ' VAL . 81.0 p -103.58 -53.86 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 955' ' ' SER . 86.7 t -34.62 114.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 8.5 t -119.93 112.7 19.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 44.5 mt -81.85 131.59 35.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -95.48 138.69 32.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.7 171.87 11.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 965' ' ' MET . 1.1 p30 -100.19 -179.07 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 962' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 963' ' ' LYS . 17.1 pt-20 -50.81 -47.1 60.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 963' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 962' ' ' GLU . 0.0 OUTLIER -63.51 -43.53 96.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 134.91 -27.34 3.19 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.415 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 0.1 OUTLIER -52.23 158.43 1.89 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 0.0 110.854 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 137.55 35.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.331 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 967' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 968' ' ' GLY . 82.5 p -100.76 37.47 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 967' ' ' THR . . . 37.07 39.14 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -141.79 145.59 34.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.94 148.56 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.0 mtt -119.0 143.18 47.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 23.8 m -135.39 160.53 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.39 147.15 47.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -129.14 137.71 51.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.66 -34.02 64.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 976' ' ' SER . . . . . 0.404 ' HB2' ' CD ' ' A' ' 979' ' ' GLU . 1.8 m -108.81 130.99 55.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -61.77 -48.91 78.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -56.91 -39.17 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 979' ' ' GLU . . . . . 0.404 ' CD ' ' HB2' ' A' ' 976' ' ' SER . 20.4 mt-10 -63.32 -44.44 94.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.88 -50.02 73.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.635 HG22 HD11 ' A' ' 985' ' ' ILE . 24.3 m -64.51 -43.41 94.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.14 93.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.68 -41.91 98.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 999' ' ' LEU . 84.1 t -66.28 -49.76 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 981' ' ' THR . 41.7 mt -58.66 -46.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.66 -30.31 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 999' ' ' LEU . 12.5 mt -109.5 28.87 8.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -89.48 133.57 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 22.9 t70 54.37 43.44 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -87.85 130.16 47.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 94.61 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 945' ' ' PHE . 15.7 mt -92.59 124.47 45.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.08 -90.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 9.5 t -131.34 -3.38 3.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.809 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -134.11 154.3 51.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -88.82 140.54 29.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 992' ' ' ILE . 4.9 m -100.1 150.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.0 129.42 56.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.711 ' HB2' HG13 ' A' ' 984' ' ' VAL . 81.7 mt -110.93 128.66 55.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 89.3 t -123.39 137.93 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 981' ' ' THR . 11.9 mt -71.55 134.27 46.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -57.94 -166.77 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 21.8 t -108.97 127.59 54.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.832 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 70.35 -162.74 53.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 135.47 33.85 Favored 'Cis proline' 0 C--O 1.231 0.141 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.364 0.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 72.9 p -45.47 130.01 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 13.6 t -64.06 136.13 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.454 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 21.4 m -147.83 157.11 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 110.859 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 41.3 p -54.55 -46.81 73.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 153.44 -162.66 30.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 92.0 p -155.11 169.51 23.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.9 t -105.77 142.42 35.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 61.0 -162.79 22.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -94.72 102.74 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 13.6 p -48.05 151.17 1.01 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.1 m -140.75 131.48 25.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -139.37 -161.59 8.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -147.22 146.94 27.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.6 0.714 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -176.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.659 2.239 . . . . 0.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 106.65 -145.64 15.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 175.73 7.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 29.9 m -91.93 125.78 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 41.6 mm -101.52 127.86 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.568 HD12 ' CE1' ' A' ' 974' ' ' PHE . 65.7 mt -107.33 146.46 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 929' ' ' LYS . . . . . 0.401 ' NZ ' ' HA2' ' A' 1002 ' ' GLY . 2.9 mppt? -113.5 130.09 56.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 999' ' ' LEU . 19.8 t -115.64 127.23 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 931' ' ' GLN . . . . . 0.434 ' HG3' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -131.71 172.48 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 49.23 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.706 ' HG3' HG12 ' A' ' 997' ' ' VAL . 16.7 mtm -114.44 129.2 25.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 167.52 24.25 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.69 -25.0 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 64.8 p -63.88 -21.78 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.552 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.3 t -60.48 139.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.0 m -144.41 177.81 8.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.03 -42.17 92.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -63.29 -46.05 88.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.47 -45.29 93.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 24.1 mt -60.98 -49.64 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.03 -42.0 89.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -72.07 -31.18 65.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 38.6 t80 -65.25 -38.43 90.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -87.91 10.96 17.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -47.03 145.58 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 99.07 -32.51 7.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 87.5 m-85 -103.57 143.78 32.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.12 87.03 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.46 127.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 953' ' ' PRO . 63.7 mt -55.48 132.71 70.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.77 132.74 23.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.12 85.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 956' ' ' VAL . 24.6 p -82.16 -60.39 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.824 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 972' ' ' VAL . 98.0 t -34.79 112.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 13.5 m -124.43 125.49 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.9 146.57 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -100.26 135.76 41.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -128.74 160.67 31.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 965' ' ' MET . 49.4 p-10 -98.81 -177.05 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.93 -41.39 61.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -67.1 -33.67 75.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 113.16 -1.32 25.43 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.463 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 8.7 ptp -80.1 151.96 73.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 133.34 25.37 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -95.45 22.23 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.88 38.87 93.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 931' ' ' GLN . 8.1 mt-10 -138.7 145.46 40.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -147.88 145.66 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 40.8 mtp -119.45 138.7 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 956' ' ' VAL . 28.1 m -135.1 163.29 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -125.06 155.14 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -133.18 144.71 50.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.43 -34.92 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.4 t -115.85 131.62 56.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -63.23 -38.13 89.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.9 -41.43 96.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.51 -46.79 78.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.78 -48.22 70.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.556 HG22 HD11 ' A' ' 985' ' ' ILE . 19.6 m -64.87 -43.65 92.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.96 94.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.72 -40.01 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 980' ' ' ALA . 81.4 t -66.03 -48.57 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.556 HD11 HG22 ' A' ' 981' ' ' THR . 37.0 mt -62.04 -44.55 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.5 -26.42 59.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.678 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.1 mt -115.34 27.39 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.86 127.9 35.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.5 t70 61.0 41.74 13.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 997' ' ' VAL . 15.3 mtp85 -87.17 134.63 36.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.72 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 85.64 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.321 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 7.5 mt -83.69 128.85 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.03 -92.97 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.5 t -131.6 -2.74 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -133.73 158.52 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -85.91 143.88 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 0.2 OUTLIER -104.98 151.03 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 998' ' ' LYS . . . . . 0.41 ' HE2' HG22 ' A' 1000 ' ' VAL . 0.8 OUTLIER -114.22 125.12 53.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.2 mt -111.04 132.32 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1000 ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 998' ' ' LYS . 23.3 t -128.14 143.34 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 981' ' ' THR . 13.5 mt -78.67 134.38 37.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1002 ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 929' ' ' LYS . . . -52.97 126.19 32.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 20.8 t -87.33 97.0 10.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 160.62 176.07 32.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 169.52 63.21 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.349 0.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 15.8 t -105.57 96.75 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 5.4 t -101.76 94.34 5.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.565 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 67.5 m -95.39 103.85 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 97.2 p -98.67 110.42 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 70.85 -131.15 20.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 39.4 p -169.74 175.95 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 48.4 t -49.6 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -44.55 123.47 5.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -132.03 129.34 39.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 10.0 t -130.76 141.97 50.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.7 p -97.2 65.53 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -178.62 137.27 3.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -57.32 144.26 71.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.586 0.708 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 167.14 25.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.366 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -117.35 -170.27 15.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.18 25.24 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 0.0 112.314 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 5.1 m -98.31 119.52 37.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.651 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 49.9 mm -91.36 129.19 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.645 HD11 ' HB1' ' A' ' 980' ' ' ALA . 95.8 mt -104.99 148.97 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 9.6 t -109.44 128.11 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.54 170.19 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.01 47.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.631 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.9 mtm -114.12 130.7 23.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.697 . . . . 0.0 110.895 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.452 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.5 Cg_endo -69.77 170.19 17.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -68.91 -28.8 66.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.7 p -59.46 -30.12 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 938' ' ' SER . 94.1 t -47.16 155.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 938' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 937' ' ' VAL . 10.0 m -162.32 170.96 18.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.89 -45.54 92.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.13 -39.32 92.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.77 -49.48 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.01 -41.56 83.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 992' ' ' ILE . 25.8 t80 -65.05 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.02 14.61 13.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -49.54 148.35 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.52 -39.52 2.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 67.1 m-85 -94.37 150.54 20.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.961 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.17 90.04 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.94 126.61 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 78.2 mt -56.28 129.73 74.55 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 125.05 11.68 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 0.0 112.343 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.25 -6.99 78.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 4.0 p -70.39 -51.5 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 110.796 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 69.1 t -41.23 109.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.18 118.95 31.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.94 146.74 26.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -97.36 138.14 35.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.93 163.91 29.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -108.39 172.38 6.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -34.41 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -69.12 -31.7 70.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 103.62 16.64 19.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 4.9 mmt -101.43 154.69 37.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.585 0.707 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.1 41.91 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 25.1 p -106.83 27.78 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 51.39 37.24 39.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.48 144.97 42.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.97 152.53 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtm -126.18 142.41 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.8 163.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -128.34 153.88 46.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.5 m-85 -134.29 143.17 47.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.75 -34.61 75.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -120.73 129.07 53.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 977' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 978' ' ' ASP . 1.4 ptp180 -61.87 -29.75 70.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 978' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 977' ' ' ARG . 7.3 m-20 -66.23 -41.5 89.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.99 -44.45 76.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 928' ' ' ILE . . . -57.16 -47.85 80.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.2 m -64.42 -43.58 93.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.46 95.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.12 -38.91 86.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 999' ' ' LEU . 79.8 t -64.75 -49.32 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.78 -43.45 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.67 -23.29 58.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.534 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.0 mt -116.42 21.46 13.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.8 t-20 -80.25 144.26 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 989' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.2 p30 49.98 39.53 19.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.509 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.6 mmp_? -84.16 127.58 66.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 86.93 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.864 HD12 HG11 ' A' ' 997' ' ' VAL . 10.5 mt -85.14 125.1 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.5 -93.98 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 49.6 p -130.04 -2.3 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -133.05 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -93.39 142.9 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.864 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -102.37 151.07 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -115.21 125.21 53.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.837 ' HB2' HG13 ' A' ' 984' ' ' VAL . 70.0 mt -111.29 128.21 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 58.0 t -133.72 141.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.7 134.45 49.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -47.33 119.5 4.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 1.4 t -86.5 32.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.879 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 103.18 173.81 26.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' 1006 ' ' SER . 53.6 Cg_endo -69.72 123.5 6.84 Favored 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 -1.798 . . . . 0.0 112.312 0.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1006 ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' 1005 ' ' PRO . 45.3 t -34.61 -58.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' 1008 ' ' GLY . 60.3 p -76.94 152.83 35.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' 1007 ' ' SER . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 95.9 p -116.14 137.94 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 10.2 t -105.99 117.71 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -100.67 159.64 19.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 89.9 p -92.95 108.9 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 58.8 m -90.8 96.43 10.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -176.74 58.48 0.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -120.86 84.62 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.336 . . . . 0.0 111.13 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 53.0 m -117.05 175.45 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 30.2 t -57.63 137.63 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.16 13.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -106.62 156.16 37.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 127.71 15.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 160.47 -155.66 26.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 170.68 16.03 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.3 m -92.0 121.93 34.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 42.9 mm -95.49 129.01 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 984' ' ' VAL . 53.5 mt -104.98 148.8 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -113.43 129.48 56.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.569 HG22 HD23 ' A' ' 999' ' ' LEU . 21.8 t -111.74 133.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.125 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 173.49 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.99 51.43 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.685 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -118.8 128.38 26.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 161.14 47.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -57.87 -31.79 67.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 82.2 p -55.8 -33.9 64.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.4 t -47.32 135.7 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.1 m -138.48 171.76 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.6 mt -58.77 -42.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -63.1 -46.05 89.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -62.39 -41.86 98.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 25.2 mt -62.47 -48.79 86.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.14 -41.94 84.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -71.93 -30.38 65.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.9 t80 -64.79 -39.65 93.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -87.62 13.29 10.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -48.05 147.78 1.99 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 97.58 -43.92 1.91 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 91.1 m-85 -91.39 159.29 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -91.54 90.74 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.49 131.35 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.0 129.59 86.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 129.14 17.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.714 2.276 . . . . 0.0 112.295 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.03 -9.61 77.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 24.4 p -70.36 -49.73 46.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 110.825 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -40.41 104.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.8 117.47 27.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.82 136.2 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 121.47 40.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.1 175.74 5.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -95.46 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.41 -39.28 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 963' ' ' LYS . . . . . 0.444 ' CE ' ' HA ' ' A' ' 963' ' ' LYS . 0.3 OUTLIER -77.4 -36.64 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.63 -1.84 4.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.448 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.19 146.3 70.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 136.75 33.73 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.0 p -101.65 -0.08 35.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.2 38.22 59.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.44 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -132.4 146.33 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -146.89 149.95 34.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 22.2 mtp -123.07 143.6 49.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.0 m -141.46 160.78 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.618 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -124.17 148.93 46.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 928' ' ' ILE . 39.2 m-85 -131.29 141.5 49.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.94 -32.43 57.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 15.7 t -114.92 130.54 56.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -63.27 -41.54 99.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.26 -38.81 81.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.96 -43.53 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.42 -50.01 75.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.632 HG22 ' CD1' ' A' ' 985' ' ' ILE . 19.7 m -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.54 97.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.15 -42.75 96.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.723 HG13 ' CB ' ' A' ' 999' ' ' LEU . 95.8 t -66.14 -48.91 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.632 ' CD1' HG22 ' A' ' 981' ' ' THR . 54.6 mt -60.18 -44.97 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -29.24 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 999' ' ' LEU . 3.8 mt -113.55 30.73 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.8 131.98 34.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 55.77 43.53 27.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 997' ' ' VAL . 20.2 mtp85 -86.69 134.1 38.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.611 0.72 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.93 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.26 . . . . 0.0 112.363 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.79 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.74 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.19 -92.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.1 p -132.45 -1.8 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -133.63 161.9 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -90.47 139.54 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -100.73 151.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.109 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -114.46 126.26 54.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.723 ' CB ' HG13 ' A' ' 984' ' ' VAL . 69.5 mt -111.17 131.83 54.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 97.4 t -130.94 137.44 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.35 132.4 43.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -45.93 -74.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.479 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 4.4 m -105.81 117.85 35.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' 1005 ' ' PRO . . . -118.0 -76.46 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.443 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.463 ' C ' ' HA3' ' A' 1004 ' ' GLY . 53.4 Cg_endo -69.84 140.09 58.7 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 0.0 112.346 0.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 45.5 t -84.19 140.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 52.7 p -159.53 170.78 20.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 41.1 t -77.89 -50.64 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.1 t -75.01 143.32 43.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 134.93 65.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 58.3 m -47.32 116.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 18.4 m -61.32 162.19 8.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 101.37 77.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -93.08 79.82 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 0.0 111.072 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.9 t -92.98 140.47 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 16.1 t -108.87 -64.81 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 112.12 -48.75 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -65.41 143.81 98.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.539 0.685 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -172.22 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.333 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 115.78 -156.68 15.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.523 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 170.82 15.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 0.0 112.337 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 93.3 m -92.39 118.92 31.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.5 mm -90.97 130.03 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.6 mt -104.99 148.34 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -112.66 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.6 HG22 HD23 ' A' ' 999' ' ' LEU . 59.9 t -110.77 124.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.06 166.58 18.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.15 52.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.474 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.0 mtm -115.85 125.24 28.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.539 0.685 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.2 Cg_endo -69.81 168.46 21.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.307 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -61.94 -39.64 92.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -49.09 -30.32 6.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.447 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.5 t -52.19 145.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 15.1 m -151.68 179.26 8.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.34 -41.98 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.173 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.04 -45.98 89.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.04 -42.17 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.25 -47.63 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.02 -41.77 88.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.7 -30.9 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.607 ' CD2' HD11 ' A' ' 992' ' ' ILE . 55.5 t80 -64.93 -39.15 93.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -88.95 12.92 14.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -48.77 147.64 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.3 -33.3 5.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 65.0 m-85 -102.56 143.37 32.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -74.97 94.04 2.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.66 122.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 52.9 mt -51.47 130.19 34.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.591 0.71 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 126.78 13.73 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.268 . . . . 0.0 112.327 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.05 -6.03 81.66 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 52.1 p -72.87 -51.62 17.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.835 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 78.1 t -38.39 110.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 19.8 m -125.34 125.76 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 46.9 mt -97.14 140.08 32.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.0 45.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -119.87 169.08 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 965' ' ' MET . 1.4 p30 -96.35 -177.38 3.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.93 -49.94 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -58.48 -43.97 89.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 134.86 -21.93 3.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.542 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.518 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtp -59.9 157.96 27.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 145.57 57.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 20.8 p -105.23 34.99 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.6 44.37 3.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -147.86 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.45 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.24 152.84 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 15.7 mtm -126.28 142.37 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.1 m -135.44 163.91 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.117 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -124.32 148.2 47.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -127.83 137.52 52.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.42 -38.52 71.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -108.72 128.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -60.96 -40.99 95.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -67.44 -44.61 78.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.64 -49.95 73.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 9.8 m -65.06 -44.02 90.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.56 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -68.07 -41.3 82.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.8 t -62.43 -48.98 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.6 -46.46 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.88 -21.21 60.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 20.0 mt -116.19 21.48 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.7 t-20 -83.27 135.71 34.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 54.89 43.82 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.8 mmp_? -86.69 130.2 49.82 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.834 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 81.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 8.8 mt -79.93 131.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.7 -92.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.1 t -131.07 -3.67 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -84.97 143.9 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.32 151.07 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -113.16 128.58 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.711 ' CB ' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -110.91 130.54 55.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 25.1 t -128.58 140.98 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.94 121.29 26.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -45.05 -48.11 9.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 47.7 t -134.88 114.93 13.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.848 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 127.68 -162.79 21.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -41.93 0.83 Allowed 'Cis proline' 0 C--N 1.341 0.149 0 C-N-CA 122.716 -1.785 . . . . 0.0 112.323 0.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1006 ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' 1007 ' ' SER . 3.6 m 62.89 25.35 15.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' 1006 ' ' SER . 91.9 p -37.06 113.98 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.846 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 912' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 912' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 911' ' ' GLY . 60.1 p -34.86 138.06 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.83 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.0 m -52.11 160.46 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -78.53 116.96 4.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 87.9 p -72.0 108.09 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 72.0 p -86.32 34.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -162.48 -134.61 1.67 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -165.28 169.92 15.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.2 m -116.81 149.9 39.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 68.2 m -69.23 131.89 45.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.851 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -101.41 172.7 23.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -138.71 146.4 50.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -167.43 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 91.79 -156.99 24.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 169.85 17.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.658 2.239 . . . . 0.0 112.336 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.12 127.53 37.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.1 125.97 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 974' ' ' PHE . 98.4 mt -105.29 147.0 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -112.02 127.69 55.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.604 HG22 ' CD2' ' A' ' 999' ' ' LEU . 14.9 t -111.85 123.5 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 931' ' ' GLN . . . . . 0.446 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.3 tm0? -127.61 173.34 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.48 53.87 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.589 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.2 mtm -119.47 125.75 27.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.415 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.2 Cg_endo -69.73 166.03 28.94 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.357 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.85 -35.14 77.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.4 p -53.75 -23.35 11.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 933' ' ' MET . 73.3 t -60.04 139.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 23.0 m -140.04 173.36 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.12 -41.96 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -63.13 -45.45 91.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.68 -42.04 98.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.9 mt -62.27 -49.33 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.13 -40.85 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.01 -31.32 66.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.794 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.5 t80 -65.51 -36.97 85.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.71 12.47 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -46.9 155.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.47 3.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 69.9 m-85 -92.57 147.14 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -79.91 100.53 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.6 t -93.93 130.88 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.43 HG23 ' HD2' ' A' ' 953' ' ' PRO . 46.7 mt -59.33 132.34 87.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.9 Cg_endo -69.79 128.03 15.42 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.664 2.243 . . . . 0.0 112.322 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.54 76.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 12.7 p -66.18 -56.09 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 972' ' ' VAL . 93.8 t -40.45 109.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -122.28 116.27 23.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 45.3 mt -82.71 132.24 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.66 136.96 33.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.48 180.0 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -114.77 -177.85 3.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.32 -32.17 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -77.19 -33.58 56.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.85 12.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.7 mtt -79.16 156.97 76.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 134.09 27.09 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 27.3 p -95.25 35.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 46.35 30.22 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.519 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 969' ' ' GLU . . . . . 0.446 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.6 mt-10 -128.85 145.19 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.909 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.97 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 60.9 mtp -121.62 141.0 51.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.504 HG12 HG22 ' A' ' 956' ' ' VAL . 15.5 m -135.89 164.35 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.83 50.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 928' ' ' ILE . 26.8 m-85 -127.48 137.29 52.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.94 -35.7 74.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 976' ' ' SER . . . . . 0.457 ' CB ' ' CD ' ' A' ' 979' ' ' GLU . 4.1 m -109.62 130.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.848 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.69 -48.46 77.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.04 -36.99 71.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 979' ' ' GLU . . . . . 0.457 ' CD ' ' CB ' ' A' ' 976' ' ' SER . 1.0 OUTLIER -64.24 -50.11 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.7 -46.0 70.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.464 HG23 HD11 ' A' 1001 ' ' LEU . 4.8 m -63.91 -42.41 97.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.66 94.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.45 -38.48 84.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 999' ' ' LEU . 69.6 t -68.32 -48.92 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -44.89 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -30.45 63.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.536 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 4.8 mt -109.72 23.79 13.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -83.2 136.0 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.22 42.73 32.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 12.4 mtt-85 -85.19 133.67 42.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 0.0 110.826 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 87.29 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.836 HD12 HG11 ' A' ' 997' ' ' VAL . 7.7 mt -87.78 130.93 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.23 -92.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.3 p -131.14 -3.66 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -134.11 158.6 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -88.05 138.36 31.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -95.8 150.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -112.7 125.63 54.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.706 ' CB ' HG13 ' A' ' 984' ' ' VAL . 80.0 mt -111.21 130.02 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 62.6 t -126.63 147.49 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -80.06 137.03 36.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -53.28 117.53 7.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 31.0 t -58.14 108.03 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.462 ' HA3' ' C ' ' A' 1005 ' ' PRO . . . -99.64 -74.62 1.13 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.478 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.462 ' C ' ' HA3' ' A' 1004 ' ' GLY . 54.0 Cg_endo -69.72 -28.13 6.42 Favored 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.385 -0.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 86.1 p -173.09 174.17 3.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 6.0 t -59.31 96.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 68.6 m -59.25 -53.28 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 110.845 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 19.7 m -78.3 130.39 36.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -136.92 173.96 21.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 29.4 t -107.3 102.61 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.84 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 8.3 t -63.32 99.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -54.68 162.87 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -96.47 113.74 25.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 11.2 t -95.12 -54.97 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 66.1 m -69.09 103.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -95.88 -103.28 1.99 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -118.72 154.85 52.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.607 0.718 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 81.51 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -153.04 -148.87 5.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 168.44 21.64 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.24 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 10.8 m -92.06 128.67 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 973' ' ' ALA . 4.1 mm -100.81 128.23 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.091 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.4 mt -105.36 145.1 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -111.02 127.49 55.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 8.5 t -107.72 127.7 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 931' ' ' GLN . . . . . 0.452 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -132.44 169.34 16.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 63.1 54.69 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.533 ' HG3' HG12 ' A' ' 997' ' ' VAL . 7.2 mtm -118.94 124.89 28.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.8 Cg_endo -69.79 168.32 21.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.662 2.241 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.1 -27.16 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 63.2 p -59.58 -27.95 66.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.41 HG23 ' HG2' ' A' ' 934' ' ' PRO . 60.1 t -57.62 144.52 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.8 m -146.72 171.64 14.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.04 -42.01 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.01 -45.84 90.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.52 -42.63 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.97 -49.55 84.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 943' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.7 mt -58.95 -41.84 88.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.41 -40.56 96.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -87.46 13.77 9.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -52.1 146.54 8.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.92 -35.06 4.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -99.58 139.42 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -70.88 90.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.5 t -86.24 124.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.434 HD12 ' CB ' ' A' ' 973' ' ' ALA . 97.3 mt -52.02 129.66 39.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.4 23.29 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.93 -2.46 87.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 956' ' ' VAL . 5.0 p -72.5 -53.37 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 955' ' ' SER . 61.1 t -36.37 108.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.49 108.18 12.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.1 mt -76.98 141.0 40.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -94.59 137.79 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 72.8 m-85 -130.5 158.61 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -97.31 178.48 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -44.07 -49.56 8.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 963' ' ' LYS . . . . . 0.463 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtmp? -61.86 -42.72 99.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 124.87 -11.14 7.85 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.9 mmt -65.74 157.48 79.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.78 43.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.4 p -107.77 33.79 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.05 44.96 6.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 969' ' ' GLU . . . . . 0.452 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.2 mt-10 -147.81 145.32 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.62 35.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 27.1 mtt -126.56 142.71 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.62 164.49 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -123.31 150.05 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 25.1 m-85 -130.36 137.67 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.65 -37.78 67.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 24.5 t -106.1 131.76 52.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.859 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -63.42 -46.91 84.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.74 -34.66 69.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -47.33 69.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.96 -49.01 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.946 HG23 HD11 ' A' 1001 ' ' LEU . 3.7 m -64.92 -43.9 91.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.91 99.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.61 97.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 999' ' ' LEU . 96.2 t -65.68 -49.85 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 981' ' ' THR . 34.5 mt -65.0 -44.8 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.98 -27.69 67.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.06 30.2 6.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.56 127.98 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 61.4 41.9 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.501 ' O ' HG22 ' A' ' 997' ' ' VAL . 11.6 mmp_? -84.08 133.87 44.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.39 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.646 2.231 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 997' ' ' VAL . 7.1 mt -85.95 129.04 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.02 -93.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 22.8 t -131.23 -3.34 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -133.47 160.83 36.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -88.31 142.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 992' ' ' ILE . 1.7 m -102.81 150.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 126.63 55.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 984' ' ' VAL . 62.8 mt -111.02 133.12 53.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.9 t -126.61 149.48 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -87.95 121.6 30.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -66.91 -63.65 3.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 97.2 p -51.8 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 175.52 -165.01 35.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 157.48 92.03 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.668 -1.805 . . . . 0.0 112.365 0.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 91.24 8.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.8 t -102.44 88.76 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 51.9 p -154.58 121.28 5.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 93.8 p -52.35 161.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -78.74 -143.04 2.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 48.9 m 62.73 42.22 8.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 73.7 p -138.72 156.89 47.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.34 20.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -110.0 113.83 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 15.0 m -95.43 149.96 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 15.8 m -77.27 88.9 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -54.1 155.54 7.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.442 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -136.23 153.22 76.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.17 7.13 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.341 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 133.79 -155.97 22.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -176.86 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.223 . . . . 0.0 112.351 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 7.0 m -96.79 118.98 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.5 mm -95.98 123.83 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.518 HD12 ' CE1' ' A' ' 974' ' ' PHE . 97.7 mt -106.48 145.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -111.95 134.25 53.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.692 HG22 ' CD2' ' A' ' 999' ' ' LEU . 70.4 t -114.47 125.95 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.92 169.0 14.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.81 53.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.5 ' HE1' ' HB2' ' A' ' 970' ' ' ALA . 14.3 mtm -117.92 121.72 31.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.615 0.722 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 162.97 40.04 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -55.35 -41.38 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.2 p -45.47 -36.33 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.5 t -49.13 142.44 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 27.9 m -148.5 179.23 7.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.02 -42.04 94.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -62.97 -45.89 90.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -65.21 -42.71 93.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 942' ' ' ILE . . . . . 0.441 ' CD1' HD21 ' A' ' 958' ' ' LEU . 26.8 mt -61.29 -48.61 88.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.1 -41.97 89.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.94 -30.78 65.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.6 t80 -64.92 -38.67 91.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.29 13.16 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -49.38 154.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 88.26 -36.66 3.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 77.6 m-85 -95.84 136.33 36.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.986 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 950' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 950' ' ' GLN . 2.6 mp0 -73.74 82.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.54 135.52 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.25 130.95 93.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 132.27 23.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 0.0 112.409 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 90.19 -4.11 82.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 957' ' ' CYS . 1.5 m -80.6 -56.47 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 955' ' ' SER . 65.2 t -36.32 95.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 957' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 955' ' ' SER . 20.9 m -112.41 136.74 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.441 HD21 ' CD1' ' A' ' 942' ' ' ILE . 71.2 mt -99.9 137.23 38.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -96.54 133.34 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.49 175.57 5.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 965' ' ' MET . 4.6 p30 -107.63 -177.58 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 962' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.36 -29.19 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -79.21 -35.57 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 124.45 -17.76 7.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.442 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 15.0 mtp -68.36 157.9 86.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.04 15.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 19.3 p -89.05 35.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.47 45.54 6.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -142.17 148.53 38.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.5 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -149.86 152.82 35.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 63.1 mtp -130.54 141.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.79 162.55 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.63 44.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.7 m-85 -129.96 141.31 50.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.32 -34.84 68.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.34 135.0 54.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.814 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -62.25 -41.37 98.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.28 -42.97 82.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -47.87 79.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 974' ' ' PHE . . . -54.89 -49.75 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.669 HG22 HD11 ' A' ' 985' ' ' ILE . 3.8 m -64.61 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.6 87.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -66.92 -45.49 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.685 HG13 ' CB ' ' A' ' 999' ' ' LEU . 79.2 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 981' ' ' THR . 37.4 mt -64.27 -46.15 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.99 -22.73 58.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 16.6 mt -116.75 23.66 11.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.8 OUTLIER -80.74 136.16 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.4 t0 50.63 45.42 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 997' ' ' VAL . 1.9 mmp_? -83.23 129.7 59.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.701 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 84.96 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 945' ' ' PHE . 10.4 mt -85.8 133.28 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.29 -91.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 3.3 m -134.64 0.54 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -134.14 155.41 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -86.65 136.72 32.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.739 HG11 HD12 ' A' ' 992' ' ' ILE . 1.9 m -97.12 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.59 128.39 56.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.4 mt -110.98 138.72 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.4 t -134.56 144.18 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 981' ' ' THR . 15.3 mt -82.72 141.51 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -47.67 167.88 0.1 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 90.0 p -114.73 10.64 16.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.929 0.395 . . . . 0.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.424 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . -115.38 172.44 14.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.424 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.8 Cg_endo -69.79 173.32 45.19 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.315 0.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 4.0 m -93.66 -56.9 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 65.6 p -101.84 130.36 48.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 84.0 p -108.74 118.21 36.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 30.5 t -44.77 -49.79 10.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.818 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 51.43 62.29 5.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 10.3 t -117.83 157.34 26.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.919 0.39 . . . . 0.0 110.817 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.5 p -161.98 129.1 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -130.47 125.72 4.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -81.75 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 1.1 t -101.74 136.57 41.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.4 t -50.22 144.4 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -129.17 173.9 19.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.27 143.78 36.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.859 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 128.67 16.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.662 2.242 . . . . 0.0 112.379 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -139.24 -166.63 10.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.424 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.27 8.29 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.9 m -96.04 120.97 37.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 33.3 mm -100.38 122.28 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 974' ' ' PHE . 85.4 mt -105.0 141.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -110.42 128.66 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.59 130.18 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.02 171.65 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 62.79 52.67 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 25.9 mtm -115.11 135.89 22.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.7 Cg_endo -69.75 171.9 13.61 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.84 -20.43 59.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 77.5 p -72.15 -15.63 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 934' ' ' PRO . 74.2 t -59.21 147.93 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.6 m -154.15 171.37 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.39 -42.03 79.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.12 -45.17 93.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.27 -41.68 93.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.4 mt -64.1 -49.53 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.83 -41.97 83.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.0 -31.2 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 992' ' ' ILE . 14.7 t80 -65.86 -36.21 82.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -88.43 10.12 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -44.24 153.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 90.48 -42.3 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 84.1 m-85 -92.85 149.4 21.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.95 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.75 91.38 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.36 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.581 HG23 ' HD2' ' A' ' 953' ' ' PRO . 92.7 mt -57.97 136.35 83.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.76 147.97 64.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.64 2.226 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 63.55 13.24 50.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 63.1 m -94.2 -51.33 4.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.938 0.399 . . . . 0.0 110.822 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 972' ' ' VAL . 93.9 t -46.94 103.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 12.1 m -117.42 134.21 55.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.85 138.77 34.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -92.42 135.85 33.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -124.71 166.86 15.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 965' ' ' MET . 1.0 OUTLIER -100.25 -176.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.01 -8.86 25.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -98.2 -28.28 13.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 112.95 -3.8 25.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 20.8 mtm -84.77 150.12 55.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.583 0.706 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 128.27 15.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 36.3 p -89.38 24.25 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.09 38.44 89.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.519 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -137.51 145.47 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.13 151.45 33.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 20.8 mtt -122.02 143.15 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 956' ' ' VAL . 15.4 m -137.85 160.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.94 151.71 43.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 928' ' ' ILE . 31.8 m-85 -133.8 138.86 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -73.22 -34.67 66.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 5.5 t -111.17 129.89 55.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -63.42 -44.37 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -57.11 -37.16 71.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -48.57 66.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.9 69.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.693 HG22 HD11 ' A' ' 985' ' ' ILE . 4.7 m -62.53 -43.57 98.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.31 93.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.48 -45.96 92.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 999' ' ' LEU . 53.3 t -61.71 -50.11 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 981' ' ' THR . 30.7 mt -61.42 -48.82 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.22 -21.9 62.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 999' ' ' LEU . 16.4 mt -119.14 26.52 9.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.5 t-20 -89.03 120.72 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.9 t0 73.13 38.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.4 mmp_? -84.4 129.69 56.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 87.51 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.849 HD12 HG11 ' A' ' 997' ' ' VAL . 14.3 mt -83.93 129.33 37.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.177 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.64 -92.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.0 p -132.76 -0.65 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -131.2 163.91 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.25 143.85 26.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.849 HG11 HD12 ' A' ' 992' ' ' ILE . 2.7 m -107.53 151.08 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 998' ' ' LYS . . . . . 0.512 ' HE3' HG22 ' A' 1000 ' ' VAL . 8.2 tmtm? -117.67 127.73 54.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 987' ' ' LEU . 37.6 mt -111.64 130.44 55.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1000 ' ' VAL . . . . . 0.512 HG22 ' HE3' ' A' ' 998' ' ' LYS . 46.4 t -131.97 136.52 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.16 155.95 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1002 ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' 1003 ' ' SER . . . -80.3 39.0 2.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1003 ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' 1002 ' ' GLY . 23.0 t 34.25 54.78 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.848 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 65.78 -162.76 41.47 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.61 92.5 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 -1.799 . . . . 0.0 112.342 0.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 27.5 m -82.04 168.85 17.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' 1008 ' ' GLY . 2.7 t -118.69 -59.57 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.849 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1008 ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' 1007 ' ' SER . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 51.1 m -110.27 -69.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.353 . . . . 0.0 110.862 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.3 t 73.84 48.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -148.3 84.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.0 m -150.04 151.85 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 81.8 p -171.34 132.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -98.35 139.91 14.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -149.92 113.5 5.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 55.6 p -113.66 100.08 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.6 m -56.33 166.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -60.03 -94.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -75.78 144.07 75.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 87.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.337 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -74.28 -161.08 7.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 169.65 18.46 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.1 m -92.53 117.87 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.197 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 927' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 47.8 mm -95.47 125.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 80.8 mt -106.13 148.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -112.65 130.55 56.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 999' ' ' LEU . 20.6 t -111.04 123.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.02 167.25 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.89 53.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.484 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 12.2 mtm -115.78 123.98 30.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.4 Cg_endo -69.73 168.32 21.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -63.93 -39.41 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.8 p -48.17 -34.32 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 938' ' ' SER . 81.3 t -45.66 154.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 938' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 937' ' ' VAL . 7.5 m -160.58 172.71 16.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.44 -41.94 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.01 -45.74 90.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.34 -41.55 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.29 -48.25 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.8 -42.06 92.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.97 -31.56 66.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 992' ' ' ILE . 9.5 t80 -64.94 -37.34 87.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -92.14 14.82 14.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.46 157.6 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.932 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 85.46 -41.7 3.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 72.1 m-85 -87.84 141.51 28.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -73.01 87.04 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.5 t -82.73 125.46 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.527 HG23 ' HD2' ' A' ' 953' ' ' PRO . 97.5 mt -51.55 134.99 34.32 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.573 0.702 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.527 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.4 Cg_endo -69.77 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.64 2.226 . . . . 0.0 112.362 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 86.42 24.86 38.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 82.3 p -93.66 -50.86 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.84 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 97.2 t -39.34 113.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 3.2 t -122.9 109.7 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 25.6 mt -81.74 136.78 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -103.13 138.88 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.84 174.44 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.481 ' ND2' ' HD3' ' A' ' 963' ' ' LYS . 7.9 p30 -98.56 176.97 5.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 962' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.26 -33.92 65.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 963' ' ' LYS . . . . . 0.481 ' HD3' ' ND2' ' A' ' 961' ' ' ASN . 0.0 OUTLIER -68.21 -45.94 71.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.838 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 138.61 -27.78 2.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 965' ' ' MET . . . . . 0.401 ' O ' ' OD1' ' A' ' 961' ' ' ASN . 85.0 mtp -63.76 153.47 83.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.556 0.693 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 144.1 52.83 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.658 2.239 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.3 p -99.37 37.7 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 39.43 42.19 1.8 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.54 145.84 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.56 153.02 35.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 9.8 mtp -122.22 143.66 49.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.61 165.7 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 973' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.46 147.18 50.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.096 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 20.8 m-85 -127.36 144.29 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -78.06 -34.43 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 50.7 m -111.57 130.76 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.57 -40.09 78.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -62.87 -45.74 91.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -55.72 -49.31 73.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.546 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -64.26 -43.9 93.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.35 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.36 -42.87 95.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 999' ' ' LEU . 91.4 t -62.7 -50.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 981' ' ' THR . 27.9 mt -63.62 -42.18 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.26 -28.04 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 999' ' ' LEU . 77.2 mt -115.68 25.86 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.25 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 t0 58.69 43.15 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.8 mmt180 -82.92 130.37 57.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 82.47 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.743 2.295 . . . . 0.0 112.309 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.828 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.02 123.36 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.88 -95.83 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 11.7 t -126.06 -6.53 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -129.48 159.65 35.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -93.15 136.42 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.787 HG11 HD12 ' A' ' 992' ' ' ILE . 5.6 m -96.15 150.14 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -113.79 129.72 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.658 ' CB ' HG13 ' A' ' 984' ' ' VAL . 68.1 mt -110.87 128.74 55.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 76.0 t -126.43 141.97 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.64 130.98 41.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -51.54 -71.78 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 67.0 p -68.96 150.01 48.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 112.19 -163.28 12.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.365 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 93.8 p -145.95 124.56 12.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 22.9 m -44.69 134.81 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.445 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 3.3 m -115.57 -55.02 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.846 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.0 t -93.51 133.84 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 101.87 72.69 0.97 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 12.7 t -73.95 140.16 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.849 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 117.04 9.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -145.02 121.8 1.61 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . 58.4 41.78 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 94.5 p -49.25 139.9 10.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -166.24 174.21 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -128.72 132.3 7.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -145.53 137.86 13.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -179.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 93.47 -157.73 23.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.447 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.31 11.17 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.653 2.235 . . . . 0.0 112.304 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.9 m -92.61 126.19 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 43.2 mm -97.6 129.94 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.123 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.611 HD12 ' CE1' ' A' ' 974' ' ' PHE . 51.3 mt -104.88 147.72 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.139 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.16 127.99 56.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 930' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 999' ' ' LEU . 16.0 t -116.39 129.72 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 931' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -136.17 168.22 19.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.53 46.89 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.537 ' CG ' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -113.86 124.99 30.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 110.88 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.315 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.98 -35.8 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 65.5 p -52.41 -25.49 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.459 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.7 t -57.5 141.69 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 67.0 m -143.76 174.21 11.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.5 mt -58.64 -42.12 84.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.17 -45.13 93.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -62.05 -44.1 97.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.24 -49.85 81.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.46 -41.62 80.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -71.91 -31.85 66.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.902 ' CD2' HD11 ' A' ' 992' ' ' ILE . 6.3 t80 -64.73 -35.78 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.09 17.38 14.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -50.59 142.99 9.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 100.28 -40.64 2.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 86.4 m-85 -89.57 148.52 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -81.62 79.57 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.92 124.23 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -53.54 129.39 53.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 111.171 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 131.54 21.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.39 84.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 955' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 956' ' ' VAL . 9.7 p -72.5 -54.8 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 956' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 972' ' ' VAL . 88.0 t -35.59 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.13 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.5 m -116.73 110.94 19.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.53 134.19 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -92.69 130.53 38.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -120.1 159.35 24.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -102.88 176.2 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.02 -28.85 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -71.59 -33.0 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 110.5 -1.55 29.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.534 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.32 161.6 24.77 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.58 0.705 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 134.4 27.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 67.1 p -93.5 16.0 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 76.27 21.72 74.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 969' ' ' GLU . . . . . 0.435 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 24.4 mt-10 -121.9 145.03 48.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 970' ' ' ALA . . . . . 0.4 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.16 150.39 31.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 14.9 mtm -129.82 140.44 51.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 34.7 m -137.54 165.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.48 149.57 44.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 928' ' ' ILE . 13.5 m-85 -128.92 141.62 51.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.41 -37.5 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -105.12 132.29 51.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -63.27 -51.03 67.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.03 -33.35 67.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -44.69 77.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.13 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.657 HG23 HD11 ' A' 1001 ' ' LEU . 11.7 m -62.6 -43.98 97.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 982' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 986' ' ' ASP . . . -62.06 -40.3 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -63.19 -39.53 94.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 999' ' ' LEU . 74.1 t -69.84 -50.21 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.96 -45.15 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 986' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 982' ' ' ALA . 5.0 t70 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 999' ' ' LEU . 1.9 mt -122.31 33.08 5.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -85.54 131.34 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 54.89 43.57 29.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 997' ' ' VAL . 24.5 mtp180 -84.45 133.53 44.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.607 0.717 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 90.51 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.911 HD12 HG11 ' A' ' 997' ' ' VAL . 10.2 mt -90.46 126.26 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.47 -92.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 4.6 m -131.31 -3.09 3.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -133.89 161.29 35.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -90.03 142.29 27.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.911 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -99.97 149.75 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.23 125.7 54.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.65 ' HB2' HG13 ' A' ' 984' ' ' VAL . 77.1 mt -111.21 127.92 55.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 90.9 t -122.64 137.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.657 HD11 HG23 ' A' ' 981' ' ' THR . 11.5 mt -77.45 127.94 33.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -55.5 -77.89 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 10.1 t -116.38 143.97 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 110.894 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 106.33 -164.9 13.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.7 12.24 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.703 -1.79 . . . . 0.0 112.38 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 30.2 p -72.75 119.06 16.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 11.2 t -134.69 88.7 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 1.9 t -68.34 94.33 0.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.861 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.7 t -101.13 89.17 3.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -122.0 119.15 3.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 80.6 p -78.9 130.16 35.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 110.845 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 3.6 t 69.36 41.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.896 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.79 6.76 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -130.59 -46.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 0.0 111.105 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 83.8 p -127.37 123.1 35.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 94.1 p -122.14 -8.6 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -109.59 123.29 6.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.454 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -139.29 140.06 24.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.705 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 109.2 2.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.66 2.24 . . . . 0.0 112.338 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 924' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 925' ' ' PRO . . . 143.9 -139.74 8.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 925' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 924' ' ' GLY . 54.0 Cg_endo -69.71 169.88 17.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 28.5 m -97.98 127.71 44.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.84 126.69 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 974' ' ' PHE . 72.4 mt -105.37 147.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 128.46 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.8 122.92 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 170.03 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 932' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 996' ' ' LYS . 0.2 OUTLIER 65.48 47.67 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 933' ' ' MET . . . . . 0.664 ' HG3' HG12 ' A' ' 997' ' ' VAL . 19.2 mtm -114.87 129.25 25.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 934' ' ' PRO . . . . . 0.419 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.75 168.53 21.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.724 2.283 . . . . 0.0 112.345 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -63.43 -35.92 82.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 75.0 p -52.44 -36.61 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 937' ' ' VAL . . . . . 0.506 HG11 ' SD ' ' A' ' 933' ' ' MET . 78.8 t -41.57 140.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.3 m -148.59 172.96 13.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.92 -42.13 77.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -45.94 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -63.34 -43.35 97.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.2 mt -63.3 -49.31 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.51 -41.95 91.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -71.21 -31.96 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 945' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 39.7 t80 -65.37 -37.1 85.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -88.84 11.49 17.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -48.04 145.68 2.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 96.06 -43.45 2.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 949' ' ' TYR . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 78.6 m-85 -90.99 132.51 35.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.359 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.07 93.29 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.73 124.88 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 952' ' ' ILE . . . . . 0.505 HG23 ' HD2' ' A' ' 953' ' ' PRO . 65.0 mt -51.53 134.34 34.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.632 0.73 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 953' ' ' PRO . . . . . 0.505 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.3 Cg_endo -69.85 126.47 13.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.241 . . . . 0.0 112.33 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.17 12.69 78.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 68.2 p -83.78 -49.16 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 67.4 t -42.12 107.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 9.9 t -115.52 110.46 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 29.3 mt -88.16 131.92 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -101.47 132.47 47.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -123.67 157.58 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 961' ' ' ASN . . . . . 0.895 ' ND2' HG22 ' A' ' 967' ' ' THR . 4.0 m120 -67.03 -175.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.63 -9.71 57.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -32.58 12.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 127.9 -18.31 5.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 57.2 mtt -67.69 154.95 92.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.76 13.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 967' ' ' THR . . . . . 0.895 HG22 ' ND2' ' A' ' 961' ' ' ASN . 44.8 p -86.42 13.42 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 64.21 30.58 78.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.2 145.35 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.17 149.81 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 5.9 mtt -124.24 144.95 49.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 972' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 16.6 m -139.31 165.62 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.57 155.55 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 974' ' ' PHE . . . . . 0.553 ' CE1' HD12 ' A' ' 928' ' ' ILE . 22.4 m-85 -136.1 140.79 44.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -72.3 -38.51 68.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 10.5 t -110.45 129.71 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -61.4 -41.87 97.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.85 -38.88 79.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.5 -44.14 83.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.3 -49.29 77.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.927 HG23 HD11 ' A' 1001 ' ' LEU . 8.3 m -63.45 -43.7 96.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.44 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 983' ' ' ALA . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.43 -39.57 89.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.692 HG13 ' CB ' ' A' ' 999' ' ' LEU . 72.2 t -67.39 -48.82 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 985' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 981' ' ' THR . 82.7 mt -64.13 -45.64 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.25 -22.15 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 987' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.5 mt -117.15 18.92 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 988' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 984' ' ' VAL . 3.6 t-20 -80.5 134.57 35.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.6 40.61 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 990' ' ' ARG . . . . . 0.522 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.2 mmp_? -84.69 130.69 52.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 82.91 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 992' ' ' ILE . . . . . 0.755 HD12 HG11 ' A' ' 997' ' ' VAL . 10.1 mt -81.76 135.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 52.6 -91.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 2.7 m -133.77 -0.35 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -133.96 161.48 34.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 996' ' ' LYS . . . . . 0.448 ' O ' ' ND2' ' A' ' 932' ' ' ASN . 61.2 mttt -90.03 140.88 29.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 997' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 992' ' ' ILE . 1.2 m -102.95 151.08 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 125.23 52.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CB ' HG13 ' A' ' 984' ' ' VAL . 41.9 mt -111.24 128.81 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.2 142.99 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1001 ' ' LEU . . . . . 0.927 HD11 HG23 ' A' ' 981' ' ' THR . 11.2 mt -80.28 132.7 35.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -42.75 -54.29 5.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.545 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 60.7 p -174.3 -179.75 1.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1004 ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 137.04 172.53 12.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1005 ' ' PRO . . . . . 0.421 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.5 Cg_endo -69.77 134.84 31.06 Favored 'Cis proline' 0 C--N 1.342 0.231 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.357 0.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1006 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1007 ' ' SER . 27.5 m -90.06 -58.5 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1007 ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' 1006 ' ' SER . 4.6 t -34.74 123.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.865 0.277 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.4 m -92.07 117.39 29.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 50.8 mm -96.45 127.31 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.688 ' HB ' HG23 ' A' ' 972' ' ' VAL . 96.5 mt -105.54 148.09 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -113.15 124.39 52.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.696 HG22 HD23 ' A' ' 999' ' ' LEU . 45.7 t -106.43 130.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.08 170.46 16.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.79 50.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.746 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.3 mtm -117.04 132.56 23.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.456 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.3 Cg_endo -69.76 167.81 23.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.73 2.287 . . . . 0.0 112.379 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.38 -29.88 70.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.5 p -59.28 -26.8 65.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.163 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 933' ' ' MET . 78.8 t -50.78 141.07 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 21.3 m -143.66 168.21 20.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.96 -42.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.96 -45.53 92.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.15 -43.24 99.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 958' ' ' LEU . 45.2 mt -61.0 -49.51 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.4 mt -56.21 -41.44 75.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.83 -31.46 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.806 ' CD2' HD11 ' A' ' 992' ' ' ILE . 11.9 t80 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -91.9 17.3 9.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -52.21 151.89 3.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 89.69 -39.01 3.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -95.08 144.15 25.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.04 100.72 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.02 125.6 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.634 HG23 ' HD2' ' A' ' 953' ' ' PRO . 53.1 mt -55.81 138.38 70.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.582 0.706 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.634 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.0 Cg_endo -69.69 138.82 38.95 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.29 -9.03 22.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 60.5 p -63.61 -56.8 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 81.1 t -41.32 100.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -113.8 110.23 19.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 942' ' ' ILE . 82.7 mt -86.98 132.51 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.07 138.12 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . 0.459 ' HA ' HG23 ' A' ' 967' ' ' THR . 76.9 m-85 -126.32 156.75 39.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.774 ' OD1' HG22 ' A' ' 967' ' ' THR . 2.9 m-80 -67.95 -178.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.01 -34.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -72.41 -36.36 68.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 128.61 -14.05 6.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.43 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.447 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 29.7 mmt -66.5 157.04 84.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 129.55 17.79 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . 0.774 HG22 ' OD1' ' A' ' 961' ' ' ASN . 17.4 p -92.51 5.8 49.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.4 23.96 77.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -123.9 145.89 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.35 152.78 34.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 10.1 mtm -127.03 143.69 51.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 928' ' ' ILE . 2.7 m -137.6 163.61 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.91 155.85 43.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 928' ' ' ILE . 42.1 m-85 -138.05 138.38 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.73 -31.28 64.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.9 t -117.57 130.05 56.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -63.21 -40.75 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . 0.451 ' OD1' ' CD ' ' A' ' 979' ' ' GLU . 0.5 OUTLIER -57.92 -40.04 79.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . 0.451 ' CD ' ' OD1' ' A' ' 978' ' ' ASP . 0.2 OUTLIER -67.29 -45.73 75.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.56 -48.8 79.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.637 HG22 HD11 ' A' ' 985' ' ' ILE . 4.0 m -63.35 -43.99 96.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.84 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.58 99.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.9 t -61.84 -48.82 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 981' ' ' THR . 21.5 mt -65.0 -41.69 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.96 -24.18 59.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.457 HD23 ' HE ' ' A' ' 990' ' ' ARG . 66.1 mt -116.79 20.65 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.1 t-20 -80.64 120.54 24.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.8 t70 73.33 39.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 997' ' ' VAL . 19.1 mmt180 -83.49 128.66 63.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 87.72 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.903 HD12 HG11 ' A' ' 997' ' ' VAL . 10.7 mt -85.98 123.28 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.71 -94.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 40.9 t -129.48 -3.15 4.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 0.0 110.797 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -133.49 156.61 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -87.29 143.31 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.903 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -101.12 151.04 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -115.22 125.2 53.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.696 HD23 HG22 ' A' ' 930' ' ' VAL . 48.7 mt -111.05 129.51 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.4 t -132.18 138.82 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.22 142.17 45.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.871 0.28 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.42 125.29 37.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.67 125.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 972' ' ' VAL . 86.9 mt -109.61 143.04 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -112.19 127.87 56.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.756 HG22 HD23 ' A' ' 999' ' ' LEU . 40.6 t -108.21 128.62 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -133.67 169.77 16.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.75 47.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.69 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -114.9 134.27 22.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.521 0.676 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.9 Cg_endo -69.67 174.22 9.75 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.89 -26.02 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.5 p -62.52 -31.43 72.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 933' ' ' MET . 88.6 t -45.64 151.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 19.1 m -158.19 172.53 18.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.9 mt -57.95 -41.86 81.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.156 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.17 -44.34 95.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.33 -43.45 90.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.08 -48.24 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 943' ' ' LEU . 13.1 mt -57.76 -42.03 83.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.35 -31.54 67.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 992' ' ' ILE . 4.0 t80 -65.73 -35.87 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -91.51 11.91 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -49.33 149.27 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.0 -39.83 2.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -94.56 150.76 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.88 83.12 8.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.19 130.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 973' ' ' ALA . 83.2 mt -57.15 129.4 79.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.644 0.735 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 133.68 26.09 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.297 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 84.35 -4.4 83.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 956' ' ' VAL . 10.1 p -75.25 -56.22 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 955' ' ' SER . 94.3 t -37.25 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -119.03 114.4 22.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.28 129.88 34.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -93.41 127.49 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -116.86 160.19 21.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.869 ' OD1' HG22 ' A' ' 967' ' ' THR . 3.4 m-80 -79.38 -178.79 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -58.49 -36.23 73.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -74.63 -27.68 60.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 119.51 -18.66 10.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.46 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 6.8 mmt -58.86 158.17 17.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 127.47 14.62 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 0.0 112.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . 0.869 HG22 ' OD1' ' A' ' 961' ' ' ASN . 71.2 p -87.12 8.77 22.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 61.92 30.07 74.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.459 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 25.4 mt-10 -134.2 146.1 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.04 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 34.5 mtp -122.04 147.44 46.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.6 m -140.84 165.32 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.475 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -130.98 148.48 52.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.483 ' CE1' HD12 ' A' ' 928' ' ' ILE . 30.1 m-85 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.86 -33.35 45.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.5 m -108.49 128.53 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -61.83 -49.96 74.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.04 -35.71 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -45.12 78.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.29 -47.85 77.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.57 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -62.71 -42.48 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.1 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.75 -43.98 94.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.106 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 999' ' ' LEU . 68.9 t -66.75 -47.93 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 981' ' ' THR . 58.2 mt -61.9 -45.55 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.2 mt -120.67 30.5 6.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -88.05 136.66 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.6 p30 49.68 43.3 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.534 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.2 mtt-85 -86.05 134.04 39.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 92.27 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 1.008 HD12 HG11 ' A' ' 997' ' ' VAL . 12.5 mt -89.98 126.73 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.83 -90.57 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.6 m -133.54 -0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -134.05 162.04 33.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -90.9 144.03 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 1.008 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.0 151.1 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . 0.419 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 0.1 OUTLIER -115.47 127.31 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.756 HD23 HG22 ' A' ' 930' ' ' VAL . 79.3 mt -110.98 133.9 53.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . 0.419 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 60.0 t -126.39 141.75 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 981' ' ' THR . 13.0 mt -81.18 137.06 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.869 0.279 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.8 m -92.02 133.94 35.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 32.7 mm -101.91 128.52 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.458 HD12 ' CE1' ' A' ' 974' ' ' PHE . 63.2 mt -105.07 144.54 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -111.46 128.36 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.59 127.98 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.469 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -138.14 164.77 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.38 45.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.701 ' HG3' HG12 ' A' ' 997' ' ' VAL . 14.3 mtm -115.18 133.02 22.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.74 170.98 15.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -67.0 -35.73 80.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 68.6 p -53.24 -30.03 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 80.3 t -49.82 143.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.8 m -147.9 170.61 17.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.05 -42.12 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.24 -45.99 89.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.02 -44.5 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.17 -49.68 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -56.03 -41.99 75.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.83 -30.16 65.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.772 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.3 t80 -66.22 -34.92 79.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -90.91 8.49 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -41.7 148.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.61 -42.95 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 987' ' ' LEU . 45.8 m-85 -91.65 146.07 24.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -82.61 85.98 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.25 125.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.3 mt -50.86 130.25 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.714 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 125.24 11.91 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.95 65.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 5.2 p -84.52 -45.5 12.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.87 100.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.3 t -114.36 108.05 16.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 37.7 mt -80.34 142.08 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 129.24 54.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . 0.434 ' C ' HG23 ' A' ' 967' ' ' THR . 88.7 m-85 -115.05 175.75 5.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.764 ' OD1' HG22 ' A' ' 967' ' ' THR . 65.7 m-80 -91.13 -175.01 4.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.06 -6.64 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -100.4 -36.78 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.37 -3.31 5.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 31.2 mtp -86.03 151.56 54.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.44 13.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.7 2.267 . . . . 0.0 112.345 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . 0.764 HG22 ' OD1' ' A' ' 961' ' ' ASN . 9.3 p -86.02 12.89 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 63.59 30.49 77.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.469 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 27.5 mt-10 -126.2 146.01 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.11 33.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtt -131.41 141.28 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 28.5 m -136.9 165.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.68 50.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.458 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.0 m-85 -128.64 137.37 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -69.86 -34.7 73.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 4.1 m -107.85 125.84 51.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -61.5 -48.19 82.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.04 -36.97 71.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.74 84.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -57.81 -48.16 80.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.691 HG23 HD11 ' A' 1001 ' ' LEU . 4.3 m -60.66 -43.59 97.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.71 99.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.555 ' O ' HD12 ' A' ' 987' ' ' LEU . . . -64.28 -40.27 95.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 999' ' ' LEU . 71.9 t -66.48 -48.61 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.05 -43.78 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.77 -21.44 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 949' ' ' TYR . 4.1 mt -120.41 24.27 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -85.65 135.39 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 55.65 41.71 30.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.567 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.2 mtp180 -84.63 131.62 49.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.8 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.924 HD12 HG11 ' A' ' 997' ' ' VAL . 13.9 mt -82.15 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 48.81 -92.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 992' ' ' ILE . 58.4 m -132.48 -1.25 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.04 160.76 36.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.2 143.83 26.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.924 HG11 HD12 ' A' ' 992' ' ' ILE . 2.1 m -104.85 151.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -114.39 126.27 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.655 ' CB ' HG13 ' A' ' 984' ' ' VAL . 82.8 mt -111.31 127.85 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 43.4 t -124.94 139.72 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.691 HD11 HG23 ' A' ' 981' ' ' THR . 12.9 mt -76.04 128.37 34.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.45 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.824 0.26 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 27.0 m -92.32 130.72 37.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.0 mm -103.84 125.46 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.509 HD12 ' CE1' ' A' ' 974' ' ' PHE . 75.6 mt -105.56 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.99 125.38 54.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.67 124.54 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.26 171.46 12.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.09 49.35 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 16.9 mtm -115.79 127.03 27.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 166.4 27.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.72 -40.5 88.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 70.8 p -48.11 -27.7 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 933' ' ' MET . 91.4 t -55.71 135.53 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 34.3 m -143.86 171.64 13.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 56.0 mt -57.22 -42.07 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.1 -45.99 89.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.48 -43.96 88.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 33.0 mt -61.1 -49.75 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.64 -41.78 77.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.35 -31.42 67.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.2 t80 -66.01 -34.4 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.23 12.93 22.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.58 150.41 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.61 -32.94 5.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 95.8 m-85 -102.22 137.61 40.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.56 89.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 88.2 t -85.43 123.09 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.66 129.48 35.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 125.56 12.29 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 0.0 112.317 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.75 -9.82 75.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 28.5 p -66.92 -49.13 66.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.843 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -43.87 107.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 t -118.95 118.28 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 970' ' ' ALA . 65.2 mt -91.09 127.12 36.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -98.03 130.37 44.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -112.14 -175.31 2.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 965' ' ' MET . 2.7 p30 -107.39 -177.01 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.12 -34.57 73.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.75 -35.76 75.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 120.64 -2.6 12.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.464 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 3.0 mmt -83.7 155.76 65.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 127.48 14.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.264 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.9 p -86.46 27.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 48.32 38.7 20.03 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.5 145.32 40.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.71 151.12 31.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 49.5 mtp -122.57 142.71 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 13.3 m -135.26 164.08 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.49 146.74 50.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.509 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.0 m-85 -129.87 139.51 51.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.17 -35.88 66.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.3 m -105.4 127.57 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -64.22 -47.79 78.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.11 -34.77 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.69 -47.61 68.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -54.63 -46.59 73.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.622 HG22 HD11 ' A' ' 985' ' ' ILE . 7.4 m -64.41 -43.75 93.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.27 89.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 980' ' ' ALA . 90.4 t -66.05 -49.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.622 HD11 HG22 ' A' ' 981' ' ' THR . 33.2 mt -59.02 -46.0 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.64 -27.95 61.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.7 mt -112.46 28.06 9.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.13 128.8 36.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.6 t0 59.84 42.67 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.3 mtp85 -86.51 133.38 40.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.827 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 85.7 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.37 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.763 HD12 HG11 ' A' ' 997' ' ' VAL . 7.4 mt -85.7 134.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.47 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 10.0 p -131.97 -2.41 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -134.02 161.49 34.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -88.65 142.88 27.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.763 HG11 HD12 ' A' ' 992' ' ' ILE . 3.0 m -104.43 151.04 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -115.73 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.657 ' HB2' HG13 ' A' ' 984' ' ' VAL . 80.1 mt -112.24 131.5 55.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.0 t -123.98 148.87 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 981' ' ' THR . 16.3 mt -91.1 129.58 37.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.894 0.289 . . . . 0.0 112.316 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 57.2 m -95.03 121.44 36.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.7 mm -92.25 128.33 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 77.6 mt -105.03 148.35 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -115.46 121.58 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 999' ' ' LEU . 18.1 t -105.66 129.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.482 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.4 tm0? -134.38 170.24 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 50.12 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.676 ' HG3' HG12 ' A' ' 997' ' ' VAL . 8.6 mtm -116.79 128.28 26.13 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.614 0.721 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 174.42 9.52 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.41 -37.89 86.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -50.96 -30.57 15.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.669 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.0 t -52.24 125.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.9 m -131.28 171.54 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.79 -42.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.113 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.1 -45.77 90.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.38 -43.34 97.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.98 -49.98 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.76 -41.5 86.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.98 -31.46 66.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.674 ' CD2' HD11 ' A' ' 992' ' ' ILE . 5.4 t80 -66.08 -35.19 79.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.12 11.31 23.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -48.36 149.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 93.25 -39.93 2.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 983' ' ' ALA . 89.6 m-85 -95.33 141.17 29.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -71.77 100.2 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.4 t -95.9 124.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.478 HD12 ' CB ' ' A' ' 973' ' ' ALA . 87.3 mt -52.75 131.11 47.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.639 0.733 . . . . 0.0 111.115 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.11 18.78 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.374 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.49 -7.21 77.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.6 p -68.01 -55.44 12.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.1 t -35.63 112.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 27.5 m -124.07 119.2 28.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 40.8 mt -87.21 132.31 33.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -93.32 137.69 32.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 66.2 m-85 -125.87 -178.62 4.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 964' ' ' GLY . 0.3 OUTLIER -121.47 177.78 5.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -40.68 -53.15 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -64.57 -27.7 69.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 111.03 -21.75 22.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 37.7 mmt -54.53 152.98 11.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.54 0.686 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 134.65 28.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 35.5 p -97.42 25.98 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 52.79 38.06 53.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 9.5 mt-10 -138.31 145.69 41.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.55 151.25 32.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 31.8 mtp -125.11 142.73 51.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 29.2 m -138.68 165.33 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -127.97 150.77 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.4 m-85 -131.8 142.96 49.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.45 -34.03 60.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 26.6 t -109.62 124.93 51.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.2 ttp-105 -61.74 -44.01 97.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.24 -37.33 74.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.83 -42.46 81.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.63 -49.86 76.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.3 m -64.75 -43.92 91.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.91 95.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 949' ' ' TYR . . . -66.11 -43.64 86.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 980' ' ' ALA . 91.3 t -60.29 -48.12 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.25 -44.84 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 999' ' ' LEU . 47.2 mt -119.91 20.07 12.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.2 t-20 -79.82 127.19 31.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 64.62 41.83 5.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.574 ' O ' HG22 ' A' ' 997' ' ' VAL . 9.1 mmm180 -84.36 131.79 49.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 83.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 997' ' ' VAL . 10.9 mt -82.39 127.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.9 -93.86 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 23.1 p -131.78 -0.26 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.886 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -133.67 163.45 29.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -91.79 143.36 26.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.823 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -106.04 151.1 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -113.48 126.07 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.746 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.7 mt -110.93 128.0 55.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 59.5 t -132.9 142.13 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.93 140.84 47.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.875 0.281 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.4 m -92.13 125.28 36.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.5 mm -99.39 126.58 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.581 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.7 mt -105.59 145.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -111.44 133.94 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 999' ' ' LEU . 21.7 t -116.15 127.97 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.24 170.17 16.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.88 51.74 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.779 ' SD ' HG11 ' A' ' 937' ' ' VAL . 21.6 mtm -118.64 129.84 25.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.473 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.79 171.43 14.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.703 2.269 . . . . 0.0 112.333 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -63.68 -37.47 87.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 67.0 p -52.07 -34.1 42.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.779 HG11 ' SD ' ' A' ' 933' ' ' MET . 76.2 t -48.54 122.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 4.6 m -130.62 176.15 8.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.9 -41.96 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.147 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.02 -45.9 90.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.56 -45.0 96.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.14 -50.0 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.11 -42.03 84.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.889 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.5 t80 -66.69 -31.14 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . 0.434 ' HB3' HG21 ' A' ' 951' ' ' VAL . 42.1 m-85 -97.0 12.17 33.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -50.51 152.88 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.04 -37.57 3.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 987' ' ' LEU . 57.0 m-85 -96.37 127.83 42.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -60.78 97.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 946' ' ' PHE . 87.4 t -94.68 122.36 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 973' ' ' ALA . 89.7 mt -48.23 130.06 12.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 123.52 10.17 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.5 -2.62 74.16 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.0 p -72.33 -53.33 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 955' ' ' SER . 99.3 t -37.04 105.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.26 114.6 22.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.72 137.47 34.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.957 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -95.48 139.28 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.897 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -132.54 161.5 33.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -95.96 -175.7 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -50.48 -51.52 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . 0.41 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 37.3 mmtt -56.48 -44.11 80.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 126.88 -4.56 7.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 43.8 mtm -73.38 153.62 90.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 128.34 15.93 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.732 2.288 . . . . 0.0 112.369 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 65.0 p -90.32 37.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.14 40.53 1.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -140.97 146.97 38.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 3.2 mtt -122.62 143.69 49.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.63 160.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -122.32 153.8 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.058 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 928' ' ' ILE . 32.0 m-85 -134.5 141.14 46.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.821 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.13 -37.41 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 19.0 m -108.06 126.12 52.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -61.01 -45.75 93.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -57.39 -38.88 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.94 -44.12 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.35 -48.28 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.421 HG23 HD11 ' A' 1001 ' ' LEU . 10.0 m -64.27 -43.37 95.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.43 89.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.91 -39.17 93.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 980' ' ' ALA . 75.4 t -64.63 -49.08 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.45 -46.54 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -23.73 59.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.8 mt -115.47 25.94 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.1 t-20 -91.45 128.57 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.93 40.63 15.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 8.2 mtp85 -86.2 133.33 40.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.845 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 85.51 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.889 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.8 mt -84.44 125.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.85 -92.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 5.1 m -129.28 -5.76 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -133.08 156.25 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -86.42 143.33 27.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.876 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -101.1 151.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -116.26 128.29 55.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.611 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.3 mt -111.01 138.43 47.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.3 t -133.84 137.14 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 981' ' ' THR . 13.6 mt -73.81 136.36 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.459 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.841 0.267 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 12.0 m -92.77 119.67 32.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.7 mm -97.89 125.15 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.609 ' HB ' HG23 ' A' ' 972' ' ' VAL . 98.3 mt -104.98 143.49 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -111.85 130.58 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 999' ' ' LEU . 6.5 t -112.02 131.34 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.471 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.68 167.23 21.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.08 53.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -121.32 128.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 156.49 63.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.324 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -54.29 -33.53 58.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.2 p -53.24 -34.69 58.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.421 HG11 ' SD ' ' A' ' 933' ' ' MET . 88.4 t -46.81 137.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 5.7 m -140.5 175.69 9.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.83 -41.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.19 -45.82 89.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.08 -38.18 87.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.21 -49.1 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.24 -41.68 84.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.72 -30.75 65.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.0 t80 -64.92 -39.06 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -87.22 13.17 10.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.66 148.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.89 2.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -92.01 134.87 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -72.14 84.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.4 t -74.66 123.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.43 129.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.645 2.23 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.19 6.1 84.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 957' ' ' CYS . 81.5 p -87.07 -55.54 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 955' ' ' SER . 48.2 t -35.99 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 955' ' ' SER . 3.0 t -112.62 126.07 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 138.04 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -94.51 123.92 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 92.3 m-85 -111.6 175.08 5.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.96 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.39 -18.47 28.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -35.97 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 120.08 -15.13 10.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 77.9 mmm -69.2 155.73 92.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 137.73 36.26 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -100.38 0.27 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 81.73 31.52 32.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.471 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 12.4 mt-10 -128.98 146.88 50.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.422 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.91 142.2 23.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 28.4 mtp -120.97 142.89 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 928' ' ' ILE . 4.1 m -137.45 166.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.55 150.1 51.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -129.95 157.21 42.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -82.31 -42.95 18.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 20.4 m -117.44 139.07 51.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.1 mtp85 -61.29 -36.6 80.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -58.08 -43.44 87.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -45.14 78.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -61.49 -48.72 79.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.613 HG23 HD11 ' A' 1001 ' ' LEU . 6.8 m -62.36 -43.98 97.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.78 89.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -60.59 -40.93 93.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 980' ' ' ALA . 86.5 t -64.76 -50.23 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.25 -45.03 99.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -22.29 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.9 mt -119.86 29.18 7.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.959 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.0 OUTLIER -89.96 128.61 36.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.71 43.09 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.7 mmp_? -85.78 131.63 46.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 110.885 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.99 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.745 2.296 . . . . 0.0 112.315 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.902 HD12 HG11 ' A' ' 997' ' ' VAL . 16.1 mt -81.26 126.91 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.58 -92.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 17.2 t -132.82 -1.13 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -132.76 163.48 28.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -92.53 141.0 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.902 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -102.6 151.08 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.57 128.17 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -111.16 131.08 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.921 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 57.6 t -124.79 143.03 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 981' ' ' THR . 19.4 mt -82.36 134.82 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.842 0.267 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 50.7 m -101.13 132.99 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 30.3 mm -100.6 128.0 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 984' ' ' VAL . 75.7 mt -108.55 145.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -114.76 131.48 56.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 999' ' ' LEU . 61.9 t -113.29 126.92 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.116 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 167.21 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.07 50.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.618 ' CG ' HG12 ' A' ' 997' ' ' VAL . 23.8 mtm -119.3 130.59 24.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 158.49 56.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -56.63 -33.46 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 47.8 p -53.11 -32.39 47.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.554 HG11 ' SD ' ' A' ' 933' ' ' MET . 94.2 t -49.71 140.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 72.7 m -145.93 172.96 12.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.81 -42.01 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.12 -46.05 89.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -65.61 -45.27 83.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . 0.482 ' CD1' HD21 ' A' ' 958' ' ' LEU . 38.5 mt -61.01 -48.48 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.4 mt -58.45 -42.02 86.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.55 -31.2 66.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.804 ' CD2' HD11 ' A' ' 992' ' ' ILE . 2.9 t80 -65.02 -41.24 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -81.41 7.7 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -41.28 149.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.32 -40.62 2.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 92.2 m-85 -97.25 130.91 44.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.58 92.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.5 t -78.04 125.68 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 953' ' ' PRO . 75.9 mt -54.18 133.83 60.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.614 0.721 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.1 Cg_endo -69.75 147.17 62.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.356 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.33 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.438 ' OG ' HG22 ' A' ' 952' ' ' ILE . 2.2 m -93.37 -56.21 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.87 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.0 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.99 129.17 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 942' ' ' ILE . 45.1 mt -94.84 139.21 31.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -93.5 131.58 38.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -115.09 160.22 19.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.0 OUTLIER -99.68 -176.41 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.33 -47.43 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -24.77 66.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . 0.582 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 117.08 -28.67 7.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.469 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 7.5 ptp -57.82 153.64 31.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.44 17.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.704 2.269 . . . . 0.0 112.358 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 38.8 p -83.97 26.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 56.35 33.04 61.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -129.11 147.96 51.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.69 147.08 26.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.5 mtt -123.0 141.82 51.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 18.9 m -139.3 164.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.49 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 925' ' ' PRO . 23.1 m-85 -128.2 148.09 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.16 -35.99 61.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 9.4 t -115.82 134.61 54.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 52.6 ttp85 -61.26 -39.91 92.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -41.68 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -62.67 -45.17 94.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.764 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.03 -49.36 77.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.942 HG23 HD11 ' A' 1001 ' ' LEU . 5.9 m -62.75 -44.0 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.92 92.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -62.59 -38.06 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 980' ' ' ALA . 84.9 t -66.04 -49.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 32.9 mt -60.95 -47.61 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.93 -21.55 61.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.2 mt -119.37 27.23 8.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.92 129.65 36.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 60.48 41.46 15.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 997' ' ' VAL . 18.0 mtp180 -84.13 130.89 52.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.617 0.722 . . . . 0.0 110.826 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 84.46 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.943 HD12 HG11 ' A' ' 997' ' ' VAL . 9.0 mt -84.39 130.66 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.52 -94.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 12.8 t -129.35 -0.87 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -133.96 163.67 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -93.07 143.28 26.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.943 HG11 HD12 ' A' ' 992' ' ' ILE . 3.8 m -101.89 149.89 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.26 127.1 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 930' ' ' VAL . 78.9 mt -111.73 131.08 55.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.858 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.2 t -120.67 140.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 981' ' ' THR . 13.4 mt -81.22 122.89 27.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . 0.439 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.822 0.259 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.4 m -94.28 117.13 29.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.35 125.27 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.8 mt -105.18 147.95 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -111.29 131.39 55.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.54 125.03 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 171.27 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.7 47.76 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.513 ' SD ' HG11 ' A' ' 937' ' ' VAL . 18.3 mtm -111.47 125.75 29.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 159.38 53.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.664 2.243 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -56.9 -32.94 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.4 p -55.04 -30.94 60.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.513 HG11 ' SD ' ' A' ' 933' ' ' MET . 75.3 t -48.31 145.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 33.4 m -153.64 173.19 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.92 -42.16 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -46.06 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -65.61 -46.13 80.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.02 -46.27 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.6 mt -57.97 -41.92 83.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.91 -34.21 68.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.9 t80 -61.81 -37.15 83.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.17 23.58 6.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -60.61 161.23 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 80.69 -41.89 2.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 79.6 m-85 -85.25 135.52 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.89 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -65.59 83.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.64 119.85 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 953' ' ' PRO . 95.3 mt -48.64 132.14 13.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.613 0.721 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.8 Cg_endo -69.76 111.62 2.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 0.0 112.357 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.81 31.72 9.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.466 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 956' ' ' VAL . 81.0 p -103.58 -53.86 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 955' ' ' SER . 86.7 t -34.62 114.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 8.5 t -119.93 112.7 19.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 44.5 mt -81.85 131.59 35.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -95.48 138.69 32.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.7 171.87 11.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.442 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.7 OUTLIER -100.19 -179.07 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 963' ' ' LYS . 17.1 pt-20 -50.81 -47.1 60.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 962' ' ' GLU . 0.0 OUTLIER -63.51 -43.53 96.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . 0.442 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.91 -27.34 3.19 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.476 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 158.43 1.89 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 137.55 35.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.331 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 968' ' ' GLY . 82.5 p -100.76 37.47 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 967' ' ' THR . . . 37.07 39.14 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -141.79 145.59 34.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.94 148.56 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.0 mtt -119.0 143.18 47.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 23.8 m -135.39 160.53 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.39 147.15 47.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -129.14 137.71 51.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.66 -34.02 64.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . 0.404 ' HB2' ' CD ' ' A' ' 979' ' ' GLU . 1.8 m -108.81 130.99 55.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -61.77 -48.91 78.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -56.91 -39.17 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . 0.404 ' CD ' ' HB2' ' A' ' 976' ' ' SER . 20.4 mt-10 -63.32 -44.44 94.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.88 -50.02 73.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.635 HG22 HD11 ' A' ' 985' ' ' ILE . 24.3 m -64.51 -43.41 94.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.14 93.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.68 -41.91 98.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 999' ' ' LEU . 84.1 t -66.28 -49.76 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 981' ' ' THR . 41.7 mt -58.66 -46.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.66 -30.31 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 999' ' ' LEU . 12.5 mt -109.5 28.87 8.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -89.48 133.57 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 22.9 t70 54.37 43.44 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -87.85 130.16 47.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 94.61 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 945' ' ' PHE . 15.7 mt -92.59 124.47 45.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.08 -90.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 9.5 t -131.34 -3.38 3.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.809 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -134.11 154.3 51.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -88.82 140.54 29.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 992' ' ' ILE . 4.9 m -100.1 150.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.0 129.42 56.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.711 ' HB2' HG13 ' A' ' 984' ' ' VAL . 81.7 mt -110.93 128.66 55.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 89.3 t -123.39 137.93 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 981' ' ' THR . 11.9 mt -71.55 134.27 46.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.29 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 29.9 m -91.93 125.78 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 41.6 mm -101.52 127.86 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.568 HD12 ' CE1' ' A' ' 974' ' ' PHE . 65.7 mt -107.33 146.46 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . 0.401 ' NZ ' ' HA2' ' A' 1002 ' ' GLY . 2.9 mppt? -113.5 130.09 56.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 999' ' ' LEU . 19.8 t -115.64 127.23 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.434 ' HG3' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -131.71 172.48 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 49.23 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.706 ' HG3' HG12 ' A' ' 997' ' ' VAL . 16.7 mtm -114.44 129.2 25.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 167.52 24.25 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.69 -25.0 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 64.8 p -63.88 -21.78 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.552 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.3 t -60.48 139.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.0 m -144.41 177.81 8.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.03 -42.17 92.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -63.29 -46.05 88.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.47 -45.29 93.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 24.1 mt -60.98 -49.64 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.03 -42.0 89.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -72.07 -31.18 65.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 38.6 t80 -65.25 -38.43 90.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -87.91 10.96 17.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -47.03 145.58 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 99.07 -32.51 7.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 87.5 m-85 -103.57 143.78 32.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.12 87.03 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.46 127.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 953' ' ' PRO . 63.7 mt -55.48 132.71 70.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.77 132.74 23.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.12 85.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 956' ' ' VAL . 24.6 p -82.16 -60.39 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.824 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 972' ' ' VAL . 98.0 t -34.79 112.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 13.5 m -124.43 125.49 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.9 146.57 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -100.26 135.76 41.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -128.74 160.67 31.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 965' ' ' MET . 49.4 p-10 -98.81 -177.05 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.93 -41.39 61.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -67.1 -33.67 75.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 113.16 -1.32 25.43 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.463 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 8.7 ptp -80.1 151.96 73.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 133.34 25.37 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -95.45 22.23 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.88 38.87 93.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 931' ' ' GLN . 8.1 mt-10 -138.7 145.46 40.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -147.88 145.66 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 40.8 mtp -119.45 138.7 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 956' ' ' VAL . 28.1 m -135.1 163.29 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -125.06 155.14 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -133.18 144.71 50.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.43 -34.92 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.4 t -115.85 131.62 56.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -63.23 -38.13 89.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.9 -41.43 96.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.51 -46.79 78.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.78 -48.22 70.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.556 HG22 HD11 ' A' ' 985' ' ' ILE . 19.6 m -64.87 -43.65 92.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.96 94.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.72 -40.01 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 980' ' ' ALA . 81.4 t -66.03 -48.57 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.556 HD11 HG22 ' A' ' 981' ' ' THR . 37.0 mt -62.04 -44.55 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.5 -26.42 59.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.678 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.1 mt -115.34 27.39 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.86 127.9 35.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.5 t70 61.0 41.74 13.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 997' ' ' VAL . 15.3 mtp85 -87.17 134.63 36.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.72 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 85.64 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.321 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 7.5 mt -83.69 128.85 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.03 -92.97 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.5 t -131.6 -2.74 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -133.73 158.52 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -85.91 143.88 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 0.2 OUTLIER -104.98 151.03 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . 0.41 ' HE2' HG22 ' A' 1000 ' ' VAL . 0.8 OUTLIER -114.22 125.12 53.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.2 mt -111.04 132.32 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 998' ' ' LYS . 23.3 t -128.14 143.34 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 981' ' ' THR . 13.5 mt -78.67 134.38 37.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 929' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.913 0.297 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 5.1 m -98.31 119.52 37.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.651 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 49.9 mm -91.36 129.19 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.645 HD11 ' HB1' ' A' ' 980' ' ' ALA . 95.8 mt -104.99 148.97 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 9.6 t -109.44 128.11 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.473 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.54 170.19 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.01 47.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.631 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.9 mtm -114.12 130.7 23.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.697 . . . . 0.0 110.895 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.452 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.5 Cg_endo -69.77 170.19 17.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -68.91 -28.8 66.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.7 p -59.46 -30.12 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 938' ' ' SER . 94.1 t -47.16 155.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 937' ' ' VAL . 10.0 m -162.32 170.96 18.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.89 -45.54 92.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.13 -39.32 92.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.77 -49.48 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.01 -41.56 83.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 992' ' ' ILE . 25.8 t80 -65.05 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.02 14.61 13.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -49.54 148.35 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.52 -39.52 2.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 67.1 m-85 -94.37 150.54 20.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.961 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.17 90.04 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.94 126.61 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 78.2 mt -56.28 129.73 74.55 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 125.05 11.68 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 0.0 112.343 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.25 -6.99 78.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 4.0 p -70.39 -51.5 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 110.796 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 69.1 t -41.23 109.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.18 118.95 31.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.94 146.74 26.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -97.36 138.14 35.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.93 163.91 29.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -108.39 172.38 6.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -34.41 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -69.12 -31.7 70.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 103.62 16.64 19.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 4.9 mmt -101.43 154.69 37.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.585 0.707 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.1 41.91 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 25.1 p -106.83 27.78 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 51.39 37.24 39.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.473 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 11.9 mt-10 -137.48 144.97 42.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.97 152.53 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtm -126.18 142.41 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.8 163.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -128.34 153.88 46.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.5 m-85 -134.29 143.17 47.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.75 -34.61 75.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -120.73 129.07 53.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 978' ' ' ASP . 1.4 ptp180 -61.87 -29.75 70.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 977' ' ' ARG . 7.3 m-20 -66.23 -41.5 89.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.99 -44.45 76.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 928' ' ' ILE . . . -57.16 -47.85 80.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.2 m -64.42 -43.58 93.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.46 95.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.12 -38.91 86.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 999' ' ' LEU . 79.8 t -64.75 -49.32 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.78 -43.45 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.67 -23.29 58.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.534 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.0 mt -116.42 21.46 13.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.8 t-20 -80.25 144.26 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.2 p30 49.98 39.53 19.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.509 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.6 mmp_? -84.16 127.58 66.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 86.93 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.864 HD12 HG11 ' A' ' 997' ' ' VAL . 10.5 mt -85.14 125.1 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.5 -93.98 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 49.6 p -130.04 -2.3 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -133.05 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -93.39 142.9 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.864 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -102.37 151.07 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -115.21 125.21 53.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.837 ' HB2' HG13 ' A' ' 984' ' ' VAL . 70.0 mt -111.29 128.21 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 58.0 t -133.72 141.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.7 134.45 49.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 179.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.846 0.269 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.3 m -92.0 121.93 34.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 42.9 mm -95.49 129.01 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 984' ' ' VAL . 53.5 mt -104.98 148.8 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -113.43 129.48 56.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.569 HG22 HD23 ' A' ' 999' ' ' LEU . 21.8 t -111.74 133.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.125 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 173.49 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.99 51.43 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.685 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -118.8 128.38 26.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 161.14 47.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -57.87 -31.79 67.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 82.2 p -55.8 -33.9 64.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.4 t -47.32 135.7 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.1 m -138.48 171.76 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.6 mt -58.77 -42.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -63.1 -46.05 89.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -62.39 -41.86 98.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 25.2 mt -62.47 -48.79 86.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.14 -41.94 84.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -71.93 -30.38 65.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.9 t80 -64.79 -39.65 93.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -87.62 13.29 10.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -48.05 147.78 1.99 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 97.58 -43.92 1.91 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 91.1 m-85 -91.39 159.29 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -91.54 90.74 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.49 131.35 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.0 129.59 86.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 129.14 17.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.714 2.276 . . . . 0.0 112.295 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.03 -9.61 77.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 24.4 p -70.36 -49.73 46.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 110.825 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -40.41 104.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.8 117.47 27.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.82 136.2 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 121.47 40.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.1 175.74 5.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -95.46 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.41 -39.28 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . 0.444 ' CE ' ' HA ' ' A' ' 963' ' ' LYS . 0.3 OUTLIER -77.4 -36.64 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.63 -1.84 4.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.448 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.19 146.3 70.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 136.75 33.73 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.0 p -101.65 -0.08 35.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.2 38.22 59.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.44 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -132.4 146.33 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -146.89 149.95 34.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 22.2 mtp -123.07 143.6 49.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.0 m -141.46 160.78 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.618 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -124.17 148.93 46.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 928' ' ' ILE . 39.2 m-85 -131.29 141.5 49.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.94 -32.43 57.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 15.7 t -114.92 130.54 56.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -63.27 -41.54 99.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.26 -38.81 81.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.96 -43.53 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.42 -50.01 75.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.632 HG22 ' CD1' ' A' ' 985' ' ' ILE . 19.7 m -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.54 97.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.15 -42.75 96.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.723 HG13 ' CB ' ' A' ' 999' ' ' LEU . 95.8 t -66.14 -48.91 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.632 ' CD1' HG22 ' A' ' 981' ' ' THR . 54.6 mt -60.18 -44.97 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -29.24 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 999' ' ' LEU . 3.8 mt -113.55 30.73 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.8 131.98 34.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 55.77 43.53 27.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 997' ' ' VAL . 20.2 mtp85 -86.69 134.1 38.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.611 0.72 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.93 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.26 . . . . 0.0 112.363 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.79 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.74 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.19 -92.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.1 p -132.45 -1.8 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -133.63 161.9 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -90.47 139.54 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -100.73 151.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.109 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -114.46 126.26 54.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.723 ' CB ' HG13 ' A' ' 984' ' ' VAL . 69.5 mt -111.17 131.83 54.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 97.4 t -130.94 137.44 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.35 132.4 43.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.479 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.834 0.264 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 93.3 m -92.39 118.92 31.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.5 mm -90.97 130.03 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.6 mt -104.99 148.34 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -112.66 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.6 HG22 HD23 ' A' ' 999' ' ' LEU . 59.9 t -110.77 124.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.0 OUTLIER -128.06 166.58 18.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . 0.521 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.1 OUTLIER 67.15 52.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.474 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.0 mtm -115.85 125.24 28.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.539 0.685 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.2 Cg_endo -69.81 168.46 21.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.307 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -61.94 -39.64 92.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -49.09 -30.32 6.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.447 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.5 t -52.19 145.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 15.1 m -151.68 179.26 8.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.34 -41.98 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.173 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.04 -45.98 89.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.04 -42.17 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.25 -47.63 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.02 -41.77 88.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.7 -30.9 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.607 ' CD2' HD11 ' A' ' 992' ' ' ILE . 55.5 t80 -64.93 -39.15 93.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -88.95 12.92 14.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -48.77 147.64 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.3 -33.3 5.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 65.0 m-85 -102.56 143.37 32.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -74.97 94.04 2.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.66 122.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 52.9 mt -51.47 130.19 34.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.591 0.71 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 126.78 13.73 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.268 . . . . 0.0 112.327 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.05 -6.03 81.66 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 52.1 p -72.87 -51.62 17.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.835 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 78.1 t -38.39 110.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 19.8 m -125.34 125.76 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 46.9 mt -97.14 140.08 32.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.0 45.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -119.87 169.08 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.8 OUTLIER -96.35 -177.38 3.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.91 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.93 -49.94 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . 0.424 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 27.0 mtmt -58.48 -43.97 89.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.86 -21.93 3.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.542 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 5.7 mtp -59.9 157.96 27.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 145.57 57.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 20.8 p -105.23 34.99 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.6 44.37 3.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -147.86 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.45 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.24 152.84 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 15.7 mtm -126.28 142.37 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.1 m -135.44 163.91 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.117 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -124.32 148.2 47.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -127.83 137.52 52.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.42 -38.52 71.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -108.72 128.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -60.96 -40.99 95.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -67.44 -44.61 78.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.64 -49.95 73.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 9.8 m -65.06 -44.02 90.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.56 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -68.07 -41.3 82.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.8 t -62.43 -48.98 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.6 -46.46 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.88 -21.21 60.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 20.0 mt -116.19 21.48 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.7 t-20 -83.27 135.71 34.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 54.89 43.82 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.8 mmp_? -86.69 130.2 49.82 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.834 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 81.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 8.8 mt -79.93 131.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.7 -92.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.1 t -131.07 -3.67 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -84.97 143.9 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.32 151.07 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -113.16 128.58 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.711 ' CB ' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -110.91 130.54 55.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 25.1 t -128.58 140.98 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.94 121.29 26.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 179.883 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.819 0.258 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.12 127.53 37.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.1 125.97 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 974' ' ' PHE . 98.4 mt -105.29 147.0 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -112.02 127.69 55.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.604 HG22 ' CD2' ' A' ' 999' ' ' LEU . 14.9 t -111.85 123.5 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.446 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.3 tm0? -127.61 173.34 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.48 53.87 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.589 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.2 mtm -119.47 125.75 27.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.415 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.2 Cg_endo -69.73 166.03 28.94 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.357 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.85 -35.14 77.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.4 p -53.75 -23.35 11.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 933' ' ' MET . 73.3 t -60.04 139.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 23.0 m -140.04 173.36 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.12 -41.96 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -63.13 -45.45 91.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.68 -42.04 98.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.9 mt -62.27 -49.33 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.13 -40.85 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.01 -31.32 66.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.794 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.5 t80 -65.51 -36.97 85.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.71 12.47 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -46.9 155.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.47 3.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 69.9 m-85 -92.57 147.14 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -79.91 100.53 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.6 t -93.93 130.88 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.43 HG23 ' HD2' ' A' ' 953' ' ' PRO . 46.7 mt -59.33 132.34 87.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.9 Cg_endo -69.79 128.03 15.42 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.664 2.243 . . . . 0.0 112.322 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.54 76.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 12.7 p -66.18 -56.09 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 972' ' ' VAL . 93.8 t -40.45 109.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -122.28 116.27 23.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 45.3 mt -82.71 132.24 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.66 136.96 33.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.48 180.0 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -114.77 -177.85 3.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.32 -32.17 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -77.19 -33.58 56.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.85 12.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.7 mtt -79.16 156.97 76.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 134.09 27.09 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 27.3 p -95.25 35.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 46.35 30.22 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.519 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.446 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.6 mt-10 -128.85 145.19 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.909 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.97 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 60.9 mtp -121.62 141.0 51.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.504 HG12 HG22 ' A' ' 956' ' ' VAL . 15.5 m -135.89 164.35 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.83 50.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 928' ' ' ILE . 26.8 m-85 -127.48 137.29 52.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.94 -35.7 74.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . 0.457 ' CB ' ' CD ' ' A' ' 979' ' ' GLU . 4.1 m -109.62 130.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.848 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.69 -48.46 77.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.04 -36.99 71.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . 0.457 ' CD ' ' CB ' ' A' ' 976' ' ' SER . 1.0 OUTLIER -64.24 -50.11 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.7 -46.0 70.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.464 HG23 HD11 ' A' 1001 ' ' LEU . 4.8 m -63.91 -42.41 97.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.66 94.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.45 -38.48 84.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 999' ' ' LEU . 69.6 t -68.32 -48.92 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -44.89 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -30.45 63.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.536 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 4.8 mt -109.72 23.79 13.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -83.2 136.0 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.22 42.73 32.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 12.4 mtt-85 -85.19 133.67 42.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 0.0 110.826 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 87.29 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.836 HD12 HG11 ' A' ' 997' ' ' VAL . 7.7 mt -87.78 130.93 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.23 -92.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.3 p -131.14 -3.66 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -134.11 158.6 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -88.05 138.36 31.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -95.8 150.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -112.7 125.63 54.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.706 ' CB ' HG13 ' A' ' 984' ' ' VAL . 80.0 mt -111.21 130.02 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 62.6 t -126.63 147.49 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -80.06 137.03 36.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.493 179.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.26 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 10.8 m -92.06 128.67 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 973' ' ' ALA . 4.1 mm -100.81 128.23 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.091 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.4 mt -105.36 145.1 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -111.02 127.49 55.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 8.5 t -107.72 127.7 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.452 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.0 OUTLIER -132.44 169.34 16.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . 0.44 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.1 OUTLIER 63.1 54.69 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.533 ' HG3' HG12 ' A' ' 997' ' ' VAL . 7.2 mtm -118.94 124.89 28.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.8 Cg_endo -69.79 168.32 21.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.662 2.241 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.1 -27.16 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 63.2 p -59.58 -27.95 66.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.41 HG23 ' HG2' ' A' ' 934' ' ' PRO . 60.1 t -57.62 144.52 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.8 m -146.72 171.64 14.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.04 -42.01 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.01 -45.84 90.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.52 -42.63 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.97 -49.55 84.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.7 mt -58.95 -41.84 88.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.41 -40.56 96.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -87.46 13.77 9.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -52.1 146.54 8.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.92 -35.06 4.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -99.58 139.42 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -70.88 90.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.5 t -86.24 124.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.434 HD12 ' CB ' ' A' ' 973' ' ' ALA . 97.3 mt -52.02 129.66 39.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.4 23.29 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.93 -2.46 87.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 956' ' ' VAL . 5.0 p -72.5 -53.37 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 955' ' ' SER . 61.1 t -36.37 108.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.49 108.18 12.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.1 mt -76.98 141.0 40.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -94.59 137.79 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 72.8 m-85 -130.5 158.61 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -97.31 178.48 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -44.07 -49.56 8.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . 0.463 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtmp? -61.86 -42.72 99.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 124.87 -11.14 7.85 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.9 mmt -65.74 157.48 79.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.78 43.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.4 p -107.77 33.79 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.05 44.96 6.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.452 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.2 mt-10 -147.81 145.32 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.62 35.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 27.1 mtt -126.56 142.71 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.62 164.49 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -123.31 150.05 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 25.1 m-85 -130.36 137.67 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.65 -37.78 67.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 24.5 t -106.1 131.76 52.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.859 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -63.42 -46.91 84.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.74 -34.66 69.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -47.33 69.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.96 -49.01 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.946 HG23 HD11 ' A' 1001 ' ' LEU . 3.7 m -64.92 -43.9 91.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.91 99.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.61 97.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 999' ' ' LEU . 96.2 t -65.68 -49.85 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 981' ' ' THR . 34.5 mt -65.0 -44.8 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.98 -27.69 67.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.06 30.2 6.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -82.56 127.98 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 61.4 41.9 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.501 ' O ' HG22 ' A' ' 997' ' ' VAL . 11.6 mmp_? -84.08 133.87 44.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.39 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.646 2.231 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 997' ' ' VAL . 7.1 mt -85.95 129.04 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.02 -93.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 22.8 t -131.23 -3.34 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -133.47 160.83 36.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -88.31 142.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 992' ' ' ILE . 1.7 m -102.81 150.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 126.63 55.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 984' ' ' VAL . 62.8 mt -111.02 133.12 53.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.9 t -126.61 149.48 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -87.95 121.6 30.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.497 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.825 0.261 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 7.0 m -96.79 118.98 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.5 mm -95.98 123.83 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.518 HD12 ' CE1' ' A' ' 974' ' ' PHE . 97.7 mt -106.48 145.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -111.95 134.25 53.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.692 HG22 ' CD2' ' A' ' 999' ' ' LEU . 70.4 t -114.47 125.95 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.92 169.0 14.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.81 53.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.5 ' HE1' ' HB2' ' A' ' 970' ' ' ALA . 14.3 mtm -117.92 121.72 31.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.615 0.722 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 162.97 40.04 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -55.35 -41.38 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.2 p -45.47 -36.33 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.5 t -49.13 142.44 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 27.9 m -148.5 179.23 7.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.02 -42.04 94.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -62.97 -45.89 90.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -65.21 -42.71 93.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . 0.441 ' CD1' HD21 ' A' ' 958' ' ' LEU . 26.8 mt -61.29 -48.61 88.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.1 -41.97 89.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.94 -30.78 65.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.6 t80 -64.92 -38.67 91.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.29 13.16 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -49.38 154.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 88.26 -36.66 3.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 77.6 m-85 -95.84 136.33 36.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.986 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 950' ' ' GLN . 2.6 mp0 -73.74 82.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.54 135.52 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.25 130.95 93.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 132.27 23.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 0.0 112.409 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 90.19 -4.11 82.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 957' ' ' CYS . 1.5 m -80.6 -56.47 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 955' ' ' SER . 65.2 t -36.32 95.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 955' ' ' SER . 20.9 m -112.41 136.74 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.441 HD21 ' CD1' ' A' ' 942' ' ' ILE . 71.2 mt -99.9 137.23 38.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -96.54 133.34 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.49 175.57 5.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 965' ' ' MET . 4.6 p30 -107.63 -177.58 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.36 -29.19 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -79.21 -35.57 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 124.45 -17.76 7.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.442 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 15.0 mtp -68.36 157.9 86.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.04 15.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 19.3 p -89.05 35.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.47 45.54 6.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -142.17 148.53 38.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.5 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -149.86 152.82 35.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 63.1 mtp -130.54 141.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.79 162.55 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.63 44.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.7 m-85 -129.96 141.31 50.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.32 -34.84 68.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.34 135.0 54.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.814 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -62.25 -41.37 98.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.28 -42.97 82.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -47.87 79.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 974' ' ' PHE . . . -54.89 -49.75 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.669 HG22 HD11 ' A' ' 985' ' ' ILE . 3.8 m -64.61 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.6 87.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -66.92 -45.49 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.685 HG13 ' CB ' ' A' ' 999' ' ' LEU . 79.2 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 981' ' ' THR . 37.4 mt -64.27 -46.15 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.99 -22.73 58.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 16.6 mt -116.75 23.66 11.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.8 OUTLIER -80.74 136.16 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.4 t0 50.63 45.42 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 997' ' ' VAL . 1.9 mmp_? -83.23 129.7 59.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.701 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 84.96 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 945' ' ' PHE . 10.4 mt -85.8 133.28 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.29 -91.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 3.3 m -134.64 0.54 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -134.14 155.41 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -86.65 136.72 32.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.739 HG11 HD12 ' A' ' 992' ' ' ILE . 1.9 m -97.12 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.59 128.39 56.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.4 mt -110.98 138.72 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.4 t -134.56 144.18 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 981' ' ' THR . 15.3 mt -82.72 141.51 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 179.873 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.891 0.288 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.9 m -96.04 120.97 37.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 33.3 mm -100.38 122.28 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 974' ' ' PHE . 85.4 mt -105.0 141.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -110.42 128.66 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.59 130.18 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.02 171.65 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.79 52.67 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 25.9 mtm -115.11 135.89 22.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.7 Cg_endo -69.75 171.9 13.61 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.84 -20.43 59.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 77.5 p -72.15 -15.63 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 934' ' ' PRO . 74.2 t -59.21 147.93 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.6 m -154.15 171.37 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.39 -42.03 79.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.12 -45.17 93.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.27 -41.68 93.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.4 mt -64.1 -49.53 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.83 -41.97 83.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.0 -31.2 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 992' ' ' ILE . 14.7 t80 -65.86 -36.21 82.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -88.43 10.12 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -44.24 153.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 90.48 -42.3 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 84.1 m-85 -92.85 149.4 21.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.95 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.75 91.38 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.36 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.581 HG23 ' HD2' ' A' ' 953' ' ' PRO . 92.7 mt -57.97 136.35 83.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.76 147.97 64.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.64 2.226 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 63.55 13.24 50.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 63.1 m -94.2 -51.33 4.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.938 0.399 . . . . 0.0 110.822 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 972' ' ' VAL . 93.9 t -46.94 103.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 12.1 m -117.42 134.21 55.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.85 138.77 34.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -92.42 135.85 33.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -124.71 166.86 15.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 965' ' ' MET . 1.0 OUTLIER -100.25 -176.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.01 -8.86 25.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -98.2 -28.28 13.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 112.95 -3.8 25.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 20.8 mtm -84.77 150.12 55.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.583 0.706 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 128.27 15.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 36.3 p -89.38 24.25 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.09 38.44 89.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.519 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -137.51 145.47 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.13 151.45 33.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 20.8 mtt -122.02 143.15 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 956' ' ' VAL . 15.4 m -137.85 160.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.94 151.71 43.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 928' ' ' ILE . 31.8 m-85 -133.8 138.86 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -73.22 -34.67 66.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 5.5 t -111.17 129.89 55.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -63.42 -44.37 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -57.11 -37.16 71.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -48.57 66.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.9 69.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.693 HG22 HD11 ' A' ' 985' ' ' ILE . 4.7 m -62.53 -43.57 98.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.31 93.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.48 -45.96 92.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 999' ' ' LEU . 53.3 t -61.71 -50.11 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 981' ' ' THR . 30.7 mt -61.42 -48.82 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.22 -21.9 62.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 999' ' ' LEU . 16.4 mt -119.14 26.52 9.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.5 t-20 -89.03 120.72 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.9 t0 73.13 38.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.4 mmp_? -84.4 129.69 56.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 87.51 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.849 HD12 HG11 ' A' ' 997' ' ' VAL . 14.3 mt -83.93 129.33 37.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.177 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.64 -92.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.0 p -132.76 -0.65 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -131.2 163.91 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.25 143.85 26.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.849 HG11 HD12 ' A' ' 992' ' ' ILE . 2.7 m -107.53 151.08 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . 0.512 ' HE3' HG22 ' A' 1000 ' ' VAL . 8.2 tmtm? -117.67 127.73 54.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 987' ' ' LEU . 37.6 mt -111.64 130.44 55.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . 0.512 HG22 ' HE3' ' A' ' 998' ' ' LYS . 46.4 t -131.97 136.52 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.16 155.95 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.803 0.251 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.1 m -92.53 117.87 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.197 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 47.8 mm -95.47 125.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 80.8 mt -106.13 148.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -112.65 130.55 56.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 999' ' ' LEU . 20.6 t -111.04 123.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.466 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.1 tm0? -125.02 167.25 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . 0.466 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.3 OUTLIER 65.89 53.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.484 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 12.2 mtm -115.78 123.98 30.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.4 Cg_endo -69.73 168.32 21.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -63.93 -39.41 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.8 p -48.17 -34.32 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 938' ' ' SER . 81.3 t -45.66 154.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 937' ' ' VAL . 7.5 m -160.58 172.71 16.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.44 -41.94 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.01 -45.74 90.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.34 -41.55 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.29 -48.25 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.8 -42.06 92.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.97 -31.56 66.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 992' ' ' ILE . 9.5 t80 -64.94 -37.34 87.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -92.14 14.82 14.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.46 157.6 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.932 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 85.46 -41.7 3.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 72.1 m-85 -87.84 141.51 28.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -73.01 87.04 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.5 t -82.73 125.46 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.527 HG23 ' HD2' ' A' ' 953' ' ' PRO . 97.5 mt -51.55 134.99 34.32 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.573 0.702 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.527 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.4 Cg_endo -69.77 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.64 2.226 . . . . 0.0 112.362 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 86.42 24.86 38.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 82.3 p -93.66 -50.86 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.84 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 97.2 t -39.34 113.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 3.2 t -122.9 109.7 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 25.6 mt -81.74 136.78 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -103.13 138.88 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.84 174.44 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.481 ' ND2' ' HD3' ' A' ' 963' ' ' LYS . 7.9 p30 -98.56 176.97 5.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.26 -33.92 65.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . 0.481 ' HD3' ' ND2' ' A' ' 961' ' ' ASN . 0.0 OUTLIER -68.21 -45.94 71.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.838 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 138.61 -27.78 2.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . 0.401 ' O ' ' OD1' ' A' ' 961' ' ' ASN . 85.0 mtp -63.76 153.47 83.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.556 0.693 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 144.1 52.83 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.658 2.239 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.3 p -99.37 37.7 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 39.43 42.19 1.8 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.54 145.84 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.56 153.02 35.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 9.8 mtp -122.22 143.66 49.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.61 165.7 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.46 147.18 50.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.096 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 20.8 m-85 -127.36 144.29 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -78.06 -34.43 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 50.7 m -111.57 130.76 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.57 -40.09 78.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -62.87 -45.74 91.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -55.72 -49.31 73.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.546 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -64.26 -43.9 93.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.35 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.36 -42.87 95.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 999' ' ' LEU . 91.4 t -62.7 -50.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 981' ' ' THR . 27.9 mt -63.62 -42.18 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.26 -28.04 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 999' ' ' LEU . 77.2 mt -115.68 25.86 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.25 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 t0 58.69 43.15 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.8 mmt180 -82.92 130.37 57.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 82.47 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.743 2.295 . . . . 0.0 112.309 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.828 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.02 123.36 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.88 -95.83 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 11.7 t -126.06 -6.53 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -129.48 159.65 35.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -93.15 136.42 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.787 HG11 HD12 ' A' ' 992' ' ' ILE . 5.6 m -96.15 150.14 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -113.79 129.72 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.658 ' CB ' HG13 ' A' ' 984' ' ' VAL . 68.1 mt -110.87 128.74 55.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 76.0 t -126.43 141.97 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.64 130.98 41.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 179.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.876 0.282 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.9 m -92.61 126.19 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 43.2 mm -97.6 129.94 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.123 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.611 HD12 ' CE1' ' A' ' 974' ' ' PHE . 51.3 mt -104.88 147.72 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.139 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.16 127.99 56.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 999' ' ' LEU . 16.0 t -116.39 129.72 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.8 tm0? -136.17 168.22 19.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.53 46.89 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.537 ' CG ' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -113.86 124.99 30.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 110.88 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.315 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.98 -35.8 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 65.5 p -52.41 -25.49 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.459 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.7 t -57.5 141.69 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 67.0 m -143.76 174.21 11.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.5 mt -58.64 -42.12 84.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.17 -45.13 93.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -62.05 -44.1 97.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.24 -49.85 81.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.46 -41.62 80.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -71.91 -31.85 66.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.902 ' CD2' HD11 ' A' ' 992' ' ' ILE . 6.3 t80 -64.73 -35.78 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.09 17.38 14.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -50.59 142.99 9.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 100.28 -40.64 2.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 86.4 m-85 -89.57 148.52 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -81.62 79.57 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.92 124.23 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -53.54 129.39 53.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 111.171 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 131.54 21.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.39 84.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 956' ' ' VAL . 9.7 p -72.5 -54.8 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 972' ' ' VAL . 88.0 t -35.59 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.13 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.5 m -116.73 110.94 19.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.53 134.19 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -92.69 130.53 38.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -120.1 159.35 24.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -102.88 176.2 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.02 -28.85 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -71.59 -33.0 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 110.5 -1.55 29.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.534 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.32 161.6 24.77 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.58 0.705 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 134.4 27.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 67.1 p -93.5 16.0 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 76.27 21.72 74.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . 0.435 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 24.4 mt-10 -121.9 145.03 48.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . 0.4 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.16 150.39 31.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 14.9 mtm -129.82 140.44 51.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 34.7 m -137.54 165.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.48 149.57 44.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 928' ' ' ILE . 13.5 m-85 -128.92 141.62 51.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.41 -37.5 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -105.12 132.29 51.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -63.27 -51.03 67.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.03 -33.35 67.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -44.69 77.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.13 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.657 HG23 HD11 ' A' 1001 ' ' LEU . 11.7 m -62.6 -43.98 97.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 986' ' ' ASP . . . -62.06 -40.3 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -63.19 -39.53 94.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 999' ' ' LEU . 74.1 t -69.84 -50.21 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.96 -45.15 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 982' ' ' ALA . 5.0 t70 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 999' ' ' LEU . 1.9 mt -122.31 33.08 5.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -85.54 131.34 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 54.89 43.57 29.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 997' ' ' VAL . 24.5 mtp180 -84.45 133.53 44.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.607 0.717 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 90.51 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.911 HD12 HG11 ' A' ' 997' ' ' VAL . 10.2 mt -90.46 126.26 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.47 -92.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 4.6 m -131.31 -3.09 3.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -133.89 161.29 35.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -90.03 142.29 27.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.911 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -99.97 149.75 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.23 125.7 54.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.65 ' HB2' HG13 ' A' ' 984' ' ' VAL . 77.1 mt -111.21 127.92 55.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 90.9 t -122.64 137.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.657 HD11 HG23 ' A' ' 981' ' ' THR . 11.5 mt -77.45 127.94 33.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.913 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.862 0.276 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 28.5 m -97.98 127.71 44.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.84 126.69 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 974' ' ' PHE . 72.4 mt -105.37 147.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 128.46 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.8 122.92 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 170.03 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 932' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 996' ' ' LYS . 0.2 OUTLIER 65.48 47.67 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 933' ' ' MET . . . . . 0.664 ' HG3' HG12 ' A' ' 997' ' ' VAL . 19.2 mtm -114.87 129.25 25.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 934' ' ' PRO . . . . . 0.419 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.75 168.53 21.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.724 2.283 . . . . 0.0 112.345 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -63.43 -35.92 82.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 75.0 p -52.44 -36.61 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 937' ' ' VAL . . . . . 0.506 HG11 ' SD ' ' A' ' 933' ' ' MET . 78.8 t -41.57 140.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.3 m -148.59 172.96 13.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.92 -42.13 77.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -45.94 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -63.34 -43.35 97.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.2 mt -63.3 -49.31 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.51 -41.95 91.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -71.21 -31.96 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 945' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 39.7 t80 -65.37 -37.1 85.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -88.84 11.49 17.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -48.04 145.68 2.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 96.06 -43.45 2.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 949' ' ' TYR . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 78.6 m-85 -90.99 132.51 35.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.359 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.07 93.29 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.73 124.88 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 952' ' ' ILE . . . . . 0.505 HG23 ' HD2' ' A' ' 953' ' ' PRO . 65.0 mt -51.53 134.34 34.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.632 0.73 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 953' ' ' PRO . . . . . 0.505 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.3 Cg_endo -69.85 126.47 13.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.241 . . . . 0.0 112.33 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.17 12.69 78.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 68.2 p -83.78 -49.16 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 67.4 t -42.12 107.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 9.9 t -115.52 110.46 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 29.3 mt -88.16 131.92 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -101.47 132.47 47.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -123.67 157.58 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 961' ' ' ASN . . . . . 0.745 ' OD1' HG22 ' A' ' 967' ' ' THR . 3.9 m-80 -67.03 -175.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.63 -9.71 57.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -32.58 12.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 127.9 -18.31 5.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 57.2 mtt -67.69 154.95 92.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.76 13.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 967' ' ' THR . . . . . 0.745 HG22 ' OD1' ' A' ' 961' ' ' ASN . 44.8 p -86.42 13.42 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 64.21 30.58 78.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.2 145.35 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.17 149.81 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 5.9 mtt -124.24 144.95 49.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 972' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 16.6 m -139.31 165.62 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.57 155.55 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 974' ' ' PHE . . . . . 0.553 ' CE1' HD12 ' A' ' 928' ' ' ILE . 22.4 m-85 -136.1 140.79 44.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -72.3 -38.51 68.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 10.5 t -110.45 129.71 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -61.4 -41.87 97.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.85 -38.88 79.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.5 -44.14 83.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.3 -49.29 77.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.927 HG23 HD11 ' A' 1001 ' ' LEU . 8.3 m -63.45 -43.7 96.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.44 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 983' ' ' ALA . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.43 -39.57 89.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.692 HG13 ' CB ' ' A' ' 999' ' ' LEU . 72.2 t -67.39 -48.82 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 985' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 981' ' ' THR . 82.7 mt -64.13 -45.64 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.25 -22.15 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 987' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.5 mt -117.15 18.92 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 988' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 984' ' ' VAL . 3.6 t-20 -80.5 134.57 35.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.6 40.61 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 990' ' ' ARG . . . . . 0.522 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.2 mmp_? -84.69 130.69 52.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 82.91 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 992' ' ' ILE . . . . . 0.755 HD12 HG11 ' A' ' 997' ' ' VAL . 10.1 mt -81.76 135.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 52.6 -91.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 2.7 m -133.77 -0.35 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -133.96 161.48 34.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 996' ' ' LYS . . . . . 0.448 ' O ' ' ND2' ' A' ' 932' ' ' ASN . 61.2 mttt -90.03 140.88 29.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 997' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 992' ' ' ILE . 1.2 m -102.95 151.08 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 125.23 52.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CB ' HG13 ' A' ' 984' ' ' VAL . 41.9 mt -111.24 128.81 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.2 142.99 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1001 ' ' LEU . . . . . 0.927 HD11 HG23 ' A' ' 981' ' ' THR . 11.2 mt -80.28 132.7 35.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.545 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 47.1 t -72.9 103.77 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 39.2 t -68.0 102.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -98.33 129.52 9.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 83.1 p -81.9 135.75 35.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.861 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 87.8 p -133.34 173.59 11.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.874 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -131.7 -67.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -155.25 123.76 5.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.733 0.301 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 10.4 t -147.38 116.21 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 24.8 p -131.06 145.14 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -71.31 164.97 53.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 152.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.665 2.244 . . . . 0.0 112.343 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 109.02 -156.43 15.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.493 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 176.59 6.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.256 . . . . 0.0 112.331 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.4 m -92.07 117.39 29.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 50.8 mm -96.45 127.31 48.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.688 ' HB ' HG23 ' A' ' 972' ' ' VAL . 96.5 mt -105.54 148.09 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -113.15 124.39 52.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.696 HG22 HD23 ' A' ' 999' ' ' LEU . 45.7 t -106.43 130.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.08 170.46 16.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.79 50.13 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.746 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.3 mtm -117.04 132.56 23.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 110.868 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.456 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.3 Cg_endo -69.76 167.81 23.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.73 2.287 . . . . 0.0 112.379 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.38 -29.88 70.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.5 p -59.28 -26.8 65.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.163 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 933' ' ' MET . 78.8 t -50.78 141.07 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 21.3 m -143.66 168.21 20.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.96 -42.03 78.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.96 -45.53 92.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -62.15 -43.24 99.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 958' ' ' LEU . 45.2 mt -61.0 -49.51 84.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.091 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.4 mt -56.21 -41.44 75.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -71.83 -31.46 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.907 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.806 ' CD2' HD11 ' A' ' 992' ' ' ILE . 11.9 t80 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -91.9 17.3 9.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -52.21 151.89 3.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 89.69 -39.01 3.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -95.08 144.15 25.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -77.04 100.72 5.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.02 125.6 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.634 HG23 ' HD2' ' A' ' 953' ' ' PRO . 53.1 mt -55.81 138.38 70.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.582 0.706 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.634 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.0 Cg_endo -69.69 138.82 38.95 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.713 2.275 . . . . 0.0 112.355 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.29 -9.03 22.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 60.5 p -63.61 -56.8 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 81.1 t -41.32 100.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -113.8 110.23 19.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 942' ' ' ILE . 82.7 mt -86.98 132.51 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -97.07 138.12 35.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . 0.459 ' HA ' HG23 ' A' ' 967' ' ' THR . 76.9 m-85 -126.32 156.75 39.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.774 ' OD1' HG22 ' A' ' 967' ' ' THR . 2.9 m-80 -67.95 -178.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.01 -34.91 73.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -72.41 -36.36 68.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 128.61 -14.05 6.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.43 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.447 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 29.7 mmt -66.5 157.04 84.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 129.55 17.79 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . 0.774 HG22 ' OD1' ' A' ' 961' ' ' ASN . 17.4 p -92.51 5.8 49.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.4 23.96 77.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -123.9 145.89 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.35 152.78 34.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 10.1 mtm -127.03 143.69 51.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 928' ' ' ILE . 2.7 m -137.6 163.61 30.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.91 155.85 43.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 928' ' ' ILE . 42.1 m-85 -138.05 138.38 38.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -72.73 -31.28 64.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.9 t -117.57 130.05 56.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -63.21 -40.75 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . 0.451 ' OD1' ' CD ' ' A' ' 979' ' ' GLU . 0.5 OUTLIER -57.92 -40.04 79.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . 0.451 ' CD ' ' OD1' ' A' ' 978' ' ' ASP . 0.2 OUTLIER -67.29 -45.73 75.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.56 -48.8 79.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.637 HG22 HD11 ' A' ' 985' ' ' ILE . 4.0 m -63.35 -43.99 96.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.84 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.58 99.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.9 t -61.84 -48.82 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.637 HD11 HG22 ' A' ' 981' ' ' THR . 21.5 mt -65.0 -41.69 92.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.96 -24.18 59.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.457 HD23 ' HE ' ' A' ' 990' ' ' ARG . 66.1 mt -116.79 20.65 13.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.1 t-20 -80.64 120.54 24.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.92 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.8 t70 73.33 39.04 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.49 ' O ' HG22 ' A' ' 997' ' ' VAL . 19.1 mmt180 -83.49 128.66 63.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 87.72 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.724 2.283 . . . . 0.0 112.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.903 HD12 HG11 ' A' ' 997' ' ' VAL . 10.7 mt -85.98 123.28 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.71 -94.15 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.47 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 40.9 t -129.48 -3.15 4.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 0.0 110.797 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 17.5 mtt85 -133.49 156.61 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -87.29 143.31 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.903 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -101.12 151.04 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -115.22 125.2 53.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.696 HD23 HG22 ' A' ' 930' ' ' VAL . 48.7 mt -111.05 129.51 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.4 t -132.18 138.82 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.22 142.17 45.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -68.96 -74.94 0.57 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 41.9 p -63.66 152.56 38.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.837 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.405 ' HA2' ' N ' ' A' 1006 ' ' SER . . . 114.57 -178.66 18.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.52 9.43 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.655 -1.81 . . . . 0.0 112.34 0.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . 0.405 ' N ' ' HA2' ' A' 1004 ' ' GLY . 10.7 t -76.74 125.33 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 3.2 m -98.69 123.23 42.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.84 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 98.2 p -125.31 108.07 11.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.364 . . . . 0.0 110.883 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 37.7 p -55.16 127.38 28.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.05 43.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 38.4 t -134.11 86.26 2.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 25.2 t -54.01 159.52 1.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -77.03 -149.08 3.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -131.88 42.59 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 11.7 t -166.02 128.03 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 3.8 m -71.85 102.02 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 53.31 176.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 922' ' ' LYS . 2.1 mppt? -129.52 148.15 68.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.582 0.706 . . . . 0.0 110.901 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 109.22 2.26 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.677 2.251 . . . . 0.0 112.319 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.25 10.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.487 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 177.35 5.69 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.695 2.263 . . . . 0.0 112.3 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.42 125.29 37.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 41.5 mm -101.67 125.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 972' ' ' VAL . 86.9 mt -109.61 143.04 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -112.19 127.87 56.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.756 HG22 HD23 ' A' ' 999' ' ' LEU . 40.6 t -108.21 128.62 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -133.67 169.77 16.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.75 47.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.69 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -114.9 134.27 22.49 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.521 0.676 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.9 Cg_endo -69.67 174.22 9.75 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.353 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.89 -26.02 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.5 p -62.52 -31.43 72.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.505 HG21 ' HB3' ' A' ' 933' ' ' MET . 88.6 t -45.64 151.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.082 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 19.1 m -158.19 172.53 18.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.9 mt -57.95 -41.86 81.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.156 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.17 -44.34 95.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -65.33 -43.45 90.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.6 mt -62.08 -48.24 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 943' ' ' LEU . 13.1 mt -57.76 -42.03 83.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -71.35 -31.54 67.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.814 ' CD2' HD11 ' A' ' 992' ' ' ILE . 4.0 t80 -65.73 -35.87 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -91.51 11.91 22.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -49.33 149.27 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.0 -39.83 2.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.491 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -94.56 150.76 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -83.88 83.12 8.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.932 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.19 130.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 973' ' ' ALA . 83.2 mt -57.15 129.4 79.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.644 0.735 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 133.68 26.09 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.297 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 84.35 -4.4 83.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 956' ' ' VAL . 10.1 p -75.25 -56.22 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 955' ' ' SER . 94.3 t -37.25 103.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -119.03 114.4 22.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.28 129.88 34.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -93.41 127.49 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -116.86 160.19 21.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.869 ' OD1' HG22 ' A' ' 967' ' ' THR . 3.4 m-80 -79.38 -178.79 6.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -58.49 -36.23 73.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -74.63 -27.68 60.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 119.51 -18.66 10.03 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.46 ' O ' ' ND2' ' A' ' 961' ' ' ASN . 6.8 mmt -58.86 158.17 17.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.595 0.712 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 127.47 14.62 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 0.0 112.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . 0.869 HG22 ' OD1' ' A' ' 961' ' ' ASN . 71.2 p -87.12 8.77 22.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 61.92 30.07 74.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.459 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 25.4 mt-10 -134.2 146.1 49.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.04 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 34.5 mtp -122.04 147.44 46.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.612 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.6 m -140.84 165.32 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.475 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -130.98 148.48 52.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.483 ' CE1' HD12 ' A' ' 928' ' ' ILE . 30.1 m-85 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.86 -33.35 45.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.5 m -108.49 128.53 54.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -61.83 -49.96 74.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.04 -35.71 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.03 -45.12 78.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -56.29 -47.85 77.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.119 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.57 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -62.71 -42.48 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.159 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.1 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.75 -43.98 94.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.106 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 999' ' ' LEU . 68.9 t -66.75 -47.93 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.57 HD11 HG22 ' A' ' 981' ' ' THR . 58.2 mt -61.9 -45.55 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.2 mt -120.67 30.5 6.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -88.05 136.66 32.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.6 p30 49.68 43.3 24.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.534 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.2 mtt-85 -86.05 134.04 39.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 92.27 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 2.214 . . . . 0.0 112.33 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 1.008 HD12 HG11 ' A' ' 997' ' ' VAL . 12.5 mt -89.98 126.73 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.83 -90.57 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.6 m -133.54 -0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 22.2 mtt85 -134.05 162.04 33.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -90.9 144.03 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 1.008 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.0 151.1 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . 0.419 ' HE3' ' CG2' ' A' 1000 ' ' VAL . 0.1 OUTLIER -115.47 127.31 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.756 HD23 HG22 ' A' ' 930' ' ' VAL . 79.3 mt -110.98 133.9 53.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . 0.419 ' CG2' ' HE3' ' A' ' 998' ' ' LYS . 60.0 t -126.39 141.75 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 981' ' ' THR . 13.0 mt -81.18 137.06 35.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' 1003 ' ' SER . . . -48.42 165.11 0.25 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' 1002 ' ' GLY . 83.7 p -34.65 149.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -146.61 -162.88 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.549 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -48.45 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 -1.814 . . . . 0.0 112.318 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 3.6 m -140.73 154.54 46.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 78.3 p -67.56 139.23 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.821 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.461 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 25.9 m -115.97 125.71 52.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.6 m -89.36 164.48 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 164.68 98.19 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 51.3 p -94.42 158.61 15.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 26.1 p -163.42 122.02 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 89.94 -61.72 3.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -89.69 40.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.4 m -65.04 -55.92 16.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 20.3 t -56.34 124.51 18.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -84.64 176.11 50.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -136.0 142.05 38.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 115.4 4.07 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 158.17 -155.01 26.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.553 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 171.33 14.69 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.695 2.263 . . . . 0.0 112.337 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 54.8 m -92.02 133.94 35.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.166 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 32.7 mm -101.91 128.52 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.458 HD12 ' CE1' ' A' ' 974' ' ' PHE . 63.2 mt -105.07 144.54 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -111.46 128.36 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.59 127.98 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.469 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -138.14 164.77 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.38 45.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.701 ' HG3' HG12 ' A' ' 997' ' ' VAL . 14.3 mtm -115.18 133.02 22.76 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.74 170.98 15.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.351 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -67.0 -35.73 80.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 68.6 p -53.24 -30.03 35.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 80.3 t -49.82 143.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.8 m -147.9 170.61 17.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.5 mt -57.05 -42.12 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.24 -45.99 89.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.02 -44.5 96.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 19.1 mt -61.17 -49.68 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -56.03 -41.99 75.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.83 -30.16 65.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.772 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.3 t80 -66.22 -34.92 79.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -90.91 8.49 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -41.7 148.59 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.61 -42.95 2.24 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.725 ' CE2' HD11 ' A' ' 987' ' ' LEU . 45.8 m-85 -91.65 146.07 24.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -82.61 85.98 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.25 125.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 63.3 mt -50.86 130.25 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.714 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 125.24 11.91 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.45 4.95 65.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.513 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 5.2 p -84.52 -45.5 12.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.87 100.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.3 t -114.36 108.05 16.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 37.7 mt -80.34 142.08 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.25 129.24 54.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . 0.434 ' C ' HG23 ' A' ' 967' ' ' THR . 88.7 m-85 -115.05 175.75 5.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.764 ' OD1' HG22 ' A' ' 967' ' ' THR . 65.7 m-80 -91.13 -175.01 4.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.06 -6.64 50.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -100.4 -36.78 9.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.37 -3.31 5.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 31.2 mtp -86.03 151.56 54.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 126.44 13.33 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.7 2.267 . . . . 0.0 112.345 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . 0.764 HG22 ' OD1' ' A' ' 961' ' ' ASN . 9.3 p -86.02 12.89 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 63.59 30.49 77.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.469 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 27.5 mt-10 -126.2 146.01 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.6 152.11 33.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtt -131.41 141.28 49.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.451 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 28.5 m -136.9 165.8 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.68 50.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.458 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.0 m-85 -128.64 137.37 51.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -69.86 -34.7 73.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 4.1 m -107.85 125.84 51.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -61.5 -48.19 82.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.04 -36.97 71.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.74 84.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -57.81 -48.16 80.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.691 HG23 HD11 ' A' 1001 ' ' LEU . 4.3 m -60.66 -43.59 97.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.71 99.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.555 ' O ' HD12 ' A' ' 987' ' ' LEU . . . -64.28 -40.27 95.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 999' ' ' LEU . 71.9 t -66.48 -48.61 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.05 -43.78 97.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.77 -21.44 59.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 949' ' ' TYR . 4.1 mt -120.41 24.27 10.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -85.65 135.39 33.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 55.65 41.71 30.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.567 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.2 mtp180 -84.63 131.62 49.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.603 0.716 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.8 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 2.246 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.924 HD12 HG11 ' A' ' 997' ' ' VAL . 13.9 mt -82.15 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 48.81 -92.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 992' ' ' ILE . 58.4 m -132.48 -1.25 3.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -133.04 160.76 36.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.2 143.83 26.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.924 HG11 HD12 ' A' ' 992' ' ' ILE . 2.1 m -104.85 151.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -114.39 126.27 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.655 ' CB ' HG13 ' A' ' 984' ' ' VAL . 82.8 mt -111.31 127.85 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 43.4 t -124.94 139.72 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.119 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.691 HD11 HG23 ' A' ' 981' ' ' THR . 12.9 mt -76.04 128.37 34.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -40.58 -60.98 1.95 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.45 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 77.7 p -162.64 134.14 5.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 0.0 110.885 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 166.88 172.38 34.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.488 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.426 ' C ' ' HA2' ' A' 1004 ' ' GLY . 54.1 Cg_endo -69.81 -23.93 8.86 Favored 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.337 0.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 86.1 p -135.82 140.95 44.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 30.6 t -143.57 117.03 9.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 44.0 m -126.28 -45.79 1.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 22.5 t 60.72 42.04 14.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 71.2 -134.35 22.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 38.2 m -40.77 160.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 2.1 m -86.37 130.7 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 153.62 160.06 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -98.89 174.31 6.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.762 0.315 . . . . 0.0 111.096 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 33.0 p -124.89 -49.48 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 6.8 t 60.35 47.45 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 45.0 -127.3 7.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.501 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . 0.404 ' NZ ' ' HA3' ' A' 1002 ' ' GLY . 0.0 OUTLIER -157.76 152.49 20.93 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.61 0.719 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 171.86 13.63 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 87.61 -157.83 29.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 27.0 m -92.32 130.72 37.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.0 mm -103.84 125.46 58.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.509 HD12 ' CE1' ' A' ' 974' ' ' PHE . 75.6 mt -105.56 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -112.99 125.38 54.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.67 124.54 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.26 171.46 12.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.09 49.35 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 16.9 mtm -115.79 127.03 27.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.594 0.711 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 166.4 27.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.315 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.72 -40.5 88.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 70.8 p -48.11 -27.7 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.518 HG11 ' SD ' ' A' ' 933' ' ' MET . 91.4 t -55.71 135.53 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.09 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 34.3 m -143.86 171.64 13.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 56.0 mt -57.22 -42.07 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.115 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.1 -45.99 89.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.48 -43.96 88.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 33.0 mt -61.1 -49.75 83.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.64 -41.78 77.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.35 -31.42 67.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.2 t80 -66.01 -34.4 78.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.23 12.93 22.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.58 150.41 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.61 -32.94 5.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.54 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 95.8 m-85 -102.22 137.61 40.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -69.56 89.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 88.2 t -85.43 123.09 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.111 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.66 129.48 35.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 125.56 12.29 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.661 2.241 . . . . 0.0 112.317 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.75 -9.82 75.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 28.5 p -66.92 -49.13 66.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.843 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -43.87 107.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 t -118.95 118.28 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 970' ' ' ALA . 65.2 mt -91.09 127.12 36.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -98.03 130.37 44.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -112.14 -175.31 2.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 965' ' ' MET . 2.7 p30 -107.39 -177.01 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.12 -34.57 73.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.75 -35.76 75.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 120.64 -2.6 12.2 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.464 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 3.0 mmt -83.7 155.76 65.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 127.48 14.72 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.264 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.9 p -86.46 27.61 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 48.32 38.7 20.03 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.467 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.5 145.32 40.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 958' ' ' LEU . . . -150.71 151.12 31.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 49.5 mtp -122.57 142.71 50.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 13.3 m -135.26 164.08 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.49 146.74 50.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.509 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.0 m-85 -129.87 139.51 51.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.17 -35.88 66.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 2.3 m -105.4 127.57 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -64.22 -47.79 78.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -57.11 -34.77 68.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -67.69 -47.61 68.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.696 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -54.63 -46.59 73.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.622 HG22 HD11 ' A' ' 985' ' ' ILE . 7.4 m -64.41 -43.75 93.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.27 89.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.69 -40.61 95.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 980' ' ' ALA . 90.4 t -66.05 -49.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.622 HD11 HG22 ' A' ' 981' ' ' THR . 33.2 mt -59.02 -46.0 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.64 -27.95 61.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.7 mt -112.46 28.06 9.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.13 128.8 36.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.6 t0 59.84 42.67 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.483 ' O ' HG22 ' A' ' 997' ' ' VAL . 5.3 mtp85 -86.51 133.38 40.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.827 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 85.7 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.37 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.763 HD12 HG11 ' A' ' 997' ' ' VAL . 7.4 mt -85.7 134.48 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.138 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.47 -92.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 10.0 p -131.97 -2.41 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -134.02 161.49 34.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -88.65 142.88 27.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.763 HG11 HD12 ' A' ' 992' ' ' ILE . 3.0 m -104.43 151.04 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -115.73 129.9 56.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.657 ' HB2' HG13 ' A' ' 984' ' ' VAL . 80.1 mt -112.24 131.5 55.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.0 t -123.98 148.87 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 981' ' ' THR . 16.3 mt -91.1 129.58 37.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . 0.404 ' HA3' ' NZ ' ' A' ' 922' ' ' LYS . . . -61.92 -47.21 91.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.456 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 31.7 t -115.59 126.84 54.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.918 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 127.22 -163.23 21.12 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -50.64 0.18 OUTLIER 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.335 0.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' 1007 ' ' SER . 36.8 m -92.45 89.9 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.824 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' 1006 ' ' SER . 75.7 p 34.52 44.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 5.0 t -140.6 131.29 25.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.902 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 17.9 m -112.06 139.01 47.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -110.35 94.89 0.82 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 1.5 p -98.02 41.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.837 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.3 t -168.28 115.73 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -114.81 113.71 3.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -97.51 -38.8 9.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.335 . . . . 0.0 111.151 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 15.5 m -165.34 107.78 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 58.4 p -60.74 125.27 23.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 60.68 135.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -121.18 140.85 31.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.534 0.683 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 88.4 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.44 26.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 54.0 Cg_endo -69.73 171.55 14.22 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 57.2 m -95.03 121.44 36.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.7 mm -92.25 128.33 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 77.6 mt -105.03 148.35 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -115.46 121.58 43.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 999' ' ' LEU . 18.1 t -105.66 129.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.482 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.4 tm0? -134.38 170.24 16.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.21 50.12 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.676 ' HG3' HG12 ' A' ' 997' ' ' VAL . 8.6 mtm -116.79 128.28 26.13 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.614 0.721 . . . . 0.0 110.855 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 174.42 9.52 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.41 -37.89 86.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -50.96 -30.57 15.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.669 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.0 t -52.24 125.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.9 m -131.28 171.54 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.79 -42.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.113 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.1 -45.77 90.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.38 -43.34 97.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.98 -49.98 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.76 -41.5 86.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.98 -31.46 66.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.674 ' CD2' HD11 ' A' ' 992' ' ' ILE . 5.4 t80 -66.08 -35.19 79.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.842 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.12 11.31 23.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -48.36 149.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 93.25 -39.93 2.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 983' ' ' ALA . 89.6 m-85 -95.33 141.17 29.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -71.77 100.2 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.4 t -95.9 124.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.478 HD12 ' CB ' ' A' ' 973' ' ' ALA . 87.3 mt -52.75 131.11 47.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.639 0.733 . . . . 0.0 111.115 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.11 18.78 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.374 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.49 -7.21 77.32 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.458 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.6 p -68.01 -55.44 12.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 955' ' ' SER . 88.1 t -35.63 112.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 27.5 m -124.07 119.2 28.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 40.8 mt -87.21 132.31 33.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -93.32 137.69 32.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 66.2 m-85 -125.87 -178.62 4.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 964' ' ' GLY . 0.3 OUTLIER -121.47 177.78 5.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -40.68 -53.15 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -64.57 -27.7 69.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 111.03 -21.75 22.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 37.7 mmt -54.53 152.98 11.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.54 0.686 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 134.65 28.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.342 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 35.5 p -97.42 25.98 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 52.79 38.06 53.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 9.5 mt-10 -138.31 145.69 41.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.55 151.25 32.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 31.8 mtp -125.11 142.73 51.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 29.2 m -138.68 165.33 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -127.97 150.77 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 36.4 m-85 -131.8 142.96 49.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.45 -34.03 60.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 26.6 t -109.62 124.93 51.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.2 ttp-105 -61.74 -44.01 97.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.24 -37.33 74.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -67.83 -42.46 81.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.63 -49.86 76.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.084 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.3 m -64.75 -43.92 91.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.48 -44.91 95.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 949' ' ' TYR . . . -66.11 -43.64 86.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.056 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 980' ' ' ALA . 91.3 t -60.29 -48.12 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.25 -44.84 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -20.25 61.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 999' ' ' LEU . 47.2 mt -119.91 20.07 12.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.2 t-20 -79.82 127.19 31.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 64.62 41.83 5.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.574 ' O ' HG22 ' A' ' 997' ' ' VAL . 9.1 mmm180 -84.36 131.79 49.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.633 0.73 . . . . 0.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 83.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.702 2.268 . . . . 0.0 112.341 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 997' ' ' VAL . 10.9 mt -82.39 127.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.9 -93.86 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 23.1 p -131.78 -0.26 3.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.886 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -133.67 163.45 29.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -91.79 143.36 26.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.823 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -106.04 151.1 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -113.48 126.07 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.746 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.7 mt -110.93 128.0 55.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 59.5 t -132.9 142.13 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.93 140.84 47.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -84.99 47.29 3.83 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.504 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 37.4 m -67.62 -55.08 14.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . -58.52 -176.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 163.43 81.85 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.662 -1.808 . . . . 0.0 112.366 0.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 70.3 m -143.46 116.53 8.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 3.6 t -84.12 125.07 31.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.457 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 28.8 p -69.69 137.08 51.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 110.838 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.5 m -111.78 163.25 14.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 149.43 -72.1 0.3 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.529 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 80.7 p -52.23 -20.31 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 0.0 110.846 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 11.6 m -105.89 -63.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 114.61 -157.44 14.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -122.22 138.07 54.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 47.0 t -76.12 120.81 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.853 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.6 m -145.02 129.84 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 157.6 -169.97 34.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -64.68 153.36 87.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.583 0.706 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 110.12 2.49 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.69 2.26 . . . . 0.0 112.317 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -121.43 -153.11 8.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.518 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 170.3 16.94 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.649 2.233 . . . . 0.0 112.349 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.4 m -92.13 125.28 36.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 4.5 mm -99.39 126.58 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.581 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.7 mt -105.59 145.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -111.44 133.94 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.59 HG22 ' CD2' ' A' ' 999' ' ' LEU . 21.7 t -116.15 127.97 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.24 170.17 16.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.88 51.74 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.779 ' SD ' HG11 ' A' ' 937' ' ' VAL . 21.6 mtm -118.64 129.84 25.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 0.0 110.876 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.473 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.79 171.43 14.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.703 2.269 . . . . 0.0 112.333 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -63.68 -37.47 87.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 67.0 p -52.07 -34.1 42.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.779 HG11 ' SD ' ' A' ' 933' ' ' MET . 76.2 t -48.54 122.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 4.6 m -130.62 176.15 8.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.9 -41.96 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.147 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.02 -45.9 90.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.56 -45.0 96.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.14 -50.0 82.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.115 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.11 -42.03 84.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.05 -32.33 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.889 ' CD2' HD11 ' A' ' 992' ' ' ILE . 8.5 t80 -66.69 -31.14 71.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . 0.434 ' HB3' HG21 ' A' ' 951' ' ' VAL . 42.1 m-85 -97.0 12.17 33.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -50.51 152.88 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.04 -37.57 3.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 987' ' ' LEU . 57.0 m-85 -96.37 127.83 42.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -60.78 97.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 946' ' ' PHE . 87.4 t -94.68 122.36 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 973' ' ' ALA . 89.7 mt -48.23 130.06 12.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 123.52 10.17 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.682 2.255 . . . . 0.0 112.316 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.5 -2.62 74.16 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.467 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 956' ' ' VAL . 82.0 p -72.33 -53.33 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 955' ' ' SER . 99.3 t -37.04 105.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.26 114.6 22.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 38.1 mt -82.72 137.47 34.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.957 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -95.48 139.28 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.897 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -132.54 161.5 33.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -95.96 -175.7 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -50.48 -51.52 46.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . 0.41 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 37.3 mmtt -56.48 -44.11 80.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 126.88 -4.56 7.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 43.8 mtm -73.38 153.62 90.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 128.34 15.93 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.732 2.288 . . . . 0.0 112.369 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 65.0 p -90.32 37.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.14 40.53 1.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -140.97 146.97 38.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 3.2 mtt -122.62 143.69 49.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.63 160.5 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -122.32 153.8 38.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.058 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 928' ' ' ILE . 32.0 m-85 -134.5 141.14 46.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.821 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.13 -37.41 64.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 19.0 m -108.06 126.12 52.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -61.01 -45.75 93.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -57.39 -38.88 74.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.94 -44.12 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.702 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.35 -48.28 77.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.421 HG23 HD11 ' A' 1001 ' ' LEU . 10.0 m -64.27 -43.37 95.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.43 89.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.91 -39.17 93.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 980' ' ' ALA . 75.4 t -64.63 -49.08 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.45 -46.54 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.02 -23.73 59.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.8 mt -115.47 25.94 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.1 t-20 -91.45 128.57 37.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.93 40.63 15.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 8.2 mtp85 -86.2 133.33 40.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.62 0.724 . . . . 0.0 110.845 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 85.51 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.669 2.246 . . . . 0.0 112.359 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.889 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.8 mt -84.44 125.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.85 -92.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 5.1 m -129.28 -5.76 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -133.08 156.25 47.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -86.42 143.33 27.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.876 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -101.1 151.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -116.26 128.29 55.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.611 ' CB ' HG13 ' A' ' 984' ' ' VAL . 72.3 mt -111.01 138.43 47.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.3 t -133.84 137.14 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 981' ' ' THR . 13.6 mt -73.81 136.36 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -81.39 61.36 4.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 12.0 t -155.15 137.09 14.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.929 0.395 . . . . 0.0 110.89 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 151.07 172.04 19.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.421 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.5 Cg_endo -69.79 123.93 7.22 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.738 -1.776 . . . . 0.0 112.292 0.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 5.3 t -59.31 98.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 58.1 m -115.63 115.73 26.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 913' ' ' SER . 4.5 m 38.95 42.17 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 110.845 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 912' ' ' SER . 33.6 t -35.96 128.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -86.31 167.95 39.92 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.6 t -88.5 131.23 34.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 26.7 p -159.75 174.28 14.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -150.72 104.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -84.58 79.92 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.084 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 54.0 m -120.76 129.56 53.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 7.4 t 71.61 42.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.863 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -68.59 -151.36 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -110.48 142.71 26.64 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 179.16 3.88 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 128.19 167.18 12.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.455 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 171.63 14.04 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.683 2.255 . . . . 0.0 112.391 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 12.0 m -92.77 119.67 32.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.7 mm -97.89 125.15 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.609 ' HB ' HG23 ' A' ' 972' ' ' VAL . 98.3 mt -104.98 143.49 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -111.85 130.58 55.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 999' ' ' LEU . 6.5 t -112.02 131.34 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.471 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.68 167.23 21.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.08 53.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.711 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -121.32 128.91 25.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 0.0 110.849 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 156.49 63.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.324 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -54.29 -33.53 58.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.2 p -53.24 -34.69 58.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.421 HG11 ' SD ' ' A' ' 933' ' ' MET . 88.4 t -46.81 137.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 5.7 m -140.5 175.69 9.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 63.0 mt -61.83 -41.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.145 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.19 -45.82 89.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.08 -38.18 87.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.21 -49.1 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.24 -41.68 84.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -71.72 -30.75 65.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.0 t80 -64.92 -39.06 92.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -87.22 13.17 10.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.66 148.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.909 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 94.73 -44.89 2.19 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 90.7 m-85 -92.01 134.87 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -72.14 84.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.4 t -74.66 123.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.43 129.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 134.11 27.07 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.645 2.23 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 85.19 6.1 84.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 957' ' ' CYS . 81.5 p -87.07 -55.54 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 955' ' ' SER . 48.2 t -35.99 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 955' ' ' SER . 3.0 t -112.62 126.07 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 138.04 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -94.51 123.92 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 92.3 m-85 -111.6 175.08 5.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -104.96 -177.88 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.39 -18.47 28.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -35.97 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 120.08 -15.13 10.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 77.9 mmm -69.2 155.73 92.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 137.73 36.26 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.382 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -100.38 0.27 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 81.73 31.52 32.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.471 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 12.4 mt-10 -128.98 146.88 50.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.422 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.91 142.2 23.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 28.4 mtp -120.97 142.89 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.609 HG23 ' HB ' ' A' ' 928' ' ' ILE . 4.1 m -137.45 166.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.55 150.1 51.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -129.95 157.21 42.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -82.31 -42.95 18.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 20.4 m -117.44 139.07 51.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 20.1 mtp85 -61.29 -36.6 80.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -58.08 -43.44 87.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.11 -45.14 78.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -61.49 -48.72 79.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.613 HG23 HD11 ' A' 1001 ' ' LEU . 6.8 m -62.36 -43.98 97.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.98 -46.78 89.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -60.59 -40.93 93.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 980' ' ' ALA . 86.5 t -64.76 -50.23 76.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.25 -45.03 99.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -22.29 59.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.844 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.9 mt -119.86 29.18 7.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.959 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.0 OUTLIER -89.96 128.61 36.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 61.71 43.09 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.7 mmp_? -85.78 131.63 46.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.588 0.709 . . . . 0.0 110.885 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.99 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.745 2.296 . . . . 0.0 112.315 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.902 HD12 HG11 ' A' ' 997' ' ' VAL . 16.1 mt -81.26 126.91 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.58 -92.56 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.466 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 17.2 t -132.82 -1.13 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -132.76 163.48 28.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -92.53 141.0 28.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.902 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -102.6 151.08 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.57 128.17 55.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -111.16 131.08 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.921 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 57.6 t -124.79 143.03 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.613 HD11 HG23 ' A' ' 981' ' ' THR . 19.4 mt -82.36 134.82 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -60.82 -124.27 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 7.9 t -48.78 177.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.945 0.402 . . . . 0.0 110.883 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' 1005 ' ' PRO . . . 76.79 79.94 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' 1004 ' ' GLY . 53.3 Cg_endo -69.84 161.07 87.16 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.349 0.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 80.1 p -86.73 -175.26 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 9.0 t -139.14 179.7 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 65.7 m -127.85 138.74 52.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 33.6 m -63.41 115.58 4.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 174.02 69.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 66.8 m -48.73 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 4.6 t -71.48 136.67 47.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 153.68 66.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -43.91 130.97 5.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 4.4 m -82.36 45.67 0.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.805 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 4.8 m -57.35 160.75 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -159.24 156.8 27.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.497 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 143.71 63.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.598 0.713 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 114.25 3.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.347 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 154.21 -151.28 22.99 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . 0.487 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.5 Cg_endo -69.83 169.03 19.96 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 50.7 m -101.13 132.99 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 30.3 mm -100.6 128.0 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 984' ' ' VAL . 75.7 mt -108.55 145.61 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -114.76 131.48 56.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 999' ' ' LEU . 61.9 t -113.29 126.92 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.116 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 167.21 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.07 50.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.618 ' CG ' HG12 ' A' ' 997' ' ' VAL . 23.8 mtm -119.3 130.59 24.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 0.0 110.893 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 158.49 56.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -56.63 -33.46 66.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 47.8 p -53.11 -32.39 47.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.554 HG11 ' SD ' ' A' ' 933' ' ' MET . 94.2 t -49.71 140.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 72.7 m -145.93 172.96 12.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.81 -42.01 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.12 -46.05 89.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.823 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -65.61 -45.27 83.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . 0.482 ' CD1' HD21 ' A' ' 958' ' ' LEU . 38.5 mt -61.01 -48.48 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.4 mt -58.45 -42.02 86.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.55 -31.2 66.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.804 ' CD2' HD11 ' A' ' 992' ' ' ILE . 2.9 t80 -65.02 -41.24 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -81.41 7.7 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -41.28 149.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 92.32 -40.62 2.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 92.2 m-85 -97.25 130.91 44.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -69.58 92.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 96.5 t -78.04 125.68 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 953' ' ' PRO . 75.9 mt -54.18 133.83 60.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.614 0.721 . . . . 0.0 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 952' ' ' ILE . 54.1 Cg_endo -69.75 147.17 62.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.356 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.33 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.438 ' OG ' HG22 ' A' ' 952' ' ' ILE . 2.2 m -93.37 -56.21 3.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.87 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 52.9 t -40.0 97.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.99 129.17 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 942' ' ' ILE . 45.1 mt -94.84 139.21 31.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -93.5 131.58 38.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -115.09 160.22 19.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.0 OUTLIER -99.68 -176.41 3.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.33 -47.43 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.33 -24.77 66.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . 0.582 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 117.08 -28.67 7.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.469 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 7.5 ptp -57.82 153.64 31.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.616 0.722 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.44 17.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.704 2.269 . . . . 0.0 112.358 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 38.8 p -83.97 26.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 56.35 33.04 61.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -129.11 147.96 51.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.69 147.08 26.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.5 mtt -123.0 141.82 51.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 18.9 m -139.3 164.68 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.49 49.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 925' ' ' PRO . 23.1 m-85 -128.2 148.09 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.16 -35.99 61.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 9.4 t -115.82 134.61 54.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . 0.424 ' NH2' ' HB3' ' A' 1005 ' ' PRO . 52.6 ttp85 -61.26 -39.91 92.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.94 -41.68 98.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -62.67 -45.17 94.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.764 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.03 -49.36 77.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.942 HG23 HD11 ' A' 1001 ' ' LEU . 5.9 m -62.75 -44.0 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.92 92.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -62.59 -38.06 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 980' ' ' ALA . 84.9 t -66.04 -49.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 32.9 mt -60.95 -47.61 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.93 -21.55 61.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.587 ' O ' HD12 ' A' ' 999' ' ' LEU . 8.2 mt -119.37 27.23 8.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.0 t-20 -90.92 129.65 36.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 60.48 41.46 15.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.558 ' O ' HG22 ' A' ' 997' ' ' VAL . 18.0 mtp180 -84.13 130.89 52.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.617 0.722 . . . . 0.0 110.826 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 84.46 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.943 HD12 HG11 ' A' ' 997' ' ' VAL . 9.0 mt -84.39 130.66 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.171 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.52 -94.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 12.8 t -129.35 -0.87 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -133.96 163.67 29.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -93.07 143.28 26.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.943 HG11 HD12 ' A' ' 992' ' ' ILE . 3.8 m -101.89 149.89 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.125 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.26 127.1 54.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 930' ' ' VAL . 78.9 mt -111.73 131.08 55.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.858 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 47.2 t -120.67 140.82 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 981' ' ' THR . 13.4 mt -81.22 122.89 27.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -46.79 -81.96 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.507 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 67.7 m -149.13 163.41 37.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.94 0.4 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 150.89 178.01 25.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.459 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.424 ' HB3' ' NH2' ' A' ' 977' ' ' ARG . 53.8 Cg_endo -69.76 158.17 91.29 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.362 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 30.2 t -72.24 110.7 6.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 19.3 m -83.87 -59.0 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.837 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 4.0 m -116.13 99.06 6.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.911 0.386 . . . . 0.0 110.888 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.5 t -58.05 149.99 22.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 75.52 157.93 6.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 52.1 m -120.18 -56.89 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 110.887 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 87.2 p -46.42 111.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -179.91 159.89 24.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -113.42 137.8 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 7.8 t -82.47 99.81 9.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.859 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 43.3 t -94.06 93.93 8.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -66.52 123.37 22.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -161.79 139.81 6.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.554 0.692 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 174.11 9.98 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 146.15 178.95 21.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . 0.439 ' CB ' ' O ' ' A' ' 974' ' ' PHE . 53.6 Cg_endo -69.76 169.58 18.57 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.354 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.4 m -94.28 117.13 29.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.35 125.27 44.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.8 mt -105.18 147.95 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.14 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -111.29 131.39 55.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.54 125.03 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 171.27 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.7 47.76 4.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.513 ' SD ' HG11 ' A' ' 937' ' ' VAL . 18.3 mtm -111.47 125.75 29.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.557 0.694 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 159.38 53.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.664 2.243 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -56.9 -32.94 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.4 p -55.04 -30.94 60.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.513 HG11 ' SD ' ' A' ' 933' ' ' MET . 75.3 t -48.31 145.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 33.4 m -153.64 173.19 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.92 -42.16 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -46.06 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -65.61 -46.13 80.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.02 -46.27 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 12.6 mt -57.97 -41.92 83.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.91 -34.21 68.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.931 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.9 t80 -61.81 -37.15 83.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.17 23.58 6.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -60.61 161.23 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 80.69 -41.89 2.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 79.6 m-85 -85.25 135.52 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.89 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -65.59 83.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.64 119.85 27.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 953' ' ' PRO . 95.3 mt -48.64 132.14 13.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.613 0.721 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.8 Cg_endo -69.76 111.62 2.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 0.0 112.357 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.81 31.72 9.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.466 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 956' ' ' VAL . 81.0 p -103.58 -53.86 2.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 955' ' ' SER . 86.7 t -34.62 114.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 8.5 t -119.93 112.7 19.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 44.5 mt -81.85 131.59 35.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -95.48 138.69 32.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.7 171.87 11.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.442 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.7 OUTLIER -100.19 -179.07 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 963' ' ' LYS . 17.1 pt-20 -50.81 -47.1 60.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 962' ' ' GLU . 0.0 OUTLIER -63.51 -43.53 96.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . 0.442 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.91 -27.34 3.19 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.476 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.23 158.43 1.89 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 0.0 110.854 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 137.55 35.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.331 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 968' ' ' GLY . 82.5 p -100.76 37.47 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 967' ' ' THR . . . 37.07 39.14 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.48 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -141.79 145.59 34.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.94 148.56 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 4.0 mtt -119.0 143.18 47.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 23.8 m -135.39 160.53 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.39 147.15 47.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.469 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -129.14 137.71 51.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.66 -34.02 64.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . 0.404 ' HB2' ' CD ' ' A' ' 979' ' ' GLU . 1.8 m -108.81 130.99 55.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -61.77 -48.91 78.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -56.91 -39.17 73.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . 0.404 ' CD ' ' HB2' ' A' ' 976' ' ' SER . 20.4 mt-10 -63.32 -44.44 94.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.88 -50.02 73.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.635 HG22 HD11 ' A' ' 985' ' ' ILE . 24.3 m -64.51 -43.41 94.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.14 93.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -63.68 -41.91 98.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 999' ' ' LEU . 84.1 t -66.28 -49.76 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 981' ' ' THR . 41.7 mt -58.66 -46.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.66 -30.31 61.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 999' ' ' LEU . 12.5 mt -109.5 28.87 8.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -89.48 133.57 34.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 22.9 t70 54.37 43.44 30.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -87.85 130.16 47.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.887 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 94.61 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.931 HD11 ' CD2' ' A' ' 945' ' ' PHE . 15.7 mt -92.59 124.47 45.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.08 -90.53 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 9.5 t -131.34 -3.38 3.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.809 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -134.11 154.3 51.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -88.82 140.54 29.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.798 HG11 HD12 ' A' ' 992' ' ' ILE . 4.9 m -100.1 150.28 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.0 129.42 56.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.711 ' HB2' HG13 ' A' ' 984' ' ' VAL . 81.7 mt -110.93 128.66 55.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 89.3 t -123.39 137.93 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 981' ' ' THR . 11.9 mt -71.55 134.27 46.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -57.94 -166.77 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 21.8 t -108.97 127.59 54.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.832 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 70.35 -162.74 53.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 135.47 33.85 Favored 'Cis proline' 0 C--O 1.231 0.141 0 C-N-CA 122.717 -1.785 . . . . 0.0 112.364 0.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 72.9 p -45.47 130.01 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 13.6 t -64.06 136.13 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.454 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 21.4 m -147.83 157.11 43.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 110.859 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 41.3 p -54.55 -46.81 73.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 153.44 -162.66 30.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 92.0 p -155.11 169.51 23.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.841 0.353 . . . . 0.0 110.868 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.9 t -105.77 142.42 35.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 61.0 -162.79 22.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -94.72 102.74 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 13.6 p -48.05 151.17 1.01 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.1 m -140.75 131.48 25.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -139.37 -161.59 8.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -147.22 146.94 27.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.6 0.714 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -176.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.659 2.239 . . . . 0.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 106.65 -145.64 15.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 175.73 7.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.272 . . . . 0.0 112.366 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 29.9 m -91.93 125.78 36.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.129 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 41.6 mm -101.52 127.86 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.568 HD12 ' CE1' ' A' ' 974' ' ' PHE . 65.7 mt -107.33 146.46 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . 0.401 ' NZ ' ' HA2' ' A' 1002 ' ' GLY . 2.9 mppt? -113.5 130.09 56.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 999' ' ' LEU . 19.8 t -115.64 127.23 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.434 ' HG3' ' CG ' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -131.71 172.48 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 49.23 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.706 ' HG3' HG12 ' A' ' 997' ' ' VAL . 16.7 mtm -114.44 129.2 25.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 167.52 24.25 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -65.69 -25.0 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 64.8 p -63.88 -21.78 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.552 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.3 t -60.48 139.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 17.0 m -144.41 177.81 8.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.03 -42.17 92.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -63.29 -46.05 88.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.47 -45.29 93.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 24.1 mt -60.98 -49.64 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.03 -42.0 89.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -72.07 -31.18 65.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 38.6 t80 -65.25 -38.43 90.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -87.91 10.96 17.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -47.03 145.58 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 99.07 -32.51 7.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.477 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 87.5 m-85 -103.57 143.78 32.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 0.0 110.883 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.12 87.03 1.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 86.8 t -77.46 127.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 953' ' ' PRO . 63.7 mt -55.48 132.71 70.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.629 0.728 . . . . 0.0 111.163 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.77 132.74 23.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.674 2.249 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 76.46 8.12 85.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 956' ' ' VAL . 24.6 p -82.16 -60.39 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 0.0 110.824 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 972' ' ' VAL . 98.0 t -34.79 112.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 13.5 m -124.43 125.49 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 51.6 mt -88.9 146.57 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -100.26 135.76 41.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -128.74 160.67 31.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 965' ' ' MET . 49.4 p-10 -98.81 -177.05 3.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -51.93 -41.39 61.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -67.1 -33.67 75.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 113.16 -1.32 25.43 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.463 ' HG2' ' ND2' ' A' ' 961' ' ' ASN . 8.7 ptp -80.1 151.96 73.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 133.34 25.37 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 17.7 p -95.45 22.23 7.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.88 38.87 93.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 931' ' ' GLN . 8.1 mt-10 -138.7 145.46 40.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -147.88 145.66 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 40.8 mtp -119.45 138.7 52.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.863 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 956' ' ' VAL . 28.1 m -135.1 163.29 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -125.06 155.14 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.568 ' CE1' HD12 ' A' ' 928' ' ' ILE . 24.1 m-85 -133.18 144.71 50.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.43 -34.92 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.911 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.4 t -115.85 131.62 56.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.855 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -63.23 -38.13 89.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.9 -41.43 96.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.51 -46.79 78.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.78 -48.22 70.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.556 HG22 HD11 ' A' ' 985' ' ' ILE . 19.6 m -64.87 -43.65 92.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.96 94.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.72 -40.01 88.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 980' ' ' ALA . 81.4 t -66.03 -48.57 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.556 HD11 HG22 ' A' ' 981' ' ' THR . 37.0 mt -62.04 -44.55 99.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.5 -26.42 59.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.678 ' O ' HD12 ' A' ' 999' ' ' LEU . 15.1 mt -115.34 27.39 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.86 127.9 35.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.5 t70 61.0 41.74 13.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 997' ' ' VAL . 15.3 mtp85 -87.17 134.63 36.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.72 . . . . 0.0 110.892 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 85.64 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.722 2.281 . . . . 0.0 112.321 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 7.5 mt -83.69 128.85 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 58.03 -92.97 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.5 t -131.6 -2.74 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -133.73 158.52 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -85.91 143.88 27.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 0.2 OUTLIER -104.98 151.03 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . 0.41 ' HE2' HG22 ' A' 1000 ' ' VAL . 0.8 OUTLIER -114.22 125.12 53.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.2 mt -111.04 132.32 54.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 998' ' ' LYS . 23.3 t -128.14 143.34 41.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 981' ' ' THR . 13.5 mt -78.67 134.38 37.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 929' ' ' LYS . . . -52.97 126.19 32.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.514 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 20.8 t -87.33 97.0 10.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 160.62 176.07 32.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 169.52 63.21 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.349 0.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 15.8 t -105.57 96.75 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 5.4 t -101.76 94.34 5.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.565 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 67.5 m -95.39 103.85 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 0.0 110.825 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 97.2 p -98.67 110.42 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 70.85 -131.15 20.79 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 39.4 p -169.74 175.95 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.823 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 48.4 t -49.6 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -44.55 123.47 5.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -132.03 129.34 39.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 10.0 t -130.76 141.97 50.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.7 p -97.2 65.53 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -178.62 137.27 3.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -57.32 144.26 71.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.586 0.708 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 167.14 25.24 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.366 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -117.35 -170.27 15.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.18 25.24 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.679 2.253 . . . . 0.0 112.314 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 5.1 m -98.31 119.52 37.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.651 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 49.9 mm -91.36 129.19 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.645 HD11 ' HB1' ' A' ' 980' ' ' ALA . 95.8 mt -104.99 148.97 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -112.23 125.71 54.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 9.6 t -109.44 128.11 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.473 ' NE2' ' HG2' ' A' ' 969' ' ' GLU . 0.0 OUTLIER -135.54 170.19 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.01 47.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.631 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.9 mtm -114.12 130.7 23.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.565 0.697 . . . . 0.0 110.895 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.452 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.5 Cg_endo -69.77 170.19 17.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -68.91 -28.8 66.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 69.7 p -59.46 -30.12 68.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.141 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 938' ' ' SER . 94.1 t -47.16 155.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 937' ' ' VAL . 10.0 m -162.32 170.96 18.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.26 -41.84 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.89 -45.54 92.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.13 -39.32 92.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.77 -49.48 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.01 -41.56 83.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -72.01 -31.07 65.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.724 ' CD2' HD11 ' A' ' 992' ' ' ILE . 25.8 t80 -65.05 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.02 14.61 13.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -49.54 148.35 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.52 -39.52 2.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 67.1 m-85 -94.37 150.54 20.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.961 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -82.17 90.04 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.94 126.61 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 78.2 mt -56.28 129.73 74.55 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 125.05 11.68 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 0.0 112.343 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 92.25 -6.99 78.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 4.0 p -70.39 -51.5 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 110.796 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 69.1 t -41.23 109.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.18 118.95 31.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.94 146.74 26.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 18.2 tptm -97.36 138.14 35.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.93 163.91 29.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -108.39 172.38 6.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -34.41 8.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -69.12 -31.7 70.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 103.62 16.64 19.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 4.9 mmt -101.43 154.69 37.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.585 0.707 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.1 41.91 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.369 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 25.1 p -106.83 27.78 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 51.39 37.24 39.41 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.473 ' HG2' ' NE2' ' A' ' 931' ' ' GLN . 11.9 mt-10 -137.48 144.97 42.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.913 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -149.97 152.53 35.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 12.2 mtm -126.18 142.41 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.8 163.96 31.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -128.34 153.88 46.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.125 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 928' ' ' ILE . 33.5 m-85 -134.29 143.17 47.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -68.75 -34.61 75.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -120.73 129.07 53.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 978' ' ' ASP . 1.4 ptp180 -61.87 -29.75 70.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 977' ' ' ARG . 7.3 m-20 -66.23 -41.5 89.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.99 -44.45 76.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 928' ' ' ILE . . . -57.16 -47.85 80.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.2 m -64.42 -43.58 93.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.46 95.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.12 -38.91 86.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 999' ' ' LEU . 79.8 t -64.75 -49.32 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.082 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.78 -43.45 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.67 -23.29 58.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.534 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 14.0 mt -116.42 21.46 13.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 984' ' ' VAL . 1.8 t-20 -80.25 144.26 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 988' ' ' ASN . 3.2 p30 49.98 39.53 19.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.509 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.6 mmp_? -84.16 127.58 66.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 86.93 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.394 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.864 HD12 HG11 ' A' ' 997' ' ' VAL . 10.5 mt -85.14 125.1 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.5 -93.98 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 49.6 p -130.04 -2.3 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -133.05 164.06 27.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -93.39 142.9 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.864 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -102.37 151.07 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -115.21 125.21 53.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.837 ' HB2' HG13 ' A' ' 984' ' ' VAL . 70.0 mt -111.29 128.21 55.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 58.0 t -133.72 141.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.7 134.45 49.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -47.33 119.5 4.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 1.4 t -86.5 32.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 0.0 110.879 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 103.18 173.81 26.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.473 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' 1006 ' ' SER . 53.6 Cg_endo -69.72 123.5 6.84 Favored 'Cis proline' 0 C--N 1.342 0.211 0 C-N-CA 122.684 -1.798 . . . . 0.0 112.312 0.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' 1005 ' ' PRO . 45.3 t -34.61 -58.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' 1008 ' ' GLY . 60.3 p -76.94 152.83 35.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' 1007 ' ' SER . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 95.9 p -116.14 137.94 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 10.2 t -105.99 117.71 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -100.67 159.64 19.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 89.9 p -92.95 108.9 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 58.8 m -90.8 96.43 10.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -176.74 58.48 0.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.464 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -120.86 84.62 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.807 0.336 . . . . 0.0 111.13 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 53.0 m -117.05 175.45 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 30.2 t -57.63 137.63 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -119.95 169.16 13.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -106.62 156.16 37.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.617 0.722 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 127.71 15.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 160.47 -155.66 26.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 170.68 16.03 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 17.3 m -92.0 121.93 34.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 42.9 mm -95.49 129.01 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 984' ' ' VAL . 53.5 mt -104.98 148.8 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -113.43 129.48 56.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.569 HG22 HD23 ' A' ' 999' ' ' LEU . 21.8 t -111.74 133.58 56.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.125 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 173.49 11.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.99 51.43 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.685 ' HG3' HG12 ' A' ' 997' ' ' VAL . 6.1 mtm -118.8 128.38 26.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 161.14 47.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.307 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -57.87 -31.79 67.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 82.2 p -55.8 -33.9 64.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 933' ' ' MET . 93.4 t -47.32 135.7 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 7.1 m -138.48 171.76 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 50.6 mt -58.77 -42.08 84.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.151 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -63.1 -46.05 89.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -62.39 -41.86 98.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 25.2 mt -62.47 -48.79 86.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.14 -41.94 84.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -71.93 -30.38 65.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.79 ' CD2' HD11 ' A' ' 992' ' ' ILE . 7.9 t80 -64.79 -39.65 93.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -87.62 13.29 10.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -48.05 147.78 1.99 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 97.58 -43.92 1.91 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 91.1 m-85 -91.39 159.29 16.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.349 . . . . 0.0 110.95 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -91.54 90.74 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.49 131.35 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.0 129.59 86.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 129.14 17.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.714 2.276 . . . . 0.0 112.295 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.03 -9.61 77.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 24.4 p -70.36 -49.73 46.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 110.825 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 99.4 t -40.41 104.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.154 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 1.8 t -120.8 117.47 27.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.82 136.2 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 121.47 40.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -107.1 175.74 5.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -95.46 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -44.41 -39.28 4.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . 0.444 ' CE ' ' HA ' ' A' ' 963' ' ' LYS . 0.3 OUTLIER -77.4 -36.64 53.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 132.63 -1.84 4.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.448 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.19 146.3 70.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 136.75 33.73 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.318 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 81.0 p -101.65 -0.08 35.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 72.2 38.22 59.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.44 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -132.4 146.33 51.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.421 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -146.89 149.95 34.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 22.2 mtp -123.07 143.6 49.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.0 m -141.46 160.78 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.618 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -124.17 148.93 46.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 928' ' ' ILE . 39.2 m-85 -131.29 141.5 49.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.94 -32.43 57.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 15.7 t -114.92 130.54 56.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -63.27 -41.54 99.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.26 -38.81 81.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.96 -43.53 78.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -59.42 -50.01 75.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.632 HG22 ' CD1' ' A' ' 985' ' ' ILE . 19.7 m -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.54 97.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.15 -42.75 96.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.091 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.723 HG13 ' CB ' ' A' ' 999' ' ' LEU . 95.8 t -66.14 -48.91 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.632 ' CD1' HG22 ' A' ' 981' ' ' THR . 54.6 mt -60.18 -44.97 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 -29.24 61.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 999' ' ' LEU . 3.8 mt -113.55 30.73 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -87.8 131.98 34.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 55.77 43.53 27.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 997' ' ' VAL . 20.2 mtp85 -86.69 134.1 38.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.611 0.72 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 83.93 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.689 2.26 . . . . 0.0 112.363 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.79 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.74 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.165 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.19 -92.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.1 p -132.45 -1.8 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -133.63 161.9 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -90.47 139.54 30.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.76 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -100.73 151.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.109 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -114.46 126.26 54.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.723 ' CB ' HG13 ' A' ' 984' ' ' VAL . 69.5 mt -111.17 131.83 54.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 97.4 t -130.94 137.44 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.35 132.4 43.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -45.93 -74.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.479 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 4.4 m -105.81 117.85 35.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' 1005 ' ' PRO . . . -118.0 -76.46 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.443 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.463 ' C ' ' HA3' ' A' 1004 ' ' GLY . 53.4 Cg_endo -69.84 140.09 58.7 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 0.0 112.346 0.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 45.5 t -84.19 140.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 52.7 p -159.53 170.78 20.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 41.1 t -77.89 -50.64 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.1 t -75.01 143.32 43.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 134.93 65.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 58.3 m -47.32 116.59 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 18.4 m -61.32 162.19 8.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 101.37 77.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.464 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -93.08 79.82 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 0.0 111.072 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.9 t -92.98 140.47 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 16.1 t -108.87 -64.81 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . 112.12 -48.75 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -65.41 143.81 98.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.539 0.685 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -172.22 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.333 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 115.78 -156.68 15.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.523 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 170.82 15.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 0.0 112.337 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 93.3 m -92.39 118.92 31.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 973' ' ' ALA . 6.5 mm -90.97 130.03 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 93.6 mt -104.99 148.34 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -112.66 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.6 HG22 HD23 ' A' ' 999' ' ' LEU . 59.9 t -110.77 124.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.0 OUTLIER -128.06 166.58 18.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . 0.521 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.1 OUTLIER 67.15 52.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.474 ' HG3' HG12 ' A' ' 997' ' ' VAL . 3.0 mtm -115.85 125.24 28.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.539 0.685 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.2 Cg_endo -69.81 168.46 21.55 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.684 2.256 . . . . 0.0 112.307 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -61.94 -39.64 92.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 60.9 p -49.09 -30.32 6.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.447 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.5 t -52.19 145.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 15.1 m -151.68 179.26 8.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.34 -41.98 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.173 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -63.04 -45.98 89.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.04 -42.17 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 48.6 mt -61.25 -47.63 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.02 -41.77 88.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.7 -30.9 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.607 ' CD2' HD11 ' A' ' 992' ' ' ILE . 55.5 t80 -64.93 -39.15 93.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -88.95 12.92 14.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -48.77 147.64 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.3 -33.3 5.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 65.0 m-85 -102.56 143.37 32.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -74.97 94.04 2.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.66 122.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 52.9 mt -51.47 130.19 34.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.591 0.71 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 126.78 13.73 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.701 2.268 . . . . 0.0 112.327 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 91.05 -6.03 81.66 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 52.1 p -72.87 -51.62 17.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.835 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 78.1 t -38.39 110.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.126 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 19.8 m -125.34 125.76 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 46.9 mt -97.14 140.08 32.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.73 131.0 45.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -119.87 169.08 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 964' ' ' GLY . 0.8 OUTLIER -96.35 -177.38 3.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.91 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.93 -49.94 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . 0.424 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 27.0 mtmt -58.48 -43.97 89.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 961' ' ' ASN . . . 134.86 -21.93 3.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.542 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 5.7 mtp -59.9 157.96 27.41 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 145.57 57.59 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 20.8 p -105.23 34.99 2.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 40.6 44.37 3.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -147.86 146.7 29.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.45 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.24 152.84 35.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 15.7 mtm -126.28 142.37 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' A' ' 928' ' ' ILE . 3.1 m -135.44 163.91 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.117 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 927' ' ' ILE . . . -124.32 148.2 47.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.121 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.4 m-85 -127.83 137.52 52.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.42 -38.52 71.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -108.72 128.07 54.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -60.96 -40.99 95.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -67.44 -44.61 78.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.842 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.64 -49.95 73.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 9.8 m -65.06 -44.02 90.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.56 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -68.07 -41.3 82.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 980' ' ' ALA . 92.8 t -62.43 -48.98 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.169 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.6 -46.46 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.88 -21.21 60.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 20.0 mt -116.19 21.48 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.7 t-20 -83.27 135.71 34.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 54.89 43.82 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.8 mmp_? -86.69 130.2 49.82 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.834 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 81.42 0.82 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.753 HD12 HG11 ' A' ' 997' ' ' VAL . 8.8 mt -79.93 131.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.7 -92.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 7.1 t -131.07 -3.67 3.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -134.07 156.22 48.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -84.97 143.9 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.753 HG11 HD12 ' A' ' 992' ' ' ILE . 2.8 m -105.32 151.07 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -113.16 128.58 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.711 ' CB ' HG13 ' A' ' 984' ' ' VAL . 78.7 mt -110.91 130.54 55.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 25.1 t -128.58 140.98 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.94 121.29 26.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -45.05 -48.11 9.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 47.7 t -134.88 114.93 13.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.848 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 127.68 -162.79 21.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.442 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -41.93 0.83 Allowed 'Cis proline' 0 C--N 1.341 0.149 0 C-N-CA 122.716 -1.785 . . . . 0.0 112.323 0.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' 1007 ' ' SER . 3.6 m 62.89 25.35 15.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' 1006 ' ' SER . 91.9 p -37.06 113.98 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.846 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.53 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 912' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 911' ' ' GLY . 60.1 p -34.86 138.06 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 110.83 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.0 m -52.11 160.46 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -78.53 116.96 4.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 87.9 p -72.0 108.09 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.876 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 72.0 p -86.32 34.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -162.48 -134.61 1.67 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -165.28 169.92 15.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 0.0 111.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 3.2 m -116.81 149.9 39.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.834 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 68.2 m -69.23 131.89 45.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.851 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -101.41 172.7 23.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -138.71 146.4 50.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -167.43 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 91.79 -156.99 24.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 169.85 17.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.658 2.239 . . . . 0.0 112.336 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 90.8 m -92.12 127.53 37.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.1 125.97 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 974' ' ' PHE . 98.4 mt -105.29 147.0 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -112.02 127.69 55.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.604 HG22 ' CD2' ' A' ' 999' ' ' LEU . 14.9 t -111.85 123.5 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.446 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.3 tm0? -127.61 173.34 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.48 53.87 2.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.589 ' HG3' HG12 ' A' ' 997' ' ' VAL . 10.2 mtm -119.47 125.75 27.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.415 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.2 Cg_endo -69.73 166.03 28.94 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.357 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -61.85 -35.14 77.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 80.4 p -53.75 -23.35 11.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.15 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.477 HG11 ' SD ' ' A' ' 933' ' ' MET . 73.3 t -60.04 139.69 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 23.0 m -140.04 173.36 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.12 -41.96 91.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -63.13 -45.45 91.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.814 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.68 -42.04 98.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 32.9 mt -62.27 -49.33 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.13 -40.85 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.01 -31.32 66.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.794 ' CD2' HD11 ' A' ' 992' ' ' ILE . 3.5 t80 -65.51 -36.97 85.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -89.71 12.47 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -46.9 155.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 87.64 -42.47 3.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 69.9 m-85 -92.57 147.14 23.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -79.91 100.53 8.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.6 t -93.93 130.88 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.43 HG23 ' HD2' ' A' ' 953' ' ' PRO . 46.7 mt -59.33 132.34 87.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.137 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.9 Cg_endo -69.79 128.03 15.42 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.664 2.243 . . . . 0.0 112.322 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.97 -9.54 76.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 12.7 p -66.18 -56.09 13.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 972' ' ' VAL . 93.8 t -40.45 109.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 2.1 m -122.28 116.27 23.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 45.3 mt -82.71 132.24 35.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.66 136.96 33.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -117.48 180.0 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -114.77 -177.85 3.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.32 -32.17 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -77.19 -33.58 56.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 118.9 -7.85 12.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.7 mtt -79.16 156.97 76.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 134.09 27.09 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 27.3 p -95.25 35.55 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 46.35 30.22 4.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.519 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.446 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.6 mt-10 -128.85 145.19 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.909 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.97 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 60.9 mtp -121.62 141.0 51.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.504 HG12 HG22 ' A' ' 956' ' ' VAL . 15.5 m -135.89 164.35 32.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.39 146.83 50.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.571 ' CE1' HD12 ' A' ' 928' ' ' ILE . 26.8 m-85 -127.48 137.29 52.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.94 -35.7 74.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . 0.457 ' CB ' ' CD ' ' A' ' 979' ' ' GLU . 4.1 m -109.62 130.65 55.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.848 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -63.69 -48.46 77.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.04 -36.99 71.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . 0.457 ' CD ' ' CB ' ' A' ' 976' ' ' SER . 1.0 OUTLIER -64.24 -50.11 69.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -53.7 -46.0 70.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.464 HG23 HD11 ' A' 1001 ' ' LEU . 4.8 m -63.91 -42.41 97.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.177 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.66 94.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -67.45 -38.48 84.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 999' ' ' LEU . 69.6 t -68.32 -48.92 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.05 -44.89 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 -30.45 63.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.536 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 4.8 mt -109.72 23.79 13.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -83.2 136.0 34.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 53.22 42.73 32.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 997' ' ' VAL . 12.4 mtt-85 -85.19 133.67 42.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.647 0.737 . . . . 0.0 110.826 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 87.29 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.836 HD12 HG11 ' A' ' 997' ' ' VAL . 7.7 mt -87.78 130.93 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.23 -92.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 6.3 p -131.14 -3.66 3.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.831 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 -134.11 158.6 43.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -88.05 138.36 31.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 992' ' ' ILE . 2.4 m -95.8 150.47 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -112.7 125.63 54.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.706 ' CB ' HG13 ' A' ' 984' ' ' VAL . 80.0 mt -111.21 130.02 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.852 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 62.6 t -126.63 147.49 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.464 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -80.06 137.03 36.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -53.28 117.53 7.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 31.0 t -58.14 108.03 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.462 ' HA3' ' C ' ' A' 1005 ' ' PRO . . . -99.64 -74.62 1.13 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.478 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.462 ' C ' ' HA3' ' A' 1004 ' ' GLY . 54.0 Cg_endo -69.72 -28.13 6.42 Favored 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.385 -0.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 86.1 p -173.09 174.17 3.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 6.0 t -59.31 96.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 68.6 m -59.25 -53.28 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 110.845 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 19.7 m -78.3 130.39 36.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.852 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -136.92 173.96 21.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 29.4 t -107.3 102.61 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.84 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 8.3 t -63.32 99.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.86 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -54.68 162.87 4.01 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -96.47 113.74 25.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 11.2 t -95.12 -54.97 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 66.1 m -69.09 103.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -95.88 -103.28 1.99 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -118.72 154.85 52.86 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.607 0.718 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 81.51 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.642 2.228 . . . . 0.0 112.33 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -153.04 -148.87 5.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.492 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 168.44 21.64 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.659 2.24 . . . . 0.0 112.327 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 10.8 m -92.06 128.67 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 973' ' ' ALA . 4.1 mm -100.81 128.23 53.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.091 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 974' ' ' PHE . 95.4 mt -105.36 145.1 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -111.02 127.49 55.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 8.5 t -107.72 127.7 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.452 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.0 OUTLIER -132.44 169.34 16.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . 0.44 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.1 OUTLIER 63.1 54.69 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.533 ' HG3' HG12 ' A' ' 997' ' ' VAL . 7.2 mtm -118.94 124.89 28.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.57 0.7 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.8 Cg_endo -69.79 168.32 21.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.662 2.241 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.1 -27.16 67.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 63.2 p -59.58 -27.95 66.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.41 HG23 ' HG2' ' A' ' 934' ' ' PRO . 60.1 t -57.62 144.52 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 29.8 m -146.72 171.64 14.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 66.4 mt -57.04 -42.01 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.01 -45.84 90.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.52 -42.63 98.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.97 -49.55 84.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 943' ' ' LEU . 12.7 mt -58.95 -41.84 88.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -64.41 -40.56 96.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -87.46 13.77 9.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -52.1 146.54 8.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 95.92 -35.06 4.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -99.58 139.42 35.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -70.88 90.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 74.5 t -86.24 124.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.434 HD12 ' CB ' ' A' ' 973' ' ' ALA . 97.3 mt -52.02 129.66 39.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.641 0.734 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.4 23.29 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.635 2.223 . . . . 0.0 112.37 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.93 -2.46 87.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 956' ' ' VAL . 5.0 p -72.5 -53.37 12.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 955' ' ' SER . 61.1 t -36.37 108.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.49 108.18 12.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.849 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 30.1 mt -76.98 141.0 40.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -94.59 137.79 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 964' ' ' GLY . 72.8 m-85 -130.5 158.61 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 963' ' ' LYS . 0.9 OUTLIER -97.31 178.48 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -44.07 -49.56 8.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . 0.463 ' HB2' ' ND2' ' A' ' 961' ' ' ASN . 5.7 mtmp? -61.86 -42.72 99.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 960' ' ' TYR . . . 124.87 -11.14 7.85 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 7.9 mmt -65.74 157.48 79.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 140.78 43.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.382 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.4 p -107.77 33.79 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.122 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.05 44.96 6.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.452 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 14.2 mt-10 -147.81 145.32 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.62 35.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 27.1 mtt -126.56 142.71 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.62 164.49 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.434 ' CB ' HD12 ' A' ' 952' ' ' ILE . . . -123.31 150.05 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.099 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 928' ' ' ILE . 25.1 m-85 -130.36 137.67 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -72.65 -37.78 67.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 24.5 t -106.1 131.76 52.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.859 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -63.42 -46.91 84.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.74 -34.66 69.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -47.33 69.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -56.96 -49.01 76.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.946 HG23 HD11 ' A' 1001 ' ' LEU . 3.7 m -64.92 -43.9 91.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.32 -42.91 99.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.61 97.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 999' ' ' LEU . 96.2 t -65.68 -49.85 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 981' ' ' THR . 34.5 mt -65.0 -44.8 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.98 -27.69 67.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.06 30.2 6.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -82.56 127.98 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 61.4 41.9 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.501 ' O ' HG22 ' A' ' 997' ' ' VAL . 11.6 mmp_? -84.08 133.87 44.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 86.39 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.646 2.231 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 997' ' ' VAL . 7.1 mt -85.95 129.04 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 59.02 -93.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 22.8 t -131.23 -3.34 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.9 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -133.47 160.83 36.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.845 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -88.31 142.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 992' ' ' ILE . 1.7 m -102.81 150.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.51 126.63 55.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 984' ' ' VAL . 62.8 mt -111.02 133.12 53.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 60.9 t -126.61 149.48 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 981' ' ' THR . 13.2 mt -87.95 121.6 30.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -66.91 -63.65 3.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.497 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 97.2 p -51.8 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 175.52 -165.01 35.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.471 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 157.48 92.03 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.668 -1.805 . . . . 0.0 112.365 0.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 91.24 8.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 47.8 t -102.44 88.76 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 51.9 p -154.58 121.28 5.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 93.8 p -52.35 161.59 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -78.74 -143.04 2.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 48.9 m 62.73 42.22 8.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 73.7 p -138.72 156.89 47.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -108.55 -163.34 20.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -110.0 113.83 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 111.096 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 15.0 m -95.43 149.96 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 15.8 m -77.27 88.9 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -54.1 155.54 7.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.442 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -136.23 153.22 76.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.17 7.13 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.341 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 133.79 -155.97 22.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -176.86 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.223 . . . . 0.0 112.351 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 7.0 m -96.79 118.98 34.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 38.5 mm -95.98 123.83 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.518 HD12 ' CE1' ' A' ' 974' ' ' PHE . 97.7 mt -106.48 145.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -111.95 134.25 53.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.692 HG22 ' CD2' ' A' ' 999' ' ' LEU . 70.4 t -114.47 125.95 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.92 169.0 14.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.81 53.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.5 ' HE1' ' HB2' ' A' ' 970' ' ' ALA . 14.3 mtm -117.92 121.72 31.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.615 0.722 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 162.97 40.04 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -55.35 -41.38 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.893 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.2 p -45.47 -36.33 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.474 HG11 ' SD ' ' A' ' 933' ' ' MET . 92.5 t -49.13 142.44 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.114 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 27.9 m -148.5 179.23 7.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -64.02 -42.04 94.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -62.97 -45.89 90.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -65.21 -42.71 93.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . 0.441 ' CD1' HD21 ' A' ' 958' ' ' LEU . 26.8 mt -61.29 -48.61 88.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.1 -41.97 89.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.94 -30.78 65.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 992' ' ' ILE . 1.6 t80 -64.92 -38.67 91.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.29 13.16 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -49.38 154.97 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 88.26 -36.66 3.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 77.6 m-85 -95.84 136.33 36.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.986 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 950' ' ' GLN . 2.6 mp0 -73.74 82.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.54 135.52 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.25 130.95 93.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 132.27 23.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 0.0 112.409 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 90.19 -4.11 82.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 957' ' ' CYS . 1.5 m -80.6 -56.47 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.869 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 955' ' ' SER . 65.2 t -36.32 95.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 955' ' ' SER . 20.9 m -112.41 136.74 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.441 HD21 ' CD1' ' A' ' 942' ' ' ILE . 71.2 mt -99.9 137.23 38.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -96.54 133.34 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -118.49 175.57 5.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.935 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 965' ' ' MET . 4.6 p30 -107.63 -177.58 3.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . 0.406 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.36 -29.19 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -79.21 -35.57 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 124.45 -17.76 7.37 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.442 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 15.0 mtp -68.36 157.9 86.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.04 15.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.682 2.255 . . . . 0.0 112.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 19.3 p -89.05 35.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 43.47 45.54 6.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -142.17 148.53 38.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.5 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -149.86 152.82 35.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 63.1 mtp -130.54 141.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.79 162.55 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.63 44.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 928' ' ' ILE . 28.7 m-85 -129.96 141.31 50.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -72.32 -34.84 68.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.34 135.0 54.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.814 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -62.25 -41.37 98.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -57.28 -42.97 82.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -47.87 79.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 974' ' ' PHE . . . -54.89 -49.75 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.669 HG22 HD11 ' A' ' 985' ' ' ILE . 3.8 m -64.61 -43.26 94.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.6 87.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -66.92 -45.49 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.685 HG13 ' CB ' ' A' ' 999' ' ' LEU . 79.2 t -63.37 -45.2 98.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 981' ' ' THR . 37.4 mt -64.27 -46.15 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.99 -22.73 58.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 945' ' ' PHE . 16.6 mt -116.75 23.66 11.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.8 OUTLIER -80.74 136.16 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 14.4 t0 50.63 45.42 26.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 997' ' ' VAL . 1.9 mmp_? -83.23 129.7 59.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.701 . . . . 0.0 110.878 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 84.96 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 945' ' ' PHE . 10.4 mt -85.8 133.28 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 54.29 -91.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.492 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 3.3 m -134.64 0.54 3.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -134.14 155.41 50.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -86.65 136.72 32.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.739 HG11 HD12 ' A' ' 992' ' ' ILE . 1.9 m -97.12 148.62 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.59 128.39 56.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 930' ' ' VAL . 71.4 mt -110.98 138.72 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 54.4 t -134.56 144.18 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 981' ' ' THR . 15.3 mt -82.72 141.51 32.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -47.67 167.88 0.1 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 90.0 p -114.73 10.64 16.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.929 0.395 . . . . 0.0 110.875 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.424 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . -115.38 172.44 14.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.424 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.8 Cg_endo -69.79 173.32 45.19 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.315 0.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 4.0 m -93.66 -56.9 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 65.6 p -101.84 130.36 48.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.536 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 84.0 p -108.74 118.21 36.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 30.5 t -44.77 -49.79 10.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.818 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 51.43 62.29 5.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 10.3 t -117.83 157.34 26.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.919 0.39 . . . . 0.0 110.817 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 30.5 p -161.98 129.1 3.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.851 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -130.47 125.72 4.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -81.75 -60.33 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 1.1 t -101.74 136.57 41.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 2.4 t -50.22 144.4 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -129.17 173.9 19.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.522 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.27 143.78 36.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.859 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 128.67 16.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.662 2.242 . . . . 0.0 112.379 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -139.24 -166.63 10.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.424 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.27 8.29 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 39.9 m -96.04 120.97 37.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.095 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 33.3 mm -100.38 122.28 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.519 HD12 ' CE1' ' A' ' 974' ' ' PHE . 85.4 mt -105.0 141.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -110.42 128.66 55.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.59 130.18 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.02 171.65 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.79 52.67 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.542 ' CG ' HG12 ' A' ' 997' ' ' VAL . 25.9 mtm -115.11 135.89 22.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.7 Cg_endo -69.75 171.9 13.61 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.84 -20.43 59.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 77.5 p -72.15 -15.63 61.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 934' ' ' PRO . 74.2 t -59.21 147.93 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.6 m -154.15 171.37 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.39 -42.03 79.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.12 -45.17 93.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.27 -41.68 93.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 26.4 mt -64.1 -49.53 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.83 -41.97 83.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -72.0 -31.2 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.629 ' CD2' HD11 ' A' ' 992' ' ' ILE . 14.7 t80 -65.86 -36.21 82.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -88.43 10.12 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -44.24 153.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 90.48 -42.3 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 84.1 m-85 -92.85 149.4 21.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.95 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -85.75 91.38 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.36 129.43 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.581 HG23 ' HD2' ' A' ' 953' ' ' PRO . 92.7 mt -57.97 136.35 83.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.741 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.581 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.6 Cg_endo -69.76 147.97 64.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.64 2.226 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 63.55 13.24 50.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 63.1 m -94.2 -51.33 4.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.938 0.399 . . . . 0.0 110.822 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 972' ' ' VAL . 93.9 t -46.94 103.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 12.1 m -117.42 134.21 55.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.85 138.77 34.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -92.42 135.85 33.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -124.71 166.86 15.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 965' ' ' MET . 1.0 OUTLIER -100.25 -176.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.01 -8.86 25.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -98.2 -28.28 13.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 112.95 -3.8 25.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 961' ' ' ASN . 20.8 mtm -84.77 150.12 55.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.583 0.706 . . . . 0.0 110.88 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 128.27 15.77 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.656 2.237 . . . . 0.0 112.334 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 36.3 p -89.38 24.25 2.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 58.09 38.44 89.52 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.519 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -137.51 145.47 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.13 151.45 33.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 20.8 mtt -122.02 143.15 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 956' ' ' VAL . 15.4 m -137.85 160.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.94 151.71 43.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 928' ' ' ILE . 31.8 m-85 -133.8 138.86 45.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -73.22 -34.67 66.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 5.5 t -111.17 129.89 55.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -63.42 -44.37 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -57.11 -37.16 71.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.44 -48.57 66.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -53.99 -48.9 69.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.693 HG22 HD11 ' A' ' 985' ' ' ILE . 4.7 m -62.53 -43.57 98.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.31 93.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -61.48 -45.96 92.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 999' ' ' LEU . 53.3 t -61.71 -50.11 81.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 981' ' ' THR . 30.7 mt -61.42 -48.82 87.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.138 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.22 -21.9 62.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.664 ' O ' HD12 ' A' ' 999' ' ' LEU . 16.4 mt -119.14 26.52 9.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 984' ' ' VAL . 2.5 t-20 -89.03 120.72 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.9 t0 73.13 38.59 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.564 ' O ' HG22 ' A' ' 997' ' ' VAL . 2.4 mmp_? -84.4 129.69 56.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.621 0.724 . . . . 0.0 110.902 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 87.51 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.849 HD12 HG11 ' A' ' 997' ' ' VAL . 14.3 mt -83.93 129.33 37.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.177 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 56.64 -92.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 90.0 p -132.76 -0.65 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -131.2 163.91 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.869 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -94.25 143.85 26.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.849 HG11 HD12 ' A' ' 992' ' ' ILE . 2.7 m -107.53 151.08 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . 0.512 ' HE3' HG22 ' A' 1000 ' ' VAL . 8.2 tmtm? -117.67 127.73 54.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 987' ' ' LEU . 37.6 mt -111.64 130.44 55.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . 0.512 HG22 ' HE3' ' A' ' 998' ' ' LYS . 46.4 t -131.97 136.52 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.16 155.95 38.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' 1003 ' ' SER . . . -80.3 39.0 2.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.5 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' 1002 ' ' GLY . 23.0 t 34.25 54.78 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.848 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 65.78 -162.76 41.47 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.61 92.5 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 -1.799 . . . . 0.0 112.342 0.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 27.5 m -82.04 168.85 17.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' 1008 ' ' GLY . 2.7 t -118.69 -59.57 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.849 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' 1007 ' ' SER . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 51.1 m -110.27 -69.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.353 . . . . 0.0 110.862 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.3 t 73.84 48.19 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -148.3 84.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 22.0 m -150.04 151.85 33.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 81.8 p -171.34 132.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.848 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -98.35 139.91 14.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -149.92 113.5 5.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 55.6 p -113.66 100.08 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 60.6 m -56.33 166.9 0.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -60.03 -94.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -75.78 144.07 75.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 87.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 0.0 112.337 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . -74.28 -161.08 7.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 169.65 18.46 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.1 m -92.53 117.87 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.197 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 973' ' ' ALA . 47.8 mm -95.47 125.93 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 974' ' ' PHE . 80.8 mt -106.13 148.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -112.65 130.55 56.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.505 HG22 ' CD2' ' A' ' 999' ' ' LEU . 20.6 t -111.04 123.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.466 ' NE2' ' H ' ' A' ' 932' ' ' ASN . 1.1 tm0? -125.02 167.25 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . 0.466 ' H ' ' NE2' ' A' ' 931' ' ' GLN . 0.3 OUTLIER 65.89 53.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.484 ' HG2' ' CG1' ' A' ' 997' ' ' VAL . 12.2 mtm -115.78 123.98 30.48 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 937' ' ' VAL . 54.4 Cg_endo -69.73 168.32 21.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -63.93 -39.41 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 81.8 p -48.17 -34.32 9.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.176 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 938' ' ' SER . 81.3 t -45.66 154.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . 0.435 ' N ' HG12 ' A' ' 937' ' ' VAL . 7.5 m -160.58 172.71 16.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 62.8 mt -58.44 -41.94 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.01 -45.74 90.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.34 -41.55 96.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.29 -48.25 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.8 -42.06 92.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.97 -31.56 66.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.828 ' CD2' HD11 ' A' ' 992' ' ' ILE . 9.5 t80 -64.94 -37.34 87.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -92.14 14.82 14.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.46 157.6 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.932 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 85.46 -41.7 3.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 72.1 m-85 -87.84 141.51 28.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -73.01 87.04 1.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 73.5 t -82.73 125.46 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.527 HG23 ' HD2' ' A' ' 953' ' ' PRO . 97.5 mt -51.55 134.99 34.32 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.573 0.702 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.527 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.4 Cg_endo -69.77 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.64 2.226 . . . . 0.0 112.362 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 86.42 24.86 38.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 82.3 p -93.66 -50.86 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.84 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 97.2 t -39.34 113.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 3.2 t -122.9 109.7 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 25.6 mt -81.74 136.78 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -103.13 138.88 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.84 174.44 9.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.481 ' ND2' ' HD3' ' A' ' 963' ' ' LYS . 7.9 p30 -98.56 176.97 5.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . 0.456 ' C ' ' OE1' ' A' ' 962' ' ' GLU . 0.8 OUTLIER -56.26 -33.92 65.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . 0.481 ' HD3' ' ND2' ' A' ' 961' ' ' ASN . 0.0 OUTLIER -68.21 -45.94 71.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.838 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 138.61 -27.78 2.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . 0.401 ' O ' ' OD1' ' A' ' 961' ' ' ASN . 85.0 mtp -63.76 153.47 83.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.556 0.693 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 144.1 52.83 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.658 2.239 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 34.3 p -99.37 37.7 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 39.43 42.19 1.8 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.54 145.84 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.56 153.02 35.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 9.8 mtp -122.22 143.66 49.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.61 165.7 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 927' ' ' ILE . . . -127.46 147.18 50.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.096 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 928' ' ' ILE . 20.8 m-85 -127.36 144.29 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -78.06 -34.43 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 50.7 m -111.57 130.76 55.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.57 -40.09 78.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -62.87 -45.74 91.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -55.72 -49.31 73.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.119 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.546 HG22 HD11 ' A' ' 985' ' ' ILE . 4.6 m -64.26 -43.9 93.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.35 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -64.36 -42.87 95.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.658 HG13 ' CB ' ' A' ' 999' ' ' LEU . 91.4 t -62.7 -50.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 981' ' ' THR . 27.9 mt -63.62 -42.18 95.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.26 -28.04 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 999' ' ' LEU . 77.2 mt -115.68 25.86 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.9 OUTLIER -82.25 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 t0 58.69 43.15 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 997' ' ' VAL . 10.8 mmt180 -82.92 130.37 57.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 82.47 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.743 2.295 . . . . 0.0 112.309 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.828 HD11 ' CD2' ' A' ' 945' ' ' PHE . 8.4 mt -82.02 123.36 38.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 61.88 -95.83 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 11.7 t -126.06 -6.53 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -129.48 159.65 35.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -93.15 136.42 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.787 HG11 HD12 ' A' ' 992' ' ' ILE . 5.6 m -96.15 150.14 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -113.79 129.72 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.658 ' CB ' HG13 ' A' ' 984' ' ' VAL . 68.1 mt -110.87 128.74 55.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 76.0 t -126.43 141.97 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.182 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.64 130.98 41.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -51.54 -71.78 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.524 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 67.0 p -68.96 150.01 48.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 112.19 -163.28 12.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.365 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 93.8 p -145.95 124.56 12.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 22.9 m -44.69 134.81 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.445 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 3.3 m -115.57 -55.02 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.846 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.0 t -93.51 133.84 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . 101.87 72.69 0.97 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 12.7 t -73.95 140.16 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.849 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 117.04 9.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . -145.02 121.8 1.61 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . 58.4 41.78 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 94.5 p -49.25 139.9 10.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 75.1 p -166.24 174.21 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -128.72 132.3 7.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -145.53 137.86 13.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.62 0.724 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -179.74 3.12 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . . . . . . . . . . . 93.47 -157.73 23.25 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.447 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.31 11.17 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.653 2.235 . . . . 0.0 112.304 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 19.9 m -92.61 126.19 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.129 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 43.2 mm -97.6 129.94 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.123 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.611 HD12 ' CE1' ' A' ' 974' ' ' PHE . 51.3 mt -104.88 147.72 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.139 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.16 127.99 56.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 999' ' ' LEU . 16.0 t -116.39 129.72 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.127 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 969' ' ' GLU . 1.8 tm0? -136.17 168.22 19.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.53 46.89 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.537 ' CG ' HG12 ' A' ' 997' ' ' VAL . 10.7 mtm -113.86 124.99 30.06 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 110.88 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.315 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.98 -35.8 62.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 65.5 p -52.41 -25.49 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.151 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.459 HG11 ' SD ' ' A' ' 933' ' ' MET . 74.7 t -57.5 141.69 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 67.0 m -143.76 174.21 11.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 65.5 mt -58.64 -42.12 84.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -63.17 -45.13 93.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -62.05 -44.1 97.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.24 -49.85 81.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.46 -41.62 80.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -71.91 -31.85 66.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.902 ' CD2' HD11 ' A' ' 992' ' ' ILE . 6.3 t80 -64.73 -35.78 82.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -95.09 17.38 14.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -50.59 142.99 9.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 100.28 -40.64 2.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.51 ' CE2' ' HA ' ' A' ' 983' ' ' ALA . 86.4 m-85 -89.57 148.52 23.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -81.62 79.57 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 71.1 t -73.92 124.23 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . . . . . . . . . 83.2 mt -53.54 129.39 53.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 0.0 111.171 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 131.54 21.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.39 84.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 956' ' ' VAL . 9.7 p -72.5 -54.8 8.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.901 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 972' ' ' VAL . 88.0 t -35.59 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.13 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 4.5 m -116.73 110.94 19.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.53 134.19 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -92.69 130.53 38.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -120.1 159.35 24.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -102.88 176.2 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.02 -28.85 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -71.59 -33.0 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 110.5 -1.55 29.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.534 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.32 161.6 24.77 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.58 0.705 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 134.4 27.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.719 2.279 . . . . 0.0 112.349 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . . . . . . . . . 67.1 p -93.5 16.0 14.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 76.27 21.72 74.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.465 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . 0.435 ' CG ' ' HG2' ' A' ' 931' ' ' GLN . 24.4 mt-10 -121.9 145.03 48.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . 0.4 ' HB2' ' HE1' ' A' ' 933' ' ' MET . . . -150.16 150.39 31.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 14.9 mtm -129.82 140.44 51.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 34.7 m -137.54 165.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -123.48 149.57 44.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 928' ' ' ILE . 13.5 m-85 -128.92 141.62 51.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.41 -37.5 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 3.4 m -105.12 132.29 51.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -63.27 -51.03 67.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -57.03 -33.35 67.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -44.69 77.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . . . . . . . . . . . -58.13 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.657 HG23 HD11 ' A' 1001 ' ' LEU . 11.7 m -62.6 -43.98 97.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 986' ' ' ASP . . . -62.06 -40.3 95.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.51 ' HA ' ' CE2' ' A' ' 949' ' ' TYR . . . -63.19 -39.53 94.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 999' ' ' LEU . 74.1 t -69.84 -50.21 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.96 -45.15 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 982' ' ' ALA . 5.0 t70 -69.66 -26.37 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 999' ' ' LEU . 1.9 mt -122.31 33.08 5.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 984' ' ' VAL . 0.7 OUTLIER -85.54 131.34 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 54.89 43.57 29.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 997' ' ' VAL . 24.5 mtp180 -84.45 133.53 44.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.607 0.717 . . . . 0.0 110.866 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 90.51 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.358 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.911 HD12 HG11 ' A' ' 997' ' ' VAL . 10.2 mt -90.46 126.26 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 60.47 -92.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 4.6 m -131.31 -3.09 3.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -133.89 161.29 35.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -90.03 142.29 27.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.911 HG11 HD12 ' A' ' 992' ' ' ILE . 2.2 m -99.97 149.75 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.23 125.7 54.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.65 ' HB2' HG13 ' A' ' 984' ' ' VAL . 77.1 mt -111.21 127.92 55.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 90.9 t -122.64 137.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.131 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.657 HD11 HG23 ' A' ' 981' ' ' THR . 11.5 mt -77.45 127.94 33.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -55.5 -77.89 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 10.1 t -116.38 143.97 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.369 . . . . 0.0 110.894 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . . . . . . . . . . . 106.33 -164.9 13.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.532 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.7 12.24 Favored 'Cis proline' 0 C--O 1.231 0.173 0 C-N-CA 122.703 -1.79 . . . . 0.0 112.38 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . . . . . . . . . 30.2 p -72.75 119.06 16.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . . . . . . . . . 11.2 t -134.69 88.7 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' SER . . . . . . . . . . . . . 1.9 t -68.34 94.33 0.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 110.861 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.7 t -101.13 89.17 3.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' GLY . . . . . . . . . . . . . . . -122.0 119.15 3.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 80.6 p -78.9 130.16 35.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 110.845 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' SER . . . . . . . . . . . . . 3.6 t 69.36 41.79 1.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.896 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.79 6.76 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' ALA . . . . . . . . . . . . . . . -130.59 -46.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.796 0.332 . . . . 0.0 111.105 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' SER . . . . . . . . . . . . . 83.8 p -127.37 123.1 35.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' SER . . . . . . . . . . . . . 94.1 p -122.14 -8.6 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' GLY . . . . . . . . . . . . . . . -109.59 123.29 6.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.454 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -139.29 140.06 24.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.705 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 109.2 2.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.66 2.24 . . . . 0.0 112.338 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 925' ' ' PRO . . . 143.9 -139.74 8.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 925' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 924' ' ' GLY . 54.0 Cg_endo -69.71 169.88 17.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 926' ' ' THR . . . . . . . . . . . . . 28.5 m -97.98 127.71 44.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 927' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.84 126.69 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 974' ' ' PHE . 72.4 mt -105.37 147.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 929' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 128.46 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 930' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.8 122.92 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 931' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 170.03 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 932' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 996' ' ' LYS . 0.2 OUTLIER 65.48 47.67 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 933' ' ' MET . . . . . 0.664 ' HG3' HG12 ' A' ' 997' ' ' VAL . 19.2 mtm -114.87 129.25 25.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 110.89 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 934' ' ' PRO . . . . . 0.419 ' HG2' HG23 ' A' ' 937' ' ' VAL . 53.6 Cg_endo -69.75 168.53 21.29 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.724 2.283 . . . . 0.0 112.345 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 935' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -63.43 -35.92 82.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 936' ' ' THR . . . . . . . . . . . . . 75.0 p -52.44 -36.61 54.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.113 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 937' ' ' VAL . . . . . 0.506 HG11 ' SD ' ' A' ' 933' ' ' MET . 78.8 t -41.57 140.89 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 938' ' ' SER . . . . . . . . . . . . . 8.3 m -148.59 172.96 13.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 939' ' ' ILE . . . . . . . . . . . . . 64.7 mt -56.92 -42.13 77.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 940' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -45.94 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 941' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -63.34 -43.35 97.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 942' ' ' ILE . . . . . . . . . . . . . 38.2 mt -63.3 -49.31 83.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 943' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.51 -41.95 91.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 944' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -71.21 -31.96 68.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 945' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 987' ' ' LEU . 39.7 t80 -65.37 -37.1 85.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 946' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -88.84 11.49 17.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 947' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -48.04 145.68 2.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . 96.06 -43.45 2.14 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 949' ' ' TYR . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 983' ' ' ALA . 78.6 m-85 -90.99 132.51 35.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.359 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 950' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -66.07 93.29 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 951' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.73 124.88 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 952' ' ' ILE . . . . . 0.505 HG23 ' HD2' ' A' ' 953' ' ' PRO . 65.0 mt -51.53 134.34 34.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.632 0.73 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 953' ' ' PRO . . . . . 0.505 ' HD2' HG23 ' A' ' 952' ' ' ILE . 53.3 Cg_endo -69.85 126.47 13.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.241 . . . . 0.0 112.33 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 954' ' ' GLY . . . . . . . . . . . . . . . 83.17 12.69 78.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.482 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 955' ' ' SER . . . . . . . . . . . . . 68.2 p -83.78 -49.16 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.808 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 956' ' ' VAL . . . . . . . . . . . . . 67.4 t -42.12 107.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' CYS . . . . . . . . . . . . . 9.9 t -115.52 110.46 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 29.3 mt -88.16 131.92 34.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -101.47 132.47 47.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -123.67 157.58 33.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.898 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' ASN . . . . . 0.745 ' OD1' HG22 ' A' ' 967' ' ' THR . 3.9 m-80 -67.03 -175.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.63 -9.71 57.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -32.58 12.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' GLY . . . . . . . . . . . . . . . 127.9 -18.31 5.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.511 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' MET . . . . . . . . . . . . . 57.2 mtt -67.69 154.95 92.51 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 126.76 13.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' THR . . . . . 0.745 HG22 ' OD1' ' A' ' 961' ' ' ASN . 44.8 p -86.42 13.42 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' GLY . . . . . . . . . . . . . . . 64.21 30.58 78.21 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.2 145.35 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' ALA . . . . . . . . . . . . . . . -150.17 149.81 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 971' ' ' MET . . . . . . . . . . . . . 5.9 mtt -124.24 144.95 49.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 972' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 928' ' ' ILE . 16.6 m -139.31 165.62 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 973' ' ' ALA . . . . . . . . . . . . . . . -128.57 155.55 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 974' ' ' PHE . . . . . 0.553 ' CE1' HD12 ' A' ' 928' ' ' ILE . 22.4 m-85 -136.1 140.79 44.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -72.3 -38.51 68.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 976' ' ' SER . . . . . . . . . . . . . 10.5 t -110.45 129.71 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 977' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -61.4 -41.87 97.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 978' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.85 -38.88 79.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 979' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.5 -44.14 83.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 980' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 984' ' ' VAL . . . -58.3 -49.29 77.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.927 HG23 HD11 ' A' 1001 ' ' LEU . 8.3 m -63.45 -43.7 96.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 982' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.44 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 983' ' ' ALA . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 949' ' ' TYR . . . -66.43 -39.57 89.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.692 HG13 ' CB ' ' A' ' 999' ' ' LEU . 72.2 t -67.39 -48.82 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 985' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 981' ' ' THR . 82.7 mt -64.13 -45.64 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 986' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.25 -22.15 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 987' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 945' ' ' PHE . 8.5 mt -117.15 18.92 14.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 988' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 984' ' ' VAL . 3.6 t-20 -80.5 134.57 35.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 34.0 t70 58.6 40.61 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 990' ' ' ARG . . . . . 0.522 ' O ' HG22 ' A' ' 997' ' ' VAL . 4.2 mmp_? -84.69 130.69 52.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 991' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 82.91 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 992' ' ' ILE . . . . . 0.755 HD12 HG11 ' A' ' 997' ' ' VAL . 10.1 mt -81.76 135.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 993' ' ' GLY . . . . . . . . . . . . . . . 52.6 -91.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 994' ' ' SER . . . . . . . . . . . . . 2.7 m -133.77 -0.35 3.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -133.96 161.48 34.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 996' ' ' LYS . . . . . 0.448 ' O ' ' ND2' ' A' ' 932' ' ' ASN . 61.2 mttt -90.03 140.88 29.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 997' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 992' ' ' ILE . 1.2 m -102.95 151.08 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 998' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 125.23 52.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 999' ' ' LEU . . . . . 0.692 ' CB ' HG13 ' A' ' 984' ' ' VAL . 41.9 mt -111.24 128.81 56.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1000 ' ' VAL . . . . . . . . . . . . . 21.8 t -118.2 142.99 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1001 ' ' LEU . . . . . 0.927 HD11 HG23 ' A' ' 981' ' ' THR . 11.2 mt -80.28 132.7 35.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.953 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1002 ' ' GLY . . . . . . . . . . . . . . . -42.75 -54.29 5.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.545 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1003 ' ' SER . . . . . . . . . . . . . 60.7 p -174.3 -179.75 1.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.863 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1004 ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' 1005 ' ' PRO . . . 137.04 172.53 12.56 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1005 ' ' PRO . . . . . 0.421 ' C ' ' HA2' ' A' 1004 ' ' GLY . 53.5 Cg_endo -69.77 134.84 31.06 Favored 'Cis proline' 0 C--N 1.342 0.231 0 C-N-CA 122.647 -1.814 . . . . 0.0 112.357 0.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1006 ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' 1007 ' ' SER . 27.5 m -90.06 -58.5 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1007 ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' 1006 ' ' SER . 4.6 t -34.74 123.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1008 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.988 . . . . . . . . 0 0 . 1 stop_ save_